<SEC-DOCUMENT>0000078003-20-000034.txt : 20200428
<SEC-HEADER>0000078003-20-000034.hdr.sgml : 20200428
<ACCEPTANCE-DATETIME>20200428082648
ACCESSION NUMBER:		0000078003-20-000034
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20200428
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200428
DATE AS OF CHANGE:		20200428

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PFIZER INC
		CENTRAL INDEX KEY:			0000078003
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				135315170
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-03619
		FILM NUMBER:		20822424

	BUSINESS ADDRESS:	
		STREET 1:		235 E 42ND ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017
		BUSINESS PHONE:		2125732323

	MAIL ADDRESS:	
		STREET 1:		235 E 42ND ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PFIZER CHARLES & CO INC
		DATE OF NAME CHANGE:	19710908
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>pfe-3292020x8kcoverpage.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!--p:83216feefe5f409aaec1bc038040810b,x:523e3b85a830436dab149d81e8b3555c-->
<!-- Document created using Wdesk  -->
<!-- Copyright 2020 Workiva -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:schedoi-fednote="http://fasb.org/dis/schedoi-fednote/2019-01-31" xmlns:fs-interest="http://fasb.org/dis/fs-interest/2019-01-31" xmlns:sfp-ibo="http://fasb.org/stm/sfp-ibo/2019-01-31" xmlns:sfp-sbo="http://fasb.org/stm/sfp-sbo/2019-01-31" xmlns:sic-std="http://xbrl.sec.gov/sic-std/2011-01-31" xmlns:stpr-std="http://xbrl.sec.gov/stpr-std-std-std/2018-01-31" xmlns:currency-ent-std="http://xbrl.sec.gov/currency-ent-std/2019-01-31" xmlns:lea="http://fasb.org/dis/lea/2019-01-31" xmlns:ctbl="http://fasb.org/dis/ctbl/2019-01-31" xmlns:guar="http://fasb.org/dis/guar/2019-01-31" xmlns:ru="http://fasb.org/dis/ru/2019-01-31" xmlns:stpr-all="http://xbrl.sec.gov/stpr-all-all-all/2018-01-31" xmlns:leas="http://fasb.org/dis/leas/2019-01-31" xmlns:sfp-clreo="http://fasb.org/stm/sfp-clreo/2019-01-31" xmlns:iaoi="http://fasb.org/dis/iaoi/2019-01-31" xmlns:soi-ins="http://fasb.org/stm/soi-ins/2019-01-31" xmlns:country-ent-std="http://xbrl.sec.gov/country-ent-std/2017-01-31" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:fs-insa="http://fasb.org/dis/fs-insa/2019-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:cce="http://fasb.org/dis/cce/2019-01-31" xmlns:inv="http://fasb.org/dis/inv/2019-01-31" xmlns:naics-ent-std="http://xbrl.sec.gov/naics-ent-std/2017-01-31" xmlns:srt-std="http://fasb.org/srt-std/2019-01-31" xmlns:stpr-ent-all="http://xbrl.sec.gov/stpr-ent-all-all-all/2018-01-31" xmlns:stpr-ent-std="http://xbrl.sec.gov/stpr-ent-std-std-std/2018-01-31" xmlns:schedoi-iiaa="http://fasb.org/dis/schedoi-iiaa/2019-01-31" xmlns:us-arcroles="http://fasb.org/us-arcroles/2019-01-31" xmlns:dccpoa="http://fasb.org/dis/dccpoa/2019-01-31" xmlns:soi-sbi="http://fasb.org/stm/soi-sbi/2019-01-31" xmlns:us-gaap-all="http://fasb.org/us-gaap-all/2019-01-31" xmlns:scf-sd="http://fasb.org/stm/scf-sd/2019-01-31" xmlns:ceclcalc3l="http://fasb.org/dis/ceclcalc3l/2019-01-31" xmlns:dei-ent-all="http://xbrl.sec.gov/dei-ent-all/2019-01-31" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:naics-all="http://xbrl.sec.gov/naics-all/2017-01-31" xmlns:re="http://fasb.org/dis/re/2019-01-31" xmlns:srt-types="http://fasb.org/srt-types/2019-01-31" xmlns:reorg="http://fasb.org/dis/reorg/2019-01-31" xmlns:invco="http://fasb.org/dis/invco/2019-01-31" xmlns:currency-ent-all="http://xbrl.sec.gov/currency-ent-all/2019-01-31" xmlns:currency-std="http://xbrl.sec.gov/currency-std/2019-01-31" xmlns:currency-ent-dep="http://xbrl.sec.gov/currency-ent-dep/2019-01-31" xmlns:aro="http://fasb.org/dis/aro/2019-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2019-01-31" xmlns:ocpfs="http://fasb.org/dis/ocpfs/2019-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2019-01-31" xmlns:naics-std="http://xbrl.sec.gov/naics-std/2017-01-31" xmlns:srt-all="http://fasb.org/srt-all/2019-01-31" xmlns:codification-part="http://fasb.org/codification-part/2019-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:deprecated1="http://www.xbrl.org/2009/role/deprecated" xmlns:sec-re="http://fasb.org/dis/sec-re/2019-01-31" xmlns:soi-int="http://fasb.org/stm/soi-int/2019-01-31" xmlns:emjv="http://fasb.org/dis/emjv/2019-01-31" xmlns:sec-suppc="http://fasb.org/dis/sec-suppc/2019-01-31" xmlns:equity="http://fasb.org/dis/equity/2019-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:se="http://fasb.org/dis/se/2019-01-31" xmlns:crcrb="http://fasb.org/dis/crcrb/2019-01-31" xmlns:edco="http://fasb.org/dis/edco/2019-01-31" xmlns:te="http://fasb.org/dis/te/2019-01-31" xmlns:dei-all="http://xbrl.sec.gov/dei-all/2019-01-31" xmlns:fs-bd="http://fasb.org/dis/fs-bd/2019-01-31" xmlns:hco="http://fasb.org/dis/hco/2019-01-31" xmlns:fs-bt="http://fasb.org/dis/fs-bt/2019-01-31" xmlns:us-roles="http://fasb.org/us-roles/2019-01-31" xmlns:dr="http://fasb.org/dis/dr/2019-01-31" xmlns:ero="http://fasb.org/dis/ero/2019-01-31" xmlns:country-ent-all="http://xbrl.sec.gov/country-ent-all/2017-01-31" xmlns:schedoi-oocw="http://fasb.org/dis/schedoi-oocw/2019-01-31" xmlns:cecl="http://fasb.org/dis/cecl/2019-01-31" xmlns:rpd="http://fasb.org/dis/rpd/2019-01-31" xmlns:schedoi-sumhold="http://fasb.org/dis/schedoi-sumhold/2019-01-31" xmlns:ceclcalc2="http://fasb.org/dis/ceclcalc2/2019-01-31" xmlns:othliab="http://fasb.org/dis/othliab/2019-01-31" xmlns:soi-egm="http://fasb.org/stm/soi-egm/2019-01-31" xmlns:schedoi-shorthold="http://fasb.org/dis/schedoi-shorthold/2019-01-31" xmlns:soi="http://fasb.org/stm/soi/2019-01-31" xmlns:diha="http://fasb.org/dis/diha/2019-01-31" xmlns:debt="http://fasb.org/dis/debt/2019-01-31" xmlns:schedoi-hold="http://fasb.org/dis/schedoi-hold/2019-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-gaap-ent-std="http://fasb.org/us-gaap-ent-std/2019-01-31" xmlns:bc="http://fasb.org/dis/bc/2019-01-31" xmlns:sic-ent-all="http://xbrl.sec.gov/sic-ent-all/2011-01-31" xmlns:exch-ent-std="http://xbrl.sec.gov/exch-ent-std/2019-01-31" xmlns:rcc="http://fasb.org/dis/rcc/2019-01-31" xmlns:rd="http://fasb.org/dis/rd/2019-01-31" xmlns:sfp-ucreo="http://fasb.org/stm/sfp-ucreo/2019-01-31" xmlns:eui="http://fasb.org/dis/eui/2019-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:ap="http://fasb.org/dis/ap/2019-01-31" xmlns:soi-reit="http://fasb.org/stm/soi-reit/2019-01-31" xmlns:fs-mort="http://fasb.org/dis/fs-mort/2019-01-31" xmlns:sec-reins="http://fasb.org/dis/sec-reins/2019-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:sec-cndfir="http://fasb.org/dis/sec-cndfir/2019-01-31" xmlns:sr="http://fasb.org/dis/sr/2019-01-31" xmlns:currency-all="http://xbrl.sec.gov/currency-all/2019-01-31" xmlns:scf-dbo="http://fasb.org/stm/scf-dbo/2019-01-31" xmlns:fs-fhlb="http://fasb.org/dis/fs-fhlb/2019-01-31" xmlns:crcpb="http://fasb.org/dis/crcpb/2019-01-31" xmlns:dei-ent-std="http://xbrl.sec.gov/dei-ent-std/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:scf-inv="http://fasb.org/stm/scf-inv/2019-01-31" xmlns:scf-indira="http://fasb.org/stm/scf-indira/2019-01-31" xmlns:bsoff="http://fasb.org/dis/bsoff/2019-01-31" xmlns:exch-ent-all="http://xbrl.sec.gov/exch-ent-all/2019-01-31" xmlns:oi="http://fasb.org/dis/oi/2019-01-31" xmlns:soi-indira="http://fasb.org/stm/soi-indira/2019-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:schedoi-otsh="http://fasb.org/dis/schedoi-otsh/2019-01-31" xmlns:sfp-dbo="http://fasb.org/stm/sfp-dbo/2019-01-31" xmlns:cc="http://fasb.org/dis/cc/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:crcsbp="http://fasb.org/dis/crcsbp/2019-01-31" xmlns:disops="http://fasb.org/dis/disops/2019-01-31" xmlns:reference="http://www.xbrl.org/2009/role/reference" xmlns:cn-part="http://fasb.org/cn-part/2019-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:srt-roles="http://fasb.org/srt-roles/2019-01-31" xmlns:country-std="http://xbrl.sec.gov/country-std/2017-01-31" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:scf-indir="http://fasb.org/stm/scf-indir/2019-01-31" xmlns:rlnro="http://fasb.org/dis/rlnro/2019-01-31" xmlns:ts="http://fasb.org/dis/ts/2019-01-31" xmlns:us-gaap-std="http://fasb.org/us-gaap-std/2019-01-31" xmlns:naics-ent-all="http://xbrl.sec.gov/naics-ent-all/2017-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:scf-dir="http://fasb.org/stm/scf-dir/2019-01-31" xmlns:dei-std="http://xbrl.sec.gov/dei-std/2019-01-31" xmlns:ni="http://fasb.org/dis/ni/2019-01-31" xmlns:sec-mort="http://fasb.org/dis/sec-mort/2019-01-31" xmlns:fifvd="http://fasb.org/dis/fifvd/2019-01-31" xmlns:otherexp="http://fasb.org/dis/otherexp/2019-01-31" xmlns:scf-re="http://fasb.org/stm/scf-re/2019-01-31" xmlns:sec-vq="http://fasb.org/dis/sec-vq/2019-01-31" xmlns:sec-sum="http://fasb.org/dis/sec-sum/2019-01-31" xmlns:exch-std="http://xbrl.sec.gov/exch-std/2019-01-31" xmlns:ir="http://fasb.org/dis/ir/2019-01-31" xmlns:sheci="http://fasb.org/stm/sheci/2019-01-31" xmlns:foct="http://fasb.org/dis/foct/2019-01-31" xmlns:soc="http://fasb.org/stm/soc/2019-01-31" xmlns:pfe="http://www.pfizer.com/20200428" xmlns:scf-sbo="http://fasb.org/stm/scf-sbo/2019-01-31" xmlns:inctax="http://fasb.org/dis/inctax/2019-01-31" xmlns:ppe="http://fasb.org/dis/ppe/2019-01-31" xmlns:country-all="http://xbrl.sec.gov/country-all/2017-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:con="http://fasb.org/dis/con/2019-01-31" xmlns:sic-ent-std="http://xbrl.sec.gov/sic-ent-std/2011-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:fs-ins="http://fasb.org/dis/fs-ins/2019-01-31" xmlns:eps="http://fasb.org/dis/eps/2019-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:iago="http://fasb.org/dis/iago/2019-01-31" xmlns:pay="http://fasb.org/dis/pay/2019-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:tin-part="http://fasb.org/tin-part/2019-01-31" xmlns:acec="http://fasb.org/dis/acec/2019-01-31" xmlns:us-gaap-entryPoint-all="http://fasb.org/us-gaap-entryPoint-all/2019-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:nt="http://fasb.org/dis/nt/2019-01-31" xmlns:spc="http://fasb.org/stm/spc/2019-01-31" xmlns:exch-all="http://xbrl.sec.gov/exch-all/2019-01-31" xmlns:ides="http://fasb.org/dis/ides/2019-01-31" xmlns:sec-supins="http://fasb.org/dis/sec-supins/2019-01-31" xmlns:sic-all="http://xbrl.sec.gov/sic-all/2011-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:regop="http://fasb.org/dis/regop/2019-01-31" xmlns:sfp-cls="http://fasb.org/stm/sfp-cls/2019-01-31" xmlns:com="http://fasb.org/stm/com/2019-01-31" xmlns:soi-re="http://fasb.org/stm/soi-re/2019-01-31" xmlns:crcgen="http://fasb.org/dis/crcgen/2019-01-31" xmlns:exch-ent-dep="http://xbrl.sec.gov/exch-ent-dep/2019-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:ei="http://fasb.org/dis/ei/2019-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
	<head>
		<meta http-equiv="Content-Type" content="text/html" />
		<title>Document</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="D2020Q2SD" name="dei:AmendmentFlag" id="Fact-21D981A6132C54C79AA6C3337981F5A5-wk-Fact-21D981A6132C54C79AA6C3337981F5A5" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric contextRef="D2020Q2SD" name="dei:EntityCentralIndexKey" id="Fact-45FFD96280F3533C89D0CE5384A39DF8-wk-Fact-45FFD96280F3533C89D0CE5384A39DF8">0000078003</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="pfe-20200428.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="D2020Q2SD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-04-28</xbrli:startDate>
			<xbrli:endDate>2020-04-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2020Q2SD_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-04-28</xbrli:startDate>
			<xbrli:endDate>2020-04-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2020Q2SD_us-gaap_StatementClassOfStockAxis_pfe_NotesDue20271.000Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">pfe:NotesDue20271.000Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-04-28</xbrli:startDate>
			<xbrli:endDate>2020-04-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2020Q2SD_us-gaap_StatementClassOfStockAxis_pfe_NotesDue20220.250Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">pfe:NotesDue20220.250Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-04-28</xbrli:startDate>
			<xbrli:endDate>2020-04-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context></ix:resources></ix:header></div><div><a id="s25517EA9F0955983ACAF3C6BADA46808"></a></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;text-align:center;-sec-extract:summary;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;font-weight:bold;">UNITED STATES</span></div><div style="line-height:120%;text-align:center;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Washington, D.C.&#160;&#160;20549</span></div><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;font-weight:bold;">FORM </span><span><ix:nonNumeric id="d308229e68-wk-Fact-AC57585F35645BF38490C182FFF8697C" name="dei:DocumentType" contextRef="D2020Q2SD"><span style="font-size:12pt;font-weight:bold;">8-K</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:12pt;font-weight:bold;"> </span></div><div style="line-height:120%;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">CURRENT REPORT</span></div><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">PURSUANT TO SECTION 13 OR 15(d) OF THE</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">SECURITIES EXCHANGE ACT OF 1934</span></div><div style="line-height:120%;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Date of report (Date of earliest event reported): </span><span style="font-family:inherit;font-size:10pt;"><span><span style="white-space:nowrap"><ix:nonNumeric id="d308229e92-wk-Fact-8174B0F36E5853E3AADBE4E9032CC022" name="dei:DocumentPeriodEndDate" contextRef="D2020Q2SD" format="ixt:datemonthdayyearen">April 28, 2020</ix:nonNumeric></span></span></span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:18pt;"><span><ix:nonNumeric id="d308229e99-wk-Fact-9AF2602DF9C35C06900BDD6413C89AE9" name="dei:EntityRegistrantName" contextRef="D2020Q2SD"><span style="font-size:18pt;font-weight:bold;">PFIZER INC</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:18pt;font-weight:bold;">.</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(Exact name of registrant as specified in its charter)</span></div><div style="line-height:120%;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d308229e123-wk-Fact-1E90F69C46465E968F646DF359792354" name="dei:EntityIncorporationStateCountryCode" contextRef="D2020Q2SD" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d308229e128-wk-Fact-185116B200265B9EB4796E7553E01C0B" name="dei:EntityFileNumber" contextRef="D2020Q2SD">1-3619</ix:nonNumeric></span></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d308229e133-wk-Fact-C75768AD7D045B13B9FE646A9810C89D" name="dei:EntityTaxIdentificationNumber" contextRef="D2020Q2SD">13-5315170</ix:nonNumeric></span></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(State or other</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(Commission File</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(I.R.S. Employer</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">jurisdiction of</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Number)</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Identification No.)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">incorporation)</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:205px;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:72px;"></td><td style="width:64px;"></td><td style="width:69px;"></td></tr><tr><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d308229e199-wk-Fact-9A7CB7CE5A3E5C7E941DD9AAFED4207F" name="dei:EntityAddressAddressLine1" contextRef="D2020Q2SD">235 East 42nd Street</ix:nonNumeric></span></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d308229e209-wk-Fact-C729B9CB0E40527DA89335CAA2BE433E" name="dei:EntityAddressPostalZipCode" contextRef="D2020Q2SD">10017</ix:nonNumeric></span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d308229e215-wk-Fact-D292D97B85705ABB935A052F1264E1C7" name="dei:EntityAddressCityOrTown" contextRef="D2020Q2SD">New York, </ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d308229e220-wk-Fact-35B7CAE8AB495DDCA6B4B8D31228617A" name="dei:EntityAddressStateOrProvince" contextRef="D2020Q2SD" format="ixt-sec:stateprovnameen">New York </ix:nonNumeric></span></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(Zip Code)</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(Address of principal executive offices)</span></div><div style="line-height:120%;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Registrant&#8217;s telephone number, including area code:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(</span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d308229e239-wk-Fact-99A6375BF4E258DE839D82330BD3330D" name="dei:CityAreaCode" contextRef="D2020Q2SD">212</ix:nonNumeric></span></span><span style="font-family:inherit;font-size:10pt;">) </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d308229e243-wk-Fact-FCE684C70A3454E583D7CBC6380CB36A" name="dei:LocalPhoneNumber" contextRef="D2020Q2SD">733-2323</ix:nonNumeric></span></span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Not Applicable</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(Former name or former address, if changed since last report)</span></div><div style="line-height:120%;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div style="line-height:120%;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span><ix:nonNumeric id="d308229e263-wk-Fact-9AC71AA62CE056868A11D93227EE432F" name="dei:WrittenCommunications" contextRef="D2020Q2SD" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;">  Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="line-height:120%;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span><ix:nonNumeric id="d308229e271-wk-Fact-961A6AB9163C57609A1F7F36CB25FFEF" name="dei:SolicitingMaterial" contextRef="D2020Q2SD" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;">  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="line-height:120%;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span><ix:nonNumeric id="d308229e280-wk-Fact-C79074B773E55B4C9734B4AD12CA956D" name="dei:PreCommencementTenderOffer" contextRef="D2020Q2SD" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;">  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))</span></div><div style="line-height:120%;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span><ix:nonNumeric id="d308229e288-wk-Fact-D075F77AC2155194AB8F856128EE7D04" name="dei:PreCommencementIssuerTenderOffer" contextRef="D2020Q2SD" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;">  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:32%;"></td><td style="width:1%;"></td><td style="width:33%;"></td><td style="width:1%;"></td><td style="width:33%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;text-decoration:underline;">Securities registered pursuant to Section 12(b) of the Act:</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;text-decoration:underline;">Title of each class</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;text-decoration:underline;">Trading Symbol(s)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;text-decoration:underline;">Name of each exchange on which registered</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span><ix:nonNumeric id="d308229e389-wk-Fact-05DC1BFE6FFD56CEB245532F7AB59409" name="dei:Security12bTitle" contextRef="D2020Q2SD_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember">Common Stock, $.05 par value</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span><ix:nonNumeric id="d308229e399-wk-Fact-013146DF83A55317B087E59B54D85427" name="dei:TradingSymbol" contextRef="D2020Q2SD_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember">PFE</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span><ix:nonNumeric id="d308229e409-wk-Fact-C62FAF5FC78A55EB9E4C63972A731025" name="dei:SecurityExchangeName" contextRef="D2020Q2SD_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span><ix:nonNumeric id="d308229e415-wk-Fact-E28EAA7A30C755A79E5386FB93145B55" name="dei:Security12bTitle" contextRef="D2020Q2SD_us-gaap_StatementClassOfStockAxis_pfe_NotesDue20220.250Member">0.250% Notes due 2022</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span><ix:nonNumeric id="d308229e425-wk-Fact-FB4CE69FAAA05A2BBE6BF205B232F02F" name="dei:TradingSymbol" contextRef="D2020Q2SD_us-gaap_StatementClassOfStockAxis_pfe_NotesDue20220.250Member">PFE22</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span><ix:nonNumeric id="d308229e435-wk-Fact-B905AA51676259CE8645A8E4011794FF" name="dei:SecurityExchangeName" contextRef="D2020Q2SD_us-gaap_StatementClassOfStockAxis_pfe_NotesDue20220.250Member" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span><ix:nonNumeric id="d308229e441-wk-Fact-4B105DAF96CD57ABB609BFF52D622C2A" name="dei:Security12bTitle" contextRef="D2020Q2SD_us-gaap_StatementClassOfStockAxis_pfe_NotesDue20271.000Member">1.000% Notes due 2027</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span><ix:nonNumeric id="d308229e451-wk-Fact-5D6D77303C9A5361A14B3FC036A19B14" name="dei:TradingSymbol" contextRef="D2020Q2SD_us-gaap_StatementClassOfStockAxis_pfe_NotesDue20271.000Member">PFE27</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span><ix:nonNumeric id="d308229e461-wk-Fact-C0254580AA8357F290FC09B844525130" name="dei:SecurityExchangeName" contextRef="D2020Q2SD_us-gaap_StatementClassOfStockAxis_pfe_NotesDue20271.000Member" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></span></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). </span></div><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Emerging growth company &#160;&#160;&#160;</span><span><ix:nonNumeric id="d308229e473-wk-Fact-E5150C68490D5962815DD28140972F94" name="dei:EntityEmergingGrowthCompany" contextRef="D2020Q2SD" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><br/></span></div><div style="line-height:120%;padding-top:4px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#160;&#160;&#160;&#160;</span><span style="font-family:Arial Unicode MS;font-size:10pt;">&#9744;</span><span style="font-family:inherit;font-size:10pt;"> </span></div><div><br/></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 2.02 Results of Operations and Financial Condition</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On </span><span style="font-family:inherit;font-size:10pt;">April&#160;28, 2020</span><span style="font-family:inherit;font-size:10pt;">, Pfizer Inc. (&#8220;Pfizer&#8221;) issued a press release announcing its financial results for the </span><span style="font-family:inherit;font-size:10pt;">first quarter</span><span style="font-family:inherit;font-size:10pt;"> of </span><span style="font-family:inherit;font-size:10pt;text-align:center;">2020</span><span style="font-family:inherit;font-size:10pt;">. A copy of the press release is furnished herewith as Exhibit 99 and is incorporated by reference herein. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The information furnished pursuant to this &#8220;Item 2.02 - Results of Operations and Financial Condition&#8221;, including Exhibit 99, shall not be deemed to be &#8220;filed&#8221; for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (&#8220;Exchange Act&#8221;) or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing made by us under the Exchange Act or Securities Act of 1933, as amended, regardless of any general incorporation language in any such filing, except as shall be expressly set forth by specific reference in such filing.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 9.01 Financial Statements and Exhibits</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(d)&#160;&#160;Exhibits</span></div><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:85%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Exhibit Number</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Exhibit Description</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="pfe-03292020xex99.htm"><span style="font-family:inherit;font-size:10pt;">Exhibit 99</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Press Release of Pfizer Inc. dated April 28, 2020, reporting</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pfizer&#8217;s financial results for the first quarter of 2020.</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">104</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cover Page Interactive Data File--the cover page XBRL tags are embedded within the Inline XBRL document.</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div><br/></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:16%;"></td><td style="width:1%;"></td><td style="width:83%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">EXHIBIT INDEX</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Exhibit No.</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Description</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="pfe-03292020xex99.htm"><span style="font-family:inherit;font-size:10pt;">99</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Press Release of Pfizer Inc. dated</span></div><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">April 28, 2020, reporting Pfizer&#8217;s financial</span></div><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">results for the first quarter of 2020.</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">104</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cover Page Interactive Data File--the cover page XBRL tags are embedded within the Inline XBRL document.</span></div></td></tr></table></div></div><div><br/></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">SIGNATURE</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:5%;"></td><td style="width:61%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">PFIZER INC.</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">By:</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-decoration:underline;">/s/ Margaret M. Madden</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Margaret M. Madden</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Senior Vice President and Corporate Secretary</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Chief Governance Counsel</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Dated: </span><span style="font-family:inherit;font-size:10pt;text-align:center;">April&#160;28, 2020</span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div>	</div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>2
<FILENAME>pfe-03292020xex99.htm
<DESCRIPTION>EXHIBIT 99
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s5A8B879E2018522CB8328DE15803526D"></a></div><div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Exhibit 99</font></div></div><div><br></div><div style="line-height:174%;padding-bottom:0px;padding-top:0px;text-align:left;"><img src="oldpfelogowhite.jpg" alt="oldpfelogowhite.jpg" style="height:58px;width:102px;"></div><div style="line-height:174%;padding-bottom:24px;padding-top:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">PFIZER REPORTS </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">FIRST-QUARTER</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-align:center;">2020</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">&#32;RESULTS</font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:0px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">First-Quarter</font><font style="font-family:inherit;font-size:11pt;">&#32;</font><font style="font-family:inherit;font-size:11pt;text-align:center;">2020</font><font style="font-family:inherit;font-size:11pt;">&#32;Revenues of </font><font style="font-family:inherit;font-size:11pt;">$12.0</font><font style="font-family:inherit;font-size:11pt;">&#32;Billion, Reflecting </font><font style="font-family:inherit;font-size:11pt;">7%</font><font style="font-family:inherit;font-size:11pt;">&#32;Operational Decline; Excluding the Impact from Consumer Healthcare</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:11pt;">, Revenues Declined 1% Operationally</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:24px;"><font style="font-family:inherit;font-size:11pt;">&#8211;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">12%</font><font style="font-family:inherit;font-size:11pt;">&#32;Operational Growth from Biopharma, Primarily Driven by Eliquis, Vyndaqel/Vyndamax, Ibrance and Inlyta as well as </font><font style="font-family:inherit;font-size:11pt;">15%</font><font style="font-family:inherit;font-size:11pt;">&#32;Operational Growth in Emerging Markets</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:24px;"><font style="font-family:inherit;font-size:11pt;">&#8211;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">37%</font><font style="font-family:inherit;font-size:11pt;">&#32;Operational Decline from Upjohn, Primarily Due to U.S. Loss of Exclusivity of Lyrica in 2019 and Declines from Lipitor and Norvasc in China due to the Volume-Based Procurement (VBP) Program</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:0px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">First-Quarter</font><font style="font-family:inherit;font-size:11pt;">&#32;</font><font style="font-family:inherit;font-size:11pt;text-align:center;">2020</font><font style="font-family:inherit;font-size:11pt;">&#32;Reported Diluted EPS</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;of </font><font style="font-family:inherit;font-size:11pt;">$0.61</font><font style="font-family:inherit;font-size:11pt;">, Adjusted Diluted EPS</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;of </font><font style="font-family:inherit;font-size:11pt;">$0.80</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:0px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Reaffirmed 2020 Financial Guidance for Revenues and Adjusted Diluted EPS</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font><font style="font-family:inherit;font-size:11pt;">, Absorbing Unfavorable Changes in Foreign Exchange Rates and Reflecting Certain Anticipated Impacts from the COVID-19 Pandemic</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:0px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Company Details COVID-19 Business Impact and Response to Pandemic, Including Researching Potential Therapeutics and Vaccines</font></div></td></tr></table><div><a name="s4DCF2315F425583AB26552203C94F453"></a></div><div style="line-height:174%;padding-bottom:8px;padding-top:20px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">NEW YORK, NY, </font><font style="font-family:inherit;font-size:11pt;">Tuesday, April&#160;28, 2020</font><font style="font-family:inherit;font-size:11pt;">&#32;&#8211; Pfizer Inc. (NYSE: PFE) reported financial results for </font><font style="font-family:inherit;font-size:11pt;">first-quarter</font><font style="font-family:inherit;font-size:11pt;">&#32;</font><font style="font-family:inherit;font-size:11pt;text-align:center;">2020</font><font style="font-family:inherit;font-size:11pt;">, reaffirmed its 2020 financial guidance for revenues and Adjusted diluted EPS</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;and updated certain other components of its 2020 financial guidance primarily to reflect actual and anticipated impacts from the novel coronavirus disease of 2019 (COVID-19).</font></div><div style="line-height:174%;padding-bottom:8px;padding-top:0px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Results for the </font><font style="font-family:inherit;font-size:11pt;">first quarter</font><font style="font-family:inherit;font-size:11pt;">&#32;of </font><font style="font-family:inherit;font-size:11pt;text-align:center;">2020</font><font style="font-family:inherit;font-size:11pt;">&#32;and </font><font style="font-family:inherit;font-size:11pt;text-align:center;">2019</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(4)</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;are summarized below.</font></div><div style="line-height:174%;padding-bottom:4px;padding-top:8px;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:62.698412698412696%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" style="padding-left:0px;padding-right:0px;padding-top:4px;padding-bottom:4px;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">OVERALL RESULTS</font></div></td></tr><tr><td style="width:43%;"></td><td style="width:18%;"></td><td style="width:1%;"></td><td style="width:18%;"></td><td style="width:1%;"></td><td style="width:19%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">($ in millions, except</font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">per share amounts)</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">First-Quarter</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$  12,028</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$  13,118</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8%)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reported Net Income</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,401</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,884</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12%)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reported Diluted EPS</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.61</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.68</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10%)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted Income</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,514</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,891</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8%)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted Diluted EPS</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.80</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.85</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5%)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:174%;padding-bottom:4px;padding-top:8px;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:62.698412698412696%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" style="padding-left:0px;padding-right:0px;padding-top:4px;padding-bottom:4px;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">REVENUES</font></div></td></tr><tr><td style="width:36%;"></td><td style="width:15%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td><td style="width:16%;"></td><td style="width:16%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($ in millions)</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">First-Quarter</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" rowspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" rowspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">% Change</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Oper.</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Biopharma</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$  10,007</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$  9,045</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Upjohn</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,022</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,214</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(37%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(37%)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consumer Healthcare</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">858</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(100%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(100%)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total Company</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$  12,028</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$  13,118</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(8%)</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(7%)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">1</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:174%;padding-bottom:16px;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Beginning in 2020, Upjohn began managing Pfizer&#8217;s Meridian subsidiary, the manufacturer of EpiPen and other auto-injector products, and a pre-existing strategic collaboration between Pfizer and Mylan N.V. (Mylan) for generic drugs in Japan (Mylan-Japan). To facilitate comparison across periods, revenues and expenses associated with Meridian and Mylan-Japan are reported in Pfizer&#8217;s Upjohn business in all periods presented. </font></div><div style="line-height:174%;padding-bottom:16px;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Acquisitions and the contribution of Pfizer&#8217;s Consumer Healthcare business to the GSK Consumer Healthcare joint venture (JV) that were completed during 2019 impacted financial results in the periods presented</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:11pt;">. Some amounts in this press release may not add due to rounding. All percentages have been calculated using unrounded amounts. References to operational variances pertain to period-over-period growth rates that exclude the impact of foreign exchange</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(5)</sup></font><font style="font-family:inherit;font-size:11pt;">.</font></div><div><a name="sdb9ef2f111de420aaf7e761e529cf491"></a></div><div style="line-height:174%;padding-bottom:12px;padding-top:32px;text-align:left;font-size:11pt;"><font style="font-family:Times New Roman;font-size:11pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">IMPACT OF COVID-19 ON BUSINESS ACTIVITIES AND FINANCIAL RESULTS</font></div><div style="line-height:174%;padding-bottom:8px;padding-top:12px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">As a result of the COVID-19 pandemic, Pfizer has taken proactive steps intended to protect the health and safety of colleagues, to maintain supply of Pfizer medicines and vaccines to patients, to continue to advance Pfizer&#8217;s pipeline and to help develop potential treatments for COVID-19 and a potential vaccine to halt the spread of the novel coronavirus.</font></div><div style="line-height:174%;padding-bottom:4px;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Information on the important steps Pfizer has taken in the battle against the COVID-19 pandemic can be found in the Corporate Developments section of this press release, beginning on page 14.</font></div><div style="line-height:174%;padding-bottom:4px;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:Times New Roman;font-size:11pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Colleague Health and Safety</font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">At this time, Pfizer colleagues in most locations who are able to perform their job functions outside of a Pfizer facility are working remotely. Certain Pfizer colleagues, primarily those in the Pfizer Global Supply, Worldwide Research and Development, and Global Product Development organizations, have roles whose physical presence at Pfizer facilities is required to perform their job function. These colleagues continue to report to work but are subject to strict protocols intended to reduce the risk of transmission, including social distancing, maintaining contact logs, increased cleaning and use of personal protective equipment as necessary.</font></div><div style="line-height:174%;padding-bottom:4px;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:Times New Roman;font-size:11pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Manufacturing</font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Pfizer&#8217;s manufacturing and supply chain professionals have been working continuously in an effort to ensure continued patient access to Pfizer medicines and vaccines. Across its plant network, Pfizer has implemented its preparedness plan to control site operations. To date, Pfizer has not seen a significant disruption in its supply chain, and all of its manufacturing sites around the world have continued to operate at or near normal levels. So far, Pfizer has been able to mitigate distribution issues that have arisen, including by using newly available commercial air capacity to transport inventory. Pfizer continues to monitor for actions by governments that could result in disruptions to supply movements.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">2</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In addition, Pfizer is taking a number of steps simultaneously to scale up manufacturing operations at risk to accelerate its ability to supply a potential novel treatment or vaccine for COVID-19. Pfizer is also committed to offering any excess manufacturing capacity and to potentially shifting production in order to support others&#8217; efforts to manufacture any life-saving breakthroughs that may be developed to combat COVID-19.</font></div><div style="line-height:174%;padding-bottom:4px;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:Times New Roman;font-size:11pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Clinical Trials</font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In late March 2020, Pfizer paused the recruitment portion of certain ongoing global interventional clinical studies and delayed most new study starts. Pfizer took this action in the interests of public health, so that clinical site partners and Pfizer could concentrate on care for patients in ongoing clinical trials and to avoid adding to the demands on the healthcare system during the peak of the COVID-19 crisis. </font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In late April 2020, Pfizer began to restart recruitment across the development portfolio, including new study starts, at all clinical trial sites that are currently operational, and where Pfizer and investigators are able to monitor safety and where health authorities have allowed recruitment to resume. Pfizer will work with investigator sites to ensure their readiness before any new study participants are enrolled.&#160;Completion of certain studies currently in the recruitment stage or studies that have yet to begin could be delayed.</font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">For all ongoing clinical trials, Pfizer is working closely with clinical trial sites to understand their needs and is performing remote monitoring to oversee study conduct. In addition, processes to enable tele-health and home healthcare are being utilized where appropriate to continue the data collection process and support patient safety.</font></div><div style="line-height:174%;padding-bottom:4px;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:Times New Roman;font-size:11pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Sales and Marketing</font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Pfizer has experienced an impact on its sales and marketing activities due to widespread restrictions on in-person meetings with healthcare professionals and the refocused attention of the medical community on fighting COVID-19. Access to prescribers for sales force colleagues during first-quarter 2020 was mixed, with those in China unable to meet with healthcare professionals for most of the quarter, while those in the U.S. were unable to meet in-person with doctors starting in the second half of March. </font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">As a result of the lower number of in-person meetings with prescribers and restrictions on patient movements due to government-mandated work-from-home or shelter-in-place policies, the rate of new prescriptions for certain products and of vaccination rates for most vaccines has slowed, which is currently expected to primarily impact second-quarter 2020 financial results. These declines are expected to be partially offset by existing patients re-filling prescriptions that extend the per-prescription treatment duration to avoid going to pharmacies as frequently, which had a modest favorable impact in first-quarter 2020 and is expected to continue in second-quarter 2020. In addition, certain Pfizer medicines saw increased demand, which Pfizer believes may be due to physicians apparently prescribing them to treat or prevent COVID-19 infections or related conditions, including Prevnar 13/Prevenar 13 in adults and certain anti-infective products, as well as certain sterile injectable products utilized in </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">3</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">the intubation and ongoing treatment of mechanically-ventilated COVID-19 patients. Please note that none of these products are approved for the treatment of COVID-19 and, therefore, Pfizer does not know the benefit/risk profile for their use in this disease.</font></div><div style="line-height:174%;padding-bottom:4px;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:Times New Roman;font-size:11pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Financial Condition and Access to Capital Markets</font></div><div style="line-height:174%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Due to Pfizer&#8217;s significant operating cash flows, as well as its financial assets, access to capital markets and revolving credit agreements, Pfizer believes it has, and will maintain, the ability to meet liquidity needs for the foreseeable future.</font></div><div style="line-height:174%;padding-bottom:0px;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Pfizer will continue to pursue efforts to maintain the continuity of its operations while monitoring for new developments related to the COVID-19 pandemic, which are unpredictable. Future COVID-19 developments could result in additional favorable or unfavorable impacts on Pfizer&#8217;s business, operations or financial condition.</font></div><div><a name="sF653991B58BB5AB481F2D72A5208CCBE"></a></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;text-align:center;">2020</font><font style="font-family:Times New Roman;font-size:11pt;color:#000000;font-style:normal;font-weight:bold;">&#32;</font><font style="font-family:Times New Roman;font-size:11pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">FINANCIAL GUIDANCE</font><font style="font-family:Times New Roman;font-size:11pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(6)</sup>&#160;</font></div><div style="line-height:174%;padding-bottom:8px;padding-top:12px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Pfizer&#8217;s 2020 financial guidance for Total Company</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(7)</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;was updated primarily to reflect actual and anticipated COVID-19-related impacts.</font></div><div style="line-height:174%;padding-bottom:8px;padding-top:12px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Today&#8217;s guidance update reflects management&#8217;s current expectations for operational performance, foreign exchange rates as well as various COVID-19-related uncertainties, primarily those related to the severity, duration and global macroeconomic impact of the pandemic. Key guidance assumptions related to COVID-19 include:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Patient visits with physicians, vaccinations and elective surgical procedures will rebound starting in second-half 2020 and align more closely with historical levels;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">New-to-brand prescription trends for certain key products and vaccination rates will resume on a similar trajectory to what was seen in 2019, beginning in second-half 2020;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Access to prescribers for sales force colleagues is restored in second-half 2020;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Clinical trial enrollment, including new study starts, will fully resume in second-half 2020;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Pfizer&#8217;s manufacturing and supply chain activities are not materially disrupted; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Pfizer&#8217;s investments in potential treatments and a potential vaccine for COVID-19 continue throughout 2020.</font></div></td></tr></table><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">4</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:174%;padding-bottom:8px;padding-top:12px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Based on these assumptions, Pfizer reaffirmed or updated the following 2020 financial guidance components for Total Company</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(7)</sup></font><font style="font-family:inherit;font-size:11pt;">, which reflects a full year of revenue and expense contributions from Biopharma and Upjohn:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Guidance range for revenues was reaffirmed at </font><font style="font-family:inherit;font-size:11pt;">$48.5 to $50.5 billion</font><font style="font-family:inherit;font-size:11pt;">, absorbing a $0.6 billion unfavorable impact from changes in foreign exchange rates in relation to the U.S. dollar since mid-January 2020, primarily the weakening of the Brazilian real, the euro, the Mexican peso and the Chinese yuan.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Guidance range for Adjusted cost of sales</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;as a percentage of revenues was lowered by 400 basis points to a range of </font><font style="font-family:inherit;font-size:11pt;">19.5% to 20.5%</font><font style="font-family:inherit;font-size:11pt;">, primarily to reflect the favorable impact of product mix and other efficiencies.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Guidance range for Adjusted SI&amp;A expenses</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;was lowered by $500 million to a range of </font><font style="font-family:inherit;font-size:11pt;">$11.5 to $12.5 billion</font><font style="font-family:inherit;font-size:11pt;">, primarily to reflect incremental cost-savings opportunities, primarily reductions in indirect SI&amp;A spend associated with corporate enabling functions, as well as actual and anticipated COVID-19-related spending reductions.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Guidance range for Adjusted R&amp;D expenses</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;was increased by $500 million to a range of </font><font style="font-family:inherit;font-size:11pt;">$8.6 to $9.0 billion</font><font style="font-family:inherit;font-size:11pt;">, solely to reflect incremental investments Pfizer anticipates making in 2020 to combat the COVID-19 pandemic, including development of potential anti-viral treatments and a potential vaccine, as well as the evaluation of existing Pfizer medicines, which are the subject of novel research projects for investigation in COVID-19 patients.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Guidance range for Adjusted diluted EPS</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;was reaffirmed at </font><font style="font-family:inherit;font-size:11pt;">$2.82 to $2.92</font><font style="font-family:inherit;font-size:11pt;">, absorbing a $0.04 unfavorable impact from changes in foreign exchange rates since mid-January 2020.</font></div></td></tr></table><div style="line-height:174%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:50%;"></td><td style="width:50%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Revenues</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$48.5 to $50.5 billion</font></div></td></tr><tr><td rowspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Adjusted Cost of Sales</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font><font style="font-family:inherit;font-size:11pt;">&#160;as a Percentage of Revenues</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">19.5% to 20.5%</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">(previously 19.9% to 20.9%)</font></div></td></tr><tr><td rowspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Adjusted SI&amp;A Expenses</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$11.5 to $12.5 billion</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">(previously $12.0 to $13.0 billion)</font></div></td></tr><tr><td rowspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Adjusted R&amp;D Expenses</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$8.6 to $9.0 billion</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">(previously $8.1 to $8.5 billion)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Adjusted Other (Income)/Deductions</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Approximately $800 million of income</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Effective Tax Rate on Adjusted Income</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Approximately 15.0%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Adjusted Diluted EPS</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$2.82 to $2.92</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:174%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Financial guidance for Adjusted diluted EPS</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;continues to assume no share repurchases in 2020.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">5</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:174%;padding-bottom:4px;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:Times New Roman;font-size:11pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">2020 Financial Guidance for New Pfizer</font><font style="font-family:Times New Roman;font-size:11pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(8)</sup>&#160;</font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Pfizer&#8217;s updated 2020 financial guidance for New Pfizer</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(8)</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;is presented below. New Pfizer</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(8)</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;revenue guidance absorbs a $500 million unfavorable impact from changes in foreign exchange rates since mid-January 2020.</font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">New Pfizer</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(8)</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;financial guidance reflects a full-year 2020 pro forma view of the company assuming the pending Upjohn combination with Mylan was completed at the beginning of 2020.</font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:50%;"></td><td style="width:50%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Revenues</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$40.7 to $42.3 billion</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Adjusted IBT Margin</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(9)</sup></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Approximately 37.0%</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Adjusted Diluted EPS</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$2.25 to $2.35</font></div></td></tr><tr><td rowspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Operating Cash Flow</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$10.0 to $11.0 billion</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">(previously $11.0 to $12.0 billion)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Financial guidance for New Pfizer</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(8)</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;operating cash flow now includes a $1.25 billion voluntary contribution to the U.S. qualified pension plans, planned for the second half of 2020.</font></div><div style="line-height:174%;padding-bottom:4px;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:Times New Roman;font-size:11pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">2020 Financial Guidance for Upjohn</font><font style="font-family:Times New Roman;font-size:11pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(10)</sup>&#160;</font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Pfizer&#8217;s reaffirmed 2020 financial guidance for Upjohn</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(10)</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;is presented below. Upjohn revenue guidance absorbs a $100 million unfavorable impact from changes in foreign exchange rates since mid-January 2020.</font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Upjohn</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(10)</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;financial guidance reflects a full-year 2020 contribution from the Upjohn business as it is presently being managed.</font></div><div style="line-height:174%;padding-bottom:4px;padding-top:16px;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:50%;"></td><td style="width:50%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Revenues</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$8.0 to $8.5 billion</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Adjusted EBITDA</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(11)</sup></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$3.8 to $4.2 billion</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div><a name="sD737172739D85E339EB2BF7F5991BAB5"></a></div><div style="line-height:174%;padding-bottom:12px;padding-top:32px;text-align:left;font-size:11pt;"><font style="font-family:Times New Roman;font-size:11pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">CAPITAL ALLOCATION</font></div><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">During </font><font style="font-family:inherit;font-size:11pt;">the first three months of</font><font style="font-family:inherit;font-size:11pt;">&#32;</font><font style="font-family:inherit;font-size:11pt;text-align:center;">2020</font><font style="font-family:inherit;font-size:11pt;">, Pfizer paid </font><font style="font-family:inherit;font-size:11pt;">$2.1 billion</font><font style="font-family:inherit;font-size:11pt;">&#32;of dividends, or $0.38 per share of common stock.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">No share repurchases have been completed to date in 2020. As of </font><font style="font-family:inherit;font-size:11pt;">April&#160;28, 2020</font><font style="font-family:inherit;font-size:11pt;">, Pfizer&#8217;s remaining share repurchase authorization was </font><font style="font-family:inherit;font-size:11pt;">$5.3 billion</font><font style="font-family:inherit;font-size:11pt;">. No share repurchases are currently planned in 2020.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The </font><font style="font-family:inherit;font-size:11pt;">first-quarter</font><font style="font-family:inherit;font-size:11pt;">&#32;</font><font style="font-family:inherit;font-size:11pt;text-align:center;">2020</font><font style="font-family:inherit;font-size:11pt;">&#32;diluted weighted-average shares used to calculate earnings per common share was </font><font style="font-family:inherit;font-size:11pt;">5,613 million</font><font style="font-family:inherit;font-size:11pt;">&#32;shares, a reduction of </font><font style="font-family:inherit;font-size:11pt;">137 million</font><font style="font-family:inherit;font-size:11pt;">&#32;shares compared to </font><font style="font-family:inherit;font-size:11pt;">first-quarter</font><font style="font-family:inherit;font-size:11pt;">&#32;</font><font style="font-family:inherit;font-size:11pt;">2019</font><font style="font-family:inherit;font-size:11pt;">.</font></div></td></tr></table><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">6</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><a name="s744DD6EC4BC655919CE7EBCC7FB135F0"></a></div><div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:174%;padding-bottom:12px;padding-top:32px;text-align:left;font-size:11pt;"><font style="font-family:Times New Roman;font-size:11pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">EXECUTIVE COMMENTARY</font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Dr. Albert Bourla, Pfizer&#8217;s Chairman and Chief Executive Officer, stated, &#8220;We are fully committed to confronting the public health challenge posed by the COVID-19 pandemic by collaborating with industry partners and academic institutions to develop potential approaches to prevent and treat COVID-19. Our researchers and scientists also have been exploring potential new uses of existing medicines in Pfizer&#8217;s portfolio to help infected patients. We aim to leave no stone unturned as we explore every option to help provide society with a treatment or vaccine. I want to thank all of our R&amp;D colleagues who are working tirelessly to find potential vaccines and treatments that could bring an end to this pandemic. I would also like to acknowledge the remarkable job that our manufacturing team has done throughout this crisis to ensure our medicines continue to reach patients in need.</font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#8220;Our strong performance in the first quarter highlights the resiliency of our business even during the most challenging times. The Biopharma business grew 12% operationally, driven by strong performances from many key brands. Upjohn faced two expected headwinds this quarter -- generic competition for Lyrica in the U.S. and the nationwide expansion of the VBP program in China -- while continuing to progress toward a successful close of our transaction with Mylan, now expected in the second half of 2020,&#8221; Dr. Bourla concluded.</font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Frank D&#8217;Amelio, Chief Financial Officer and Executive Vice President, Business Operations and Global Supply, stated, &#8220;Today we reaffirmed our 2020 financial guidance for revenues and Adjusted diluted EPS</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;and updated certain other guidance components primarily to reflect actual and anticipated impacts from the COVID-19 pandemic. Importantly, our guidance for Total Company</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(7)</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;revenues absorbs a $0.6 billion unfavorable impact from changes in foreign exchange rates since mid-January 2020. Likewise, our guidance for Adjusted diluted EPS</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;absorbs a $0.04 impact from unfavorable foreign exchange. The decrease in our guidance for Adjusted SI&amp;A expenses</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;reflects incremental cost-savings opportunities, as well as actual and anticipated COVID-19-related spending reductions. These actual and projected Adjusted SI&amp;A expense</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;reductions were offset by an increase in our guidance for Adjusted R&amp;D expenses</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font><font style="font-family:inherit;font-size:11pt;">, which now includes anticipated incremental investments to develop potential therapies and a potential vaccine to combat COVID-19. While our near-term outlook has greater macroeconomic uncertainty than usual due to COVID-19, we are confident that the long-term outlook for our businesses remains solid.</font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#8220;Despite the impact of COVID-19, 2020 is still expected to be a transformational year for Pfizer. Following the pending close of the Upjohn-Mylan transaction, New Pfizer will be positioned to deliver revenue and Adjusted diluted EPS</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;growth that is expected to be among the industry leaders. New Pfizer will be a smaller, science-based company with a singular focus on innovation while also continuing to allocate significant capital directly to shareholders, primarily through dividends,&#8221; Mr. D&#8217;Amelio concluded.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">7</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><a name="s34D60FDC2666596AAC20E554411FE313"></a></div><div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:174%;padding-bottom:12px;padding-top:32px;text-align:left;font-size:11pt;"><font style="font-family:Times New Roman;font-size:11pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">QUARTERLY FINANCIAL HIGHLIGHTS (</font><font style="font-family:Times New Roman;font-size:11pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">First-Quarter</font><font style="font-family:Times New Roman;font-size:11pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">&#32;</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;text-align:center;">2020</font><font style="font-family:Times New Roman;font-size:11pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">&#32;vs. </font><font style="font-family:Times New Roman;font-size:11pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">First-Quarter</font><font style="font-family:Times New Roman;font-size:11pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">&#32;</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;text-align:center;">2019</font><font style="font-family:Times New Roman;font-size:11pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">) </font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">First-quarter</font><font style="font-family:inherit;font-size:11pt;">&#32;</font><font style="font-family:inherit;font-size:11pt;text-align:center;">2020</font><font style="font-family:inherit;font-size:11pt;">&#32;revenues totaled </font><font style="font-family:inherit;font-size:11pt;">$12.0 billion</font><font style="font-family:inherit;font-size:11pt;">, a decrease of </font><font style="font-family:inherit;font-size:11pt;">$1.1 billion</font><font style="font-family:inherit;font-size:11pt;">, or </font><font style="font-family:inherit;font-size:11pt;">8%</font><font style="font-family:inherit;font-size:11pt;">, compared to the prior-year quarter, reflecting an operational decline of </font><font style="font-family:inherit;font-size:11pt;">$1.0 billion</font><font style="font-family:inherit;font-size:11pt;">, or </font><font style="font-family:inherit;font-size:11pt;">7%</font><font style="font-family:inherit;font-size:11pt;">, as well as the unfavorable impact of foreign exchange of </font><font style="font-family:inherit;font-size:11pt;">$134 million</font><font style="font-family:inherit;font-size:11pt;">, or </font><font style="font-family:inherit;font-size:11pt;">1%</font><font style="font-family:inherit;font-size:11pt;">. Excluding the impact of Consumer Healthcare</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:11pt;">, revenues declined 1% operationally compared to the prior-year quarter.</font></div><div style="line-height:174%;padding-bottom:4px;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:Times New Roman;font-size:11pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Impact of COVID-19 on</font><font style="font-family:Times New Roman;font-size:11pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">&#32;</font><font style="font-family:Times New Roman;font-size:11pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">First-Quarter</font><font style="font-family:Times New Roman;font-size:11pt;color:#000000;font-style:normal;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;text-align:center;">2020</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;text-align:center;">&#32;Revenues</font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">First-quarter</font><font style="font-family:inherit;font-size:11pt;">&#32;</font><font style="font-family:inherit;font-size:11pt;text-align:center;">2020</font><font style="font-family:inherit;font-size:11pt;">&#32;revenues included an estimated net </font><font style="font-family:inherit;font-size:11pt;">favorable impact of approximately $150 million, or 1%, due to COVID-19, primarily reflecting increased demand for certain products in Pfizer&#8217;s Hospital portfolio and an increase in wholesaler buying patterns for Eliquis, partially offset by a decline in patient visits to doctors&#8217; offices and elective surgical procedures during first-quarter 2020</font><font style="font-family:inherit;font-size:11pt;">.</font></div><div style="line-height:174%;padding-bottom:4px;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:Times New Roman;font-size:11pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Biopharma Revenue Highlights</font></div><div style="line-height:174%;padding-bottom:4px;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">First-quarter</font><font style="font-family:inherit;font-size:11pt;">&#32;</font><font style="font-family:inherit;font-size:11pt;text-align:center;">2020</font><font style="font-family:inherit;font-size:11pt;">&#32;Biopharma revenues totaled </font><font style="font-family:inherit;font-size:11pt;">$10.0 billion</font><font style="font-family:inherit;font-size:11pt;">, up </font><font style="font-family:inherit;font-size:11pt;">12%</font><font style="font-family:inherit;font-size:11pt;">&#32;operationally, primarily driven by:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Eliquis globally, up </font><font style="font-family:inherit;font-size:11pt;">29%</font><font style="font-family:inherit;font-size:11pt;">&#32;operationally, primarily driven by continued increased adoption in non-valvular atrial fibrillation as well as oral anti-coagulant market share gains. U.S. growth was also favorably impacted by COVID-19-related wholesaler buying patterns, partially offset by a lower net price;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">the Hospital business globally, up </font><font style="font-family:inherit;font-size:11pt;">11%</font><font style="font-family:inherit;font-size:11pt;">&#32;operationally, driven by the U.S. and emerging markets, primarily due to continued uptake of anti-infective products in China and continued growth from Panzyga following its November 2018 U.S. launch, as well as increased demand in the U.S. for certain anti-infectives and other sterile injectable products utilized in the intubation and ongoing treatment of mechanically-ventilated COVID-19 patients;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Vyndaqel/Vyndamax global revenues were </font><font style="font-family:inherit;font-size:11pt;">$231 million</font><font style="font-family:inherit;font-size:11pt;">, driven by:</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:36px;"><font style="font-family:inherit;font-size:11pt;">&#8211;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">the U.S. launches of Vyndaqel in May 2019 and Vyndamax in September 2019 for the treatment of transthyretin amyloid cardiomyopathy (ATTR-CM); and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:36px;"><font style="font-family:inherit;font-size:11pt;">&#8211;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">156% operational growth in international markets, primarily driven by the March 2019 launch of the ATTR-CM indication in Japan;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Ibrance in the U.S. and emerging markets, collectively up 17% operationally, primarily driven by:</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:36px;"><font style="font-family:inherit;font-size:11pt;">&#8211;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;text-transform:default;">15%</font><font style="font-family:inherit;font-size:11pt;">&#32;growth in the U.S., primarily driven by increased cyclin-dependent kinase (CDK) class penetration and Ibrance&#8217;s continued CDK market share leadership in its approved metastatic breast cancer indications; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:36px;"><font style="font-family:inherit;font-size:11pt;">&#8211;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">37%</font><font style="font-family:inherit;font-size:11pt;">&#32;operational growth in emerging markets, reflecting continued strong volume growth in most markets;</font></div></td></tr></table><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">8</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Prevenar 13 internationally, up </font><font style="font-family:inherit;font-size:11pt;">11%</font><font style="font-family:inherit;font-size:11pt;">&#32;operationally, primarily reflecting continued pediatric uptake in&#160;China as well as the overall favorable impact of timing associated with government purchases for the pediatric indication in certain emerging markets;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Inlyta in the U.S., up 255%, primarily reflecting increased uptake resulting from the second-quarter 2019 U.S. Food and Drug Administration (FDA) approvals for combinations of certain immune checkpoint inhibitors plus Inlyta for the first-line treatment of patients with advanced renal cell carcinoma;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Retacrit in the U.S., up 363%, primarily reflecting continued uptake for the only biosimilar short-acting erythropoiesis-stimulating agent in the market;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Xeljanz in international markets, up </font><font style="font-family:inherit;font-size:11pt;">38%</font><font style="font-family:inherit;font-size:11pt;">&#32;operationally, primarily reflecting continued uptake in the rheumatoid arthritis indication and, to a lesser extent, from the recent launch of the ulcerative colitis indication in certain developed markets; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Xtandi in the U.S., up </font><font style="font-family:inherit;font-size:11pt;">25%</font><font style="font-family:inherit;font-size:11pt;">, primarily driven by continued strong demand in the metastatic and non-metastatic castration-resistant prostate cancer indications and, to a lesser extent, uptake from the metastatic castration-sensitive prostate cancer indication, which was approved in the U.S. in December 2019;</font></div></td></tr></table><div style="line-height:174%;padding-bottom:4px;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">partially offset primarily by lower revenues for:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Enbrel internationally, down </font><font style="font-family:inherit;font-size:11pt;text-transform:default;">21%</font><font style="font-family:inherit;font-size:11pt;">&#32;operationally, primarily reflecting continued biosimilar competition in most developed Europe markets as well as in Brazil and Japan;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Prevnar 13 in the U.S., down </font><font style="font-family:inherit;font-size:11pt;">10%</font><font style="font-family:inherit;font-size:11pt;">, primarily reflecting the unfavorable impact of timing associated with government purchases for the pediatric indication compared with the prior-year quarter;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Ibrance in developed Europe, down </font><font style="font-family:inherit;font-size:11pt;">11%</font><font style="font-family:inherit;font-size:11pt;">&#32;operationally, primarily reflecting continued strong demand, more than offset by pricing pressures in certain markets; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Xeljanz in the U.S., down </font><font style="font-family:inherit;font-size:11pt;">4%</font><font style="font-family:inherit;font-size:11pt;">, reflecting continued strong demand across all approved indications, more than offset by a lower net price due to higher rebating from commercial contracts signed in 2019 as well as a temporary lowering of wholesaler inventories in first-quarter 2020. Wholesaler inventory levels for Xeljanz were restored to normal levels in early April 2020, during Pfizer&#8217;s second quarter, as underlying volume demand has remained consistently strong.</font></div></td></tr></table><div style="line-height:174%;padding-bottom:4px;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:Times New Roman;font-size:11pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Upjohn Revenue Highlights</font></div><div style="line-height:174%;padding-bottom:4px;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">First-quarter</font><font style="font-family:inherit;font-size:11pt;">&#32;</font><font style="font-family:inherit;font-size:11pt;text-align:center;">2020</font><font style="font-family:inherit;font-size:11pt;">&#32;Upjohn revenues totaled </font><font style="font-family:inherit;font-size:11pt;">$2.0 billion</font><font style="font-family:inherit;font-size:11pt;">, down </font><font style="font-family:inherit;font-size:11pt;">37%</font><font style="font-family:inherit;font-size:11pt;">&#32;operationally, primarily driven by the expected significant volume declines for Lyrica in the U.S. due to multi-source generic competition that began in July 2019. Upjohn revenues in China declined 41% operationally, driven by expected declines from Lipitor and </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">9</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:174%;padding-bottom:4px;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Norvasc, primarily resulting from the VBP program, which was initially implemented in March 2019, and expanded nationwide beginning in December 2019.</font></div><div style="line-height:174%;padding-bottom:4px;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:Times New Roman;font-size:11pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">GAAP Reported</font><font style="font-family:Times New Roman;font-size:11pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font><font style="font-family:Times New Roman;font-size:11pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">&#32;Income Statement Highlights</font></div><div style="line-height:174%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:70.63492063492063%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" style="padding-left:0px;padding-right:0px;padding-top:4px;padding-bottom:4px;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">SELECTED TOTAL COMPANY REPORTED COSTS AND EXPENSES</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup>&#160;</font></div></td></tr><tr><td style="width:32%;"></td><td style="width:16%;"></td><td style="width:1%;"></td><td style="width:16%;"></td><td style="width:1%;"></td><td style="width:17%;"></td><td style="width:17%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($ in millions)</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">First-Quarter</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" rowspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" rowspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">% Change</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Oper.</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of Sales</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$  2,378</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$  2,433</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3%)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Percent of Revenues</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.8</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.5</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">N/A</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">N/A</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">SI&amp;A Expenses</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;2,873</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;3,339</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(14%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13%)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">R&amp;D Expenses</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;1,724</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;1,703</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$  6,975</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$  7,474</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(7%)</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(7%)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other (Income)/Deductions&#8211;&#8211;net</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">221</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">140%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">140%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effective Tax Rate on Reported Income</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.2</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.0</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:174%;padding-bottom:12px;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">First-quarter</font><font style="font-family:inherit;font-size:11pt;">&#32;</font><font style="font-family:inherit;font-size:11pt;text-align:center;">2020</font><font style="font-family:inherit;font-size:11pt;text-align:center;">&#32;Cost of Sales</font><font style="font-family:inherit;font-size:11pt;text-align:center;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font><font style="font-family:inherit;font-size:11pt;text-align:center;">, SI&amp;A Expenses</font><font style="font-family:inherit;font-size:11pt;text-align:center;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font><font style="font-family:inherit;font-size:11pt;text-align:center;">&#32;and R&amp;D Expenses</font><font style="font-family:inherit;font-size:11pt;text-align:center;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font><font style="font-family:inherit;font-size:11pt;text-align:center;">&#32;were favorably impacted primarily by </font><font style="font-family:inherit;font-size:11pt;">the July 31, 2019 completion of the Consumer Healthcare JV transaction with GSK</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;and, to a lesser extent, lower indirect SI&amp;A expenses associated with corporate enabling functions.</font></div><div style="line-height:174%;padding-bottom:12px;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Pfizer&#8217;s response to the COVID-19 pandemic increased certain operating expenses in first-quarter 2020, including expenses incurred to protect colleagues that continue to work in Pfizer&#8217;s manufacturing facilities and R&amp;D sites, incremental transport expenses to ensure supply chain continuity and&#160;other expenses incurred to comply with other restrictions related to COVID-19.</font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Pfizer recorded higher other deductions&#8211;&#8211;net</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2) </sup></font><font style="font-family:inherit;font-size:11pt;">in </font><font style="font-family:inherit;font-size:11pt;">first-quarter</font><font style="font-family:inherit;font-size:11pt;">&#32;</font><font style="font-family:inherit;font-size:11pt;text-align:center;">2020</font><font style="font-family:inherit;font-size:11pt;text-align:center;">&#32;compared with </font><font style="font-family:inherit;font-size:11pt;">the prior-year quarter, primarily driven by:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">net losses on equity securities in </font><font style="font-family:inherit;font-size:11pt;">first-quarter</font><font style="font-family:inherit;font-size:11pt;">&#32;</font><font style="font-family:inherit;font-size:11pt;text-align:center;">2020</font><font style="font-family:inherit;font-size:11pt;text-align:center;">&#32;compared with net gains on equity securities in </font><font style="font-family:inherit;font-size:11pt;">first-quarter</font><font style="font-family:inherit;font-size:11pt;">&#32;2019;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">an unfavorable change in the fair value of contingent consideration; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">higher interest expense,</font></div></td></tr></table><div style="line-height:174%;padding-bottom:4px;padding-top:8px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">partially offset primarily by:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">lower asset impairment charges;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">the non-recurrence of net losses on the early retirement of certain outstanding debt securities recorded in first-quarter 2019; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">lower business and legal entity alignment costs.</font></div></td></tr></table><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">10</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:174%;padding-bottom:4px;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:Times New Roman;font-size:11pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Adjusted</font><font style="font-family:Times New Roman;font-size:11pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font><font style="font-family:Times New Roman;font-size:11pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">&#32;Income Statement Highlights</font></div><div style="line-height:174%;padding-bottom:0px;padding-top:8px;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:70.63492063492063%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" style="padding-left:0px;padding-right:0px;padding-top:4px;padding-bottom:4px;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">SELECTED TOTAL COMPANY ADJUSTED COSTS AND EXPENSES</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup>&#160;</font></div></td></tr><tr><td style="width:32%;"></td><td style="width:16%;"></td><td style="width:1%;"></td><td style="width:16%;"></td><td style="width:1%;"></td><td style="width:17%;"></td><td style="width:17%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($ in millions)</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">First-Quarter</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" rowspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" rowspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">% Change</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Oper.</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted Cost of Sales</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$  2,350</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$  2,415</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4%)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Percent of Revenues</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.5</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.4</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">N/A</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">N/A</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted SI&amp;A Expenses</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;2,745</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;3,311</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16%)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted R&amp;D Expenses</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;1,727</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;1,693</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$  6,821</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$  7,419</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(8%)</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(8%)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted Other (Income)/Deductions&#8211;&#8211;net</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(186</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(135</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effective Tax Rate on Adjusted Income</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.0</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.2</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:174%;padding-bottom:4px;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">First-quarter</font><font style="font-family:inherit;font-size:11pt;">&#32;</font><font style="font-family:inherit;font-size:11pt;text-align:center;">2020</font><font style="font-family:inherit;font-size:11pt;">&#32;diluted weighted-average shares outstanding used to calculate Reported</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;and Adjusted</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;diluted EPS declined by </font><font style="font-family:inherit;font-size:11pt;">137 million</font><font style="font-family:inherit;font-size:11pt;">&#32;shares compared to the prior-year quarter primarily due to Pfizer&#8217;s share repurchase program, reflecting the impact of share repurchases during 2019, partially offset by shares issued for employee compensation programs.</font></div><div style="line-height:174%;padding-bottom:4px;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">A full reconciliation of Reported</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;to Adjusted</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;financial measures and associated footnotes can be found starting on page 27 of this press release.</font></div><div><a name="sF72869E216EE5D63963EA1C27455D3D4"></a></div><div style="line-height:174%;padding-bottom:12px;padding-top:32px;text-align:left;font-size:11pt;"><font style="font-family:Times New Roman;font-size:11pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">RECENT NOTABLE DEVELOPMENTS (Since </font><font style="font-family:Times New Roman;font-size:11pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">January&#160;28, 2020</font><font style="font-family:Times New Roman;font-size:11pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">)</font></div><div style="line-height:174%;padding-bottom:4px;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:Times New Roman;font-size:11pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Product Developments</font></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Bavencio (avelumab)</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:30px;"><font style="font-family:inherit;font-size:11pt;">&#8211;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In April 2020, EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada, and Pfizer announced the submission of a supplemental Biologics License Application (sBLA) to the FDA for Bavencio for first-line maintenance treatment of patients with locally advanced or metastatic urothelial carcinoma. The FDA granted Breakthrough Therapy Designation to Bavencio for this indication, and the sBLA is being reviewed by the FDA under its Real-Time Oncology Review pilot program.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:30px;"><font style="font-family:inherit;font-size:11pt;">&#8211;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In March 2020, EMD Serono and Pfizer announced that the Phase 3 JAVELIN Head and Neck 100 study evaluating avelumab in addition to chemoradiotherapy (CRT) versus standard-of-care CRT in patients with untreated, locally advanced squamous cell carcinoma of the head and neck was terminated based on the recommendation of the independent Data Monitoring Committee as the study was unlikely to show a statistically significant improvement in the primary endpoint of progression-free survival </font></div></td></tr></table><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">11</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:174%;padding-left:60px;padding-bottom:4px;padding-top:8px;text-align:left;"><font style="font-family:inherit;font-size:11pt;">based on a pre-planned interim analysis. A detailed analysis of the Phase 3 JAVELIN Head and Neck 100 study is being conducted and study findings will be shared with the scientific community.</font></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Braftovi (encorafenib) </font><font style="font-family:inherit;font-size:11pt;">-- In April 2020, Pfizer announced that the FDA approved Braftovi in combination with Erbitux</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(12)</sup></font><font style="font-family:inherit;font-size:11pt;">&#160;(cetuximab) for the treatment of adult patients with metastatic colorectal cancer with a&#160;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;">BRAF</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">V600E</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;mutation, as detected by an FDA-approved test, after prior therapy.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Eucrisa/Staquis (crisaborole ointment, 2%)</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:30px;"><font style="font-family:inherit;font-size:11pt;">&#8211;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In March 2020, the European Commission (EC) approved Staquis for treatment of mild to moderate atopic dermatitis (AD) in adults and pediatric patients from 2 years of age with 40% or less body surface area affected.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:30px;"><font style="font-family:inherit;font-size:11pt;">&#8211;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In March 2020, Pfizer announced that the FDA approved its supplemental New Drug Application for Eucrisa, extending the lower age limit from 24 months down to 3 months in children with mild-to-moderate AD. Eucrisa was previously approved in the U.S. for use in adults and children 2 years of age and older. This supplemental approval makes Eucrisa the first and only steroid-free, topical prescription medication for mild-to-moderate AD patients as young as 3 months of age.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Ruxience (rituximab)</font><font style="font-family:inherit;font-size:11pt;">&#32;-- In April 2020, Pfizer announced that the EC approved Ruxience, a biosimilar to MabThera</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;(13)</sup></font><font style="font-family:inherit;font-size:11pt;">, for the treatment of non-Hodgkin&#8217;s lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis and microscopic polyangiitis, and pemphigus vulgaris.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Steglatro (ertugliflozin)</font><font style="font-family:inherit;font-size:11pt;">&#32;-- In April 2020, Merck &amp; Co., Inc. (Merck), known as MSD outside the U.S. and Canada, and Pfizer reported top-line results for the Phase 3 VERTIS CV cardiovascular (CV) outcomes trial for Steglatro, an oral sodium-glucose cotransporter 2 inhibitor, which achieved its primary endpoint of non-inferiority for major adverse CV events (MACE) compared to placebo in patients with type 2 diabetes mellitus and established atherosclerotic CV disease. MACE was defined as time to the first event of CV death, nonfatal myocardial infarction or nonfatal stroke. The key secondary endpoints of superiority for Steglatro versus placebo for time to composite of CV death or hospitalization for heart failure, CV death alone and the composite of renal death, dialysis/transplant or doubling of serum creatinine from baseline were not met. While not a pre-specified hypothesis for statistical testing, a reduction in hospitalization for heart failure was observed with Steglatro. The safety profile of Steglatro was consistent with that reported in previous studies. Detailed results of VERTIS CV are scheduled to be presented on June 16, 2020 at the virtual American Diabetes Association&#8217;s 80</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">th</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;Scientific Sessions.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Vyndaqel (tafamidis)</font><font style="font-family:inherit;font-size:11pt;">&#32;-- In February 2020, Pfizer announced that the EC approved Vyndaqel, a once-daily 61 mg oral capsule, for the treatment of wild-type or hereditary transthyretin amyloidosis in adult patients with ATTR-CM. Vyndaqel is the first and only treatment approved in the European Union (EU) for patients with ATTR-CM. In 2011, the tafamidis meglumine 20 mg capsule formulation of Vyndaqel was approved in the EU for transthyretin amyloidosis in adult patients with stage 1 symptomatic polyneuropathy to delay </font></div></td></tr></table><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">12</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:174%;padding-left:30px;padding-bottom:4px;padding-top:8px;text-align:left;"><font style="font-family:inherit;font-size:11pt;">peripheral neurologic impairment.</font></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Xtandi (enzalutamide)</font><font style="font-family:inherit;font-size:11pt;">&#32;-- In February 2020, Astellas Pharma Inc. and Pfizer announced results of the final overall survival (OS) analysis from the Phase 3 PROSPER trial, which evaluated Xtandi plus androgen deprivation therapy (ADT) versus placebo plus ADT in men with non-metastatic castration-resistant prostate cancer (nmCRPC). The results demonstrated a statistically significant improvement in OS in patients with nmCRPC who were treated with Xtandi plus ADT. OS was a key secondary endpoint of the trial. In a preliminary analysis, adverse events were generally consistent with those previously reported from PROSPER. Detailed efficacy and safety results from the final PROSPER OS analysis will be shared at a later date.</font></div></td></tr></table><div><a name="s95C06C14457E5323A236F54410A7956A"></a></div><div style="line-height:174%;padding-bottom:4px;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:Times New Roman;font-size:11pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Pipeline Developments</font></div><div style="line-height:174%;padding-bottom:12px;padding-top:12px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">A comprehensive update of Pfizer&#8217;s development pipeline was published today and is now available at www.pfizer.com/science/drug-product-pipeline. It includes an overview of Pfizer&#8217;s research and a list of compounds in development with targeted indication and phase of development, as well as mechanism of action for some candidates in Phase 1 and all candidates from Phase 2 through registration.</font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Abrocitinib (PF-04965842)</font><font style="font-family:inherit;font-size:11pt;">&#160;-- In March 2020, Pfizer announced positive top-line results from the Phase 3 JADE COMPARE study. The study met its co-primary efficacy endpoints and evaluated the safety and efficacy of abrocitinib, an investigational oral once-daily Janus kinase (JAK) 1 inhibitor, in adults with moderate-to-severe AD who were also on background topical therapy. The study also included an active control arm, dupilumab, a biologic treatment administered by subcutaneous injection, compared with placebo. These data, along with other results from other pivotal trials, MONO-1 and MONO-2, are expected to support filings with regulatory agencies, starting with the FDA, planned for later this year.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">PF-06482077 (20-Valent Pneumococcal Conjugate Vaccine)</font><font style="font-family:inherit;font-size:11pt;">&#32;-- In March 2020, Pfizer announced top-line results from one of its Phase 3 studies (NCT03760146), which evaluated the safety and immunogenicity of PF-06482077 in adults 18 years of age or older not previously vaccinated against pneumococcal disease. The primary immunogenicity objectives of non-inferiority for the 20 serotypes included in PF-06482077 in adults 60 years of age and older at one month after vaccination were met for all serotypes in common with licensed Prevnar 13 (13-valent pneumococcal conjugate vaccine [Diphtheria CRM197 Protein]) and six of the seven additional serotypes when compared to a licensed pneumococcal polysaccharide vaccine (PPSV23); one of the new seven serotypes missed noninferiority criteria by a small margin. Secondary immunogenicity objectives for adults 18-59 years old compared to those 60-64 years old met non-inferiority for all 20 serotypes. The safety objectives were met in adults 18 years of age or older, demonstrating that the safety and tolerability of PF-06482077 were comparable to licensed pneumococcal vaccines. Based on prior discussions with regulators, these data are expected to meet licensure criteria. Pfizer will seek to present and publish outcomes from this clinical trial at a future date once safety and immunogenicity data have been </font></div></td></tr></table><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">13</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:174%;padding-left:30px;padding-bottom:12px;padding-top:4px;text-align:left;"><font style="font-family:inherit;font-size:11pt;">fully analyzed. Pfizer expects to file the adult indication for PF-06482077 with the FDA in the early part of the fourth quarter of 2020.</font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">PF-06928316 (Respiratory Syncytial Virus (RSV) Vaccine)</font><font style="font-family:inherit;font-size:11pt;">&#32;-- In April 2020, positive top-line results were achieved for a Phase 2b proof-of-concept study, which evaluated the safety, tolerability and immunogenicity of PF-06928316 in vaccinated pregnant women ages 18 through 49 and their infants. Detailed results from this study will be shared at a future medical conference. The Phase 3 program for PF-06928316 is projected to begin in the coming months.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Tanezumab (PF-04383119)</font><font style="font-family:inherit;font-size:11pt;">&#32;-- In March 2020, Pfizer and Eli Lilly and Company (Lilly) announced that the FDA accepted for review a Biologics License Application for tanezumab 2.5 mg administered subcutaneously, which is being evaluated for patients with chronic pain due to moderate-to-severe osteoarthritis (OA) who have experienced inadequate pain relief with other analgesics. The Prescription Drug User Fee Act goal date for a decision by the FDA is in December 2020. In its filing acceptance letter, the FDA stated that it was planning to hold an Advisory Committee meeting to discuss this application. In addition, the European Medicines Agency validated for review a Marketing Authorisation Application for tanezumab 2.5 mg administered subcutaneously for adult patients with moderate-to-severe chronic pain associated with OA for whom treatment with nonsteroidal anti-inflammatory drugs and/or an opioid is ineffective, not tolerated or inappropriate.</font></div></td></tr></table><div><a name="sB5FF87F8E5915409AC72E2B71A6702AA"></a></div><div style="line-height:174%;padding-bottom:4px;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:Times New Roman;font-size:11pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Corporate Developments</font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Since March 2020, Pfizer has made a series of announcements related to the COVID-19 pandemic:</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:30px;"><font style="font-family:inherit;font-size:11pt;">&#8211;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In April 2020, Pfizer announced important advances in the battle against the COVID-19 pandemic, including:</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:60px;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">&#9702;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Antiviral Compound Screening</font><font style="font-family:inherit;font-size:11pt;">:  Pfizer confirmed a lead compound and analogues to be potent inhibitors of the SARS-CoV-2 3C-like protease, based on the results of initial screening assays. In addition, preliminary data suggest the lead protease inhibitor shows antiviral activity against SARS-CoV-2. Consequently, Pfizer will continue to perform pre-clinical confirmatory studies, including further antiviral profiling and assessment of the suitability of the lead molecule for IV administration clinically. In parallel, the company is also investing in materials that aim to accelerate the start of a potential clinical study of the lead molecule to third-quarter 2020, three or more months in advance of earlier estimates, subject to positive completion of the pre-clinical confirmatory studies.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:60px;"><font style="font-family:inherit;font-size:11pt;">&#9702;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Applying Pfizer&#8217;s Long History in Vaccine R&amp;D Expertise to Collaborate with BioNTech:</font><font style="font-family:inherit;font-size:11pt;">&#32;&#32;Pfizer and BioNTech entered into a global collaboration agreement to co-develop a potential first-in-class, mRNA-based coronavirus vaccine program, BNT162, aimed at preventing COVID-19 </font></div></td></tr></table><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">14</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:174%;padding-left:84px;padding-bottom:4px;padding-top:8px;text-align:left;"><font style="font-family:inherit;font-size:11pt;">infection. In March 2020, the companies announced a letter of intent to collaborate and began working together at that time. The two companies plan to jointly conduct clinical trials for the COVID-19 vaccine candidates initially in Europe and the U.S., across multiple research sites. In late April 2020, Pfizer and BioNTech announced that the German regulatory authority, the Paul-Ehrlich-Institut, approved the Phase 1/2 clinical trial and the first patient was dosed with a BNT162 vaccine candidate shortly thereafter. Pfizer and BioNTech also plan to conduct trials for BNT162 in the U.S. upon regulatory approval, which is expected shortly.</font></div><div style="line-height:174%;padding-bottom:4px;padding-top:8px;text-align:left;padding-left:84px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The companies estimate that there is potential to supply millions of vaccine doses by the end of 2020, subject to technical success of the development program and approval by regulatory authorities, and the potential to rapidly scale up the capacity to produce hundreds of millions of doses in 2021.</font></div><div style="line-height:174%;padding-bottom:4px;padding-top:8px;text-align:left;padding-left:84px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Under the terms of the agreement, Pfizer will pay BioNTech $72 million in cash and make an equity investment of $113 million. BioNTech is eligible to receive future milestone payments of up to $563 million for a potential total consideration of $748 million. Pfizer and BioNTech will share development costs equally. Pfizer will initially be responsible for all of the development costs until commercialization of the vaccine. Thereafter, BioNTech would repay Pfizer its 50% share of these development costs over time. BioNTech and Pfizer will also work jointly to commercialize the vaccine worldwide (excluding China, which is subject to a separate collaboration between BioNTech and Fosun Pharma) if development is successful and regulatory approval is obtained.</font></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:60px;"><font style="font-family:inherit;font-size:11pt;">&#9702;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Analysis of Azithromycin as an Agent with Antiviral Activity</font><font style="font-family:inherit;font-size:11pt;">:  In an effort to share information that could benefit COVID-19 mitigation efforts, Pfizer researchers published a review in </font><font style="font-family:inherit;font-size:11pt;font-style:italic;">Clinical Pharmacology and Therapeutics</font><font style="font-family:inherit;font-size:11pt;">, which assesses published in vitro and clinical data regarding azithromycin as an agent with antiviral properties. This open access review may serve to facilitate the use of azithromycin in future research on COVID-19. Azithromycin is not approved for the treatment of viral infections.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:60px;"><font style="font-family:inherit;font-size:11pt;">&#9702;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Studying Pfizer&#8217;s Existing Medicines for Critical Patient Populations in Need</font><font style="font-family:inherit;font-size:11pt;">:</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:132px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:108px;"><font style="font-family:inherit;font-size:11pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Pfizer and the Liverpool School of Tropical Medicine&#8217;s Respiratory Infection Clinical Research Group initiated two new studies to provide insights on the interaction between </font><font style="font-family:inherit;font-size:11pt;font-style:italic;">S. pneumoniae</font><font style="font-family:inherit;font-size:11pt;">&#32;and SARS-CoV-2. The studies (SAFER study (SARS-CoV-2 Acquisition in Frontline Health Care Workers &#8211; Evaluation to Inform Response) and the FASTER study (Facilitating A SARS CoV-2 Test for Rapid triage)) will help demonstrate whether patients infected with COVID-19 have a higher risk of also developing pneumococcal pneumonia and if having both infections leads to more severe disease and poorer outcomes. The SAFER study will enroll 100 healthcare workers at the Royal Liverpool Hospital and </font></div></td></tr></table><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">15</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:174%;padding-left:132px;padding-bottom:4px;padding-top:8px;text-align:left;"><font style="font-family:inherit;font-size:11pt;">examine rates of SARS-CoV-2 acquisition and dynamics of pneumococcal colonization. The FASTER study will recruit 400 patients from the infectious disease ward at the Royal Liverpool Hospital suspected of having COVID-19. Enrollment has already begun, and data are expected over the next few months. </font></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:132px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:108px;"><font style="font-family:inherit;font-size:11pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Pfizer is in discussions with other institutions about studies involving its immuno-kinase portfolio. This research is based on the hypothesis that modulation of the immune response could mitigate systemic and alveolar inflammation in patients with COVID-19-related pneumonia by inhibiting essential cytokine signaling involved in immune-mediated inflammatory response that could lead to damage of the lungs, resulting in acute respiratory distress syndrome in patients with COVID-19-related pneumonia.</font></div></td></tr></table><div style="line-height:174%;padding-bottom:4px;padding-top:8px;text-align:left;padding-left:60px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Pfizer will continue to share information from its portfolio and emerging candidates that could benefit the many companies and organizations who are working quickly to provide solutions to combat this unprecedented healthcare crisis.</font></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:30px;"><font style="font-family:inherit;font-size:11pt;">&#8211;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In April 2020, Pfizer and The Pfizer Foundation announced the commitment of $40 million in medical and charitable cash grants to help combat the health effects of the COVID-19 pandemic in the U.S. and around the world. The donation addresses the urgent needs of partners who are working to slow the spread of the virus within communities and strengthen vulnerable healthcare systems against future public health threats. Pfizer is also responding to patient and healthcare provider needs during this unprecedented time by evolving its U.S. Patient Assistance Program and donating additional critical medicines and vaccines in the U.S. and around the world. The Pfizer Foundation is a charitable organization established by Pfizer Inc. It is a separate legal entity from Pfizer Inc. with distinct legal restrictions.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:30px;"><font style="font-family:inherit;font-size:11pt;">&#8211;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In April 2020, Pfizer, Merck and Lilly announced medical service volunteer programs to enable employees who are licensed medical professionals to aid in the fight against COVID-19. Pfizer created a new Global COVID-19 Medical Service Program that empowers medical colleagues to provide diagnostic, treatment and public health support in the battle against COVID-19. Licensed medical professionals who feel duty-bound to provide their services during this crisis will now have a way to engage in the fight against COVID-19. Colleagues will continue to receive their pay, benefits and be able to return to their position upon completion of service.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:30px;"><font style="font-family:inherit;font-size:11pt;">&#8211;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In March 2020, Pfizer announced that, given the unique circumstances of the COVID-19 pandemic and Pfizer&#8217;s responsibility to prioritize the health and safety of colleagues and invited guests, the company will reschedule its Investor Day that had been planned for March 31, 2020 to a later date. At this point, there is no timetable for rescheduling the event. Pfizer will work within the context of appropriate guidance from health authorities to determine a future date.</font></div></td></tr></table><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">16</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:30px;"><font style="font-family:inherit;font-size:11pt;">&#8211;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In March 2020, Pfizer issued a five-point plan calling on the biopharmaceutical industry to join the company in committing to unprecedented collaboration to combat COVID-19. Pfizer is making five promises that will help scientists more rapidly bring forward therapies and vaccines to protect humankind from this escalating pandemic and prepare the industry to better respond to future global health crises.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:60px;"><font style="font-family:inherit;font-size:11pt;">1.</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Sharing tools and insights</font><font style="font-family:inherit;font-size:11pt;">:  With very little known about this virus, many are working to develop cell-based assays, viral screening, serological assays and translational models to test potential therapies and vaccines. Pfizer is committed to making the vital tools it develops available on an open source platform to the broader scientific community and to sharing the data and learnings gained with other companies in real time to rapidly advance therapies and vaccines to patients.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:60px;"><font style="font-family:inherit;font-size:11pt;">2.</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Marshalling Pfizer&#8217;s people</font><font style="font-family:inherit;font-size:11pt;">:  Human capital is Pfizer&#8217;s most valuable resource. Pfizer has created a SWAT team of leading virologists, biologists, chemists, clinicians, epidemiologists, vaccine experts, pharmaceutical scientists and other key experts to focus solely on addressing this pandemic. This team is applying their passion, commitment and expertise to a single focus of accelerating the discovery and development process that will deliver therapies and vaccines to patients as soon as possible.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:60px;"><font style="font-family:inherit;font-size:11pt;">3.</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Applying Pfizer&#8217;s drug development expertise</font><font style="font-family:inherit;font-size:11pt;">: Many smaller biotech companies are screening compounds or existing therapies for activity against the virus causing COVID-19, but some lack the experience in late stage development and navigating the complex regulatory systems. Pfizer is committed to sharing its clinical development and regulatory expertise to support the most promising candidates these companies bring forward.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:60px;"><font style="font-family:inherit;font-size:11pt;">4.</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Offering Pfizer&#8217;s manufacturing capabilities</font><font style="font-family:inherit;font-size:11pt;">:  Once a therapy or vaccine is approved it will need to be rapidly scaled and deployed around the world to put an end to this pandemic. As one of the largest manufacturers of vaccines and therapeutics, Pfizer is committed to using any excess manufacturing capacity and to potentially shifting production to support others in rapidly getting these life-saving breakthroughs into the hands of patients as quickly as possible.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:60px;"><font style="font-family:inherit;font-size:11pt;">5.</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Improving future rapid response</font><font style="font-family:inherit;font-size:11pt;">:  Finally, to address future global health threats, Pfizer is reaching out to federal agencies including the National Institutes of Health, the National Institute of Allergy and Infectious Diseases, and the Centers for Disease Control and Prevention to build a cross-industry rapid response team of scientists, clinicians and technicians able to move into action immediately when future epidemics surface.</font></div></td></tr></table><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">17</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Since February 2020, Pfizer announced the election of three new members to its Board of Directors, including:</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:30px;"><font style="font-family:inherit;font-size:11pt;">&#8211;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In April 2020, Dr. Susan Desmond-Hellmann was elected to Pfizer&#8217;s Board of Directors, effective immediately, and was appointed to the Governance &amp; Sustainability Committee and the Science and Technology Committee of the Board.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:30px;"><font style="font-family:inherit;font-size:11pt;">&#8211;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In March 2020, Dr. Susan Hockfield was elected to Pfizer&#8217;s Board of Directors, effective immediately, and was appointed to the Regulatory and Compliance Committee and the Science and Technology Committee of the Board.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:30px;"><font style="font-family:inherit;font-size:11pt;">&#8211;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In February 2020, James Quincey was elected to Pfizer&#8217;s Board of Directors, effective immediately, and was appointed to the Compensation Committee and the Science and Technology Committee of the Board.</font></div></td></tr></table><div style="line-height:174%;padding-bottom:4px;padding-top:8px;text-align:left;text-indent:30px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In addition, at its April 2020 Annual Meeting of Shareholders, all 14 current Pfizer directors were re-elected.</font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Since February 2020, Pfizer and Mylan have made a series of announcements regarding the pending combination of Mylan with Upjohn, a division of Pfizer, into a new global pharmaceutical company, Viatris, including:</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:30px;"><font style="font-family:inherit;font-size:11pt;">&#8211;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In April 2020, the EC approved the combination of Mylan and Upjohn, conditioned upon the completion of the sale of certain of Mylan&#8217;s products in Europe.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:30px;"><font style="font-family:inherit;font-size:11pt;">&#8211;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In March 2020, Pfizer and Mylan announced that due to the unprecedented circumstances surrounding the COVID-19 pandemic, including associated delays in the regulatory review process, the proposed transaction is now anticipated to close in the second half of 2020. There are no additional changes to the previously announced terms or plans regarding the transaction. Pfizer and Mylan remain highly confident in the benefits of the pending transaction to their respective shareholders and other stakeholders. Mylan, Pfizer and Upjohn are working closely on integration planning and are making significant progress toward Day 1 readiness while continuing to progress toward a successful transaction close. Mylan&#8217;s extraordinary general meeting of shareholders to approve certain matters in connection with the transaction was rescheduled from April 27, 2020, to June 30, 2020, and will be hosted in conjunction with Mylan&#8217;s annual general meeting of shareholders.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:30px;"><font style="font-family:inherit;font-size:11pt;">&#8211;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In February 2020, Pfizer and Mylan announced that Sanjeev Narula, current chief financial officer (CFO) of Upjohn was named incoming CFO of Viatris. As the Viatris CFO, Mr. Narula will report to Michael Goettler, who was previously announced as incoming CEO of Viatris. The Mylan and Upjohn teams will continue to work together over the coming months to fill additional leadership positions and further its comprehensive integration planning efforts. Mylan and Upjohn will continue to operate as independent organizations under their existing organization structures until the transaction closes.</font></div></td></tr></table><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">18</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:30px;"><font style="font-family:inherit;font-size:11pt;">&#8211;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In February 2020, Pfizer and Mylan announced the remaining appointees to the inaugural 13-member Board of Directors for Viatris. In addition to the previously announced Pfizer-designated appointments of Ian Read and Jim Kilts, Pfizer has appointed current Pfizer board member W. Don Cornwell, who will resign from the Pfizer board to serve as a director of Viatris upon the close of the transaction. Additionally, Mylan has appointed eight of its own directors to serve on the Viatris Board of Directors, including JoEllen Lyons Dillon, Neil Dimick, Melina Higgins, Harry A. Korman, Rajiv Malik, Richard A. Mark, Mark W. Parrish and Pauline van der Meer Mohr. As previously announced, the Board of Directors of Viatris will also include Viatris Executive Chairman Robert J. Coury and Viatris CEO Michael Goettler.</font></div></td></tr></table><div style="line-height:174%;padding-bottom:12px;padding-top:4px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:174%;padding-bottom:4px;padding-top:8px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">19</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><a name="sD31E979F64CA551A8049D7B0AE2893F0"></a></div><div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">For additional details, see the attached financial schedules, product revenue tables and disclosure notice.</font></div><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:42px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The following acquisitions and divestitures impacted financial results for the periods presented:</font><font style="font-family:inherit;font-size:11pt;">&#32;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:48px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">On July 31, 2019, Pfizer and GlaxoSmithKline plc (GSK) completed a transaction that combined the two companies&#8217; respective consumer healthcare businesses into a joint venture (JV), operating under the GSK Consumer Healthcare name. In exchange for contributing its Consumer Healthcare business to the JV, Pfizer received a 32% equity stake in the JV and GSK owns the remaining 68% of the JV.</font><font style="font-family:inherit;font-size:11pt;">&#32;Upon the closing of the transaction, Pfizer deconsolidated its Consumer Healthcare business and began recording its share of earnings from the Consumer Healthcare JV on a quarterly basis on a one-quarter lag in Other (income)/deductions</font><font style="font-family:inherit;font-size:9.5pt;">&#8211;&#8211;</font><font style="font-family:inherit;font-size:11pt;">net commencing from August 1, 2019. Therefore, Pfizer recorded its share of the JV&#8217;s earnings generated in fourth-quarter 2019 in its first-quarter 2020 operating results.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:48px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">On July 30, 2019, Pfizer announced the successful completion of its acquisition of Array BioPharma Inc.</font><font style="font-family:inherit;font-size:11pt;">&#32;(Array). Array&#8217;s portfolio included two approved products, Braftovi (encorafenib) and Mektovi (binimetinib).</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:48px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">On July 1, 2019, Pfizer announced the successful completion of its acquisition of the privately held clinical-stage biotechnology company, Therachon Holding AG.</font><font style="font-family:inherit;font-size:11pt;">&#32;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:42px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Revenues is defined as revenues in accordance with U.S. generally accepted accounting principles (GAAP).&#160;</font><font style="font-family:inherit;font-size:11pt;">Reported net income is defined as net income attributable to Pfizer Inc. in accordance with U.S. GAAP.&#160;Reported diluted earnings per share (EPS) is defined as diluted EPS attributable to Pfizer Inc. common shareholders in accordance with U.S. GAAP.</font><font style="font-family:inherit;font-size:11pt;">&#32;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:42px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-size:11pt;">Adjusted income and its components and Adjusted diluted EPS are defined as reported U.S. GAAP net income</font><font style="font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font><font style="font-size:11pt;">&#32;and its components and reported diluted EPS</font><font style="font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font><font style="font-size:11pt;">&#32;excluding purchase accounting adjustments, acquisition-related costs, discontinued operations and certain significant items (some of which may recur, such as gains on the completion of joint venture transactions, restructuring charges, legal charges or gains and losses from equity securities, but which management does not believe are reflective of ongoing core operations).&#160;Adjusted cost of sales, Adjusted selling, informational and administrative (SI&amp;A) expenses, Adjusted research and development (R&amp;D) expenses and Adjusted other (income)/deductions are income statement line items prepared on the same basis as, and therefore components of, the overall Adjusted income measure.</font><font style="font-family:inherit;font-size:11pt;">&#160;As described in the </font><font style="font-family:inherit;font-size:11pt;font-style:italic;">Financial Review&#8211;&#8211;Non-GAAP Financial Measure (Adjusted Income) </font><font style="font-family:inherit;font-size:11pt;">section of Pfizer&#8217;s </font><font style="font-family:inherit;font-size:11pt;text-align:center;">2019</font><font style="font-family:inherit;font-size:11pt;">&#32;Financial Report, which was filed as Exhibit 13 to Pfizer&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, </font><font style="font-family:inherit;font-size:11pt;text-align:center;">2019</font><font style="font-family:inherit;font-size:11pt;">, management uses Adjusted income, among other factors, to set performance goals and to measure the performance of the overall company.&#160;Because </font></div></td></tr></table><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">20</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:174%;padding-left:42px;padding-bottom:16px;padding-top:16px;text-align:left;"><font style="font-family:inherit;font-size:11pt;">Adjusted income is an important internal measurement for Pfizer, management believes that investors&#8217; understanding of our performance is enhanced by disclosing this performance measure.&#160;Pfizer reports Adjusted income, certain components of Adjusted income, and Adjusted diluted EPS in order to portray the results of the company&#8217;s major operations&#8211;&#8211;the discovery, development, manufacture, marketing and sale of prescription medicines and vaccines&#8211;&#8211;prior to considering certain income statement elements.&#160;See the accompanying reconciliations of certain GAAP Reported to Non-GAAP Adjusted information for the </font><font style="font-family:inherit;font-size:11pt;">first quarter</font><font style="font-family:inherit;font-size:11pt;">&#32;of </font><font style="font-family:inherit;font-size:11pt;text-align:center;">2020</font><font style="font-family:inherit;font-size:11pt;">&#32;and </font><font style="font-family:inherit;font-size:11pt;text-align:center;">2019</font><font style="font-family:inherit;font-size:11pt;">. The Adjusted income and its components and Adjusted diluted EPS measures are not, and should not be viewed as, substitutes for U.S. GAAP net income and its components and diluted EPS.</font></div><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:42px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">(4)</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Pfizer&#8217;s fiscal year-end for international subsidiaries is November 30 while Pfizer&#8217;s fiscal year-end for U.S. subsidiaries is December 31. Therefore, Pfizer&#8217;s </font><font style="font-family:inherit;font-size:11pt;">first quarter</font><font style="font-family:inherit;font-size:11pt;">&#32;for U.S. subsidiaries reflects the </font><font style="font-family:inherit;font-size:11pt;">three months</font><font style="font-family:inherit;font-size:11pt;">&#32;ending on </font><font style="font-family:inherit;font-size:11pt;">March&#160;29, 2020</font><font style="font-family:inherit;font-size:11pt;">&#32;and </font><font style="font-family:inherit;font-size:11pt;text-align:center;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;">&#32;while Pfizer&#8217;s </font><font style="font-family:inherit;font-size:11pt;">first quarter</font><font style="font-family:inherit;font-size:11pt;">&#32;for subsidiaries operating outside the U.S. reflects the </font><font style="font-family:inherit;font-size:11pt;">three months</font><font style="font-family:inherit;font-size:11pt;">&#32;ending on </font><font style="font-family:inherit;font-size:11pt;">February&#160;23, 2020</font><font style="font-family:inherit;font-size:11pt;">&#32;and </font><font style="font-family:inherit;font-size:11pt;">February&#160;24, 2019</font><font style="font-family:inherit;font-size:11pt;">.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:42px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">(5)</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">References to operational variances in this press release pertain to period-over-period growth rates that exclude the impact of foreign exchange. The operational variances are determined by multiplying or dividing, as appropriate, the current period U.S. dollar results by the current period average foreign exchange rates and then multiplying or dividing, as appropriate, those amounts by the prior-year period average foreign exchange rates. Although exchange rate changes are part of Pfizer&#8217;s business, they are not within Pfizer&#8217;s control. Exchange rate changes, however, can mask positive or negative trends in the business; therefore, Pfizer believes presenting operational variances provides useful information in evaluating the results of its business.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:42px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">(6)</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Pfizer does not provide guidance for GAAP Reported financial measures (other than revenues) or a reconciliation of forward-looking non-GAAP financial measures to the most directly comparable GAAP Reported financial measures on a forward-looking basis because it is unable to predict with reasonable certainty the ultimate outcome of pending litigation, unusual gains and losses, acquisition-related expenses, gains and losses from equity securities and potential future asset impairments without unreasonable effort. These items are uncertain, depend on various factors, and could have a material impact on GAAP Reported results for the guidance period.</font><font style="font-family:inherit;font-size:11pt;">&#32;</font></div></td></tr></table><div style="line-height:174%;padding-bottom:16px;padding-top:16px;text-align:left;padding-left:42px;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"></font><font style="font-family:inherit;font-size:11pt;">In addition to the assumptions outlined in the 2020 Financial Guidance section of this press release, the 2020 financial guidance for Total Company</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(7)</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;reflects the following:</font><font style="font-family:inherit;font-size:11pt;">&#32;</font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:48px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Does not assume the completion of any business development transactions&#160;not completed as of</font><font style="font-family:inherit;font-size:11pt;">&#32;</font><font style="font-family:inherit;font-size:11pt;">March&#160;29, 2020</font><font style="font-family:inherit;font-size:11pt;">, including any one-time upfront payments associated with such transactions.</font><font style="font-family:inherit;font-size:11pt;">&#32;</font></div></td></tr></table><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">21</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:48px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-size:11pt;">Includes Pfizer&#8217;s pro rata share of the Consumer Healthcare JV</font><font style="font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-size:11pt;">&#32;anticipated earnings, which is recorded in Adjusted other (income)/deductions</font><font style="font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font><font style="font-size:11pt;">&#32;on a one-quarter lag. Therefore, 2020 financial guidance for Adjusted other (income)/deductions</font><font style="font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font><font style="font-size:11pt;">&#32;and Adjusted diluted EPS</font><font style="font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font><font style="font-size:11pt;">&#32;reflects Pfizer&#8217;s share of the JV&#8217;s earnings that were generated in fourth-quarter 2019 (recorded by Pfizer in first-quarter 2020) as well as Pfizer&#8217;s share of the JV&#8217;s projected earnings during the first three quarters of 2020.</font><font style="font-family:inherit;font-size:11pt;">&#32;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:48px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Reflects an anticipated negative revenue impact of </font><font style="font-family:inherit;font-size:11pt;">$2.4 billion</font><font style="font-family:inherit;font-size:11pt;">&#32;due to recent and expected generic and biosimilar competition for certain products that have recently lost or are anticipated to soon lose patent protection.</font><font style="font-family:inherit;font-size:11pt;">&#32;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:48px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Exchange rates assumed are a blend of actual exchange rates in effect through first-quarter 2020 and mid-April 2020 rates for the remainder of the year. Financial guidance reflects the anticipated unfavorable impact of approximately </font><font style="font-family:inherit;font-size:11pt;">$0.9 billion</font><font style="font-family:inherit;font-size:11pt;">&#32;on revenues and approximately </font><font style="font-family:inherit;font-size:11pt;">$0.06</font><font style="font-size:11pt;">&#32;on Adjusted diluted EPS</font><font style="font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font><font style="font-size:11pt;">&#32;as a result of changes in foreign exchange rates relative to the U.S. dollar compared to foreign exchange rates from 2019.</font><font style="font-family:inherit;font-size:11pt;">&#32;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:48px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-size:11pt;">Guidance for Adjusted diluted EPS</font><font style="font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font><font style="font-size:11pt;">&#32;assumes diluted weighted-average shares outstanding of approximately </font><font style="font-family:inherit;font-size:11pt;">5.6 billion</font><font style="font-family:inherit;font-size:11pt;">&#32;shares, which assumes no share repurchases in 2020.</font><font style="font-family:inherit;font-size:11pt;">&#32;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:42px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">(7)</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Financial guidance for Total Company reflects a full-year 2020 contribution from Biopharma and Upjohn, the current construct of the company, and excludes any impact from the pending Upjohn combination with Mylan.</font><font style="font-family:inherit;font-size:11pt;">&#32;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:42px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">(8)</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Financial guidance for New Pfizer reflects a full-year 2020 pro forma view of the company assuming the pending Upjohn combination with Mylan was completed at the beginning of 2020. Therefore, New Pfizer reflects contributions from the Biopharma business as it is presently being managed, which excludes contributions from Pfizer&#8217;s Meridian subsidiary and the Pfizer-Mylan strategic collaboration in Japan (Mylan-Japan). Pfizer&#8217;s Meridian subsidiary and Mylan-Japan were managed by Pfizer&#8217;s Biopharma business in 2019 but were moved to Upjohn in 2020. Financial guidance for New Pfizer also includes the full-year effect of</font><font style="font-family:inherit;font-size:11pt;">&#32;the following items that assume the completion of the Upjohn combination with Mylan:</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:48px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$12 billion of net proceeds from Upjohn to be retained by Pfizer, which Pfizer will use to repay its own existing indebtedness</font><font style="font-family:inherit;font-size:11pt;">; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:48px;"><font style="font-family:inherit;font-size:11pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">other transaction-related items, such as income from transition services agreements between Pfizer and Viatris.</font><font style="font-family:inherit;font-size:11pt;">&#32;</font></div></td></tr></table><div style="line-height:174%;padding-bottom:12px;padding-top:12px;text-align:left;padding-left:42px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In addition, 2020 financial guidance for New Pfizer Adjusted IBT Margin</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(9)</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;</font><font style="font-family:inherit;font-size:11pt;">and Adjusted diluted EPS</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;reflects Pfizer&#8217;s share of the earnings generated by the Consumer Healthcare JV</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;in fourth-quarter 2019 </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">22</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:174%;padding-bottom:12px;padding-top:12px;text-align:left;padding-left:42px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(recorded by Pfizer in first-quarter 2020) as well as Pfizer&#8217;s share of the JV&#8217;s projected earnings during the first three quarters of 2020.</font><font style="font-family:inherit;font-size:11pt;">&#32;</font></div><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:42px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">(9)</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-size:11pt;">Adjusted income</font><font style="font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font><font style="font-size:11pt;">&#32;before tax margin (Adjusted IBT margin) is defined as revenue less the sum of Adjusted cost of sales</font><font style="font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font><font style="font-size:11pt;">, Adjusted SI&amp;A expenses</font><font style="font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font><font style="font-size:11pt;">, Adjusted R&amp;D expenses</font><font style="font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font><font style="font-size:11pt;">, Adjusted amortization of intangible assets</font><font style="font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font><font style="font-size:11pt;">&#32;and Adjusted other (income)/deductions</font><font style="font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font><font style="font-size:11pt;">&#32;as a percentage of revenue. Adjusted IBT Margin is presented because management believes this performance measure supplements investors&#8217; and other readers&#8217; understanding and assessment of the financial performance of New Pfizer</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(8)</sup></font><font style="font-family:inherit;font-size:11pt;">. </font><font style="font-family:inherit;font-size:11pt;">Adjusted IBT margin is not, and should not be viewed as, a substitute for U.S. GAAP income before tax margin.</font><font style="font-family:inherit;font-size:11pt;">&#32;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:42px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">(10)</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Financial guidance for Upjohn reflects a full-year 2020 contribution from the Upjohn business as it is presently being managed, which includes contributions from Pfizer&#8217;s Meridian subsidiary and the Pfizer-Mylan strategic collaboration in Japan (Mylan-Japan). Pfizer&#8217;s Meridian subsidiary and Mylan-Japan were managed by Pfizer&#8217;s Biopharma business in 2019 but were moved to Upjohn in 2020.</font><font style="font-family:inherit;font-size:11pt;">&#32;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:42px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">(11)</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-size:11pt;">Adjusted Earnings Before Interest, Tax, Depreciation and Amortization (EBITDA) is defined as reported U.S. GAAP net income</font><font style="font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font><font style="font-size:11pt;">, and its components, adjusted for interest expense, provision for taxes on income and depreciation and amortization, further adjusted to exclude purchase accounting adjustments, acquisition-related costs, discontinued operations and certain significant items (some of which may recur, such as gains on the completion of joint venture transactions, restructuring charges, legal charges or gains and losses from equity securities, but which management does not believe are reflective of ongoing core operations). Adjusted EBITDA is presented because management believes this performance measure supplements investors&#8217; and other readers&#8217; understanding and assessment of the financial performance of Upjohn. Adjusted EBITDA as defined is not a measurement of financial performance under GAAP, and should not be considered as an alternative to net income</font><font style="font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font><font style="font-size:11pt;">&#32;or cash flow from operations determined in accordance with GAAP. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:42px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">(12)</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Erbitux</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;is a registered trademark of ImClone LLC.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:42px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:174%;font-size:11pt;padding-left:6px;"><font style="font-family:inherit;font-size:11pt;">(13)</font></div></td><td style="vertical-align:top;"><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">MabThera</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;is a registered trademark of Roche, Inc.</font></div></td></tr></table><div style="line-height:174%;padding-bottom:16px;padding-top:16px;text-align:left;padding-left:42px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:19%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:21%;"></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contacts:</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">Media</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">Investors</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amy Rose</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">212.733.7410</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chuck Triano</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">212.733.3901</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ryan Crowe</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">212.733.8160</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Bryan Dunn</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">212.733.8917</font></div></td></tr></table></div></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">23</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><a name="s292EB3C5F50A5310B7B87719B93BD024"></a></div><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PFIZER INC. AND</font><font style="font-family:inherit;font-size:9pt;">&#32;SUBSIDIARY COMPANIES</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">CONSOLIDATED STATEMENTS OF INCOME</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup>&#160;</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(UNAUDITED)</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(millions, except per common share data)</font></div></div><div><br></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div><a name="sF916B7BC336A5499AD03FB59C278F8EB"></a></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.74329501915709%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"></td></tr><tr><td style="width:73%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">First-Quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">% Incr. /</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">2020</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">2019</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">(Decr.)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:18px;text-indent:-18px;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">12,028</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">13,118</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">(8)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:18px;text-indent:-18px;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Costs and expenses:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:24px;text-indent:-12px;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Cost of sales</font><font style="font-family:inherit;font-size:9.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#160;(2), (3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">2,378</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">2,433</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">(2)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:24px;text-indent:-12px;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Selling, informational and administrative expenses</font><font style="font-family:inherit;font-size:9.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(2), (3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">2,873</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">3,339</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">(14)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:24px;text-indent:-12px;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Research and development expenses</font><font style="font-family:inherit;font-size:9.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(2), (3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">1,724</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">1,703</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">1</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:24px;text-indent:-12px;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Amortization of intangible assets</font><font style="font-family:inherit;font-size:9.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">885</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">1,183</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">(25)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:24px;text-indent:-12px;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Restructuring charges and certain acquisition-related costs</font><font style="font-family:inherit;font-size:9.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(4)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">69</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">46</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">49</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:24px;text-indent:-12px;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">(Gain) on completion of Consumer Healthcare JV transaction</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">(6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">*</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:24px;text-indent:-12px;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Other (income)/deductions&#8211;&#8211;net</font><font style="font-family:inherit;font-size:9.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(5)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">221</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">92</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">*</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Income from continuing operations before provision for taxes on income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">3,885</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">4,323</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">(10)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Provision for taxes on income</font><font style="font-family:inherit;font-size:9.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(6)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">475</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">433</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">10</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Income from continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">3,410</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">3,889</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">(12)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Discontinued operations&#8211;&#8211;net of tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">&#8212;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:18px;text-indent:-18px;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Net income before allocation to noncontrolling interests</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">3,410</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">3,889</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">(12)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Less: Net income attributable to noncontrolling interests</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">9</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">62</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Net income attributable to Pfizer Inc.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">3,401</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">3,884</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">(12)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Earnings per common share&#8211;&#8211;basic:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-6px;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Income from continuing operations attributable to Pfizer Inc. common shareholders</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">0.61</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">0.69</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">(11)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Discontinued operations&#8211;&#8211;net of tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">&#8212;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Net income attributable to Pfizer Inc. common shareholders</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">0.61</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">0.69</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">(11)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Earnings per common share&#8211;&#8211;diluted:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-6px;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Income from continuing operations attributable to Pfizer Inc. common shareholders</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">0.61</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">0.68</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">(10)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Discontinued operations&#8211;&#8211;net of tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">&#8212;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Net income attributable to Pfizer Inc. common shareholders</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">0.61</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">0.68</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">(10)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Weighted-average shares used to calculate earnings per common share:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">5,545</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">5,635</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Diluted</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">5,613</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">5,750</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">&#160;</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Indicates calculation not meaningful or result is equal to or greater than 100%.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:1px;padding-top:1px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See end of tables for notes (1) through (6).</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts may not add due to rounding. All percentages have been calculated using unrounded amounts.</font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">24</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><a name="sC01033B914D5527EB87DFDA0A03C33F0"></a></div><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:3pt;"><font style="font-family:inherit;font-size:3pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">PFIZER INC. AND SUBSIDIARY COMPANIES</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">NOTES TO CONSOLIDATED STATEMENTS OF INCOME</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(UNAUDITED)</font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:0px;"><font style="font-family:inherit;font-size:11pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;">The financial statements present the </font><font style="font-family:inherit;font-size:10pt;">three months</font><font style="font-family:inherit;font-size:10pt;">&#32;ended </font><font style="font-family:inherit;font-size:10pt;text-align:center;">March&#160;29, 2020</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;text-align:center;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">. Subsidiaries operating outside the U.S. are included for the </font><font style="font-family:inherit;font-size:10pt;">three months</font><font style="font-family:inherit;font-size:10pt;">&#32;ended </font><font style="font-family:inherit;font-size:10pt;">February&#160;23, 2020</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">February&#160;24, 2019</font><font style="font-family:inherit;font-size:10pt;">.</font></div></td></tr></table><div style="line-height:120%;padding-left:4px;padding-bottom:4px;padding-top:0px;text-align:left;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The financial results for the three months ended </font><font style="font-family:inherit;font-size:10pt;text-align:center;">March&#160;29, 2020</font><font style="font-family:inherit;font-size:10pt;text-align:center;">&#32;</font><font style="font-family:inherit;font-size:10pt;">are not necessarily indicative of the results that ultimately could be achieved for the full year.</font></div><div style="line-height:120%;padding-bottom:4px;padding-top:0px;text-align:left;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">The Array BioPharma Inc. and Therachon Holding AG acquisitions and the contribution of our Consumer Healthcare business to the GSK Consumer Healthcare joint venture that were completed in 2019 impacted our results of operations in the periods presented. </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">Our financial results, and our Consumer Healthcare segment&#8217;s operating results, for the first quarter of 2019 reflect three months of Consumer Healthcare segment operations while financial results for the first quarter of 2020 do not reflect any contribution from the Consumer Healthcare business. We record our share of earnings from the GSK Consumer Healthcare joint venture on a quarterly basis on a one-quarter lag in </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-style:italic;">Other (income)/deductions&#8211;&#8211;net</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">&#32;commencing from August 1, 2019. Therefore, we recorded our share of the joint venture&#8217;s earnings/losses generated in the fourth quarter of 2019 in our operating results in the first quarter of 2020.</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">&#32;See footnote (5) below.</font></div><div style="line-height:120%;padding-bottom:4px;padding-top:0px;text-align:left;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain amounts in the consolidated statements of income and associated notes may not add due to rounding. All percentages have been calculated using unrounded amounts.</font></div><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exclusive of amortization of intangible assets, except as discussed in footnote (3) below.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization expense related to finite-lived acquired intangible assets that contribute to our ability to sell, manufacture, research, market and distribute products, compounds and intellectual property is included in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Amortization of intangible assets,</font><font style="font-family:inherit;font-size:10pt;">&#32;as these intangible assets benefit multiple business functions. Amortization expense related to intangible assets that are associated with a single function is included in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Cost of sales</font><font style="font-family:inherit;font-size:10pt;">,</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#32;Selling</font><font style="font-family:inherit;font-size:10pt;">,</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#32;informational and administrative expenses</font><font style="font-family:inherit;font-size:10pt;">&#32;and/or </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Research and development expenses</font><font style="font-family:inherit;font-size:10pt;">, as appropriate.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(4)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Restructuring charges and certain acquisition-related costs </font><font style="font-family:inherit;font-size:10pt;">include the following:</font></div></td></tr></table><div style="line-height:120%;padding-left:4px;padding-bottom:0px;padding-top:0px;text-align:left;padding-left:36px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:93.84920634920636%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:76%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">First-Quarter</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(MILLIONS OF DOLLARS)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:6px;text-indent:-6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restructuring credits</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#8211;&#8211;</font><font style="font-family:inherit;font-size:10pt;">acquisition-related costs</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(a)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:6px;text-indent:-6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restructuring charges</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#8211;&#8211;</font><font style="font-family:inherit;font-size:10pt;">cost reduction initiatives</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(b)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;text-indent:-6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restructuring charges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:6px;text-indent:-6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Transaction costs</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(c)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:18px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Integration costs and other</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(d)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Restructuring charges and certain acquisition-related costs</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:1px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Includes employee termination costs, asset impairments and other exit costs associated with business combinations. Credits in the first quarter of 2019 are due to the reversal of previously recorded accruals.</font><font style="font-family:inherit;font-size:10pt;">&#32;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:1px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Includes employee termination costs, asset impairments and other exit costs not associated with acquisitions.</font><font style="font-family:inherit;font-size:10pt;">&#32;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">(c)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Transaction costs represent external costs for banking, legal, accounting and other similar services.</font><font style="font-family:inherit;font-size:10pt;">&#32;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">(d)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Integration costs and other represent external, incremental costs directly related to integrating acquired businesses, such as expenditures for consulting and the integration of systems and processes, and certain other qualifying costs.</font><font style="font-family:inherit;font-size:10pt;">&#32;</font></div></td></tr></table><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">25</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:3pt;"><font style="font-family:inherit;font-size:3pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">PFIZER INC. AND SUBSIDIARY COMPANIES</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">NOTES TO CONSOLIDATED STATEMENTS OF INCOME</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(UNAUDITED)</font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(5)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other (income)/deductions&#8211;&#8211;net</font><font style="font-family:inherit;font-size:10pt;">&#32;includes the following:</font></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;padding-left:36px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.84126984126983%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:76%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="7" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">First-Quarter</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(MILLIONS OF DOLLARS)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(34</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(66</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">390</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">361</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net interest expense</font></div></td><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">356</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">295</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Royalty-related income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(119</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(89</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;text-indent:-6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net (gains)/losses on asset disposals</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:6px;text-indent:-6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net (gains)/losses recognized during the period on equity securities</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(a)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">255</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#2c2c2c;">(111</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#2c2c2c;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;text-indent:-6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income from collaborations, out-licensing arrangements and sales of compound/product rights</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(115</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(82</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;text-indent:-6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net periodic benefit credits other than service costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(67</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(40</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;text-indent:-6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain legal matters, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;text-indent:-6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain asset impairments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">150</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Business and legal entity alignment costs</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(b)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">119</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net losses on early retirement of debt</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">138</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GSK Consumer Healthcare JV equity method (income)/loss</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(c)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other, net</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(d)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(132</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(291</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other (income)/deductions&#8211;&#8211;net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">221</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">T</font><font style="font-family:inherit;font-size:10pt;">he losses in the </font><font style="font-family:inherit;font-size:10pt;">first quarter</font><font style="font-family:inherit;font-size:10pt;">&#32;of </font><font style="font-family:inherit;font-size:10pt;">2020</font><font style="font-family:inherit;font-size:10pt;">, include, among other things, unrealized losses of </font><font style="font-family:inherit;font-size:10pt;">$134 million</font><font style="font-family:inherit;font-size:10pt;">&#32;related to our investment in Allogene Therapeutics, Inc. (Allogene). The gains in the </font><font style="font-family:inherit;font-size:10pt;">first quarter</font><font style="font-family:inherit;font-size:10pt;">&#32;of </font><font style="font-family:inherit;font-size:10pt;">2019</font><font style="font-family:inherit;font-size:10pt;">&#32;included, among other things, unrealized gains of </font><font style="font-family:inherit;font-size:10pt;">$43 million</font><font style="font-family:inherit;font-size:10pt;">&#32;related to our investment in Allogene.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:1px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the first quarter of 2019, represents incremental costs associated with the design, planning and implementation of our new organizational structure, effective in the beginning of 2019, and primarily includes consulting, legal, tax and advisory services.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:1px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">(c)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For additional information, see footnote (1) above.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">(d)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The </font><font style="font-family:inherit;font-size:10pt;">first quarter</font><font style="font-family:inherit;font-size:10pt;">&#32;of </font><font style="font-family:inherit;font-size:10pt;">2020</font><font style="font-family:inherit;font-size:10pt;">&#32;includes, among other things, dividend income of </font><font style="font-family:inherit;font-size:10pt;">$77 million</font><font style="font-family:inherit;font-size:10pt;">&#32;from our investment in ViiV Healthcare Limited (ViiV). The </font><font style="font-family:inherit;font-size:10pt;">first quarter</font><font style="font-family:inherit;font-size:10pt;">&#32;of </font><font style="font-family:inherit;font-size:10pt;">2019</font><font style="font-family:inherit;font-size:10pt;">&#32;included, among other things, credits of </font><font style="font-family:inherit;font-size:10pt;">$72 million</font><font style="font-family:inherit;font-size:10pt;">, reflecting the change in the fair value of contingent consideration, and dividend income of </font><font style="font-family:inherit;font-size:10pt;">$64 million</font><font style="font-family:inherit;font-size:10pt;">&#32;from our investment in ViiV.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(6)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The increase in the effective tax rate for the first quarter of 2020 compared to the first quarter of 2019 was primarily due to the non-recurrence of the tax benefit recorded in the first quarter of 2019 as a result of additional guidance issued by the U.S. Department of Treasury related to the legislation commonly referred to as the U.S. Tax Cuts and Jobs Act of 2017 and the decrease in tax benefits associated with the resolution of certain tax positions pertaining to prior years, partially offset by the favorable change in the jurisdictional mix of earnings as a result of operating fluctuations in the normal course of business.</font></div></td></tr></table><div style="line-height:120%;padding-left:4px;padding-bottom:4px;padding-top:0px;text-align:left;padding-left:60px;text-indent:-24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">26</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><a name="sFA21FD4AA665542AB61E93FF7D272826"></a></div><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:3pt;"><font style="font-family:inherit;font-size:3pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">PFIZER INC. AND SUBSIDIARY COMPANIES</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">RECONCILIATION OF GAAP REPORTED TO NON-GAAP ADJUSTED INFORMATION</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup>&#160;</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">CERTAIN LINE ITEMS - (UNAUDITED)</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(millions of dollars, except per common share data)</font></div></div><div><br></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="25"></td></tr><tr><td style="width:30%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="23" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">First-Quarter 2020</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">GAAP Reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Purchase Accounting Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Acquisition-Related Items</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Discontinued Operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Certain Significant Items</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Non-GAAP Adjusted</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(4)</sup></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">12,028</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12,028</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cost of sales</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(5), (6)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2,378</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(32</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,350</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Selling, informational and administrative expenses</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(5), (6)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2,873</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(129</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,745</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Research and development expenses</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#160;(5), (6)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">1,724</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,727</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Amortization of intangible assets</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(6)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">885</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(814</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">71</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Restructuring charges and certain acquisition-related costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">69</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(13</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(55</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(Gain) on completion of Consumer Healthcare JV transaction</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other (income)/deductions&#8211;&#8211;net</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(7)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">221</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(403</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(186</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Income from continuing operations before provision for taxes on income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">3,885</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">812</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">612</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,322</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Provision for taxes on income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">475</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">180</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">140</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">799</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Income from continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">3,410</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">632</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">472</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,523</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Discontinued operations&#8211;&#8211;net of tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net income attributable to noncontrolling interests</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">9</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net income attributable to Pfizer Inc.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">3,401</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">632</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">472</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,514</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Earnings per common share attributable to Pfizer Inc.&#8211;&#8211;diluted</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">0.61</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.11</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.08</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.80</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"></td></tr><tr><td style="width:30%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:11%;"></td></tr><tr><td colspan="13" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="25"></td></tr><tr><td style="width:30%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="23" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">First-Quarter 2019</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">GAAP Reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Purchase Accounting Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Acquisition-Related Items</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Discontinued Operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Certain Significant Items</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Non-GAAP Adjusted</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(4)</sup></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">13,118</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13,118</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cost of sales</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(5), (6)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2,433</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(22</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,415</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Selling, informational and administrative expenses</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(5), (6)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">3,339</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(27</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,311</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Research and development expenses</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(5), (6)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">1,703</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(11</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,693</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Amortization of intangible assets</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(6)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">1,183</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,120</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">63</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Restructuring charges and certain acquisition-related costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">46</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(27</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(19</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(Gain) on completion of Consumer Healthcare JV transaction</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other (income)/deductions&#8211;&#8211;net</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(7)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">92</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">76</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(303</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(135</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Income from continuing operations before provision for taxes on income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">4,323</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,038</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">382</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,771</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Provision for taxes on income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">433</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">224</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">212</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">875</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Income from continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">3,889</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">814</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">23</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">171</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,896</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Discontinued operations&#8211;&#8211;net of tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net income attributable to noncontrolling interests</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net income attributable to Pfizer Inc.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">3,884</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">814</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">23</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">171</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,891</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Earnings per common share attributable to Pfizer Inc.&#8211;&#8211;diluted</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">0.68</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.14</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.03</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.85</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">See end of tables for notes (1) through (7).</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Amounts may not add due to rounding.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"></td></tr><tr><td style="width:30%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:11%;"></td></tr><tr><td colspan="13" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">27</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><a name="s9D315B420E965DF18ECFDB8E6FDA3D50"></a></div><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:3pt;"><font style="font-family:inherit;font-size:3pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">PFIZER INC. AND SUBSIDIARY COMPANIES</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">NOTES TO RECONCILIATION OF GAAP REPORTED TO NON-GAAP ADJUSTED INFORMATION</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">CERTAIN LINE ITEMS - (UNAUDITED)</font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">The Array BioPharma Inc. and Therachon Holding AG acquisitions and the contribution of our Consumer Healthcare business to the GSK Consumer Healthcare joint venture that were completed in 2019 impacted our results of operations in the periods presented.</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">Our financial results, and our Consumer Healthcare segment&#8217;s operating results, for the first quarter of 2019 reflect three months of Consumer Healthcare segment operations while financial results for the first quarter of 2020 do not reflect any contribution from the Consumer Healthcare business. We record our share of earnings from the GSK Consumer Healthcare joint venture on a quarterly basis on a one-quarter lag in </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-style:italic;">Other (income)/deductions&#8211;&#8211;net</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">&#32;commencing from August 1, 2019. Therefore, we recorded our share of the joint venture&#8217;s earnings/losses generated in the fourth quarter of 2019 in our operating results in the first quarter of 2020.</font><font style="font-family:inherit;font-size:10pt;">&#32;For the non-GAAP measure of Adjusted Earnings (see footnote (4) below), charges primarily related to our pro rata share of restructuring and business combination accounting charges recorded by the Consumer Healthcare joint venture have been excluded from the measure.</font></div></td></tr></table><div style="line-height:120%;padding-left:4px;padding-bottom:4px;padding-top:0px;text-align:left;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain amounts in the reconciliation of GAAP reported to Non-GAAP adjusted information and associated notes may not add due to rounding. </font></div><div style="line-height:120%;padding-left:4px;padding-bottom:4px;padding-top:0px;text-align:left;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The financial statements present the </font><font style="font-family:inherit;font-size:10pt;">three months</font><font style="font-family:inherit;font-size:10pt;">&#32;ended </font><font style="font-family:inherit;font-size:10pt;text-align:center;">March&#160;29, 2020</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;text-align:center;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">. Subsidiaries operating outside the U.S. are included for the </font><font style="font-family:inherit;font-size:10pt;">three months</font><font style="font-family:inherit;font-size:10pt;">&#32;ended </font><font style="font-family:inherit;font-size:10pt;">February&#160;23, 2020</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">February&#160;24, 2019</font><font style="font-family:inherit;font-size:10pt;">.</font></div><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition-related items include the following:</font></div></td></tr></table><div style="line-height:174%;padding-bottom:0px;padding-top:0px;text-align:left;padding-left:36px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.64285714285714%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:70%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">First-Quarter</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(MILLIONS OF DOLLARS)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">2020</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">2019</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restructuring credits</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(a)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Transaction costs</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(b)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Integration costs and other</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(c)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additional depreciation&#8211;&#8211;asset restructuring</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(d)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total acquisition-related items&#8211;&#8211;pre-tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income taxes</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(e)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total acquisition-related items&#8211;&#8211;net of tax</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:1px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:9.5pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-size:10pt;">Includes employee termination costs, asset impairments and other exit costs associated with business combinations. Credits in the first quarter of 2019 are due to the reversal of previously recorded accruals.</font><font style="font-family:inherit;font-size:10pt;">&#32;All of these items are included in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Restructuring charges and certain acquisition-related costs</font><font style="font-family:inherit;font-size:10pt;">.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:1px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-size:10pt;">Transaction costs represent external costs for banking, legal, accounting and other similar services.</font><font style="font-family:inherit;font-size:10pt;">&#32;All of these items are included in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Restructuring charges and certain acquisition-related costs</font><font style="font-family:inherit;font-size:10pt;">.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:1px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">(c)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Integration costs and other represent external, incremental costs directly related to integrating acquired businesses, such as expenditures for consulting and the integration of systems and processes, and certain other qualifying costs.</font><font style="font-family:inherit;font-size:10pt;">&#32;All of these costs and charges are included in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Restructuring charges and certain acquisition-related costs</font><font style="font-family:inherit;font-size:10pt;">.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:1px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">(d)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Represents the impact of changes in the estimated useful lives of assets involved in restructuring actions related to acquisitions.</font><font style="font-family:inherit;font-size:10pt;">&#32;In the </font><font style="font-family:inherit;font-size:10pt;">first quarter</font><font style="font-family:inherit;font-size:10pt;">&#32;of </font><font style="font-family:inherit;font-size:10pt;">2019</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">, </font><font style="font-family:inherit;font-size:10pt;">included in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Selling, informational and administrative expenses.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">(e)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Included in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Provision for taxes on income</font><font style="font-family:inherit;font-size:10pt;">. </font><font style="font-family:inherit;font-size:10pt;">Income taxes includes the tax effect of the associated pre-tax amounts, calculated by determining the jurisdictional location of the pre-tax amounts and applying that jurisdiction&#8217;s applicable tax rate.</font><font style="font-family:inherit;font-size:10pt;">&#32;</font></div></td></tr></table><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">28</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:3pt;"><font style="font-family:inherit;font-size:3pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">PFIZER INC. AND SUBSIDIARY COMPANIES</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">NOTES TO RECONCILIATION OF GAAP REPORTED TO NON-GAAP ADJUSTED INFORMATION</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">CERTAIN LINE ITEMS - (UNAUDITED)</font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain significant items include the following:</font></div></td></tr></table><div style="line-height:174%;padding-bottom:0px;padding-top:0px;text-align:left;padding-left:36px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:76%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">First-Quarter</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(MILLIONS OF DOLLARS)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">2020</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">2019</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restructuring charges</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#8211;&#8211;</font><font style="font-family:inherit;font-size:10pt;">cost reduction initiatives</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(a)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:6px;text-indent:-6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Implementation costs and additional depreciation&#8211;&#8211;asset restructuring</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(b)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net (gains)/losses recognized during the period on equity securities</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(c)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">195</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(111</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain legal matters, net</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(c)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain asset impairments</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(c)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">139</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Business and legal entity alignment costs</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(d)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">115</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">119</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net losses on early retirement of debt</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(c)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">138</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(e)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">212</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total certain significant items&#8211;&#8211;pre-tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">612</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">382</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income taxes</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(f)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">140</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">212</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total certain significant items&#8211;&#8211;net of tax</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">472</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">171</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:1px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Includes employee termination costs, asset impairments and other exit costs not associated with acquisitions, which are included in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Restructuring charges and certain acquisition-related costs</font><font style="font-family:inherit;font-size:10pt;">.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:1px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Relates to our cost-reduction and productivity initiatives not related to acquisitions. Primarily included in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Cost of sales</font><font style="font-family:inherit;font-size:10pt;">&#32;(</font><font style="font-family:inherit;font-size:10pt;">$15 million</font><font style="font-family:inherit;font-size:10pt;">) and </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Selling, informational and administrative expenses</font><font style="font-family:inherit;font-size:10pt;">&#32;(</font><font style="font-family:inherit;font-size:10pt;">$15 million</font><font style="font-family:inherit;font-size:10pt;">) for the </font><font style="font-family:inherit;font-size:10pt;">first quarter</font><font style="font-family:inherit;font-size:10pt;">&#32;of </font><font style="font-family:inherit;font-size:10pt;text-align:center;">2020</font><font style="font-family:inherit;font-size:10pt;">. Primarily included in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Cost of sales</font><font style="font-family:inherit;font-size:10pt;">&#32;(</font><font style="font-family:inherit;font-size:10pt;">$22 million</font><font style="font-family:inherit;font-size:10pt;">) for the </font><font style="font-family:inherit;font-size:10pt;">first quarter</font><font style="font-family:inherit;font-size:10pt;">&#32;of </font><font style="font-family:inherit;font-size:10pt;">2019</font><font style="font-family:inherit;font-size:10pt;">.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:1px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">(c)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Included in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other (income)/deductions&#8211;&#8211;net.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:1px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">(d)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the </font><font style="font-family:inherit;font-size:10pt;">first quarter</font><font style="font-family:inherit;font-size:10pt;">&#32;of </font><font style="font-family:inherit;font-size:10pt;">2020</font><font style="font-family:inherit;font-size:10pt;">, primarily included in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Cost of sales </font><font style="font-family:inherit;font-size:10pt;">(</font><font style="font-family:inherit;font-size:10pt;">$15 million</font><font style="font-family:inherit;font-size:10pt;">) and </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Selling, informational and administrative expenses </font><font style="font-family:inherit;font-size:10pt;">(</font><font style="font-family:inherit;font-size:10pt;">$98 million</font><font style="font-family:inherit;font-size:10pt;">)</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#32;</font><font style="font-family:inherit;font-size:10pt;">and represents separation costs associated with our planned Upjohn transaction with Mylan, and mainly includes consulting, legal, tax and advisory services. In the </font><font style="font-family:inherit;font-size:10pt;">first quarter</font><font style="font-family:inherit;font-size:10pt;">&#32;of </font><font style="font-family:inherit;font-size:10pt;">2019</font><font style="font-family:inherit;font-size:10pt;">, included in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other (income)/deductions&#8211;&#8211;net </font><font style="font-family:inherit;font-size:10pt;">and represents incremental costs associated with the design, planning and implementation of our new organizational structure, effective in the beginning of 2019, and primarily includes consulting, legal, tax and advisory services.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:1px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">(e)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the </font><font style="font-family:inherit;font-size:10pt;">first quarter</font><font style="font-family:inherit;font-size:10pt;">&#32;of</font><font style="font-family:inherit;font-size:11pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;text-align:center;">2020</font><font style="font-family:inherit;font-size:10pt;">, primarily included in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Selling, informational and administrative expenses </font><font style="font-family:inherit;font-size:10pt;">(</font><font style="font-family:inherit;font-size:10pt;">$17 million</font><font style="font-family:inherit;font-size:10pt;">)</font><font style="font-family:inherit;font-size:9.5pt;font-style:italic;">&#32;</font><font style="font-family:inherit;font-size:9.5pt;">and </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other (income)/deductions&#8211;&#8211;net</font><font style="font-family:inherit;font-size:10pt;">&#32;(</font><font style="font-family:inherit;font-size:10pt;">$199 million</font><font style="font-family:inherit;font-size:10pt;">)</font><font style="font-family:inherit;font-size:9.5pt;font-style:italic;">.</font><font style="font-family:inherit;font-size:10pt;">&#32;For the </font><font style="font-family:inherit;font-size:10pt;">first quarter</font><font style="font-family:inherit;font-size:10pt;">&#32;of </font><font style="font-family:inherit;font-size:10pt;text-align:center;">2019</font><font style="font-family:inherit;font-size:10pt;">, primarily included in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Selling, informational and administrative expenses </font><font style="font-family:inherit;font-size:10pt;">(</font><font style="font-family:inherit;font-size:10pt;">$18 million</font><font style="font-family:inherit;font-size:10pt;">) and </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other (income)/deductions&#8211;&#8211;net</font><font style="font-family:inherit;font-size:10pt;">&#32;(</font><font style="font-family:inherit;font-size:10pt;">$24 million</font><font style="font-family:inherit;font-size:10pt;">). The </font><font style="font-family:inherit;font-size:10pt;">first quarter</font><font style="font-family:inherit;font-size:10pt;">&#32;of </font><font style="font-family:inherit;font-size:10pt;text-align:center;">2020</font><font style="font-family:inherit;font-size:10pt;">&#32;includes, among other things, charges of </font><font style="font-family:inherit;font-size:10pt;">$160 million</font><font style="font-family:inherit;font-size:10pt;">&#32;recorded in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other (income)/deductions&#8211;&#8211;net </font><font style="font-family:inherit;font-size:10pt;">primarily representing our pro rata share of restructuring and business combination accounting charges recorded by the GSK Consumer Healthcare joint venture. See footnote (1) above.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">(f)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Included in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Provision for taxes on income</font><font style="font-family:inherit;font-size:10pt;">. Income taxes includes the tax effect of the associated pre-tax amounts, calculated by determining the jurisdictional location of the pre-tax amounts and applying that jurisdiction&#8217;s applicable tax rate.</font><font style="font-family:inherit;font-size:10pt;">&#32;The first quarter of 2019 was favorably impacted primarily by the tax benefit recorded as a result of additional guidance issued by the U.S. Department of Treasury related to the legislation commonly referred to as the U.S. Tax Cuts and Jobs Act of 2017.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(4)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-GAAP Adjusted income and its components and Non-GAAP Adjusted diluted EPS are not, and should not be viewed as, substitutes for U.S. GAAP net income and its components and diluted EPS. Despite the importance of these measures to management in goal setting and performance measurement (as described in the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Review&#8211;&#8211;Non-GAAP Financial Measure (Adjusted Income)</font><font style="font-family:inherit;font-size:10pt;">&#32;section of Pfizer&#8217;s </font><font style="font-family:inherit;font-size:10pt;">2019</font><font style="font-family:inherit;font-size:10pt;">&#32;Financial Report, which was filed as Exhibit 13 to Pfizer&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, </font><font style="font-family:inherit;font-size:10pt;">2019</font><font style="font-family:inherit;font-size:10pt;">), Non-GAAP Adjusted income and its components and Non-GAAP Adjusted diluted EPS are non-GAAP financial measures that have no standardized meaning prescribed by U.S. GAAP and, therefore, are limited in their usefulness to investors.&#160;Because of their non-standardized definitions, Non-GAAP Adjusted income and its components and Non-GAAP Adjusted diluted EPS (unlike U.S. GAAP net income and its components and diluted EPS) may not be comparable to the calculation of similar measures of other companies.&#160;Non-GAAP Adjusted income and its components and Non-GAAP Adjusted diluted EPS are presented solely to permit investors to more fully understand how management assesses performance.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(5)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exclusive of amortization of intangible assets, except as discussed in footnote (6) below.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(6)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization expense related to finite-lived acquired intangible assets that contribute to our ability to sell, manufacture, research, market and distribute products, compounds and intellectual property is included in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Amortization of intangible assets</font><font style="font-family:inherit;font-size:10pt;">&#32;as these intangible assets benefit multiple business functions. Amortization expense </font></div></td></tr></table><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">29</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:3pt;"><font style="font-family:inherit;font-size:3pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">PFIZER INC. AND SUBSIDIARY COMPANIES</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">NOTES TO RECONCILIATION OF GAAP REPORTED TO NON-GAAP ADJUSTED INFORMATION</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">CERTAIN LINE ITEMS - (UNAUDITED)</font></div></div><div><br></div><div style="line-height:120%;padding-left:36px;padding-bottom:4px;padding-top:0px;text-align:left;"><font style="font-family:inherit;font-size:10pt;">related to intangible assets that are associated with a single function is included in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Cost of sales, Selling, informational and administrative expenses</font><font style="font-family:inherit;font-size:10pt;">&#32;and/or </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Research and development expenses</font><font style="font-family:inherit;font-size:10pt;">, as appropriate.</font></div><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(7)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-GAAP Adjusted </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other (income)/deductions&#8211;&#8211;net</font><font style="font-family:inherit;font-size:10pt;">&#32;includes the following:</font></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;padding-left:36px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:76%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">First-Quarter</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(MILLIONS OF DOLLARS)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(34</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(66</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">395</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">366</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net interest expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">361</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">300</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Royalty-related income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(119</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(89</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;text-indent:-6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net (gains)/losses on asset disposals</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;text-indent:-6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net losses recognized during the period on equity securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;text-indent:-6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income from collaborations, out-licensing arrangements and sales of compound/product rights</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(115</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(82</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;text-indent:-6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net periodic benefit credits other than service costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(102</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(46</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;text-indent:-6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain legal matters, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;text-indent:-6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain asset impairments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GSK Consumer Healthcare JV equity method (income)/loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(127</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(145</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(238</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-GAAP Adjusted </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other (income)/deductions&#8211;&#8211;net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(186</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(135</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:left;padding-left:36px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;">For additional information regarding the adjustments, see the accompanying reconciliations. See Note (5) to Consolidated Statements of Income for the </font><font style="font-family:inherit;font-size:10pt;">first quarter</font><font style="font-family:inherit;font-size:10pt;">&#32;of </font><font style="font-family:inherit;font-size:10pt;">2020</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;text-align:center;">2019</font><font style="font-family:inherit;font-size:10pt;">&#32;above for additional information on the components comprising GAAP reported </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other (income)/deductions</font><font style="font-family:inherit;font-size:11pt;">&#8211;&#8211;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">net</font><font style="font-family:inherit;font-size:10pt;">. For additional information on certain significant items excluded from GAAP reported </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other (income)/deductions</font><font style="font-family:inherit;font-size:11pt;">&#8211;&#8211;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">net</font><font style="font-family:inherit;font-size:10pt;">&#32;in calculating Non-GAAP Adjusted </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other (income)/deductions&#8211;&#8211;net,</font><font style="font-family:inherit;font-size:10pt;">&#32;refer to footnote (4) above.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">30</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><a name="sD2EDD18D5B7C54B290AF1A9C5C14D14E"></a></div><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">PFIZER INC. AND SUBSIDIARY COMPANIES</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">OPERATING SEGMENT INFORMATION</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1) </sup></font><font style="font-family:inherit;font-size:9pt;">- (UNAUDITED)</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(millions of dollars)</font></div></div><div><br></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.81481481481481%;border-collapse:collapse;text-align:left;"><tr><td colspan="25"></td></tr><tr><td style="width:39%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td></tr><tr><td colspan="25" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The following tables provide revenue and cost information by reportable operating segment and a reconciliation of that information to our consolidated statements of income:</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="23" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">First-Quarter 2020</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">Biopharma</font><font style="font-family:inherit;font-size:8.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">Upjohn</font><font style="font-family:inherit;font-size:8.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">Other</font><font style="font-family:inherit;font-size:8.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">Non-GAAP Adjusted</font><font style="font-family:inherit;font-size:8.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(4)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">Reconciling Items</font><font style="font-family:inherit;font-size:8.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(5)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;font-weight:bold;">GAAP Reported</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">Revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">10,007</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">2,022</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">12,028</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;font-weight:bold;">12,028</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">Cost of sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">1,775</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">497</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">78</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">2,350</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">28</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;font-weight:bold;">2,378</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">% of revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">17.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">24.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">*</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">19.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">*</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;font-weight:bold;">19.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;font-weight:bold;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">Selling, informational and administrative expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">1,492</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">286</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">967</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">2,745</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">128</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;font-weight:bold;">2,873</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">Research and development expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">185</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">55</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">1,487</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">1,727</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">(3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;font-weight:bold;">1,724</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">Amortization of intangible assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">71</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">71</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">814</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;font-weight:bold;">885</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">Restructuring charges and certain acquisition-related costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">69</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;font-weight:bold;">69</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">(Gain) on completion of Consumer Healthcare JV transaction</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">(6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;font-weight:bold;">(6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;font-weight:bold;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">Other (income)/deductions&#8211;&#8211;net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">(245</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">(7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">66</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">(186</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">407</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;font-weight:bold;">221</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">Income/(loss) from continuing operations before provision for taxes on income</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">6,729</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">1,191</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">(2,598</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">5,322</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">(1,437</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;font-weight:bold;">3,885</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.81481481481481%;border-collapse:collapse;text-align:left;"><tr><td colspan="25"></td></tr><tr><td style="width:39%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="23" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">First-Quarter 2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">Biopharma</font><font style="font-family:inherit;font-size:8.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">Upjohn</font><font style="font-family:inherit;font-size:8.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">Other</font><font style="font-family:inherit;font-size:8.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">Non-GAAP Adjusted</font><font style="font-family:inherit;font-size:8.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(4)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">Reconciling Items</font><font style="font-family:inherit;font-size:8.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(5)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;font-weight:bold;">GAAP Reported</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">Revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">9,045</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">3,214</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">858</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">13,118</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;font-weight:bold;">13,118</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">Cost of sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">1,642</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">537</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">236</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">2,415</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">18</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;font-weight:bold;">2,433</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">% of revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">18.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">16.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">*</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">18.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">*</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;font-weight:bold;">18.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;font-weight:bold;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">Selling, informational and administrative expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">1,516</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">336</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">1,459</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">3,311</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">27</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;font-weight:bold;">3,339</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">Research and development expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">164</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">55</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">1,474</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">1,693</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">10</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;font-weight:bold;">1,703</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">Amortization of intangible assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">63</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">63</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">1,120</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;font-weight:bold;">1,183</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">Restructuring charges and certain acquisition-related costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">46</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;font-weight:bold;">46</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">(Gain) on completion of Consumer Healthcare JV transaction</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">Other (income)/deductions&#8211;&#8211;net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">(222</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">7</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">80</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">(135</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">227</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;font-weight:bold;">92</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">Income/(loss) from continuing operations before provision for taxes on income</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">5,883</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">2,279</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">(2,391</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">5,771</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">(1,449</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><font style="font-family:inherit;font-size:8.5pt;font-weight:bold;">4,323</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">See end of tables for notes (1) through (5).</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Amounts may not add due to rounding.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">* Indicates calculation not meaningful or result is equal to or greater than 100%.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">31</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><a name="sB928120C9F255E359F44C549EC0A7844"></a></div><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:3pt;"><font style="font-family:inherit;font-size:3pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">PFIZER INC. AND SUBSIDIARY COMPANIES</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">NOTES TO OPERATING SEGMENT INFORMATION - (UNAUDITED)</font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At the beginning of our 2019 fiscal year, we reorganized our commercial operations and began to manage our commercial operations through a new global structure consisting of three distinct business segments: Pfizer Biopharmaceuticals Group (Biopharma), Upjohn and through </font><font style="font-family:inherit;font-size:10pt;">July&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">, Pfizer&#8217;s Consumer Healthcare business (Consumer Healthcare). See footnote (2) below for additional information.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;padding-top:0px;text-align:left;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Beginning in 2020, Upjohn began managing our Meridian subsidiary, the manufacturer of EpiPen and other auto-injector products, and a pre-existing strategic collaboration between Pfizer and Mylan N.V. for generic drugs in Japan (Mylan-Japan). As a result, revenues and expenses associated with Meridian and Mylan-Japan are reported in our Upjohn business beginning in the first quarter of 2020. In 2019, revenues and expenses from Meridian and Mylan-Japan were recorded in our Biopharma business. We have revised prior-period information (Revenues and Earnings, as defined by management) to conform to the current management structure.</font></div><div style="line-height:120%;padding-bottom:4px;padding-top:0px;text-align:left;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">The Array BioPharma Inc. and Therachon Holding AG acquisitions and the contribution of our Consumer Healthcare business to the GSK Consumer Healthcare joint venture that were completed in 2019 impacted our results of operations in the periods presented. </font><font style="font-family:inherit;font-size:10pt;">Our financial results, and our Consumer Healthcare segment&#8217;s operating results, for the first quarter of 2019 reflect three months of Consumer Healthcare segment operations while financial results for the first quarter of 2020 do not reflect any contribution from the Consumer Healthcare business. We record our share of earnings from the GSK Consumer Healthcare joint venture on a quarterly basis on a one-quarter lag in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other (income)/deductions&#8211;&#8211;net</font><font style="font-family:inherit;font-size:10pt;">&#32;commencing from August 1, 2019. Therefore, we recorded our share of the joint venture&#8217;s earnings/losses generated in the fourth quarter of 2019 in our operating results in the first quarter of 2020.</font></div><div style="line-height:120%;padding-bottom:4px;padding-top:0px;text-align:left;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain amounts in the operating segment information and associated notes may not add due to rounding. </font></div><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts represent the revenues and costs managed by each of the Biopharma and Upjohn reportable operating segments for the periods presented. The expenses generally include only those costs directly attributable to the operating segment. The segment information presents the </font><font style="font-family:inherit;font-size:10pt;">three months</font><font style="font-family:inherit;font-size:10pt;">&#32;ended </font><font style="font-family:inherit;font-size:10pt;text-align:center;">March&#160;29, 2020</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;text-align:center;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">. Subsidiaries operating outside the U.S. are included for the </font><font style="font-family:inherit;font-size:10pt;">three months</font><font style="font-family:inherit;font-size:10pt;">&#32;ended </font><font style="font-family:inherit;font-size:10pt;">February&#160;23, 2020</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">February&#160;24, 2019</font><font style="font-family:inherit;font-size:10pt;">.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Operating Segments</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;padding-left:12px;text-indent:-12px;font-size:16pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.02380952380952%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:10%;"></td><td style="width:40%;"></td><td style="width:1%;"></td><td style="width:49%;"></td></tr><tr><td colspan="4" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Some additional information about our Biopharma and Upjohn business segments follows:</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px dotted #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-left:72px;text-indent:-72px;"><img src="pfizerlogo2019.jpg" alt="pfizerlogo2019.jpg" style="height:28px;width:48px;"></div></td><td style="vertical-align:middle;border-bottom:1px dotted #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:16pt;"><font style="font-family:inherit;font-size:16pt;font-weight:bold;">Pfizer</font></div><div style="text-align:left;padding-left:72px;text-indent:-72px;font-size:16pt;"><font style="font-family:inherit;font-size:16pt;font-weight:bold;">Biopharmaceuticals</font></div><div style="text-align:left;padding-left:72px;text-indent:-72px;font-size:16pt;"><font style="font-family:inherit;font-size:16pt;font-weight:bold;">Group</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px dotted #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;"><img src="upjohnlogo.jpg" alt="upjohnlogo.jpg" style="height:74px;width:194px;"></div></td></tr><tr><td colspan="2" style="vertical-align:top;border-bottom:1px dotted #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Biopharma is a science-based medicines business that includes six business units &#8211; Oncology, Inflammation &amp; Immunology, Rare Disease, Hospital, Vaccines and Internal Medicine. The Hospital unit commercializes our global portfolio of sterile injectable and anti-infective medicines and includes Pfizer&#8217;s contract manufacturing operation, Pfizer CentreOne. Each business unit is committed to delivering breakthroughs that change patients&#8217; lives.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px dotted #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Upjohn is a global, primarily off-patent branded and generic medicines business, which includes a portfolio of 20 globally recognized solid oral dose brands, as well as a U.S.-based generics platform, Greenstone.</font></div></td></tr><tr><td colspan="2" style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Select products include:<br></font><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Prevnar 13/Prevenar 13<br></font><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Eliquis</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Ibrance<br></font><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Xeljanz</font><font style="font-family:inherit;font-size:10pt;"><br>- </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Enbrel </font><font style="font-family:inherit;font-size:10pt;">(outside the U.S. and Canada)</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"><br></font><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Chantix/Champix</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">- Vyndaqel/Vyndamax</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">- Xtandi</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Sutent</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Select products include:<br></font><font style="font-family:inherit;font-size:10pt;font-style:italic;">- Lipitor</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Lyrica<br>- Norvasc</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">- Celebrex</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">- Viagra<br></font><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Certain generic medicines</font></div></td></tr></table></div></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">32</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:3pt;"><font style="font-family:inherit;font-size:3pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">PFIZER INC. AND SUBSIDIARY COMPANIES</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">NOTES TO OPERATING SEGMENT INFORMATION - (UNAUDITED)</font></div></div><div><br></div><div style="line-height:120%;padding-bottom:6px;padding-top:10px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;text-decoration:underline;">First Quarter</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;text-decoration:underline;">&#32;of </font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;text-align:center;text-decoration:underline;">2020</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;text-decoration:underline;">&#32;vs. </font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;text-decoration:underline;">First Quarter</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;text-decoration:underline;">&#32;of </font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;text-align:center;text-decoration:underline;">2019</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Biopharma Operating Segment</font></div><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Cost of sales </font><font style="font-family:inherit;font-size:10pt;">as a percentage of </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenues </font><font style="font-family:inherit;font-size:10pt;">was relatively flat</font><font style="font-family:inherit;font-size:10pt;">.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The </font><font style="font-family:inherit;font-size:10pt;">increase</font><font style="font-family:inherit;font-size:10pt;">&#32;in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Cost of sales</font><font style="font-family:inherit;font-size:10pt;">&#32;of </font><font style="font-family:inherit;font-size:10pt;">8%</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-size:10pt;">was mainly driven by an increase in sales volumes for various products within our product portfolio, an unfavorable change in product mix, and an increase in royalty expenses based on the mix of products sold.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The </font><font style="font-family:inherit;font-size:10pt;">decrease</font><font style="font-family:inherit;font-size:10pt;">&#32;in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Selling, informational and administrative expenses</font><font style="font-family:inherit;font-size:10pt;">&#32;of </font><font style="font-family:inherit;font-size:10pt;">2%</font><font style="font-size:10pt;">&#32;was mostly driven by lower investments across the Inflammation &amp; Immunology portfolio, lower healthcare reform expenses, and a favorable impact of foreign exchange, partially offset by additional investment in emerging markets, the Oncology portfolio in developed markets, and for marketing and promotional expenses associated with the U.S. launches of Vyndaqel in May 2019 and Vyndamax in September 2019.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The </font><font style="font-family:inherit;font-size:10pt;">increase</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#32;</font><font style="font-family:inherit;font-size:10pt;">in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Research and development</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">expenses</font><font style="font-family:inherit;font-size:10pt;">&#32;of </font><font style="font-family:inherit;font-size:10pt;">13%</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-size:10pt;">was mainly related to increased medical spending, primarily for Oncology, Internal Medicine and Rare Disease.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The </font><font style="font-family:inherit;font-size:10pt;">favorable</font><font style="font-family:inherit;font-size:10pt;">&#32;change in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other (income)/deductions&#8211;&#8211;net</font><font style="font-family:inherit;font-size:10pt;">&#32;includes, among other things, an increase in royalty-related income, an increase in income from collaborations, out-licensing arrangements and sales of compound/product rights, and an increase in dividend income from our investment in ViiV Healthcare Limited.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:6px;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Upjohn Operating Segment</font></div><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Cost of sales </font><font style="font-family:inherit;font-size:10pt;">as a percentage of </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenues </font><font style="font-family:inherit;font-size:10pt;">increase</font><font style="font-family:inherit;font-size:10pt;">d </font><font style="font-family:inherit;font-size:10pt;">7.9</font><font style="font-family:inherit;font-size:10pt;">&#32;percentage points, </font><font style="font-size:10pt;">driven by lower Lyrica revenues, primarily in the U.S. due to multi-source generic competition that began in July 2019, lower Lipitor and Norvasc revenues due to the</font><font style="font-family:inherit;font-size:10pt;">&#32;Volume-Based Procurement (VBP) </font><font style="font-size:10pt;">program in China, which was initially implemented in March 2019 and expanded nationwide beginning in December 2019, and an unfavorable impact of foreign exchange, partially offset by lower royalty expense for Lyrica due to the patent expiration.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The </font><font style="font-family:inherit;font-size:10pt;">decrease</font><font style="font-family:inherit;font-size:10pt;">&#32;in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Cost of sales</font><font style="font-family:inherit;font-size:10pt;">&#32;of </font><font style="font-family:inherit;font-size:10pt;">7%</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-size:10pt;">was mainly driven by lower royalty expense and a decrease in sales volume due to the Lyrica patent expiration and multi-source generic competition that began in July 2019, as well as decreases in sales volumes of Lipitor and Norvasc due to the VBP program in China, which was initially implemented in March 2019 and expanded nationwide beginning in December 2019, partially offset by an unfavorable impact of foreign exchange.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Selling, informational and administrative</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">expenses </font><font style="font-family:inherit;font-size:10pt;">decrease</font><font style="font-family:inherit;font-size:10pt;">d </font><font style="font-family:inherit;font-size:10pt;">15%</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-size:10pt;">driven by a reduction in field force expense as well as advertising and promotion expenses, primarily related to Lyrica in the U.S. due to the patent expiration, as well as a decrease in Lipitor and Norvasc expenses due to the VBP program in China, which was initially implemented in March 2019 and expanded nationwide beginning in December 2019, partially offset by expenses for enabling functions that provide autonomy and position Upjohn to operate as a stand-alone division</font><font style="color:#2c2c2c;font-size:10pt;">.</font><font style="font-family:inherit;font-size:10pt;">&#32;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Research and development expenses </font><font style="font-family:inherit;font-size:10pt;">and </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other (income)/deductions&#8211;&#8211;net </font><font style="background-color:#ffffff;font-size:10pt;">were relatively unchanged.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;padding-left:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprises the revenues and costs included in our Adjusted income components (see footnote (c) below) that are managed outside Biopharma and Upjohn and includes the following: </font></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;padding-left:36px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.84126984126983%;border-collapse:collapse;text-align:left;"><tr><td colspan="21"></td></tr><tr><td style="width:45%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="19" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">First-Quarter 2020</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other Business Activities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(IN MILLIONS)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">WRDM</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(a)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">GPD</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(b)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(c)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Corporate and Other Unallocated</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(d)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cost of sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">79</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">78</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Selling, informational and administrative expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">29</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">106</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">832</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">967</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Research and development expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">578</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">771</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">132</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,487</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Amortization of intangible assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Restructuring charges and certain acquisition-related costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(Gain) on completion of Consumer Healthcare JV transaction</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other (income)/deductions&#8211;&#8211;net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">66</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">66</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Income/(loss) from continuing operations before provision for taxes on income</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(609</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(767</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(113</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,110</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,598</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;padding-left:36px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.64285714285714%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"></td></tr><tr><td style="width:45%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:9%;"></td></tr><tr><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">33</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:3pt;"><font style="font-family:inherit;font-size:3pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">PFIZER INC. AND SUBSIDIARY COMPANIES</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">NOTES TO OPERATING SEGMENT INFORMATION - (UNAUDITED)</font></div></div><div><br></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;padding-left:36px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.64285714285714%;border-collapse:collapse;text-align:left;"><tr><td colspan="21"></td></tr><tr><td style="width:45%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">First-Quarter 2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other Business Activities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(IN MILLIONS)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">WRDM</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(a)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">GPD</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(b)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(c)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Corporate and Other Unallocated</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(d)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">858</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">858</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cost of sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">275</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(38</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">236</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Selling, informational and administrative expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">21</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">388</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,050</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,459</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Research and development expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">532</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">726</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">30</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">185</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,474</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Amortization of intangible assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Restructuring charges and certain acquisition-related costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(Gain) on completion of Consumer Healthcare JV transaction</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other (income)/deductions&#8211;&#8211;net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">80</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">80</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Income/(loss) from continuing operations before provision for taxes on income</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(552</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(726</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">164</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,278</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,391</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;padding-left:36px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.64285714285714%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"></td></tr><tr><td style="width:45%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:9%;"></td></tr><tr><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:1px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:54px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">WRDM</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#8211;&#8211;</font><font style="font-family:inherit;font-size:10pt;">the R&amp;D and Medical expenses managed by our Worldwide Research, Development and Medical (WRDM) organization, which is generally responsible for research projects for our Biopharma portfolio until proof-of-concept is achieved and then for transitioning those projects to the GPD organization for possible clinical and commercial development. R&amp;D spending may include upfront and milestone payments for intellectual property rights. The WRDM organization also has responsibility for certain science-based and other platform-services organizations, which provide end-to-end technical expertise and other services to the various R&amp;D projects, as well as the Worldwide Medical and Safety group, which ensures that Pfizer provides all stakeholders</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#8211;&#8211;</font><font style="font-family:inherit;font-size:10pt;">including patients, healthcare providers, pharmacists, payers and health authorities</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#8211;&#8211;</font><font style="font-family:inherit;font-size:10pt;">with complete and up-to-date information on the risks and benefits associated with Pfizer products so that they can make appropriate decisions on how and when to use Pfizer&#8217;s medicines.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:1px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:54px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GPD</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#8211;&#8211;</font><font style="font-family:inherit;font-size:10pt;">the costs associated with our GPD organization, which is generally responsible for clinical trials from WRDM in the Biopharma portfolio, including late stage portfolio spend. GPD also provides technical support and other services to Pfizer R&amp;D projects. GPD is responsible for facilitating all regulatory submissions and interactions with regulatory agencies. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:1px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:54px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">(c)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#8211;&#8211;</font><font style="font-family:inherit;font-size:10pt;">the operating results of our Consumer Healthcare business, through July 31, 2019, and costs associated with other commercial activities not managed as part of Biopharma or Upjohn, including all strategy, business development, portfolio management and valuation capabilities, which previously had been reported in various parts of the organization. See Note (1) above.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:54px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">(d)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate and Other Unallocated</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#8211;&#8211;</font><font style="font-family:inherit;font-size:10pt;">the costs associated with platform functions (such as worldwide technology, global real estate operations, legal, finance, human resources, worldwide public affairs, compliance and worldwide procurement), patient advocacy activities and certain compensation and other corporate costs, such as interest income and expense, and gains and losses on investments, as well as overhead expenses associated with our manufacturing (which include manufacturing variances associated with production) and commercial operations that are not directly assessed to an operating segment, as business unit (segment) management does not manage these costs.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(4)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These &#8220;Adjusted Income&#8221; components are defined as the corresponding reported U.S. GAAP components, excluding purchase accounting adjustments, acquisition-related costs and certain significant items (some of which may recur, such as gains on the completion of joint venture transactions, restructuring charges, legal charges or gains and losses from equity securities, but which management does not believe are reflective of our ongoing core operations). Adjusted Cost of Sales, Adjusted Selling, Informational and Administrative (SI&amp;A) expenses, Adjusted Research and Development (R&amp;D) expenses, Adjusted Amortization of Intangible Assets and Adjusted Other (Income)/Deductions&#8211;&#8211;Net are income statement line items prepared on the same basis as, and therefore components of, the overall adjusted income measure. As described in the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Review&#8211;&#8211;Non-GAAP Financial Measure (Adjusted Income) </font><font style="font-family:inherit;font-size:10pt;">section of Pfizer&#8217;s </font><font style="font-family:inherit;font-size:10pt;">2019</font><font style="font-family:inherit;font-size:10pt;">&#32;Financial Report, which was filed as Exhibit 13 to Pfizer&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, </font><font style="font-family:inherit;font-size:10pt;">2019</font><font style="font-family:inherit;font-size:10pt;">, management uses Adjusted income, among other factors, to set performance goals and to measure the performance of the overall company. Because Adjusted income is an important internal measurement for Pfizer, we believe that investors&#8217; understanding of our performance is enhanced by disclosing this performance measure. We report Adjusted income and certain components of Adjusted income in order to portray the results of our major operations&#8211;&#8211;the discovery, development, manufacture, marketing and sale of </font></div></td></tr></table><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">34</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:3pt;"><font style="font-family:inherit;font-size:3pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">PFIZER INC. AND SUBSIDIARY COMPANIES</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">NOTES TO OPERATING SEGMENT INFORMATION - (UNAUDITED)</font></div></div><div><br></div><div style="line-height:120%;padding-left:36px;padding-bottom:4px;padding-top:4px;text-align:left;"><font style="font-family:inherit;font-size:10pt;">prescription medicines and vaccines&#8211;&#8211;prior to considering certain income statement elements. See the accompanying reconciliations of certain GAAP reported to non-GAAP adjusted information for the </font><font style="font-family:inherit;font-size:10pt;">first quarter</font><font style="font-family:inherit;font-size:10pt;">&#32;of </font><font style="font-family:inherit;font-size:10pt;text-align:center;">2020</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;text-align:center;">2019</font><font style="font-family:inherit;font-size:10pt;">. The Adjusted income component measures are not, and should not be viewed as, substitutes for the U.S. GAAP component measures.</font></div><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(5)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Includes costs associated with (i) purchase accounting adjustments; (ii) acquisition-related costs; and (iii) certain significant items, which are substantive and/or unusual, and in some cases recurring, items (such as gains on the completion of joint venture transactions, restructuring charges, legal charges or gains and losses from equity securities) that are evaluated on an individual basis by management. For additional information about these reconciling items and/or our non-GAAP adjusted measure of performance, see the accompanying reconciliations of certain GAAP reported to non-GAAP adjusted information for the </font><font style="font-family:inherit;font-size:10pt;">first quarter</font><font style="font-family:inherit;font-size:10pt;">&#32;of </font><font style="font-family:inherit;font-size:10pt;text-align:center;">2020</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;text-align:center;">2019</font><font style="font-family:inherit;font-size:10pt;">.</font></div></td></tr></table><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">35</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><a name="s23B9BEE6CD5E54108DB9A6CB184F6916"></a></div><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:2pt;"><font style="font-family:inherit;font-size:2pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">PFIZER INC. - REVENUES </font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">FIRST-QUARTER 2020 and 2019 - (UNAUDITED) </font></div></div><div><br></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="25"></td></tr><tr><td style="width:39%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:4%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:4%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:5%;"></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="8" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">WORLDWIDE</font></div></td><td colspan="7" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">UNITED STATES</font></div></td><td colspan="8" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">TOTAL INTERNATIONAL</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(a)</sup></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" rowspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2020</font></div></td><td colspan="3" rowspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2019</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">% Change</font></div></td><td colspan="3" rowspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2020</font></div></td><td colspan="3" rowspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">% Change</font></div></td><td colspan="3" rowspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2020</font></div></td><td colspan="3" rowspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2019</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">% Change</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(MILLIONS OF DOLLARS)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Oper.</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Oper.</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">TOTAL REVENUES</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">12,028</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">13,118</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(8%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(7%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">5,651</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">6,175</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(8%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">6,377</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">6,943</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(8%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(6%)</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">PFIZER BIOPHARMACEUTICALS GROUP (BIOPHARMA)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">10,007</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">9,045</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">11%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">12%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">5,213</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">4,461</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">17%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">4,793</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">4,584</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">5%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">7%</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Internal Medicine</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(b)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2,332</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2,137</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">9%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">10%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">1,348</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">1,181</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">14%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">984</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">956</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">3%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">5%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Eliquis alliance revenues and direct sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">1,300</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">1,011</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">29%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">29%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">805</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">601</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">34%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">495</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">410</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">21%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">23%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Chantix/Champix</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">270</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">273</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(1%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">212</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">212</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">59</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">61</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(3%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(1%)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Premarin family</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">152</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">168</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(10%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(10%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">141</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">158</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(10%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">10</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">10</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">1%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">1%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">BMP2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">69</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">67</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">4%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">4%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">69</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">67</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">4%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Toviaz</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">60</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">60</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">19</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">17</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">13%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">41</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">43</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(5%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(5%)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">All other Internal Medicine</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">480</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">559</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(14%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(12%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">102</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">127</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(20%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">378</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">432</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(12%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(10%)</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Oncology</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2,435</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">1,961</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">24%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">25%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">1,572</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">1,179</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">33%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">863</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">782</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">10%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">14%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Ibrance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">1,248</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">1,133</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">10%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">11%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">852</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">741</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">15%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">396</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">392</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">1%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">5%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Xtandi alliance revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">209</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">168</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">25%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">25%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">209</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">168</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">25%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Sutent</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">205</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">232</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(12%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(9%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">52</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">71</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(27%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">153</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">161</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(5%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(2%)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Inlyta</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">169</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">73</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">*</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">*</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">116</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">33</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">*</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">53</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">40</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">32%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">36%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Xalkori</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">149</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">123</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">22%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">24%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">39</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">34</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">14%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">110</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">88</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">24%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">27%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Bosulif</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">100</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">80</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">24%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">24%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">68</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">54</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">26%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">32</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">27</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">21%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">21%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Retacrit</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(c)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">89</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">31</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">*</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">*</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">66</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">14</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">*</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">23</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">17</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">37%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">42%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Braftovi</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">37</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">*</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">*</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">37</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">*</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Mektovi</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">37</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">*</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">*</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">37</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">*</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">All other Oncology</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">192</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">122</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">57%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">58%</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">96</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">65</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">49%</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">95</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">57</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">66%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">69%</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Hospital</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(b), (d)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2,012</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">1,827</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">10%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">11%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">814</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">692</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">18%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">1,198</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">1,135</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">6%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">7%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Sulperazon</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">187</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">177</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">6%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">8%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">187</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">177</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">6%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">8%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Zithromax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">138</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">104</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">32%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">34%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(3</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">*</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">136</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">107</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">26%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">28%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Medrol</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">129</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">120</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">8%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">8%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">78</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">70</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">10%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">51</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">50</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">4%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">4%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Vfend</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">74</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">85</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(12%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(11%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(68%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">73</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">81</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(9%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(8%)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Panzyga</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">74</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">17</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">*</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">*</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">74</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">17</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">*</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Zyvox</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">70</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">64</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">11%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">12%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">20%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">64</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">58</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">10%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">12%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Fragmin</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">59</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">60</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(1%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">6%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">57</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">58</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(1%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:12px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Pfizer CentreOne</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(e)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">152</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">176</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(13%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(13%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">76</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">97</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(21%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">76</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">79</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(4%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(2%)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">All other Anti-infectives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">444</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">405</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">10%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">11%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">136</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">128</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">6%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">308</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">277</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">11%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">13%</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:12px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">All other Hospital</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(d)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">684</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">620</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">10%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">11%</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">438</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">371</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">18%</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">246</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">249</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(1%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Vaccines</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">1,611</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">1,612</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">1%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">812</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">894</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(9%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">799</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">718</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">11%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">14%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Prevnar 13/Prevenar 13</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">1,450</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">1,486</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(2%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(1%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">794</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">878</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(10%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">656</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">608</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">8%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">11%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Nimenrix</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">75</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">50</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">50%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">54%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">75</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">50</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">50%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">54%</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">All other Vaccines</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">86</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">77</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">13%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">15%</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">18</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">17</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">7%</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">69</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">60</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">14%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">17%</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Inflammation &amp; Immunology (I&amp;I)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">978</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">1,037</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(6%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(4%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">391</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">378</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">3%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">587</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">659</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(11%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(8%)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Xeljanz</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">451</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">423</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">7%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">8%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">286</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">298</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(4%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">166</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">125</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">33%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">38%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Enbrel (Outside the U.S. and Canada)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">347</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">451</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(23%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(21%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">347</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">451</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(23%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(21%)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Inflectra/Remsima</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(c)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">158</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">138</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">14%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">15%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">84</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">57</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">46%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">74</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">81</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(8%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(6%)</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">All other I&amp;I</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">22</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">25</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(12%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(13%)</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">21</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">22</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(4%)</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(70%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(82%)</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Rare Disease</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">639</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">470</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">36%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">38%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">277</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">137</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">*</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">362</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">333</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">9%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">12%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Vyndaqel/Vyndamax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">231</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">41</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">*</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">*</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">127</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">*</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">105</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">41</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">*</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">*</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">BeneFIX</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">121</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">125</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(3%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(2%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">66</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">65</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">1%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">55</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">60</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(8%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(4%)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Genotropin</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">103</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">107</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(4%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(3%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">31</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">13</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">*</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">72</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">95</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(24%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(22%)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Refacto AF/Xyntha</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">89</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">106</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(16%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(14%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">19</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">27</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(31%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">71</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">79</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(10%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(8%)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Somavert</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">64</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">59</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">7%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">9%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">25</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">22</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">17%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">38</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">38</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">1%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">4%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">All other Rare Disease</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">31</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">31</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">5%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">9</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">10</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(6%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">21</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">20</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">4%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">11%</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">UPJOHN</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(b)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2,022</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">3,214</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(37%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(37%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">438</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">1,273</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(66%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">1,584</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">1,941</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(18%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(17%)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Lipitor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">405</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">622</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(35%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(34%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">25</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">21</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">17%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">380</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">601</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(37%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(35%)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Lyrica</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">357</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">1,186</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(70%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(70%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">80</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">889</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(91%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">277</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">298</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(7%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(7%)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Norvasc</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">197</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">300</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(34%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(33%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">9</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">10</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(13%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">188</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">289</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(35%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(34%)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Celebrex</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">156</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">174</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(10%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(10%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">11</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">15</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(23%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">145</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">159</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(9%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(9%)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Viagra</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">127</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">145</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(12%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(12%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">17</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">40</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(57%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">110</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">105</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">5%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">5%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Zoloft</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">78</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">69</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">13%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">15%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">12</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">11</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">7%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">66</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">58</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">14%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">17%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Effexor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">77</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">77</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(1%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">16</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">17</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(6%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">61</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">60</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">1%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">2%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">EpiPen</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(b)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">72</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">56</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">28%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">28%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">72</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">56</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">28%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Xalatan/Xalacom</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">61</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">62</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(2%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(1%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(43%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">58</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">56</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">2%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">3%</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">All other Upjohn</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">492</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">523</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(6%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(5%)</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">192</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">209</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(8%)</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">300</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">313</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(4%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(4%)</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">CONSUMER HEALTHCARE BUSINESS</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(f)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">858</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(100%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(100%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">440</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(100%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">418</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(100%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(100%)</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Total Alliance revenues</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">1,382</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">1,090</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">27%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">27%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">1,022</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">775</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">32%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">360</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">314</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">15%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">16%</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Total Biosimilars</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(c)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">288</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">179</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">61%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">63%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">167</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">73</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">*</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">122</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">106</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">15%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">17%</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Total Sterile Injectable Pharmaceuticals</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(g)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">1,407</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">1,237</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">14%</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">15%</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">721</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">591</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">22%</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">686</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">645</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">6%</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">8%</font></div></td></tr></table></div><font style="font-family:inherit;font-size:7.5pt;">See end of tables for notes.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">36</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><a name="s6191D48699AE51748AEA2A6D2D7379B4"></a></div><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">PFIZER INC.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">INTERNATIONAL REVENUES BY GEOGRAPHIC REGION</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">FIRST-QUARTER 2020 and 2019 - (UNAUDITED)</font></div></div><div><br></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="26"></td></tr><tr><td style="width:39%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:5%;"></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="8" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">DEVELOPED EUROPE</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(h)</sup></font></div></td><td colspan="8" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">DEVELOPED REST OF WORLD</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(i)</sup></font></div></td><td colspan="8" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">EMERGING MARKETS</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(j)</sup></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" rowspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2020</font></div></td><td colspan="3" rowspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2019</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">% Change</font></div></td><td colspan="3" rowspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2020</font></div></td><td colspan="3" rowspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2019</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">% Change</font></div></td><td colspan="3" rowspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2020</font></div></td><td colspan="3" rowspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2019</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">% Change</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(MILLIONS OF DOLLARS)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Oper.</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Oper.</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Oper.</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">TOTAL INTERNATIONAL REVENUES</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">1,921</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2,086</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(8%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(6%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">1,456</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">1,535</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(5%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(5%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">3,001</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">3,322</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(10%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(7%)</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;padding-left:6px;text-indent:-6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">PFIZER BIOPHARMACEUTICALS GROUP (BIOPHARMA)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">1,708</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">1,762</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(3%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(1%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">919</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">878</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">5%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">5%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2,166</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">1,944</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">11%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">15%</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Internal Medicine</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(b)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">455</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">428</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">6%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">9%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">212</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">212</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">317</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">316</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">4%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Eliquis alliance revenues and direct sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">278</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">239</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">16%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">19%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">87</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">79</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">10%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">10%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">130</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">92</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">42%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">44%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Chantix/Champix</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">34</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">20</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">68%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">72%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">15</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">17</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(13%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(11%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">10</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">24</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(57%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(56%)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Premarin family</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">1%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">1%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">1%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">2%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">BMP2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Toviaz</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">16</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">17</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(6%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(4%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">22</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">24</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(7%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(8%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">12%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">17%</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">All other Internal Medicine</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">127</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">152</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(16%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(14%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">83</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">87</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(5%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(5%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">168</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">193</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(13%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(8%)</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Oncology</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">365</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">393</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(7%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(5%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">167</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">153</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">9%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">9%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">332</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">236</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">41%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">48%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Ibrance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">197</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">228</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(13%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(11%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">85</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">74</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">15%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">14%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">114</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">90</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">27%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">37%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Xtandi alliance revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Sutent</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">61</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">76</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(19%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(17%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">21</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">26</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(18%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(18%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">71</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">59</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">19%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">25%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Inlyta</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">14</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">9</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">63%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">67%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">16</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">17</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(6%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(7%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">23</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">15</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">58%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">65%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Xalkori</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">23</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">29</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(22%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(20%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">11</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">13</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(17%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(16%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">76</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">46</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">65%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">69%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Bosulif</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">15</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">15</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">3%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">5%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">11</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">10</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">13%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">11%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">*</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">*</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Retacrit</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(c)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">22</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">16</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">36%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">40%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Braftovi</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Mektovi</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">All other Oncology</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">31</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">20</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">54%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">57%</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">23</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">13</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">70%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">69%</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">42</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">24</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">75%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">78%</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Hospital</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(b), (d)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">207</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">219</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(5%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(3%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">168</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">184</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(9%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(8%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">822</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">732</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">12%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">14%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Sulperazon</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">2</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">2</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">1%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(1%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">185</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">175</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">6%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">8%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Zithromax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">15</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">15</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">3%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">9</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">10</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(18%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(18%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">112</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">82</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">37%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">39%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Medrol</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">15</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">17</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(11%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(9%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">10</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">8</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">33%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">31%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">26</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">25</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">4%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">5%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Vfend</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(21%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(19%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">15</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">18</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(15%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(16%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">54</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">57</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(7%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(5%)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Panzyga</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Zyvox</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(29%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(27%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">13</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(53%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(53%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">56</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">42</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">33%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">35%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Fragmin</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">29</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">29</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(1%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">13</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">14</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(8%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(9%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">16</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">15</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">4%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">7%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Pfizer CentreOne</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(e)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">37</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">37</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(2%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">*</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">*</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">34</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">39</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(13%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(12%)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">All other Anti-infectives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">71</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">71</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">3%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">24</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">27</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(9%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(9%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">213</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">179</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">18%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">21%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">All other Hospital</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(d)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">34</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">42</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(17%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(16%)</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">84</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">90</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(7%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(6%)</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">128</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">118</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">9%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">10%</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Vaccines</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">250</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">226</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">10%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">13%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">103</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">92</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">13%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">14%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">446</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">400</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">11%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">15%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Prevnar 13/Prevenar 13</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">149</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">143</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">4%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">6%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">97</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">86</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">13%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">14%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">410</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">379</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">8%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">12%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Nimenrix</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">40</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">29</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">36%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">39%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">11%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">15%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">29</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">15</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">91%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">96%</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">All other Vaccines</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">61</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">54</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">14%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">17%</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(24%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(25%)</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">26%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">30%</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Inflammation &amp; Immunology (I&amp;I)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">270</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">325</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(17%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(15%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">149</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">151</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(2%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(2%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">168</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">182</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(8%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(1%)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Xeljanz</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">66</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">45</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">45%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">48%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">54</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">43</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">26%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">26%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">45</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">36</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">27%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">39%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Enbrel (Outside the U.S. and Canada)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">154</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">217</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(29%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(27%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">75</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">93</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(19%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(18%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">117</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">141</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(17%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(12%)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Inflectra/Remsima</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(c)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">59</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">71</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(16%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(14%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">10</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">84%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">84%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">3%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">10%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">All other I&amp;I</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(9</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(7</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(18%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(22%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">9</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">10</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(10%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(11%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Rare Disease</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">161</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">170</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(5%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(3%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">120</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">86</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">40%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">40%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">81</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">78</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">5%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">11%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Vyndaqel/Vyndamax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">38</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">25</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">53%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">57%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">61</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">12</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">*</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">*</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">37%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">46%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">BeneFIX</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">20</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">26</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(23%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(21%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">17</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">19</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(12%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(10%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">19</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">15</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">24%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">32%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Genotropin</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">32</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">38</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(17%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(15%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">25</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">36</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(31%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(32%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">16</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">21</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(25%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(19%)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Refacto AF/Xyntha</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">39</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">46</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(15%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(13%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">9</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">11</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(21%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(18%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">23</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">22</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">5%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">9%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Somavert</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">30</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">31</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(3%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">18%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">17%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">19%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">30%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">All other Rare Disease</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(36%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(36%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">15%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">16%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">14</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">12</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">14%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">26%</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">UPJOHN</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(b)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">213</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">217</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(2%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">537</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">572</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(6%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(6%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">834</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">1,152</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(28%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(26%)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Lipitor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">35</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">38</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(6%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(4%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">43</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">50</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(14%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(11%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">302</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">513</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(41%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(40%)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Lyrica</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">39</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">45</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(14%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(12%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">183</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">189</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(3%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(3%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">54</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">63</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(14%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(13%)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Norvasc</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">13</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">15</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(11%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(8%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">36</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">41</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(12%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(11%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">139</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">234</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(41%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(39%)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Celebrex</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(6%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(4%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">75</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">71</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">6%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">5%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">64</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">82</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(22%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(21%)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Viagra</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">17</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">8</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">*</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">*</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">15</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">15</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(2%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(2%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">78</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">82</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(5%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(4%)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Zoloft</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">9</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">7</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">28%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">32%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">11</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">12</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(10%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(10%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">45</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">38</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">18%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">23%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Effexor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">13</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">12</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">14%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">17%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">30</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">27</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">10%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">9%</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">18</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">22</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(17%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(14%)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">EpiPen</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(b)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Xalatan/Xalacom</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">12</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">14</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(9%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(7%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">22</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">25</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(11%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(11%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">23</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">18</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">29%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">31%</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">All other Upjohn</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">67</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">72</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(7%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(5%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">121</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">141</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(14%)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(15%)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">112</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">100</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">12%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">13%</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">CONSUMER HEALTHCARE BUSINESS</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(f)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">107</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(100%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(100%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">85</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(100%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(100%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">226</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(100%)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(100%)</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Total Alliance revenues</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">266</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">230</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">16%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">18%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">94</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">85</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">10%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">10%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">*</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">*</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Total Biosimilars</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(c)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">94</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">95</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">13</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">6</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">*</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:3px double #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">*</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">14</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">6</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">*</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">*</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Total Sterile Injectable Pharmaceuticals</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(g)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">106</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">114</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(7%)</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(5%)</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">101</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">108</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(6%)</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">(6%)</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">479</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">424</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">13%</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">15%</font></div></td></tr></table></div></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">37</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><a name="s9B57B314DC8B5F0EA9FD1F7EBE143CB0"></a></div><div><br></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">PFIZER INC.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">NOTES TO REVENUES TABLE INFORMATION</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(UNAUDITED)</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:left;padding-left:6px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.08925318761385%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:3%;"></td><td style="width:97%;"></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(a)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><font style="font-family:inherit;font-size:7.5pt;">Total International represents Developed Europe region + Developed Rest of World region + Emerging Markets region. Details for these regions are described in footnotes (h) to (j) below, respectively.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(b)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><font style="font-family:inherit;font-size:7.5pt;">Beginning in 2020, Upjohn began managing our Meridian subsidiary, the manufacturer of EpiPen and other auto-injector products, and a pre-existing strategic collaboration between Pfizer and Mylan N.V. for generic drugs in Japan (Mylan-Japan). As a result, revenues associated with our Meridian subsidiary, except for product revenues for EpiPen sold in Canada, and Mylan-Japan, are reported in our Upjohn business beginning in the first quarter of 2020. We have reclassified revenues associated with our Meridian subsidiary and Mylan-Japan from the Hospital and Internal Medicine categories to the Upjohn business to conform 2019 product revenues to the current presentation.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(c)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:18px;text-indent:-18px;font-size:7.5pt;"><font style="font-family:inherit;font-size:7.5pt;">Biosimilars are highly similar versions of approved and authorized biological medicines and primarily include revenues from Inflectra/Remsima and Retacrit.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(d)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><font style="font-family:inherit;font-size:7.5pt;">Hospital is a business unit that commercializes our global portfolio of sterile injectable and anti-infective medicines. Hospital also includes Pfizer CentreOne</font><font style="font-family:inherit;font-size:7.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(e)</sup></font><font style="font-family:inherit;font-size:7.5pt;">. All other Hospital primarily includes revenues from legacy Sterile Injectable Pharmaceuticals (SIP) products (that are not anti-infective products) and, to a much lesser extent, solid oral dose products (that are not anti-infective products). SIP anti-infective products that are not individually listed above are recorded in &#8220;All other Anti-infectives&#8221;.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(e)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><font style="font-family:inherit;font-size:7.5pt;">Pfizer CentreOne includes revenues from our contract manufacturing and active pharmaceutical ingredient sales operation, including sterile injectables contract manufacturing, and revenues related to our manufacturing and supply agreements.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(f)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><font style="font-family:inherit;font-size:7.5pt;">On July 31, 2019, Pfizer&#8217;s Consumer Healthcare business, an over-the-counter medicines business, was combined with GSK&#8217;s consumer healthcare business to form a new consumer healthcare joint venture, of which we own 32%. Upon the closing of the transaction, we deconsolidated our Consumer Healthcare business. Our financial results, and our Consumer Healthcare segment&#8217;s operating results, for the first quarter of 2019 reflect three months of Consumer Healthcare segment operations, while our financial results for the first quarter of 2020 do not reflect any contribution from the Consumer Healthcare business.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(g)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><font style="font-family:inherit;font-size:7.5pt;">Total Sterile Injectable Pharmaceuticals represents the total of all branded and generic injectable products in the Hospital business, including anti-infective sterile injectable pharmaceuticals.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(h)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:18px;text-indent:-18px;font-size:7.5pt;"><font style="font-family:inherit;font-size:7.5pt;">Developed Europe region includes the following markets: Western Europe, Scandinavian countries and Finland.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(i)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:6px;text-indent:-6px;font-size:7.5pt;"><font style="font-family:inherit;font-size:7.5pt;">Developed Rest of World region includes the following markets: Japan, Canada, South Korea, Australia and New Zealand.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(j)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><font style="font-family:inherit;font-size:7.5pt;">Emerging Markets region includes, but is not limited to, the following markets: Asia (excluding Japan and South Korea), Latin America, Eastern Europe, Africa, the Middle East, Central Europe and Turkey.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:7.5pt;"><font style="font-family:inherit;font-size:7.5pt;">*</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><font style="font-family:inherit;font-size:7.5pt;">Indicates calculation not meaningful or result is equal to or greater than 100%.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><font style="font-family:inherit;font-size:7.5pt;">Amounts may not add due to rounding. All percentages have been calculated using unrounded amounts.</font></div></td></tr></table></div></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">38</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><a name="sFC218625CAEA52A79EC4D7DC05B427CD"></a></div><div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DISCLOSURE NOTICE: Except where otherwise noted, the information contained in this earnings release and the related attachments is as of </font><font style="font-family:inherit;font-size:10pt;">April&#160;28, 2020</font><font style="font-family:inherit;font-size:10pt;">. We assume no obligation to update any forward-looking statements contained in this earnings release and the related attachments as a result of new information or future events or developments.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This earnings release and the related attachments contain forward-looking statements about our anticipated future operating and financial performance, business plans and prospects, expectations for our product pipeline, in-line products and product candidates, including anticipated regulatory submissions, data read-outs, study starts, approvals, revenue contribution, growth, performance, timing of exclusivity and potential benefits, strategic reviews, capital allocation objectives, benefits anticipated from the reorganization of our commercial operations in 2019, plans for and prospects of our acquisitions and other business development activities, including our proposed transaction with Mylan N.V. (Mylan) to combine Upjohn and Mylan to create a new global pharmaceutical company, our acquisition of Array BioPharma Inc. and our transaction with GSK which combined our respective consumer healthcare businesses into a new consumer healthcare joint venture, our ability to successfully capitalize on growth opportunities or prospects, manufacturing and product supply, our efforts to respond to COVID-19, our expectations regarding the impact of COVID-19 on our business, operations and financial results and plans relating to share repurchases and dividends, among other things, that involve substantial risks and uncertainties.&#160;You can identify these statements by the fact that they use future dates or use words such as &#8220;will,&#8221; &#8220;may,&#8221; &#8220;could,&#8221; &#8220;likely,&#8221; &#8220;ongoing,&#8221; &#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;project,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;believe,&#8221; &#8220;assume,&#8221; &#8220;target,&#8221; &#8220;forecast,&#8221; &#8220;guidance,&#8221; &#8220;goal,&#8221; &#8220;objective,&#8221; &#8220;aim,&#8221; &#8220;seek&#8221; and other words and terms of similar meaning. Among the factors that could cause actual results to differ materially from past results and future plans and projected future results are the following:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:6px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the outcome of R&amp;D activities, including, without limitation, the ability to meet anticipated pre-clinical or clinical endpoints, commencement and/or completion dates for our pre-clinical or clinical trials, regulatory submission dates, regulatory approval dates and/or launch dates, as well as the possibility of unfavorable pre-clinical and clinical trial results, including the possibility of unfavorable new clinical data and further analyses of existing clinical data;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the risk we may not be able to successfully address all of the comments received from regulatory authorities such as the FDA or the EMA, or obtain approval from regulators, which will depend on myriad factors, including such regulator making a determination as to whether a product&#8217;s benefits outweigh its known risks and a determination of the product&#8217;s efficacy; regulatory decisions impacting labeling, manufacturing processes, safety and/or other matters; and recommendations by technical or advisory committees, such as ACIP, that may impact the use of our vaccines;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the speed with which regulatory authorizations, pricing approvals and product launches may be achieved;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">claims and concerns that may arise regarding the safety or efficacy of in-line products and product candidates, including claims and concerns that may arise from the outcome of post-approval clinical trials, which could result in the loss of marketing approval, changes in product labeling, and/or new or increased concerns about the side effects or efficacy of, a product that could affect its availability or commercial potential, such as the update to the U.S. and EU prescribing information for Xeljanz;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the success of external business-development activities, including the ability to identify and execute on potential business development opportunities, the ability to satisfy the conditions to closing of announced transactions in the anticipated time frame or at all, the ability to realize the anticipated benefits of any such transactions, and the potential need to obtain additional equity or debt financing to pursue these opportunities, which could result in increased leverage and impact our credit ratings;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">competitive developments, including the impact on our competitive position of new product entrants, in-line branded products, generic products, private label products, biosimilars and product candidates that treat diseases and conditions similar to those treated by our in-line drugs and drug candidates;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the implementation by the FDA and regulatory authorities in certain countries of an abbreviated legal pathway to approve biosimilar products, which could subject our biologic products to competition from biosimilar products, with attendant competitive pressures, after the expiration of any applicable exclusivity period and patent rights;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">risks related to our ability to develop and commercialize biosimilars, including risks associated with &#8220;at risk&#8221; launches, defined as the marketing of a product by Pfizer before the final resolution of litigation (including any appeals) brought by a third party alleging that such marketing would infringe one or more patents owned or controlled by the third party, and access challenges for our biosimilar products where our product may not receive appropriate formulary access or remains in a disadvantaged position relative to the innovator product;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the ability to meet competition from generic, branded and biosimilar products after the loss or expiration of patent protection for our products or competitor products;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the ability to successfully market both new and existing products domestically and internationally;</font></div></td></tr></table><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">39</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">difficulties or delays in manufacturing, sales or marketing, including delays caused by natural events, such as hurricanes; supply disruptions, shortages or stock-outs at our facilities; and legal or regulatory actions, such as warning letters, suspension of manufacturing, seizure of product, injunctions, debarment, recall of a product, delays or denials of product approvals, import bans or denial of import certifications; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the impact of public health outbreaks, epidemics or pandemics (such as the COVID-19 pandemic) on our operations, including due to travel limitations and stay-at-home or work-from-home orders, manufacturing disruptions or delays, supply chain interruptions, disruptions to pipeline development and clinical trials, decreased product demand, including due to reduced numbers of in-person meetings with prescribers, patient visits with physicians and elective surgeries as well as increased unemployment resulting in lower new prescriptions, challenges presented by reallocating human capital, R&amp;D, manufacturing and other resources to assist in responding to such outbreaks without disruption to our operations, costs associated with the COVID-19 pandemic, including protocols intended to reduce the risk of transmission, increased supply chain costs and additional R&amp;D costs incurred in our effort to develop a potential vaccine or treatment for COVID-19, and other challenges presented by disruptions to our normal operations in response to the pandemic, as well as uncertainties regarding the duration and severity of the pandemic and its impacts and government or regulatory actions to contain the virus or control the supply of medicines, each of which may also amplify the impact of the other factors listed in this section; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">uncertainties related to our efforts to develop a potential treatment or vaccine for COVID-19, including that our development programs may not be successful or commercially viable or receive approval from regulatory authorities, any disruption in the relationships between us and our collaboration partners or third-party suppliers, other companies may produce superior or competitive products, the demand for such products may no longer exist, lack of availability of raw materials to manufacture such products, we may not be able to recoup costs associated with our R&amp;D and manufacturing efforts or create or scale up manufacturing capacity on a timely basis or have access to logistics or supply channels commensurate with global demand for any approved vaccine or product candidate and any pricing and access challenges for such products, including in the U.S.;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">trade buying patterns;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the impact of existing and future legislation and regulatory provisions on product exclusivity;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">trends toward managed care and healthcare cost containment, and our ability to obtain or maintain timely or adequate pricing or favorable formulary placement for our products;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the impact of any significant spending reductions or cost controls affecting Medicare, Medicaid or other publicly funded or subsidized health programs or changes in the tax treatment of employer-sponsored health insurance that may be implemented;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226; </font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the impact of any U.S. healthcare reform or legislation, including any replacement, repeal, modification or invalidation of some or all of the provisions of the U.S. Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226; </font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. federal or state legislation or regulatory action and/or policy efforts affecting, among other things, pharmaceutical product pricing, intellectual property, reimbursement or access, including under Medicaid, Medicare and other publicly funded or subsidized health programs; patient out-of-pocket costs for medicines, manufacturer prices and/or price increases that could result in new mandatory rebates and discounts or other pricing restrictions; general budget control actions; the importation of prescription drugs from outside the U.S. at prices that are regulated by governments of various foreign countries; revisions to reimbursement of biopharmaceuticals under government programs; restrictions on U.S. direct-to-consumer advertising; limitations on interactions with healthcare professionals; or the use of comparative effectiveness methodologies that could be implemented in a manner that focuses primarily on the cost differences and minimizes the therapeutic differences among pharmaceutical products and restricts access to innovative medicines; as well as pricing pressures for our products as a result of highly competitive insurance markets;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">legislation or regulatory action in markets outside the U.S., including China, affecting pharmaceutical product pricing, intellectual property, reimbursement or access, including, in particular, continued government-mandated reductions in prices and access restrictions for certain biopharmaceutical products to control costs in those markets;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the exposure of our operations outside the U.S. to possible capital and exchange controls, economic conditions, expropriation and other restrictive government actions, changes in intellectual property legal protections and remedies, as well as political unrest, unstable governments and legal systems and inter-governmental disputes;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">contingencies related to actual or alleged environmental contamination;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">any significant breakdown, infiltration or interruption of our information technology systems and infrastructure;</font></div></td></tr></table><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">40</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">legal defense costs, insurance expenses and settlement costs;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the risk of an adverse decision or settlement and the adequacy of reserves related to legal proceedings, including patent litigation, such as claims that our patents are invalid and/or do not cover the product of the generic drug manufacturer or where one or more third parties seeks damages and/or injunctive relief to compensate for alleged infringement of its patents by our commercial or other activities, product liability and other product-related litigation, including personal injury, consumer, off-label promotion, securities, antitrust and breach of contract claims, commercial, environmental, government investigations, employment and other legal proceedings, including various means for resolving asbestos litigation, as well as tax issues;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the risk that our currently pending or future patent applications may not result in issued patents, or be granted on a timely basis, or any patent-term extensions that we seek may not be granted on a timely basis, if at all;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">our ability to protect our patents and other intellectual property, both domestically and internationally, including in response to any pressure, or legal or regulatory action by, various stakeholders or governments that potentially results in us not seeking intellectual property protection for or agreeing not to enforce intellectual property related to potential vaccines and treatments for COVID-19;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">interest rate and foreign currency exchange rate fluctuations, including the impact of possible currency devaluations in countries experiencing high inflation rates;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">governmental laws and regulations affecting domestic and foreign operations, including, without limitation, tax obligations and changes affecting the tax treatment by the U.S. of income earned outside the U.S. that may result from pending and possible future proposals, including further clarifications and/or interpretations of or changes to the Tax Cuts and Jobs Act enacted in 2017;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">any significant issues involving our largest wholesale distributors, which account for a substantial portion of our revenues;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the possible impact of the increased presence of counterfeit medicines in the pharmaceutical supply chain on our revenues and on patient confidence in the integrity of our medicines;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">uncertainties based on the formal change in relationship between the U.K. government and the EU, which could have implications on our research, commercial and general business operations in the U.K. and the EU, including the approval and supply of our products;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">any significant issues that may arise related to the outsourcing of certain operational and staff functions to third parties, including with regard to quality, timeliness and compliance with applicable legal or regulatory requirements and industry standards;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">any significant issues that may arise related to our joint ventures and other third-party business arrangements;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">further clarifications and/or changes in interpretations of existing laws and regulations, or changes in laws and regulations, in the U.S. and other countries, including changes in U.S. generally accepted accounting principles;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">uncertainties related to general economic, political, business, industry, regulatory and market conditions including, without limitation, uncertainties related to the impact on us, our customers, suppliers and lenders and counterparties to our foreign-exchange and interest-rate agreements of challenging global economic conditions and recent and possible future changes in global financial markets; the related risk that our allowance for doubtful accounts may not be adequate; and the risks related to volatility of our income due to changes in the market value of equity investments;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">any changes in business, political and economic conditions due to actual or threatened terrorist activity or civil unrest in the U.S. and other parts of the world, and related U.S. military action overseas;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">growth in costs and expenses;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">changes in our product, segment and geographic mix; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the impact of purchase accounting adjustments, acquisition-related costs, discontinued operations and certain significant items;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the impact of product recalls, withdrawals and other unusual items;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the risk of an impairment charge related to our intangible assets, goodwill or equity-method investments; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the impact of, and risks and uncertainties related to, acquisitions and divestitures, such as the acquisition of Array, our transaction with GSK which combined our respective consumer healthcare businesses into a new consumer healthcare joint venture and our agreement to combine Upjohn with Mylan to create a new global pharmaceutical company, Viatris, including, among other things, risks related to the satisfaction of the conditions to closing to any pending transaction (including the failure to obtain any necessary shareholder and regulatory approvals) in the anticipated timeframe or at all and the possibility that such transaction does not close; the ability to realize the anticipated benefits of those transactions, including the possibility that the </font></div></td></tr></table><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">41</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-left:12px;padding-bottom:0px;padding-top:4px;text-align:left;"><font style="font-family:inherit;font-size:10pt;">expected cost savings and/or accretion from certain of those transactions will not be realized or will not be realized within the expected time frame; the risk that the businesses will not be integrated successfully; negative effects of the announcement or the consummation of the transaction on the market price of Pfizer&#8217;s common stock, Pfizer&#8217;s credit ratings and/or Pfizer&#8217;s operating results; disruption from the transactions making it more difficult to maintain business and operational relationships; risks related to our ability to grow revenues for certain acquired products; significant transaction costs; unknown liabilities; the risk of litigation and/or regulatory actions related to the transaction, other business effects, including the effects of industry, market, economic, political or regulatory conditions, future exchange and interest rates, changes in tax and other laws, regulations, rates and policies, future business combinations or disposals; competitive developments; and as it relates to the Consumer Healthcare JV with GSK, the possibility that a future separation of the joint venture as an independent company via a demerger of GSK&#8217;s equity interest to GSK&#8217;s shareholders and a listing of the joint venture on the U.K. equity market may not occur; and</font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the impact of, and risks and uncertainties related to, restructurings and internal reorganizations, including the reorganization of our commercial operations in 2019, as well as any other corporate strategic initiatives, and cost-reduction and productivity initiatives, each of which requires upfront costs but may fail to yield anticipated benefits and may result in unexpected costs or organizational disruption.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We cannot guarantee that any forward-looking statement will be realized. Achievement of anticipated results is subject to substantial risks, uncertainties and inaccurate assumptions. Should known or unknown risks or uncertainties materialize or should underlying assumptions prove inaccurate, actual results could vary materially from past results and those anticipated, estimated or projected. Investors should bear this in mind as they consider forward-looking statements, and are cautioned not to put undue reliance on forward-looking statements. A further list and description of risks, uncertainties and other matters can be found in our Annual Report on Form 10-K for the fiscal year ended </font><font style="font-family:inherit;font-size:10pt;text-align:center;">December&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">&#32;and in our subsequent reports on Form 10-Q, in each case including in the sections thereof captioned &#8220;Forward-Looking Information and Factors That May Affect Future Results&#8221; and &#8220;Item 1A. Risk Factors&#8221;, and in our subsequent reports on Form 8-K.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The operating segment information provided in this earnings release and the related attachments does not purport to represent the revenues, costs and income from continuing operations before provision for taxes on income that each of our operating segments would have recorded had each segment operated as a standalone company during the periods presented.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This earnings release may include discussion of certain clinical studies relating to various in-line products and/or product candidates. These studies typically are part of a larger body of clinical data relating to such products or product candidates, and the discussion herein should be considered in the context of the larger body of data. In addition, clinical trial data are subject to differing interpretations, and, even when we view data as sufficient to support the safety and/or effectiveness of a product candidate or a new indication for an in-line product, regulatory authorities may not share our views and may require additional data or may deny approval altogether.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ADDITIONAL INFORMATION AND WHERE TO FIND IT</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#333333;">This communication shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended. In connection with the proposed combination of Upjohn Inc. (&#8220;Newco&#8221;), a wholly owned subsidiary of Pfizer Inc. (&#8220;Pfizer&#8221;) and Mylan N.V. (&#8220;Mylan&#8221;), which will immediately follow the proposed separation of the Upjohn business (the &#8220;Upjohn Business&#8221;) from Pfizer (the &#8220;proposed transaction&#8221;), Newco and Mylan have filed certain materials with the SEC, including, among other materials, the Form S-4, Form 10 and Prospectus filed by Newco and the Proxy Statement filed by Mylan. The Form S-4 was declared effective on February 13, 2020 and the Proxy Statement and the Prospectus were first mailed to shareholders of Mylan on or about February 14, 2020 to seek approval of the proposed transaction. The Form 10 has not yet become effective. After the Form 10 is effective, a definitive information statement will be made available to the Pfizer stockholders relating to the proposed transaction. Newco and Mylan intend to file additional relevant materials with the SEC in connection with the proposed transaction. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT MYLAN, NEWCO AND THE PROPOSED TRANSACTION. The documents relating to the proposed transaction (when they are available) can be obtained free of charge from the SEC&#8217;s website at www.sec.gov. These documents (when they are available) can also be obtained free of charge from Mylan, upon written request to Mylan or by contacting Mylan at (724) 514-1813 or investor.relations@mylan.com or from Pfizer on Pfizer&#8217;s internet website at https://investors.Pfizer.com/financials/sec-filings/default.aspx or by contacting Pfizer&#8217;s Investor Relations Department at (212) 733-2323, as applicable.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">42</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:174%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:0px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">PARTICIPANTS IN THE SOLICITATION</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#333333;">This communication is not a solicitation of a proxy from any investor or security holder. However, Pfizer, Mylan, Newco and certain of their respective directors and executive officers may be deemed to be participants in the solicitation of proxies in connection with the proposed transaction under the rules of the SEC. Information about the directors and executive officers of Pfizer may be found in its Annual Report on Form 10-K filed with the SEC on February 27, 2020, and its definitive proxy statement relating to its 2020 Annual Meeting filed with the SEC on March 13, 2020, as supplemented by its supplement to proxy statement filed with the SEC on April 7, 2020. Information about the directors and executive officers of Mylan may be found in its Annual Report on Form 10-K filed with the SEC on February 28, 2020, and its definitive proxy statement relating to its 2019 Annual Meeting filed with the SEC on May 24, 2019. Additional information regarding the interests of these participants can also be found in the Form S-4, the Proxy Statement and the Prospectus. These documents can be obtained free of charge from the sources indicated above.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">43</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>pfe-20200428.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<xsd:schema attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.pfizer.com/20200428" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:pfe="http://www.pfizer.com/20200428" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import namespace="http://fasb.org/srt-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-roles/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/currency/2019-01-31" schemaLocation="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/exch/2019-01-31" schemaLocation="https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pfe-20200428_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pfe-20200428_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pfe-20200428_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pfe-20200428_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple" />
      <link:roleType id="CoverPage" roleURI="http://www.pfizer.com/role/CoverPage">
        <link:definition>0001000 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element abstract="true" id="pfe_NotesDue20220.250Member" name="NotesDue20220.250Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="pfe_NotesDue20271.000Member" name="NotesDue20271.000Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>4
<FILENAME>pfe-20200428_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.pfizer.com/role/CoverPage" xlink:href="pfe-20200428.xsd#CoverPage" xlink:type="simple" />
  <link:calculationLink xlink:role="http://www.pfizer.com/role/CoverPage" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>pfe-20200428_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.pfizer.com/role/CoverPage" xlink:href="pfe-20200428.xsd#CoverPage" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple" />
  <link:definitionLink xlink:role="http://www.pfizer.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInformationLineItems" xlink:label="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitiesTable" xlink:label="loc_dei_EntitiesTable_946CF6486E8630108ED5E9E2A97853A4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_EntitiesTable_946CF6486E8630108ED5E9E2A97853A4" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_D7CE5A78906A1E47489DE9E2A9789814" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_946CF6486E8630108ED5E9E2A97853A4" xlink:to="loc_us-gaap_StatementClassOfStockAxis_D7CE5A78906A1E47489DE9E2A9789814" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_97F481FC487404534665E9E2A97860CE_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_D7CE5A78906A1E47489DE9E2A9789814" xlink:to="loc_us-gaap_ClassOfStockDomain_97F481FC487404534665E9E2A97860CE_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_97F481FC487404534665E9E2A97860CE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_D7CE5A78906A1E47489DE9E2A9789814" xlink:to="loc_us-gaap_ClassOfStockDomain_97F481FC487404534665E9E2A97860CE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_9B9E4D38F04DD2B37659E9E2A97872AD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_97F481FC487404534665E9E2A97860CE" xlink:to="loc_us-gaap_CommonStockMember_9B9E4D38F04DD2B37659E9E2A97872AD" xlink:type="arc" />
    <link:loc xlink:href="pfe-20200428.xsd#pfe_NotesDue20220.250Member" xlink:label="loc_pfe_NotesDue20220.250Member_A853CEF81E355FC6E5F6E9E2A978D0F6" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_97F481FC487404534665E9E2A97860CE" xlink:to="loc_pfe_NotesDue20220.250Member_A853CEF81E355FC6E5F6E9E2A978D0F6" xlink:type="arc" />
    <link:loc xlink:href="pfe-20200428.xsd#pfe_NotesDue20271.000Member" xlink:label="loc_pfe_NotesDue20271.000Member_F326392D69C01DE1448FE9E2A978311E" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_97F481FC487404534665E9E2A97860CE" xlink:to="loc_pfe_NotesDue20271.000Member_F326392D69C01DE1448FE9E2A978311E" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_4082DF9A8B76A24DB916E9E2A9787D4B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_Security12bTitle_4082DF9A8B76A24DB916E9E2A9787D4B" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_4A08B9438C36D0A16C96E9E2A9780C05" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_DocumentType_4A08B9438C36D0A16C96E9E2A9780C05" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_74D65FEA819D10687082E9E2A97826B7" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_DocumentPeriodEndDate_74D65FEA819D10687082E9E2A97826B7" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_A7C4F7BDD8635A6C4A1DE9E2A9781720" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_EntityRegistrantName_A7C4F7BDD8635A6C4A1DE9E2A9781720" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_2DADBC7BA2CF312B69E0E9E2A9784086" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_EntityIncorporationStateCountryCode_2DADBC7BA2CF312B69E0E9E2A9784086" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_46DC5F91818B30E05B59E9E2A978ADE8" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_EntityFileNumber_46DC5F91818B30E05B59E9E2A978ADE8" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_8384919CB5BC04EA937CE9E2A9782B30" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_EntityTaxIdentificationNumber_8384919CB5BC04EA937CE9E2A9782B30" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_1A01BDC2218655927882E9E2A97849C2" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_EntityAddressAddressLine1_1A01BDC2218655927882E9E2A97849C2" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_45D21ED561CB0AB81E81E9E2A9785A6A" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_EntityAddressPostalZipCode_45D21ED561CB0AB81E81E9E2A9785A6A" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_C1E20527B2B69996FE2BE9E2A978D83B" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_EntityAddressCityOrTown_C1E20527B2B69996FE2BE9E2A978D83B" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_CA5F3A1441CD3A68202AE9E2A9786E25" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_EntityAddressStateOrProvince_CA5F3A1441CD3A68202AE9E2A9786E25" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_AEE08BC5F24AFF75BA0AE9E2A978C564" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_CityAreaCode_AEE08BC5F24AFF75BA0AE9E2A978C564" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_BE958FB6EA7BA9B17979E9E2A978E0F3" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_LocalPhoneNumber_BE958FB6EA7BA9B17979E9E2A978E0F3" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_dei_WrittenCommunications_AF8BC8DE604BB82A4959E9E2A978CCC4" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_WrittenCommunications_AF8BC8DE604BB82A4959E9E2A978CCC4" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_dei_SolicitingMaterial_8C6B17429179ED51E10AE9E2A97821F9" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_SolicitingMaterial_8C6B17429179ED51E10AE9E2A97821F9" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_dei_PreCommencementTenderOffer_C91CF86943E204311527E9E2A978F77D" xlink:type="locator" />
    <link:definitionArc order="16" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_PreCommencementTenderOffer_C91CF86943E204311527E9E2A978F77D" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_A9A0E8ADA328B4BAF99EE9E2A978CE3C" xlink:type="locator" />
    <link:definitionArc order="17" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_A9A0E8ADA328B4BAF99EE9E2A978CE3C" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_DF0B837A1DD6C9A71616E9E2A9785225" xlink:type="locator" />
    <link:definitionArc order="18" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_EntityEmergingGrowthCompany_DF0B837A1DD6C9A71616E9E2A9785225" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_F1DA93820B3FA01B1FF1E9E2A978DC2A" xlink:type="locator" />
    <link:definitionArc order="19" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_AmendmentFlag_F1DA93820B3FA01B1FF1E9E2A978DC2A" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_EDE59F64249E6C2E8A3BE9E2A978E45E" xlink:type="locator" />
    <link:definitionArc order="20" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_EntityCentralIndexKey_EDE59F64249E6C2E8A3BE9E2A978E45E" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_125794D99C74C252234AE9E2A978EE6D" xlink:type="locator" />
    <link:definitionArc order="21" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_TradingSymbol_125794D99C74C252234AE9E2A978EE6D" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_0F9E66FAB98D47526C0FE9E2A978CE2D" xlink:type="locator" />
    <link:definitionArc order="22" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_SecurityExchangeName_0F9E66FAB98D47526C0FE9E2A978CE2D" xlink:type="arc" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>pfe-20200428_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_CoverAbstract_62B66F7D967A049D9802E9E2A978DD26_label_en-US" xlink:label="lab_dei_CoverAbstract_62B66F7D967A049D9802E9E2A978DD26" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover page.</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_62B66F7D967A049D9802E9E2A978DD26" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract_62B66F7D967A049D9802E9E2A978DD26" xlink:to="lab_dei_CoverAbstract_62B66F7D967A049D9802E9E2A978DD26" xlink:type="arc" />
    <link:label id="lab_dei_EntitiesTable_946CF6486E8630108ED5E9E2A97853A4_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable_946CF6486E8630108ED5E9E2A97853A4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_946CF6486E8630108ED5E9E2A97853A4_label_en-US" xlink:label="lab_dei_EntitiesTable_946CF6486E8630108ED5E9E2A97853A4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitiesTable" xlink:label="loc_dei_EntitiesTable_946CF6486E8630108ED5E9E2A97853A4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable_946CF6486E8630108ED5E9E2A97853A4" xlink:to="lab_dei_EntitiesTable_946CF6486E8630108ED5E9E2A97853A4" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_D7CE5A78906A1E47489DE9E2A9789814_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis_D7CE5A78906A1E47489DE9E2A9789814" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_D7CE5A78906A1E47489DE9E2A9789814_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis_D7CE5A78906A1E47489DE9E2A9789814" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_D7CE5A78906A1E47489DE9E2A9789814" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis_D7CE5A78906A1E47489DE9E2A9789814" xlink:to="lab_us-gaap_StatementClassOfStockAxis_D7CE5A78906A1E47489DE9E2A9789814" xlink:type="arc" />
    <link:label id="lab_us-gaap_ClassOfStockDomain_97F481FC487404534665E9E2A97860CE_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain_97F481FC487404534665E9E2A97860CE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_97F481FC487404534665E9E2A97860CE_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain_97F481FC487404534665E9E2A97860CE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_97F481FC487404534665E9E2A97860CE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain_97F481FC487404534665E9E2A97860CE" xlink:to="lab_us-gaap_ClassOfStockDomain_97F481FC487404534665E9E2A97860CE" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockMember_9B9E4D38F04DD2B37659E9E2A97872AD_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember_9B9E4D38F04DD2B37659E9E2A97872AD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_9B9E4D38F04DD2B37659E9E2A97872AD_label_en-US" xlink:label="lab_us-gaap_CommonStockMember_9B9E4D38F04DD2B37659E9E2A97872AD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_9B9E4D38F04DD2B37659E9E2A97872AD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember_9B9E4D38F04DD2B37659E9E2A97872AD" xlink:to="lab_us-gaap_CommonStockMember_9B9E4D38F04DD2B37659E9E2A97872AD" xlink:type="arc" />
    <link:label id="lab_pfe_NotesDue20220.250Member_A853CEF81E355FC6E5F6E9E2A978D0F6_terseLabel_en-US" xlink:label="lab_pfe_NotesDue20220.250Member_A853CEF81E355FC6E5F6E9E2A978D0F6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes Due 2022, 0.250% [Member]</link:label>
    <link:label id="lab_pfe_NotesDue20220.250Member_A853CEF81E355FC6E5F6E9E2A978D0F6_label_en-US" xlink:label="lab_pfe_NotesDue20220.250Member_A853CEF81E355FC6E5F6E9E2A978D0F6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Due 2022, 0.250% [Member]</link:label>
    <link:label id="lab_pfe_NotesDue20220.250Member_A853CEF81E355FC6E5F6E9E2A978D0F6_documentation_en-US" xlink:label="lab_pfe_NotesDue20220.250Member_A853CEF81E355FC6E5F6E9E2A978D0F6" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Notes Due 2022, 0.250% [Member]</link:label>
    <link:loc xlink:href="pfe-20200428.xsd#pfe_NotesDue20220.250Member" xlink:label="loc_pfe_NotesDue20220.250Member_A853CEF81E355FC6E5F6E9E2A978D0F6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pfe_NotesDue20220.250Member_A853CEF81E355FC6E5F6E9E2A978D0F6" xlink:to="lab_pfe_NotesDue20220.250Member_A853CEF81E355FC6E5F6E9E2A978D0F6" xlink:type="arc" />
    <link:label id="lab_pfe_NotesDue20271.000Member_F326392D69C01DE1448FE9E2A978311E_terseLabel_en-US" xlink:label="lab_pfe_NotesDue20271.000Member_F326392D69C01DE1448FE9E2A978311E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes Due 2027, 1.000% [Member]</link:label>
    <link:label id="lab_pfe_NotesDue20271.000Member_F326392D69C01DE1448FE9E2A978311E_label_en-US" xlink:label="lab_pfe_NotesDue20271.000Member_F326392D69C01DE1448FE9E2A978311E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Due 2027, 1.000% [Member]</link:label>
    <link:label id="lab_pfe_NotesDue20271.000Member_F326392D69C01DE1448FE9E2A978311E_documentation_en-US" xlink:label="lab_pfe_NotesDue20271.000Member_F326392D69C01DE1448FE9E2A978311E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Notes Due 2027, 1.000% [Member]</link:label>
    <link:loc xlink:href="pfe-20200428.xsd#pfe_NotesDue20271.000Member" xlink:label="loc_pfe_NotesDue20271.000Member_F326392D69C01DE1448FE9E2A978311E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pfe_NotesDue20271.000Member_F326392D69C01DE1448FE9E2A978311E" xlink:to="lab_pfe_NotesDue20271.000Member_F326392D69C01DE1448FE9E2A978311E" xlink:type="arc" />
    <link:label id="lab_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE_label_en-US" xlink:label="lab_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInformationLineItems" xlink:label="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="lab_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:type="arc" />
    <link:label id="lab_dei_Security12bTitle_4082DF9A8B76A24DB916E9E2A9787D4B_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle_4082DF9A8B76A24DB916E9E2A9787D4B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_4082DF9A8B76A24DB916E9E2A9787D4B_label_en-US" xlink:label="lab_dei_Security12bTitle_4082DF9A8B76A24DB916E9E2A9787D4B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_4082DF9A8B76A24DB916E9E2A9787D4B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle_4082DF9A8B76A24DB916E9E2A9787D4B" xlink:to="lab_dei_Security12bTitle_4082DF9A8B76A24DB916E9E2A9787D4B" xlink:type="arc" />
    <link:label id="lab_dei_DocumentType_4A08B9438C36D0A16C96E9E2A9780C05_terseLabel_en-US" xlink:label="lab_dei_DocumentType_4A08B9438C36D0A16C96E9E2A9780C05" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_4A08B9438C36D0A16C96E9E2A9780C05_label_en-US" xlink:label="lab_dei_DocumentType_4A08B9438C36D0A16C96E9E2A9780C05" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_4A08B9438C36D0A16C96E9E2A9780C05" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType_4A08B9438C36D0A16C96E9E2A9780C05" xlink:to="lab_dei_DocumentType_4A08B9438C36D0A16C96E9E2A9780C05" xlink:type="arc" />
    <link:label id="lab_dei_DocumentPeriodEndDate_74D65FEA819D10687082E9E2A97826B7_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_74D65FEA819D10687082E9E2A97826B7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_74D65FEA819D10687082E9E2A97826B7_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_74D65FEA819D10687082E9E2A97826B7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_74D65FEA819D10687082E9E2A97826B7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate_74D65FEA819D10687082E9E2A97826B7" xlink:to="lab_dei_DocumentPeriodEndDate_74D65FEA819D10687082E9E2A97826B7" xlink:type="arc" />
    <link:label id="lab_dei_EntityRegistrantName_A7C4F7BDD8635A6C4A1DE9E2A9781720_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName_A7C4F7BDD8635A6C4A1DE9E2A9781720" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_A7C4F7BDD8635A6C4A1DE9E2A9781720_label_en-US" xlink:label="lab_dei_EntityRegistrantName_A7C4F7BDD8635A6C4A1DE9E2A9781720" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_A7C4F7BDD8635A6C4A1DE9E2A9781720" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName_A7C4F7BDD8635A6C4A1DE9E2A9781720" xlink:to="lab_dei_EntityRegistrantName_A7C4F7BDD8635A6C4A1DE9E2A9781720" xlink:type="arc" />
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_2DADBC7BA2CF312B69E0E9E2A9784086_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode_2DADBC7BA2CF312B69E0E9E2A9784086" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_2DADBC7BA2CF312B69E0E9E2A9784086_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode_2DADBC7BA2CF312B69E0E9E2A9784086" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_2DADBC7BA2CF312B69E0E9E2A9784086" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode_2DADBC7BA2CF312B69E0E9E2A9784086" xlink:to="lab_dei_EntityIncorporationStateCountryCode_2DADBC7BA2CF312B69E0E9E2A9784086" xlink:type="arc" />
    <link:label id="lab_dei_EntityFileNumber_46DC5F91818B30E05B59E9E2A978ADE8_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber_46DC5F91818B30E05B59E9E2A978ADE8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_46DC5F91818B30E05B59E9E2A978ADE8_label_en-US" xlink:label="lab_dei_EntityFileNumber_46DC5F91818B30E05B59E9E2A978ADE8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_46DC5F91818B30E05B59E9E2A978ADE8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber_46DC5F91818B30E05B59E9E2A978ADE8" xlink:to="lab_dei_EntityFileNumber_46DC5F91818B30E05B59E9E2A978ADE8" xlink:type="arc" />
    <link:label id="lab_dei_EntityTaxIdentificationNumber_8384919CB5BC04EA937CE9E2A9782B30_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber_8384919CB5BC04EA937CE9E2A9782B30" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_8384919CB5BC04EA937CE9E2A9782B30_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber_8384919CB5BC04EA937CE9E2A9782B30" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_8384919CB5BC04EA937CE9E2A9782B30" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber_8384919CB5BC04EA937CE9E2A9782B30" xlink:to="lab_dei_EntityTaxIdentificationNumber_8384919CB5BC04EA937CE9E2A9782B30" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressAddressLine1_1A01BDC2218655927882E9E2A97849C2_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1_1A01BDC2218655927882E9E2A97849C2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_1A01BDC2218655927882E9E2A97849C2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1_1A01BDC2218655927882E9E2A97849C2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_1A01BDC2218655927882E9E2A97849C2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1_1A01BDC2218655927882E9E2A97849C2" xlink:to="lab_dei_EntityAddressAddressLine1_1A01BDC2218655927882E9E2A97849C2" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressPostalZipCode_45D21ED561CB0AB81E81E9E2A9785A6A_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode_45D21ED561CB0AB81E81E9E2A9785A6A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_45D21ED561CB0AB81E81E9E2A9785A6A_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode_45D21ED561CB0AB81E81E9E2A9785A6A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_45D21ED561CB0AB81E81E9E2A9785A6A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode_45D21ED561CB0AB81E81E9E2A9785A6A" xlink:to="lab_dei_EntityAddressPostalZipCode_45D21ED561CB0AB81E81E9E2A9785A6A" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressCityOrTown_C1E20527B2B69996FE2BE9E2A978D83B_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown_C1E20527B2B69996FE2BE9E2A978D83B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_C1E20527B2B69996FE2BE9E2A978D83B_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown_C1E20527B2B69996FE2BE9E2A978D83B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_C1E20527B2B69996FE2BE9E2A978D83B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown_C1E20527B2B69996FE2BE9E2A978D83B" xlink:to="lab_dei_EntityAddressCityOrTown_C1E20527B2B69996FE2BE9E2A978D83B" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressStateOrProvince_CA5F3A1441CD3A68202AE9E2A9786E25_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince_CA5F3A1441CD3A68202AE9E2A9786E25" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_CA5F3A1441CD3A68202AE9E2A9786E25_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince_CA5F3A1441CD3A68202AE9E2A9786E25" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_CA5F3A1441CD3A68202AE9E2A9786E25" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince_CA5F3A1441CD3A68202AE9E2A9786E25" xlink:to="lab_dei_EntityAddressStateOrProvince_CA5F3A1441CD3A68202AE9E2A9786E25" xlink:type="arc" />
    <link:label id="lab_dei_CityAreaCode_AEE08BC5F24AFF75BA0AE9E2A978C564_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode_AEE08BC5F24AFF75BA0AE9E2A978C564" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_AEE08BC5F24AFF75BA0AE9E2A978C564_label_en-US" xlink:label="lab_dei_CityAreaCode_AEE08BC5F24AFF75BA0AE9E2A978C564" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_AEE08BC5F24AFF75BA0AE9E2A978C564" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode_AEE08BC5F24AFF75BA0AE9E2A978C564" xlink:to="lab_dei_CityAreaCode_AEE08BC5F24AFF75BA0AE9E2A978C564" xlink:type="arc" />
    <link:label id="lab_dei_LocalPhoneNumber_BE958FB6EA7BA9B17979E9E2A978E0F3_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber_BE958FB6EA7BA9B17979E9E2A978E0F3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_BE958FB6EA7BA9B17979E9E2A978E0F3_label_en-US" xlink:label="lab_dei_LocalPhoneNumber_BE958FB6EA7BA9B17979E9E2A978E0F3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_BE958FB6EA7BA9B17979E9E2A978E0F3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber_BE958FB6EA7BA9B17979E9E2A978E0F3" xlink:to="lab_dei_LocalPhoneNumber_BE958FB6EA7BA9B17979E9E2A978E0F3" xlink:type="arc" />
    <link:label id="lab_dei_WrittenCommunications_AF8BC8DE604BB82A4959E9E2A978CCC4_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications_AF8BC8DE604BB82A4959E9E2A978CCC4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_AF8BC8DE604BB82A4959E9E2A978CCC4_label_en-US" xlink:label="lab_dei_WrittenCommunications_AF8BC8DE604BB82A4959E9E2A978CCC4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_dei_WrittenCommunications_AF8BC8DE604BB82A4959E9E2A978CCC4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications_AF8BC8DE604BB82A4959E9E2A978CCC4" xlink:to="lab_dei_WrittenCommunications_AF8BC8DE604BB82A4959E9E2A978CCC4" xlink:type="arc" />
    <link:label id="lab_dei_SolicitingMaterial_8C6B17429179ED51E10AE9E2A97821F9_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial_8C6B17429179ED51E10AE9E2A97821F9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_8C6B17429179ED51E10AE9E2A97821F9_label_en-US" xlink:label="lab_dei_SolicitingMaterial_8C6B17429179ED51E10AE9E2A97821F9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_dei_SolicitingMaterial_8C6B17429179ED51E10AE9E2A97821F9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial_8C6B17429179ED51E10AE9E2A97821F9" xlink:to="lab_dei_SolicitingMaterial_8C6B17429179ED51E10AE9E2A97821F9" xlink:type="arc" />
    <link:label id="lab_dei_PreCommencementTenderOffer_C91CF86943E204311527E9E2A978F77D_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer_C91CF86943E204311527E9E2A978F77D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_C91CF86943E204311527E9E2A978F77D_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer_C91CF86943E204311527E9E2A978F77D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_dei_PreCommencementTenderOffer_C91CF86943E204311527E9E2A978F77D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer_C91CF86943E204311527E9E2A978F77D" xlink:to="lab_dei_PreCommencementTenderOffer_C91CF86943E204311527E9E2A978F77D" xlink:type="arc" />
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_A9A0E8ADA328B4BAF99EE9E2A978CE3C_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer_A9A0E8ADA328B4BAF99EE9E2A978CE3C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_A9A0E8ADA328B4BAF99EE9E2A978CE3C_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer_A9A0E8ADA328B4BAF99EE9E2A978CE3C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_A9A0E8ADA328B4BAF99EE9E2A978CE3C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer_A9A0E8ADA328B4BAF99EE9E2A978CE3C" xlink:to="lab_dei_PreCommencementIssuerTenderOffer_A9A0E8ADA328B4BAF99EE9E2A978CE3C" xlink:type="arc" />
    <link:label id="lab_dei_EntityEmergingGrowthCompany_DF0B837A1DD6C9A71616E9E2A9785225_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany_DF0B837A1DD6C9A71616E9E2A9785225" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_DF0B837A1DD6C9A71616E9E2A9785225_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany_DF0B837A1DD6C9A71616E9E2A9785225" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_DF0B837A1DD6C9A71616E9E2A9785225" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany_DF0B837A1DD6C9A71616E9E2A9785225" xlink:to="lab_dei_EntityEmergingGrowthCompany_DF0B837A1DD6C9A71616E9E2A9785225" xlink:type="arc" />
    <link:label id="lab_dei_AmendmentFlag_F1DA93820B3FA01B1FF1E9E2A978DC2A_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag_F1DA93820B3FA01B1FF1E9E2A978DC2A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_F1DA93820B3FA01B1FF1E9E2A978DC2A_label_en-US" xlink:label="lab_dei_AmendmentFlag_F1DA93820B3FA01B1FF1E9E2A978DC2A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_F1DA93820B3FA01B1FF1E9E2A978DC2A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag_F1DA93820B3FA01B1FF1E9E2A978DC2A" xlink:to="lab_dei_AmendmentFlag_F1DA93820B3FA01B1FF1E9E2A978DC2A" xlink:type="arc" />
    <link:label id="lab_dei_EntityCentralIndexKey_EDE59F64249E6C2E8A3BE9E2A978E45E_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey_EDE59F64249E6C2E8A3BE9E2A978E45E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_EDE59F64249E6C2E8A3BE9E2A978E45E_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey_EDE59F64249E6C2E8A3BE9E2A978E45E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_EDE59F64249E6C2E8A3BE9E2A978E45E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey_EDE59F64249E6C2E8A3BE9E2A978E45E" xlink:to="lab_dei_EntityCentralIndexKey_EDE59F64249E6C2E8A3BE9E2A978E45E" xlink:type="arc" />
    <link:label id="lab_dei_TradingSymbol_125794D99C74C252234AE9E2A978EE6D_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol_125794D99C74C252234AE9E2A978EE6D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_125794D99C74C252234AE9E2A978EE6D_label_en-US" xlink:label="lab_dei_TradingSymbol_125794D99C74C252234AE9E2A978EE6D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_125794D99C74C252234AE9E2A978EE6D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol_125794D99C74C252234AE9E2A978EE6D" xlink:to="lab_dei_TradingSymbol_125794D99C74C252234AE9E2A978EE6D" xlink:type="arc" />
    <link:label id="lab_dei_SecurityExchangeName_0F9E66FAB98D47526C0FE9E2A978CE2D_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName_0F9E66FAB98D47526C0FE9E2A978CE2D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_0F9E66FAB98D47526C0FE9E2A978CE2D_label_en-US" xlink:label="lab_dei_SecurityExchangeName_0F9E66FAB98D47526C0FE9E2A978CE2D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_0F9E66FAB98D47526C0FE9E2A978CE2D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName_0F9E66FAB98D47526C0FE9E2A978CE2D" xlink:to="lab_dei_SecurityExchangeName_0F9E66FAB98D47526C0FE9E2A978CE2D" xlink:type="arc" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>pfe-20200428_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.pfizer.com/role/CoverPage" xlink:href="pfe-20200428.xsd#CoverPage" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:presentationLink xlink:role="http://www.pfizer.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_62B66F7D967A049D9802E9E2A978DD26" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitiesTable" xlink:label="loc_dei_EntitiesTable_946CF6486E8630108ED5E9E2A97853A4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_62B66F7D967A049D9802E9E2A978DD26" xlink:to="loc_dei_EntitiesTable_946CF6486E8630108ED5E9E2A97853A4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_D7CE5A78906A1E47489DE9E2A9789814" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_946CF6486E8630108ED5E9E2A97853A4" xlink:to="loc_us-gaap_StatementClassOfStockAxis_D7CE5A78906A1E47489DE9E2A9789814" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_97F481FC487404534665E9E2A97860CE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_D7CE5A78906A1E47489DE9E2A9789814" xlink:to="loc_us-gaap_ClassOfStockDomain_97F481FC487404534665E9E2A97860CE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_9B9E4D38F04DD2B37659E9E2A97872AD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_97F481FC487404534665E9E2A97860CE" xlink:to="loc_us-gaap_CommonStockMember_9B9E4D38F04DD2B37659E9E2A97872AD" xlink:type="arc" />
    <link:loc xlink:href="pfe-20200428.xsd#pfe_NotesDue20220.250Member" xlink:label="loc_pfe_NotesDue20220.250Member_A853CEF81E355FC6E5F6E9E2A978D0F6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_97F481FC487404534665E9E2A97860CE" xlink:to="loc_pfe_NotesDue20220.250Member_A853CEF81E355FC6E5F6E9E2A978D0F6" xlink:type="arc" />
    <link:loc xlink:href="pfe-20200428.xsd#pfe_NotesDue20271.000Member" xlink:label="loc_pfe_NotesDue20271.000Member_F326392D69C01DE1448FE9E2A978311E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_97F481FC487404534665E9E2A97860CE" xlink:to="loc_pfe_NotesDue20271.000Member_F326392D69C01DE1448FE9E2A978311E" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInformationLineItems" xlink:label="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_946CF6486E8630108ED5E9E2A97853A4" xlink:to="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_4082DF9A8B76A24DB916E9E2A9787D4B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_Security12bTitle_4082DF9A8B76A24DB916E9E2A9787D4B" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_4A08B9438C36D0A16C96E9E2A9780C05" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_DocumentType_4A08B9438C36D0A16C96E9E2A9780C05" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_74D65FEA819D10687082E9E2A97826B7" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_DocumentPeriodEndDate_74D65FEA819D10687082E9E2A97826B7" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_A7C4F7BDD8635A6C4A1DE9E2A9781720" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_EntityRegistrantName_A7C4F7BDD8635A6C4A1DE9E2A9781720" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_2DADBC7BA2CF312B69E0E9E2A9784086" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_EntityIncorporationStateCountryCode_2DADBC7BA2CF312B69E0E9E2A9784086" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_46DC5F91818B30E05B59E9E2A978ADE8" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_EntityFileNumber_46DC5F91818B30E05B59E9E2A978ADE8" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_8384919CB5BC04EA937CE9E2A9782B30" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_EntityTaxIdentificationNumber_8384919CB5BC04EA937CE9E2A9782B30" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_1A01BDC2218655927882E9E2A97849C2" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_EntityAddressAddressLine1_1A01BDC2218655927882E9E2A97849C2" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_45D21ED561CB0AB81E81E9E2A9785A6A" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_EntityAddressPostalZipCode_45D21ED561CB0AB81E81E9E2A9785A6A" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_C1E20527B2B69996FE2BE9E2A978D83B" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_EntityAddressCityOrTown_C1E20527B2B69996FE2BE9E2A978D83B" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_CA5F3A1441CD3A68202AE9E2A9786E25" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_EntityAddressStateOrProvince_CA5F3A1441CD3A68202AE9E2A9786E25" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_AEE08BC5F24AFF75BA0AE9E2A978C564" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_CityAreaCode_AEE08BC5F24AFF75BA0AE9E2A978C564" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_BE958FB6EA7BA9B17979E9E2A978E0F3" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_LocalPhoneNumber_BE958FB6EA7BA9B17979E9E2A978E0F3" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_dei_WrittenCommunications_AF8BC8DE604BB82A4959E9E2A978CCC4" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_WrittenCommunications_AF8BC8DE604BB82A4959E9E2A978CCC4" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_dei_SolicitingMaterial_8C6B17429179ED51E10AE9E2A97821F9" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_SolicitingMaterial_8C6B17429179ED51E10AE9E2A97821F9" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_dei_PreCommencementTenderOffer_C91CF86943E204311527E9E2A978F77D" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_PreCommencementTenderOffer_C91CF86943E204311527E9E2A978F77D" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_A9A0E8ADA328B4BAF99EE9E2A978CE3C" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_A9A0E8ADA328B4BAF99EE9E2A978CE3C" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_DF0B837A1DD6C9A71616E9E2A9785225" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_EntityEmergingGrowthCompany_DF0B837A1DD6C9A71616E9E2A9785225" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_F1DA93820B3FA01B1FF1E9E2A978DC2A" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_AmendmentFlag_F1DA93820B3FA01B1FF1E9E2A978DC2A" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_EDE59F64249E6C2E8A3BE9E2A978E45E" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_EntityCentralIndexKey_EDE59F64249E6C2E8A3BE9E2A978E45E" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_125794D99C74C252234AE9E2A978EE6D" xlink:type="locator" />
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_TradingSymbol_125794D99C74C252234AE9E2A978EE6D" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_0F9E66FAB98D47526C0FE9E2A978CE2D" xlink:type="locator" />
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_57C89A8329DE361CC154E9E2A978ABCE" xlink:to="loc_dei_SecurityExchangeName_0F9E66FAB98D47526C0FE9E2A978CE2D" xlink:type="arc" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>oldpfelogowhite.jpg
<TEXT>
begin 644 oldpfelogowhite.jpg
M_]C_X  02D9)1@ ! @$ E@"6  #_X16,17AI9@  34T *@    @ !P$2  ,
M   !  $   $:  4    !    8@$;  4    !    :@$H  ,    !  (   $Q
M  (    >    <@$R  (    4    D(=I  0    !    I    -  %N-@   G
M$  6XV   "<0061O8F4@4&AO=&]S:&]P($-3-"!-86-I;G1O<V@ ,C P.3HQ
M,#HP-2 Q-3HT-CHP-P   Z !  ,    !__\  * "  0    !   "!* #  0
M   !   !+          & 0,  P    $ !@   1H !0    $   $> 1L !0
M  $   $F 2@  P    $  @   @$ !     $   $N @( !     $  !16
M     $@    !    2     '_V/_@ !!*1DE&  $"  !( $@  /_M  Q!9&]B
M95]#30 !_^X #D%D;V)E &2      ?_; (0 # @(" D(# D)#!$+"@L1%0\,
M# \5&!,3%1,3&!$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# $-"PL-#@T0#@X0% X.#A04#@X.#A01# P,# P1$0P,# P,#!$,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,_\  $0@ 70"@ P$B  (1 0,1 ?_=  0
M"O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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M//YVPM^BRO\ \$0,3/F>&!_FZ )UKVO_ $-?&<<7)&>0$^^3*48GAXO?\?\
M9H_^:O4?]-3_ -+_ ,BJV?T/*P,<Y%]M1;N#0UN[<2XQIN']I:WU6.3;7D9%
M]UEK=PK8+'N?&T;WN&]SOI>I_P!! ^MV1[L;%!XW7/'_ (%7_P!5:I89<WOC
M$9 @?,0/#B:^3E^7^Z'.(2B2/0)2O4RX(_\ ?-+$^KF?EXU>36^MC;1N:U^Z
M8/T3[1^=]).[ZG]4/%U'_3_\BLUN9U%SF48]^07.AE55=C_DQC&O77=&P,C
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MQQ/CIX?*Q>X $DP!J2O5OJ!]6W]'Z:[+RV%F?GAKK&.$.JK'\SCG^7[O5O\
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M/__9_^T::%!H;W1O<VAO<" S+C  .$))300E       0
M     #A"24T#[0      $ "6     0 ! )8    !  $X0DE-!"8       X
M            /X   #A"24T$#0      !    '@X0DE-!!D       0    >
M.$))30/S       )           ! #A"24TG$       "@ !          $X
M0DE- _4      $@ +V9F  $ ;&9F  8       $ +V9F  $ H9F:  8
M  $ ,@    $ 6@    8       $ -0    $ +0    8       $X0DE- _@
M     '   /____________________________\#Z     #_____________
M________________ ^@     _____________________________P/H
M /____________________________\#Z   .$))300        "  $X0DE-
M! (       0     .$))300P       " 0$X0DE-!"T       8  0    ,X
M0DE-! @      !     !   "0    D      .$))300>       $     #A"
M24T$&@     #20    8              2P   ($    "@!5 &X = !I '0
M; !E &0 +0 Q     0                         !              ($
M   !+                      !                         !     !
M        ;G5L;     (    &8F]U;F1S3V)J8P    $       !28W0Q
M!     !4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG
M   !+     !29VAT;&]N9P   @0    &<VQI8V5S5FQ,<P    %/8FIC
M 0      !7-L:6-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)
M1&QO;F<         !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U
M=&]'96YE<F%T960     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@
M    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M         $QE9G1L;VYG          !"=&]M;&]N9P   2P     4F=H=&QO
M;F<   ($     W5R;%1%6%0    !        ;G5L;%1%6%0    !
M37-G951%6%0    !       &86QT5&%G5$585     $       YC96QL5&5X
M=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$585     $       EH;W)Z06QI
M9VYE;G5M    #T53;&EC94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!
M;&EG;F5N=6T    /15-L:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#
M;VQO<E1Y<&5E;G5M    $453;&EC94)'0V]L;W)4>7!E     $YO;F4    )
M=&]P3W5T<V5T;&]N9P         *;&5F=$]U='-E=&QO;F<         #&)O
M='1O;4]U='-E=&QO;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))
M300H       ,     C_P        .$))3001       ! 0 X0DE-!!0
M  0    $.$))300,     !1R     0   *    !=   !X   KF   !16 !@
M ?_8_^  $$I&248  0(  $@ 2   _^T #$%D;V)E7T--  '_[@ .061O8F4
M9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,
M#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.
M%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,
M# P,# S_P  1" != * # 2(  A$! Q$!_]T !  *_\0!/P   04! 0$! 0$
M         P ! @0%!@<("0H+ 0 !!0$! 0$! 0         !  (#! 4&!P@)
M"@L0  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$
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MK8.7EIVCXO;N8U31Q8(FA&%]CZI?\YK3S\W,<4IY.']X7"'_ #.&*S\S-?\
M3R;G?&Q\?=N0'.>?I.<?B2?RIU$J8 #84US(G<D^:&Q -US#++;&$<;7N;_U
M+D:PJM8451TV2-ZSU>EP=7G9 C@.L<\?YMWJ-5RCZ\=>QS^E=5E-G7U&;71Y
M/H]-O_@2QWH#U'+%CEO")^C9QY\L?EG(?71[G!_QA]-M(;GT689_TC?TU?\
MG5M;=_[+KI<3,Q,VD7XES,BEV@?6X.$_NRW\Y>-/38N=F]/R/M.#>_&N[O8?
MI ?FV,,UVL_D6L>JV3D8'Y#PGL=8M[%\0F-,@XAW&DGVQ)<C]6/KY1U&RO Z
MH&XV<\[:K6Z56N/T6-W3Z-[O]$]WZ3_!6?X%=<J.3'*$N&0HNCCR1G'BB;#_
M /_0]5225?-S:,*@W7F!PUHU<YW[C!^\B 20 +)1*0B#*1J(U)*6ZZJBIUMS
MQ76P2YSC "YWJ'UBNN)JP@::^#<1[W#^0TC]%_:_2?\ %*K9DY/6,^FN[^;?
M8 VEOT6M^E9_7L](/_2+JLF]N/CVWNU%3'/(_JC<K/MQP&/''W)R_1OTQ_[Y
MH>]/FXY/;F<&*&G'5SR?O?I1]MX<NU+G$RXRYSIDG]YSG?22!!$@R/);E?UJ
ML!'KXPV_G&M\D?!KVMW?YZT,KI73^HT"VMHK?8T.KR*Q!U&YKG#V^HW^38K4
MN8,"/<QF /Z0EQM"')1RB1P9ADE'4PE&6(_\YY);G0>C5VL;G9;=[7:T5.&D
M?Z9X_.W?X+_MS_B\FG#LMSFX+Q#S9Z5D=@W^=<W_ *VUSF+L<JYF'AVW  -H
MK+FMX'M'M:F\WE($80/JGV_=_P#0E_P[EXRE/+D'IQ=#^_UO^X\[UOK619DO
MQ\:QU-%!+7.82USW-^G[Q[FL8[V>Q;O21>.FX_VAYMM<P.+R9,.][6EWYVQC
MMFY<2) &XR[N?$]U?Q>O=2Q<<8];F.8T0PV-+G-'9K2'L]K?S-Z.;EKQQAC
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M2S]S;[/_ #VCGD>8E&&($Q&\J]*WE8#DX3R9R(RD/3"[G0_[Y'TEC<GK^;E
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MBSPG_!A_W3)WO.Y\O/BXEQ_Z2BYQ#21J8T'FDK72J/M'4\:KMZ@>[X5_I?\
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MH'&YQL ^%=;<;_JES'5>H]1S[1EY]C[K7LFDN&UI9):W[.QH:STG65[?T?\
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M6225.?'Q>N^+^MNWH<'"."N'^KLI)))-7*22224__]DX0DE-!"$      %4
M   ! 0    \ 00!D &\ 8@!E "  4 !H &\ = !O ', : !O '     3 $$
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MZZ]^ZUU'^O/]>?>SQZ\.L3_7W9>'7CY=87/^]?[W[WY]>X*3U@/NPZJG$GK
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M9YSP?=.EBTZ:*@_7_8_[P+>Z]+$ ITT3GZ_[;_B/^(]U/2M.'3#4M^H_Z_\
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M*B:Z6FIJ:BIJ>CHZ>"DI*2"*FI:6FBC@IJ:F@C6*"GIX(E2*&"&) J(H"JH
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MQ[<'5&\^F"I;Z_ZQ_P!YX_XCW=>F&..F"I;_ (D_\1_Q/NX\^J>8Z:ICP?\
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M ,5]U/2J,=-DI^O^O_O7'MH\>ET8Z;93R?\ ??[[CW4^72R,=-TI^O\ OO\
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MO'S2$+XI<C6M_ *I5;DR4]9*BKRQ7D#!OF#V3]QM@N)8OZORWEN"=,EK^LK
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MO_<#<^1/:I8]@W:XL]^W*_A@CE@D:*:-$U3RNDB%704B6)BI!(ET\">J6_\
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M .-#W4\.E:"O31,WU/\ ON>!_MA[J>'2M!GIGJ&X/^^_WUO>AQZ4^73!4O\
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M/7$DF?E_/J2;/[F'.Q ^MYLVJ,T_ )Y,^G=%'CY_RZ0.[?Y WR]Q=+)5[:[
MZ)W:T:,?X<FXMY8/)S/J.E:5<GL?^$G4OU,M9#8\<CGVML_O-<C3N$N]KW*
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MN10$  MJ_P /8TIU%^L^G7M7^'OU.O>)\NN]?^O_ +[_ &/OU.MZU].O:_\
M7_WW^Q]^T]>UKZ="'U)LQ^Q^S]A;&1':/<^ZL-BJPJ65HL9-61'*U&I#K44N
M,260D<@+Q[#W-N\KRYRQOV^$@-:VLCK\W"GPQG'<^D?GT-/;GEEN=N?.4.4U
M0E+_ '"&)Z5%(F<>*V,]D0=L9QUM11QQPQI%$B111(L<44:JD<<:*%1$10%1
M$4   6 ]\LV9G9G=B6)J2<DD^9Z^@-$2-$CC0+&H   H !@  8  X#KG[UU;
MKWOW7NJ!OYBV^SNGY S[<@EUT/7NV\/@ B,&A.4R43;CR=0#_P =C'EJ>GD
M-@:4"P(/O/?[N^R#:^0$W%TI/N%S)+7ST(?!0?96-G'^G]*=<@/OI\U'F#WC
MDV6.6MILUC#;T&1XLH^IE;[:31QMZ&*G&O1"B?\ 'W.^3UB-15ZXZOZ<^_4Z
MT7'D.NN3]??L=5.H\3CJ['X!_%;(;$@'=/8>,DH=U9>@DIMDX*MCT5>!PF0@
M"U6<KX7'DI,OF:9S#%$0KT]&SZ_5.4BPM]^O=*WWV3^IG+UR)-KBD!N95-5E
MD0]L2D8:.,C4S9#2 :<("W4G[H'W?[SE*$>Y_.5BT/,%S"5L8'%'MX)%[YY
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M+F@]H_\ NJ?]\[KK_AVK_OP'_L5?_P!&_O?_  *G_A^?]F7_ &]]6_Y.!_\
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MRNFG7U<]5-/4U4\M34U4LE14U$\CS3SS2NTDLTTLA:26::5BS,Q)8DDF_OI
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M+@>\9KBWFM+B>UN8REQ$[(RGBK*2&!^8((ZRHMKF"\MK>[MI ]M*BNC#@RL
MRD?(@@]//MGI_KWOW7NODC]V46+Q?<7;&,P:PKA<=V7ONAPZTTBS4ZXNCW1E
M:?'K!*K.LL(I8TT,"0R@&Y]]3=I>63:-KDFKXS6T9:O'444FOSKURTW.**+=
M]TBA \%;F4+3AI#L!0_9T%+G_??ZW_&_:P];B%!7K=+_ -DTKO\ H&4_NO\
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M4W%W/S=RSGYGK@-[@<Y7_N!SIS'SEN=1<W]TT@4FOAQ_#%$"?PQ1!(U^2CI
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M)999&"1Q11H&>221V 50"238>Z.ZHK.[ (!4DX  XDGR ZW'')-(D42%I6(
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M_K7=;TO\/R,^+^RKL1G\7Y5G_A.Y]MYFER.W=R8P3H)%AKJ6=(I562,+(JN
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M62,3U,H75+*Q6"FA#2RLJ*3[%O)?)6^<][U#LNR05D.9)&KX<,=<R2,. '
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M6=N@?+O+VU<K[19;'LUL(K"!: <2Q_$[G\3N>YF\R<4% .9?-',^\\X;Y?\
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M]FR4AI-P[VB@J$*56+V!B:YJ6DE"M&V9JB\;K/C7'O&7[P7/8L;"/DO;IO\
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M^P_WW'NI/2I%Z9ZB3ZCWX#IT],53)]1?Z?[W^3_L/;@'3;'ICJ)/K_A_O?\
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M-Z-(<B*,G\;"I%="N01U*_MG[/<U^YMZAV^ VVPH]);N13X:^JQC!FE _ A
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M'B:6KJI9X,;2R5+R5$E-0Q2"*-I&9RB@L223[Z-6\;PV\$,DQDD5%4N:58@
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MU)69*LI<=CZ6IK\A7U,%%0T-%!+55E;654J04U)24T"R35-3432*D<:*7=F
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M7#>3 X21<#MXW''&#Q=..+@?2Y^OOJ7[=;$.7.1^5]FT:98K-"X])9!XLO\
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MI%!!#&J(J@!5  ]\I9)'E=Y9'+2,223DDG))/J3UV<CCCACCBB0+$J@ #
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M_KS_ +[_ (K[WTZJT^WIHFGO<WX_WWT_J3[\3^WIP+PZ:II_Z_[ #\?\5/\
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M2.-% 5$10     /?*)F9V9W8ER:DG))/$D]?0@B)&B1QH%C4   4  P  ,
M<!US]ZZMU[W[KW6NA_-4[&_O'\A<=LFFFO1];;,Q5!4PZ]83/;F+;DKY0!94
M\N&J\:A7D@Q7)Y &?/W:-B_=W(=QN[I^MN%V[ \/TX?TE'SI(LI_/]O(K[\7
M-1WOW:L^7(I/\6V?;HD85K2>X_QAS\JPM;BG'MKYT%7TM3_C_L?S^/\ ;>\B
M?MZPU"^@Z;)JKZ\_[[_?'W[IP+Z]-4U5?\_[8_[V?Q[W3IP#IKFJ1_6_]/\
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MJ@B_B6?S%2]3F]RYAXE"O6Y&IJJMU #2$ 6Q8WSF'>^9;Y]RWW<Y;J\/XG.
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MTRT#&GB+YE:"116JZ1J/)#WJ^[;SI[0SS;B(VW+DQG[+R)3^F"<+=1BIA;@
M]3$Y("OJ)12.?>_XC_;_ /&O<OTZQTH/3KWWG^*_[?\ XU[]0=>IUQ^\_P 1
M_MV_XI[]3Y]>IUP^[)_)_P!L3_Q/OU!UO3\NL9JC?ZG_ '@?[W[]CKU#UB-7
M];L/^2B?]Z][I\NMZ>L#57^U?[8 ?[R;>_9ZWIZCM5CGFY_Q)/X_PL/?J=;T
M\.L#59_!_P!M8?\ %3[]3Y=;IU&:H)_/^^_US[W4>O5@O5MW\G;KQMS]^;T[
M&J(1+0=9[%>EII;$FGW'OFK;&XYPQ!51)M_%9=2+@F_' /O&C[SV^BQY-VO8
MXVI-?WE2/6*W&IO^JCPGK-G[C?*AW3W(WWFF6.MOM.W%5-/AGNV\-,_.&.Y'
MY_;ULH^\$>NK'7O?NO=1:ZMI,;15F1KYXZ6AQ]+45M;53'3%34E+$\]1/*W.
MF.&&,LQ_ 'MR**2>6."%"TKL%4#B230 ?,G'34\\-K!-<W$@2WC0LS'@JJ*L
M3\@ 2>M%GMWL6L[1[0[#['KV<5.^-Y[CW.R26U4\68RU574U(+$JD=%2RI"B
MCA40 <#WUFY<V>+E_8-EV.&FBTM8HL>91 I;[6()/J3UP!YRYAGYMYMYEYGN
M:^-N%]-/0\0)9&=5^Q5(4 <  .@P>H_VW];V'^W/)]G70="GCPZAR5 _)O\
MX?0?[;W[JX7T'4&2I_Q_WW^]#WOJX7\STWRU/^-_]Z_XW[]U<#J!+/\ U/\
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MC_Q3WHGI]4\^F^6:P//^^_XU[T!7IW Z:II_K<_[#W8#JI/31-/]>?\ >?\
M>O\ BONX'5">H]+2Y#+UU+C,50UF3R-=,E-0X['TT];75M3*VF*GI:2F22HJ
M)I&X5$4LQ^@]Z=XX8WEFD5(U%2S$  >I)P.M1QRSR1P6\3/,YH%4$L3Y  9/
MV#JR#HC^3O\ S _D$:.MQ?2&0ZQVS6>,C=G=M6.MJ"".:Q@J/[N9*"H["KJ2
M:*[K-1X6IB* '5ZDU1;S%[V>W'+FN.7?EN[I?]#M1XY/J-:D0@^1#2J:^6#2
M8>5_N_>ZG-7ARP\MO96;?Z+>'Z=17@?#8&<@\:K"PIYY%;O?CY_PFSZFP!HL
MS\FN[=T=CY!&6>?9G6%!#L7:BN%"M0U^Y<L,WNC.41-V\E-%@YKD#@ ZX$YD
M^\_O%SXD'*NQ16L7 2SGQ9/M"+IC0_)C*/\ )DIRI]T'8K3P[CG+F.:\E&3%
M;J(8OL:1M<CCYJ(3P_.]KH+X??&+XO8\4/0W2>PNNIFIUI:K/XK#QUF\<G3J
MBH(<QO?,-D=WYB+TW"5-;*@9F( +&^/W,7.G-7-<GB<P[[<7*UJ$9J1J?58E
MTQK]JJ.LF^5^0N3>2XO"Y8Y=M;1J4+JE96'H\SZI7'R9R./KT9+V&.A=U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?_TM_CW[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]TUYK"87<>,K,)N'
M$8O/8;(PM3Y#$9J@I,IC*ZG<6>"LH*Z*>EJ86'U5T93_ $]J+6[NK&XBNK*Y
MDAND-5=&*.I]592"#\P>DE]86.YVD]AN5E%<6,JT>.5%DC<'R9'!5A\B".JU
M^[/Y3GQ=[2^[R6SJ#+]+[DG$LB56QYDJ-KR53A@CUNS,N:B@BI([C]C&38M3
MI'/)O./*WWB>?]@\*#<YX]TL5H*3BDH']&9*,2?XI1+]G6+W/7W/O:?FSQKK
M9;:;8]T:IU6IK 6/ M;250*/X(&@&./&M2_<?\H3Y0]??=5_7TNV.YL'"6:(
M;?KTVYNL4Z LTU5MK<<]/1E^/3#19&NE;Z!2?>1'+7WD>0]Y\.'>5GVR[/'Q
M%\2*OH)8P6_-XXP/7K$#G3[F/NIR[XMQR[):[W8+P\%A#<4'FT$Q"U]%CFE8
M^0ZK0WSU_P!A=9Y1L)V)LC=FQLL&D5<?NO;N4V_4RB.VJ2GCRM+3&IA(8$21
MZD96!!(()F_:M[V;?;<76S;K;W=O_%%(L@%?7230_(T(X'K&+?>5^8N5[LV/
M,FPWEA=U/9<0O"33S =5U#A0BH(((-".D(U2/ZD_ZY/^]<#V:=$H7A1>L+5-
MOH0/]]_3Z^]]6TGUZ-/\'NN3W!\LNC-E2TIK,<^^<=N/.P-'Y*>7;^RUFWAF
M:>K+ JE/74&#>G)-KM*%'J8>X_\ =/??ZN>WW-6YK)IF%HT<9KD234A0CYJS
MAORKP!ZEKV*Y5'.'NWR)LKPZ[8WZ32BF#%;5N) WR9(BGVL ,D=;MOOEUUW&
MZ][]U[KWOW7NM.K^;5VN>QOFEOO&T\ZU&*ZOP^W.M,8RN2HEQ=&V=W AC!*K
M+3[JW#70,?J1"M_Z#HQ]W[8OW+[:;5,ZZ;B^DDN6_P!L=$?Y&*-&_/KC[]['
MF8\R>\^^VZ2:K3:X8;-/M1?%EQZB>:53_I1U62]3_4W_ ,/Q_MA[FOK&T#J(
M]0?ZV_WW]/I[]U<(3\NHCS$WY_V)/O1(Z=6+Y=1FE_V/^)X'O18]*4BZC/,/
MR;_[U_MOS[I7I0L0'4.2?_'_ (K_ ,4'O73H '#J%)/;\_[[_7]ZZN%)Z@23
MW_/_ !3W[[>G GKU"DF_Q]ZKTZ%K]G4&2;_'_BI_XI[K7IY8^H,DW]3_ +#\
M?\;/O73ZI3AU"DF_Q_XK;W4GI]4IQZA23?T]ZZ>5>H,DO^/^^_P]ZKT^B=09
M)?\ 'C_>/^-GWKI]5].H,DOU_P!\3_K^ZD]/JE.FZ:<"_OP'5^C!]5?#KY7=
M[?:2=3?'OMG>F.KM/VVX:'9F8H]H'7I*>;>>5IZ#:E-K#77RUB74$C@&P8WG
MGCD[E[6-YYELX)5XH95,GY1*3(?R4]##8O;SGKF?PVV'E._N87X2+"XB_.9@
ML0_-QZ]6A]._\)Z_F/OO[.M[9W7U?T=C)F3[['UF8E[$WG1JS#68\1L[R;/J
MS&@/ W"EVL+V)(B+?/O*<D;?KCV:SN]PE' A?!B/^VE_4'_.$]3=R]]T_P!P
MMS\.3?;ZRVR$\5+FXF'^UB_2/_.<?YK8^E/^$\WP[V&]+D.W]T]E]\92+3]S
MCJW*+UQLFITA2&7#;.E7=T+%[W!W Z%;#3<$F&]^^\ISMN(>/9;2UVZ(\&"^
M-*/]M*/#_P"J(/SZG;EO[IWM]M927?[Z\W28<5+?3PG_ &D1\4?\YR/EU;UT
MW\8/CM\>Z/[/I/I7K;K0M$(*C([5VIB:#/Y"-0ZJ,ON7[=]PYEU5RH:KJIF"
MFU[<>X6WOFSF;F1]>_;[=76:A9)&*+_I4KH7_:J.I]Y>Y+Y2Y3C\/EOERSL\
M4+11*KM_II*>(_\ MF/0[>P_T)^O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K__T]_CW[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]TS9_;NW]U8
MNIP>Z,%AMR86M7168?/XRBS&+JTL1IJ<?D8*BDG6Q/#(1S[4VE[>;?.EU87<
ML%TO!XV9&'V,I!'Y'I%N&V[=NUK+8[I80W-D_P 4<J+(C?Z9'!4_F.B(=G?R
MNOA?V::FI/5O]P,K4ER<IUEF*[:8@+DG_)MO!J[9L(5C=0,98?3Z<>Y8V/WW
M]S-CT(-^^KMU_#<HLM?MD[9C_P Y?Y]0+S/]UGV4YG,LIY5_=]VU>^RD:"E?
MX8>ZV'R_1^7#'5?/8_\ (MIW^YJ>I._*B"VLT>$[%VI%4!OIXUJ=T[9K:71:
MQ#%,.U[W %K&7]F^]5(-"<P\I ^KV\I'VTBE!_G-UCYS%]Q.$^++RCS\R_PQ
M7< /V5GA9:?.EN>A5_ER?RY>W/BQWSO'L7MVHV3EJ.GV#5[9V7D=HYJLRM+/
ME,[F,749+("#)XC"92BEH\3B7IP98%5EK' U$7 >]YO>?E_GWE3;MFY>2ZCD
M-V))EE0*0J(P5:J[JP+N&PQ(*#AT+ONX_=QYL]J^?-XYCYN>REB7;VAMWMY&
MD!>61"[4>.-U*QQE.Y0")#2M*B[GWC!UFYU[W[KW3+N3<&+VGMW/[JS<_P!K
MA=LX7*[@R]38'[?%X:AGR-?/9F13X:2F=N2!Q]?:FRM)[^\M+&V75<S2K&@]
M6=@JC\R1TCW&_MMJV^^W2]?39VT+RR'T2-2['\E!/7SZ>P=\Y;L;?6].P,ZY
M?-[YW7N'=^78,7!R>Y,M5YBMTL534HJ:Q@#8<?@?3WUJVG;K?9MJVW:+7%M:
MV\<2?Z6- B_R'7!/?=SNN8=\WG?[]JWM]=2W$G^GFD:1O^-,>D4TW^/^VY/M
M?J].B]8O0=1VE_V'^O\ 7W4GY]/K#U&><#_$_P"^_'X]UKTH6,#J+)/?\\?[
M[_8#WKIP >0ZAR5 _K_OO]?Z^]=6"D]0I*@_U_V ]^^WIP)Z]0GF_P ?>J^G
M3@7TZAR3_P"(_P!]_3^OO5>G53J$\W^-O][_ .* >]5Z?5/7CU">;Z@?[[_B
MONI/3RI7[.H<DW^/NO3ZK3KNBHLEF*R+'XF@KLI7U!*T]#CJ2>MK)V N1#34
MT<LTA 'X4^VY9H8$:6>54C'$L0 /M)QTJM[6>YD2*WA:24\%4%B?L J3T8O9
M?PE^8?8_C?9OQD[ORU),0(LI+USN?$X1V:-90!G<UCL=ARQB=6MY_P!+*?HP
MN$=P]P>1]KJ+_FW;T<?A\>-F_P!X1F;^7E\NA[M7M;[B;QI.W<D;G)&>#&WE
M1/7^T=53AGXO3UZ.)L7^2!_,%WKX7S&P=D]:4]04TU._>Q]MMHB==7FGH]BS
M;WR=.J_1HW@68'ZI[ 6Y?>"]M+#4(-RN+MAY0P/^P&81*?M!I\^I-VG[L'NU
MN6@W.TVUDA\Y[B/AZD0&9A]A6ORZ.]UY_P )RMYU?V]1VW\FMLX4*]ZO$=<[
M#RFY_.GJ'CIMP[FS6T?M&^AUMBYQP1I_M>X\W3[T5BNM=EY3ED]&GF6.GVI&
MLE?L\0?;U*FS?<\W!M#[_P Z01TXK;P-)7Y"21XJ?;X3?9T?GK/^0A\%]EFG
MGWHO:W<%6I$E3#N_?!V_AI9 H713T77>.V=DX*:XU:)*Z=]1-W*V41ONWWC/
M<*_U+8?1V*>1CBUM^9F:52?L0#Y=2QLOW6/;';=#[B+[<)!Q$LWAI^2VZQ,!
M]KL?G3'5B_57PP^)W2/VDO5OQXZEVED:'QFFS]-LS#Y#=:&*_C9]W9BGR.YY
MW0L2#)5L023]3[C#>.>N<M_UC=^9KV:)N*&5EC_YQJ5C'Y+U+VQ>W7(G+7AM
ML?*5A;RKP<0HTN.'ZKAI#^;]&:]A/H:=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=?_4W^/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW0:=S?Z.O]
M$G9?^E__ )E5_<;<_P#I(O\ QW1_<?\ @]7_ 'H\W]V?]_!]M_!O-Y?M/W_'
MJT\^SKES]\?O_9?ZO_\ )=^JB^G^#^VUCPJ>)^G772FOMK2O0<YO_J__ %5Y
MC_K9_P JQ]%-]7_:4^F\-O&KX/ZM/#U5\/NI6G6MKV)_PQ3JJ/[N?Z8;>&?Q
M?Z._]+FGR?91>/[?_2MZ_-Y]6CS?M^;5K_:T^\QMI_X)^B?6?N_B*_4?2_Q'
MC]+Y4XTS2E.ZO7/7?/\ @**R?N[]Z_":?2_7?PCA];FM>&K&JM>RG1-]Z?\
M#4>N?^YO^SY_<>>FT>3_ $$_P+[;[8?<?;??_P"YSS^:U_-Z=6O3Z-'N0=O_
M -?:B_O'^J^BAX?6ZZUQ73V4IZ>5*YKU%VZ_\#%J?]T?UU\34./[N\.E,TU?
MJ5KZXK6F*=%>W7_LK=JK^Y?^S W_ (@_V?\ >C_1UI_A6N;Q_=?PGU??^/QZ
MM/[6K5;BWL8V7]=^S]Y?NKX,^']1\6*TU?AX\<\.@!N/^MM23]S_ +\KK.GQ
MOI?@S2NC\5*5ICCT"6XO[N?<0_W6_COV?@_RC^/?8?<?<:WOX?X=^UX/%I_5
MZM5_Q;V(;7ZW0WUOA>)7&C52GSU9K7H*7O[N\1/W=XWA4SXNFM:^6G%*?G7I
M+2>3\_3_ 'W^P]J>DJT\^H3Z_P _[[_?'W[[.GA3RZBOKY_WC^G^'NOV]7&F
MO0IXK_0/_$:?^\'^E_\ A/[WW?\ !_[F?Q'_ #$OV_VWWW^2_P# G1KU_P"Z
M]5N;>R&X_K/X3_2_0>/BFKQ=/$5KISPK2GGQZ%=I_4SQX_K?WG]-FNCP-7 T
MIJQQI6OE6F>AQVE_PW'_ )'_ '^_V=R_W,G\0_NA_H)U?9<^+[+^-?\ *3_J
MM?H_I["]]_KL?J?NS^KO#M\7ZSC\]'E]G0WVS_6._2_>_P#6OXN[P?H/A\J:
M_/[<=&CV3_PQ_P"*/^\'^SO:_MJG5_?C^Y7E\WWH\7D_T:_L?=>&_CT_L^&_
MD_=M[!6Y?\$34_3?U=I4?V/C<*?\/S2O'SKP[>I&VC_@4J+]7_6JND_[D>!Q
MU8K]+BM.%.W3Q[NCP=??] \/EA\?@_B>J2W^D+_9I?#X_-%I\WW?^_0TZK:=
M7[NC5J].KW'&Z?\ !1Z6U5\'_A'[OK^5/U?\E:4ZEO9O^ SU+II]1G_<C]Z\
M*CC7]&G\Z5KBO5@_5O\ PS%>'^X'^R)??Z?\E_O#_HJ_O';17^7[/^_W^_@U
M?;^;S>/U>'3Y/1X_<7[Q_K]]W[S_ *R>'YZ/J='EQ\'LXTI7SK3->IEV#_@9
MNS]S?U3\7R\3Z3Q/Q5IX_P"IPU:J>5*XIU9%L+_1E_#9/]&']Q/X/Z?+_<+^
M[_\ #?\ @16:/)_=[_)?^!7W%K_[L\GYU>XHW+][>*/WO]3X_P#P[7JX#^//
M#3^5/EU->T_N/P#^XOI/IO/P/#T\6_WWCCJ_/5YUZ7?LNZ-NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
HOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>pfizerlogo2019.jpg
<TEXT>
begin 644 pfizerlogo2019.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_X1$T17AI9@  34T *@    @ " $.  (
M   ,   (>@$2  ,    !  $   $Q  (    >   (A@$R  (    4   (I(=I
M  0    !   (N)R;  $    8   0_)R?  $    8   1%.H<  <   @,
M;@     <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                     %!F:7IE
M<B!L;V=O $%D;V)E(%!H;W1O<VAO<"!#4S0@36%C:6YT;W-H #(P,#DZ,3 Z
M,#4@,34Z-#8Z,#<   2@ 0 #     ?__  "@ @ $     0   @2@ P $
M 0   2SJ'  '   (#   ".X     '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                 %  9@!I 'H 90!R "  ; !O &< ;P   %  9@!I 'H
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M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(_\  $0@
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MC<+Y-PG6_=Y;3HS:[<LG^-V?B?'?$W'U%*IGE;$0C/;F<HQ?Y(M>(_B)X_\
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( !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>upjohnlogo.jpg
<TEXT>
begin 644 upjohnlogo.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@"_P?0 P$1  (1 0,1 ?_$ 18  0 !! (# 0
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MM%71PF.#HY34A487\-+#1%2DQ"5%I<56=C@9X?%FA.3E9)6U)K;_V@ , P$
M A$#$0 _ )_
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M]8
M
M
M
M
M
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MZ5K1I^)D;%R[&;863C2ZK,N3HU7[*3.8SX#Z
M
M
M
M
M
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MB5S4D?'$Z-LLC6=>YS(W3,1RHG1%>G7Z4,8T=*^!ZL]R@
M
M
M
M
M
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M=EW\.75:4G&M&N*H^3X\FN:,I3IC[@
M
M
M
M
M
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MIP=>F2]E:--/DTUQI5Y@TS4K&JXD<O'JHO@T^<9+FG]GGXIIF8!T1V
M
M
M
M
M
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MIT7-I-\B5:87/<@
M
M
M
M
M
M        $5;]9(]RN7B'CJ#P1X>S[JW(W+^!CR_.F8Q5OMMZEQ+?>^/'Z,LT
M"J^KE^37P/==C5[)(\#$K)(W0Y.-Z9H[3;16=E/<F?&N)8E2RFN$KJYS^2WX
M?HW5.L&>&WCK+Q[/XKQW]^N*LVO"'W/RR\?T/Z8@NDCC&0
M!V.?ZNGP/K7$?MH<;;SCH:LFU>0>T[URCN62CC<L[W4-HRO'VL8CYJ5$F?2Q
M>M:;!*D*(V&&Y<M*Q'+(Z62*/=74KV=NZ]C3KY.+"%N"^6*G)T]KE-JO-I+V
M467]HXL,?1H75^R792DW\[BE\R7V6S>P8W/3@
M
M
M
M
M
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M=LJS'2,EM75)^6Z-IIMOI=.33KQ?"G#A0E]&"S(
M
M
M
M
M
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MG[28 8*,@
M
M
M
M
M
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M+FGZ3;LWE2]*LI+V.7)/WI43]YM</%'>@
M
M
M
M
M
M                      ]))(X8Y)II&111,=)++(YK(XXV-5SY)'N5&L8Q
MJ*JJJHB(A5)MT7,'6->\OY[S^?'F9M^UZWE9K?"'%/S?%_!U5K^E&[K.'ORK
MF][CA9(L3[/(NP-EOQS.8RQ]U)0KRIUK(B2^V#ME;9T"W8O1IJ-^ER\_%2:X
M0_41^&G+JZFN9A;<6JO5=1E<@_WM;^&'R+G+]4^/R47@:G#VYT0
M       ) OL-^V%O_EWSOA/([:GYC2_';@G9ZF1GV>M7^5RW(>_T6+9H:7HF
M3M4IV8^7"]\=K*9FF^/(X7OKK0FKY"6"W4QAW*WABZ'ILM)L]-S5<F%.GFH0
M?.<TGQKRC!_#/CU)Q3C+U>U]%NZAE+,G6.):E6OC*7LB_=S;7%<*-.C78@P0
MQ5H8:\#&Q0P11PPQM_@QQ1,1D;&]>J]K&-1$(LMMNKYLRVN'!<BJ4
M
M
M
M
M
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M27!)<$DDN",SXV/9Q+$<;'BHV8*B7_AS;YM\V^+.3SXSG
M
M
M
M
M
M                                  !8Y3)X["8S(YG,7JF+Q&(HV\GE
M,G?L15*..QU"O):O7KMJ=S(:U2I6B=))(]4:QC5551$+H0G<FK=M-SDTDEQ;
M;X)+WLI*2C%RDZ12JV=6A[I/FQEO/7S*Y/YL2[=DX\H77:%PKB;7J1MPW$^J
MW+L.NO;4E1'TKFT6K%G.78G*Y8[V3F8BJQC$296S=O0VUH%G3Z+ZTUUW6O&Y
M)+JX^*BJ07NBF80UO4I:KJ,\FK\E/I@O9%<OL\9/WMFO$]4=2
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M =B
M
M
M
M
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MZ,>'!N5<Q;=T..D8W7=2>=<7Q/V+[A/V+QIS?N2-T)C\]&
M
M
M
M
M
M                                     4;-FO3KSV[<\-6I5AELVK5F
M5D%>M7@8Z6:>>:5S8X888VJYSG*C6M155>A5)R:C%5DRC:2J^1U</NT>:-CS
MI\WN5^7,;E9LAQGK]U.,^%87=[*U?C#3+5RMBLE5@D<Z2#\\LO8NYZ5KU[V2
MY1S.C6L:QLR-D;?6V]NV,&<:9DEYEW]LFE5/](J07NB82U[47J>IW,A.ME/I
MA^E7+[+K+YS6P>M.G               )LGZNO[3GYEX; >X)Y":YV[;LV,=
M:\9M-R]7H_6]5RU66O-S!E*=F+O;F=KQ\[H]?141(,5*Z\GJ.N57UX]=U-[?
M6+DMKZ7/[Q!_OB:?TI+_ !2:\(OZ?ME\/#I=<D;1T'RXK5LM??)+[VGX)_;O
MWO[7W<?%4ESF#CWP
M
M
M
M
M
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M!7K5X&-BA@@AB:V.&&&-J-:UJ(UK41$3H15;<FY2=9,RZDDJ+D5BA4
M
M
M
M
M
M                                              '7!?K!WE^[R?\
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M8F.J6X*GO;\6_>WQ9D =8?6
M
M
M
M
M
M               #$3SV\F:7AYX>^0'D78DKIDN.>/\ )V-0KVFLDKY#D//2
M0:OQSC+$3T<DE2_O&:H1S]&O5M=SW=KD:J'>[9TB6O:]BZ4J]%VZNKW0C\5Q
M_*H*5/?0Z_5<U:?I]W,?.$'3],^$5_?-'4^Y3)Y#-9/(YG+7+&1RN6O6\GD\
MA;D=-:O9"_8DM7;EF9ZJZ6Q:LRN>]R_%SG*I->$(VX*W!)0BDDER27!(P5*3
ME)RDZR;JRQ+B@             .P#_5S/;MC\;/'5_EAR5@75>;/)?"5;&L0
MY&L^'(Z3P3)8KY+6\>R.3XPV^1[56#/67)_#H-QC%1DD4R.C%W6W4]6U7\28
MDJZ?B2?53E.]RD_DMJL%[^OFFC*NT-(^IX?U^\OWS>7#W0YK^^^D_=TDD@Q,
M>Q
M
M
M
M
M                                                        (C7Z
MU5Y-_<G''CSXC8++NBO[UGLGS;R'C:SY8IOS7U)EG5N/ZU]6N;'9Q>=V7)9>
MPV)4<B6L%'(O:K&=<X]E]'\S+RM<NQ^&W%68/]%+XIT]ZBHJOLFT>!WSF]-F
MSI\7QDW.7R+A'YFV_GB0F20IC<             &V#V:O B3SY\S-1T_9L9-
M:X1XM97Y0YPL_:CJW=6PU^!F'T99^U&NL\A;"L./DB8^.PF+^>L0JCJRJGB=
M_;F6V= G?LNFHWOO=GW2:XS_ %$:R]G5TI\SO=NZ5^-=1C;FOWM#XI_(N4?U
M3X?)5^!V<M:M7IUX*E2"&K4JPQ5JM6M$R"O6KP,;%#!!#$UL<,,,;4:UK41K
M6HB(G0B VY-RDZR9FA))47(K%"H
M
M
M
M
M
M                    !U9_NS^3C_+3W ?(SE.CG'Y[3,?NUSCCC.RUR+CT
MX]XX>[5,#9P[&OD2/&;#+CY\NWJJ.DER,DCFL<]S4F7LC1_Q)MC$PI1Z<AVU
M<N>WKN?$Z^^-5']2D80U[-^OZK>OIUMJ73']+'@J>Y\_G-<AZLZ@
M     '9?>Q[X(S>#OA/JU3<L)]U<W\X35N5^78[,369/#39*DV/2M"MO^,D?
MYEZO(Q+%=RJD&7NW^U>CR(O<7<BW'N&<L>75IV-][M>QT?QS7Z>7)^,5$S+M
MK2_Q9IL5<5,F[\4_:O9'YE^:V;C3P9Z$
M
M
M
M
M
M                          UX>Z[Y(S^*7M]^3/+V+N/I;7%H%C1M$L03
M^A=K;OR=<J<?:[EJ"HJ.?9UJWL?WJK4^/I47K]"*>IV5I*UK=&'@S5;'F]<_
M9T6TYR3_ $RCT_.=1KN8\#2;V1%TN='3']-+X4_FK7YCJPR9IA
M    &YSV*/"23S)\Z](N;)A69/A[Q\?0YEY/6[7=/BLE8PE]B\?:9::O]SV7
M[3N$,,DU67JRSBJ%Y%:Y&JU? =R-PK0-MW(V94S\JMJW3FJKXY_J8UHURE*)
MZ+;&F_C'5(N:KCVOCE[.'T5\[\/%)G97D2#,@
M
M
M
M
M
M                                (@OZUEY'_=^E^-/B9A[_ &V-ESF;
MYYWJE%+Z4S,5K=:[HW';)T8OJ6,?ELGFMAE=&_I'Z^+B?T<]C5CSIV6TGKR,
MO6[BX0BK,'[Y4G/YTE#YI/Y\?[ZS*6[.!%\9-SE\B^&/V6Y?8(5Q((QR
M         #LBO8%\+8_$OP0U/;=DP[:'+7DT['<R[Q+8KO@RE#6,A05O%6I6
MO69#8CBPVI6UR#X)6-DK9'-7(UZ]$(F]S=P/6]R3L6I5P<.MJ'L<D_ODE\LE
MTU\8PBS,.U=-^H:7&Y-4R+WQR]M/M5\RX^YMF\$QV>E
M
M
M
M
M
M                                      !UDOOE^0[O(OW+_(?*5+K;
MNL\49BGP+J79*LT5>CQ7'+AME;#*DLD,E>YR--F[<:Q]K%993X*O5SI>]N=*
M_%6T<6$E2]?B[TOEN<8_8M]"^8PON;+^N:S>DG\%M]"_4\'_ (74S4<>Y.A
M           -@OM;^(T_FSYQ<'<(6Z$US1G[''O'+,L<?=#5XLT9T>>VRO9E
M^*5/SEC@BPE>96O;'=RD"JUR=4/+[RUQ;>V[DZC%I9/1T6O?<GPC\O3QFU[(
ML[71-/>I:G:QFOO5>J7Z6/%_9Y?*T=J!6K5Z=>"I4@AJU*L,5:K5K1,@KUJ\
M#&Q0P00Q-;'###&U&M:U$:UJ(B)T(9-N3<I.LF9P225%R*Q0J
M
M
M
M
M
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M:A-?'<?3']+'G3Y9</U)*[,*GN@
M
M
M
M
M
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M:YOYW5_.<\G6GU
M
M
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M_#J==>Q<G'2=^W<@GRZHM5^RD=MCYN%E-QQ;UJY)+BH3C*GRT;H?I' ?4
M
M
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M[& BH9>
M
M
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M_*6>61,YR5O^921(VR)EMQV+(H](E1T2/^<R,W<D;DZMZ_0OT'H<;;FWL/\
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MFN:J*CD5.J*BI\%14/$--.CYF0TTU5<CR"H
M
M                                 .LD]]'F%.9O=%\H<C5M_-8?C_8\
M%P]AXT<Q[:*\7ZQB-6V:HU[%<B_^/=3+2JB_:8Z56KT5"7O;C ^H;.PXM4N7
M8.Z_?YDG*+_O'$PON?(^LZW?:^C!J"_4I)_X534>>Y.A            .P%_
M5C?&J/BKP;V7GS)TF1;+Y.\BY+)4K2PMBL+QSQ79R>C:O3F5W69>FWILEIBK
MVL?!;C<UO3[;XQ=X-7>;N.&F0?WG#M)-?\)<I.3_ +WRU\J9E79>'Y&F2RI+
MX[\V_P!3&L5^;U/YR2,8F/8@
M
M
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ML5',]GP62QC;;E5.J]5ZJN&-?],/;O55*YI+R]-OODK=SS;=7[87NN=/=&Y
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M#>5CZQM;4L/.@EQ5J[&4X_I[=?,@_=.,7Q1R^>=/4@
M
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M8?1MP4?EHJ5^?F<T'7GT@
M
M
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M<)S@
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M-KXOUO6K2:K"W6;_ %/+_"Z3LQ2(IF8
M
M
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M\*[%2A<MRC.$XOBI1G%N,HOP:;3/UC@/I
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MF(F!S(0
M
M
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MBJEE9/5CXJ?A*%KADWE[8S6*_%29J4YB\N?('G-UFOO7(66^X+*O3\T-??\
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M?PTC=23;MJ/Q/9>89,[
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MF/5W<&5Q3<K=?AO8\W&#O6Z45Q="G:GPFNF5N<]B!A@DF
M      1 ?ULGD!]73/"_BR"S*L>;V?F/D#*4VND2%K]6Q6AZ[@K,S/A%)*]N
MX9%L2IW.8C9.O:CD[LZ]DL52R-0S6N,86H)_IG.3_61_,,?[\NTMXUA>,IR?
MS**7Y[(61($QR            =FC[$_!GZ"O;!\;:=NG\KGN4\-E^<\_)Z?I
M?/?I3R]G/:A<[%3N_P 6WW'%W*KN_P!+N3HUR-;$/N1J7XRWAERBZVK,E9C[
MO+73)?NG6_G,S;8Q?JNB64U\<TYO]4ZK_!Z3;T>%/0
M
M
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MB\M7_05.1%H]?I_9^(K["^):/7X@O1:/^HJO%G)XEJ]?@[\G^H%R+UR+5_\
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MX-2C*,E52C)-J46N*:;37%%^<1S
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M=F,?R]NY&2^=S,:^:%N%/'VREX+Y^!BW?%SJU.U:\(V4_G<I?W$B,49@/%@
M         ^LT+3<QR+O6E\?:]%Z^?WO;-<TW!P].[ULQL^8IX3&1=J*BKZEV
M\Q.G5/I.#)R+>)C7,J[^Q6H2F_DBFW^8B^U;E>NQM0^G*22^5NB.WQT#2\+Q
MOH>D\=ZW VMKNA:CK>EX&LUJ,;7PNK8:E@\7 UC>K6-BHT8VHB?!.A!?*R+F
M7DW,J[QNW;DIR^63;?YK,_VK<;-J-F'T(127R)41]<<!R
M
M
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MX#L0
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MVXG2=RVK2]_FR4)+^\<G\B.]VUC_ %G6[$7]&,NM_J$Y+\U([.LA^9I
M
M
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MQ',
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M*Y=6DY5ZL;F;@6VW:M7>KC];L65%R3;=RW&3;<K4YSW9D6R=8
M   !U;'O![0_;_<Y\U,M(]\CJG-VP:NCI&5V.1FD5<?I<3$;51(U9%'@$:U5
M_C'-1%D_C%<3)V)95C9^GP7CCQE_?MS_ -]_N<#".X)^9K63+_A6O[WA_<-;
M9ZTZ<          $J3]5.XG9L'E!Y*<SSP^M%QCPI@M%JJZ)71U<KRUN,64@
MMLE_@Q6DQ7%=V%J?2Z.>3I]"F&.].;Y6CXFGKG>R'-^]6HTI]FXG\R/<;&L=
M>;>R7RA;4?GFZ_G19.G(X&3@
M
M
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M+UZ=?@C24OI2U&]:WCJ.E)OZM?TUW6N-.NS>M1BZ<OHWI\?F\2#/KPT?&O\
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MI&Y%]5N3_3+DWX1DHR:XT/3Z;K.GZK']Z3K<2XQ?"2^;Q7O55[S/0\T=H
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M\N]:DE.W.G)2BE)?%!RBU)\UGESW0                          !KO\
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M/A"TKLWP4+=^%R[8<I.BA"=RW<N-J,(.3H;+C!I*,
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MQEQ7"E^"59I<*1O1<;L:<(]3A5N#,]#&!E<
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M]NUIUK/N^5J.E)K]X9[C*YUXZHNK"RXPN7++BJ6IPN6FK?PVXX5&4#!@
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M_>ED;BT"]#'E<F^JY<QKD92Q9W'S<TH7;/4ZN:LJ<I2G*3-MQ'4F,
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MCU^/[14O1:/4+FV7EJ]?X2_L_ $<BY%J\KX%\2S>O[ZE?<7KF6LB_257,O\
M8BU>H7.IR+D6CU^"_C4%\46CU^DKX%ZXLM9/J0J7FXSV1?*B7@/R\Q?&N=RO
MRG'GD;'2X\RD%B3MIUM^BEL3<999&][4^=L9FW-AF?2U6YE5<B]K5;'SU(;)
MCNC8<]8QH=6K:16_%KF[#261'Y%!*Z_VKAS=9)^F'?<MI]P;>BY5SIT?65''
MDGR5]-O&G^F<V[*_;N/)-3@S6X;/P
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M3/N'9^KX=JQ]Q;C'^]BE_<.:3KSZ0             =27YI?TQ?++^LOSO\
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MK!W_ #1O\O?_ !+$V_1Q_P!H_P#J_P#]M-8O]HY_V-_ZV_\ IA&Z)MFL8
MD"^P'<LLY3\A\>R9S:=GC_3KD]=.G9+9H[%D8:DSOAW=T$60F:G1>G21>OU=
M(>>L"W;>@:->:^^QS+R3]BE;BVOG<8_8-B_]G9>NQW;N3'4GY$].QI->#E"]
M-1?S*<E\[)0A PVN
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MOG-S^R-R6MW[1T[<UFB69B6[DDN4;CC2[#]1<4H?J3G4\R>I
M                                              !J,]XKQ9L<\^-R
M\CZMCTM\@<!OR>X5XH8FON9?0+-6/\^\3"K6>K)-0K4:^5C;W+U;CY8V-=),
MA(STU;_AM'>_XDU"?3H^KJ-EMOX89";\B;\*2<I6G^V1DVE%D-_6KVEN=P>V
M/Y3:3;Z]Q[><\E)+XKF)**^MVUXMPC"&1%5Y69QBG*:(=)LJ-*@
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MG_S&SO\ B?\ 6+1Z':G\?X_ZO\',[+DB.9E
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M!?\ &_Y ?S;:S_*>0B!ZO_YMZ/\ PZ[^"-B7]G=_/3<7\EV/P[)1I @VP@
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M*_27KLM2[:W=(NNL].U"["*]EJ\HWX_9NSO?8KXF](C22B
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M_P"ET\2O\O/_ +LO,YX'N?\ S&SO^)_UBT>AVI_'^/\ J_P<SLN2(YF4
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M=#VYB8^#H]B-+=FS"-NW%>-(Q256^,I.LI2;E)MML^K.O.W
M              (W?ZP=_P T;_+W_P 2Q-OT<?\ :/\ ZO\ _;36+_:.?]C?
M^MO_ *81NB;9K&   -_GL"_XW_(#^;;6?Y3R$0/5_P#S;T?^'7?P1L2_L[OY
MZ;B_DNQ^'9*-($&V$
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MV=2OA0N1:/7Z@7^):O7X+^,KXG)[BU<OQ_:!>N1:/7]]2I?'F6LB_3^+X%?
MO\:%H]?J!R>!:N7X+^,J^9?$M7K\5_$5+D6CU^A O:<GB6CU^"_C^'[/W <A
M:O4KX%\2T>O[ZE?$O1)N_5MMMFAVKRNT5ZO?7R6 XIVRNBMZLKS8/([OA[JM
M=WHC76V;#!U16N[D@3HK>BHZ&OJ\P8RPM#U-?2A=R;3]ZG&S-?8Z)?9^Q-WT
M:9\HYVO:6_H3LXMU>YPE>@_L^9'^]\/&5H0B)W@
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MW=O^3M!VZ_LN3:C]CJG_ +SP_.J>KV9;Z]:4ON+4G^='_?'8AD63+8
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M7JR2)[F.3XHJGB;ENY9F[5V,HW8NC3333]C3XIG>QE&<5.#3B^37%,_4+"X
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MJ2(QLG&S,>&7AW(7<6Y%2A.$E*$HOBI1E%M237%--IEZ<1S@
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MRXU3V?BK_P!HLDQ$@(;#P
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M3O?P_I'<.?S)1_R[VXV">D3^9.I_RJ_P%DU%_P!H9_2;HG\A+_6\@T3DLB
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M-/ZK%8.[\6">5A2FI22X+S[$N#NX[D^GJHIVY-0N175;E<SX,0DA@
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MP
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M;M5K/9S?N7LW5JW+$'YF-?I19&+-ORKJ7A+@X7(IOHNPG%-I*3QB/=F*P
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M7=VKU;(YSU3[36HUBNCYWMO]67I^-]S;NR_OG!?[PR/L.W2SDW?;*"^PI/\
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M+)M\3>AV%VG^1?:'0M#G'HROJ,;]U-4:O93>1<C+WPE=\OY()+@D95&.C+P
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M.UH^MZW)?#>R<>Q%\/\ $PN7))/GQ\^#EX.D?829"'A-$
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M=_W%]DREL:--+NS]M]_F0A_NDF\Q >T               .I]]Q?_2#^=O\
M7)\GO\]N\$U]J?S7TW^ 8_X&!@G5_P"-LK^$7/U\C#8[\Z\   [%/]6K_P!&
M#JW\\O+O]]L>16[M_P \9_P>U^<S+FS?XEC^V3_/1OX,9'J@       1</UK
M#^AUXZ_UEX?\UO(!F3LM_'V5_ __ "D#Q.^?XNL_MW^]D00R21B\   W)?J_
M?^ET\2O\O/\ [LO,YX'N?_,;._XG_6+1Z':G\?X_ZO\ !S.RY(CF90 =27YI
M?TQ?++^LOSO_ )TMJ)O[?_B'!_@=G\'$P+J7\8W_ -NG^N9C0=N?&
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M=[<;!/2)_,G4_P"57^ LFHO^T,_I-T3^0E_K>0:)R61
M $@_V&>>+.*WOE7QRRUY?NG;,*SD[3Z\TG2*OLNNR4L+M%2FSZ7VL[@+M2P]
M/H2/#JJ=%5>L./5QM*&1I.G[UQX?OC'N_5;S2XNU<ZIVG+W6[D9Q7OO?8V._
MV?'<&[B;@U?MGF7/WGF6%G8T6^"OV7&U?C%?=7;,K<W^AQG\\GH@@;5@
M            :WO<F\GG\'<2)HFJ9%*_)'*U>]B*4M>;LNZ[IZ1K7V+86+&O
MJUKEM)DHT7_8=ZLLLT;N^JJ&?_3[VY6\MT?CK4[?5M_3)1G)-?#=OUK:M<>#
MC&GF7%Q5%&$E2Y4B'ZO^\TNVVP_R9T.[T;OUR$[4'%TGCXM.F_?5.,9RKY-E
M_"^J4[D)=5EHC'=R&Q2C-,U&>>J?A0<2E&>>J_A!0=5_"HJ*(=5_"HJ*(Y^\
M6..7\L^1'$6B.A6Q2RVZ8NYF8>WO237M?<_8]C8J*J-3OP>)L(BKU1%5/@OT
M+X?N5K_Y,;#U76E+IO6L2<;;]EV[]ZM?\I.)E/LCM![Z[LZ!MAQZ\>_J-N=U
M4K6Q8KD9"^>S:FOE\'R)B1JD/T"   &A+WB^1OFMJXCXHJV&^GA<)E][S$#'
M=W=9SUS[CP:3HBJV.6K6P=US6KT=V647Z%;UFQZ4=!5K3=4W-=C\5Z]#&MOW
M6X^9<I[5)W+:]E84YIFK_P#M =V>?K>@['LR73CXUW-NI/[:]/R;-?8XQLWF
MESI<KR:-*RK^%27=7X&NQ(]%<*-\RZGM/57%:"J7(V1^ _A#FO(#:L=R)R!B
M;5#A+7KB6Y)+<4D"<B9.C95B:[B%<K'RX6*S"YN2MLZM1&+7C7U7O=#'_O9W
MBP]CZ;<T'0[L9[POPZ5TM/ZK"2_99\Z7&FO*@^/%7)?"DIR\],'IPU+NEK=G
M=>Z;$[7;G$N=3<DX_7[D)4\BUR;LJ2:R+JX))VHOKE*5N3G###6ABKUXHH*\
M$4<,$$,;8H888FHR***)B-9'%&QJ(UJ(B(B=$-=LYSN3=RXW*<FVVW5MOFV_
M%OQ9N2MV[=FW&U:BHVHI))))))4227!)+@DN"15+2\ &'WF]Y(T/&S@[/[!6
MOQ0[_M,%O5^-Z".C=;DV"Y6<R;.MKJO>ZAJM67YN5ZM6+UDAA<J.G9URGV@V
M#?W_ +QL8-R#>B8THWLJ7VJM1?"W7[J\UT17/IZYKA!TP/ZB>[6+VD[<Y6J6
M;L8[GS8RQ\"%5U._*-'>Z>?1C1?FR=.GJ\NVVG<C6(K--)-+)//+)-/-(^6:
M:5[I)999'*^2221ZJ]\CWJJJY5555>JFS^*C"*A!)12HDN"27))>"7L-&4Y3
MNS=RXW*Y)MMMU;;XMMOBVWS9(5]F[CK[KXPY2Y1M5NRSN.W8_5,9-+']MV)T
M['+=L3U7JGPK6\KLTD3^U?M24^BI]A"#7JKU[ZSN+3MNVY5ABXLKTTN77?ET
MI/WQA:37L5SAS9M+]!&T_J.S]9WE>A2[GYT,:VVN/E8MOKDXO[F5S(<73G*U
MQ^BC<L12)]  MKMRKCJ=O(7IXZM*A6GN7+,J]L5>K5B?/8GD=\>D<4+%<J_@
M0Y+5JY?NQL64Y7IR48I<VVZ)+WM\#AR+]G%L3RLB2ACVX.4I/E&,4W)OW))M
MD:#,>[_Y-/RV4?A,3Q=7PS\C==B(+NJ9B>Y#C'695H16YF;5&R:S'55C9'(U
MJ.<BJB)]!/[%]+W;Y8UM9=W499:MQZW&]!1<Z+J<5Y+HFZT5>"-2^=ZX^[DL
MV]+ L:/' =V?EJ>/=<E;ZGT*360DY*-%)I*KJZ'Y;O=^\KD_^IW$G_F?FO\
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M15%<$EC7?^D%-?>3\MT_^IO$'_F;F_\ "\/TO]MO\IJ=?V^W_F2Y>MCO(_\
M%:+_ ,VN_P#22B[WEO+E/@F-X?Z_^1F<_P ,!_5>[;?Y34_W>W_F2[^NQWB_
MR6B_\VN_](*+O>:\NDZ_^#>'NB?_ -F9S_# K_5>[;<O,U.O[?;_ ,R7KUK=
MXO&UHO\ S:[_ -),G_$7SW\\/++EO%Z!KF*XDQ^N47ULKR%MZ:/FGU=2U5+"
M,LVD]3<4CLYG(=KH,?5^+I["]SNV".:6/'_<GL_VA[<[<N:QFW-2GG33ACV?
M/A6]>IP7"S50C]*Y/[6/!5G*,995[/>H#OYW<W?:V_IMK2+>F6W&YEY'U6YT
MX]BM'+CD4E<GQC9ASE/BZ0C.49!9#,V'@  $8_W?_-R'D+8'^+O&>72?3-,R
MS+7*F7HS(ZMLNZ8V1KJ6K0S1.Z6,3IUE'/M(JN9+E4:G1%IM<^=?IO[62T;#
M6_==M].IY5NF+"2XVK$OI76GRG>7"'BK5?"ZTM9_JZ[UPW#J#[7[:O=6C8=W
MJSKD7\-[(@_AL)KG;QW5SYJ5^G!.RF]%#U)8<W4A N"J9T^"/@WN/F9R')76
M6[K/$FI6:LO(6\LKJKVMD5LL>JZPZ>)]2WM>5@^*=Z.BH5U^8F:_^)@GQ+W9
M[JZ;VTT=3I&_N+(BUCV*_-YMVCJK4'[*.Y+X(M?%*&=>QG9+5^\&ONVW/&VI
MBRB\O)2X\>*L6:IQE?FO;6-J/WR:?P0N3$^(N(./."M"P?&O%^M4=7U/ 5VQ
MUJ=2-%L7;:QQLM9C,753YG+9O).B1]FU.Y\LSOI7HB(FMK<6X]9W7J]W7->O
MSOZC>=7)\HKPA"/*$(UI&$:)+YS;OM/:6W]D:%8VYMG&AC:58C11BN,I475<
MN2YSN3I6<Y5E)^-*(Y+.C/1GS6X;CJO'VL9O=-WV#%:MJ>MT9<EG-@S=R*AC
M,;2B5K5FLV9G-8BOD>UD;$ZOEE>UC$<]S6K]NFZ;GZQG6M,TNS<OZA>FHPMP
M3E*4GX)+[+?))-MI)LZ[5M6TS0M-O:QK-^UC:7CP<[EVY)1A"*\6W[71)<VV
MDDVTB,?YA^]7R-N.2RVE>*C%X[TJ":6DO)N3QU>YONS1-66&2UA,=E*]C':;
MBKD;^L2O@FRJ(UDJ2U)%=$V<7;GTRZ-IMBWJ>_G]<U1I2^K1DU8M/@Z3E%J5
MZ:\:2C:YQZ;BI)ZZ.ZWJ_P!?U?)NZ/VR7U#1XMQ^N3BI9-Y<4W;A-.%B$O"L
M97N4E*U*L5I%WCD?D#DG*RYOD+>-NWK,SR++-E-NV/+['?>]>[X_-9>W;F1&
MHY41$5$:B]$1$).Z9HVD:+86+H^+CXN,EPC9MPMQ^Q!)$0-7U_7-P9#S=>S,
MK-RY/C._=G=E_?3E)FPWVS?,SFCB'R2XAXT_/+8]CXKY3WW5^-LYH>9RMK*8
M6E-NV6IZUB=@P-;(3RQX#(X;*Y"O/*^KZ?S-:)\,B/16=N'>]W;?;6XMEZCK
M7U:S9U[ Q+N3"_"*C.2LP=R=NXXI>9&<(RBE*O3)J2IQKGST\=V-V[6W_I>W
MOK>1?VWJ6;9Q;F-<FYVXO(G&U"[;4FU;E;G*,FX4ZX)QDGPI-"-:IMK !')_
M6$-9Q+]5\:=R588L[4S_ ")K*-1&I/=Q.0QVLY5RO=ZB/?#B[F,3M3L<C76W
M?%O=T=,7TCYN0L[6M.XO%E9Q[GN4XRN1^S)2]OVBYTX04];>GXST[0-5X+-C
M?R;7OE"4;4_;RA*'L^W?%5XQ@7+^^3<]YK\BB2K^KX\1JK_('GJ[67HB:]Q#
MK=SM3M556/<MVK*Y4[NK>FOO1$5$^/QZ_#I"_P!6NX*+2=JVY?Y3+N+_ )&R
M_P .B?'HIVSQUK>5V/\ D\*U+[%^^O\ 5G_X(DOD+B>P /Q]BNY3&Z_G<C@\
M2[/YNAA\G=P^"99KTWYK*5:4\^/Q++ER6"I4=D;;&0I)*]D<:O[G.1J*I]&)
M;L7LNU9R;GE8T[D5.=&^B+:4I42;?2JNB3;I1*I\V;=R+&'>O8EOSLJ%J4H6
MZJ/7-1;C"K:2ZG2-6TE6K:1A%X.>$VJ>(&E9W8-BN8K;N?N2K-_:>;N670K%
M]YY;)W[&<O8+ 37&LGQFFXBY.YR(J1/OSL6W.QBK%#7R5W,[DYW<#4K6)B1G
MC[5PXQM8>+6O3",5",YI<)7II>]0B_+BW\4IXJ[4=K-/[;:5=S,V5O)WAG2E
M=SLNE.J<Y.Y*W;<N,;,)/W.Y)>9-+X8PUI^97ORZCQELV4X_\4M1UWEK*82Q
M+2RO*&WV,JG&ZY"M(L5FIJ^&PEO$9K<:,<B*Q<BE_'U)',[JWS4#V3KF/MYZ
M7L_6L*&K;ZR+V!8N)..-:4?K'2^3N3FIPM2_X/HG)5I/HDG$PCW,]6VG:%G7
M-'[?8UG4<BU)QEE7G/ZMU)T:M0@X3O17+S/,MP;58>9!J9P1X:>^IS9OW/O'
M/%WD+I_&,VC\D[5BM*9L^DX;8-=S^K9S9KE;$:_D;++^S9W$Y/ -R]B*.Y&L
M$$\4,SYVS.]%()/3=P_3+MO2MK9>M[3R,U:EAV)7O+O3MW(786TY3BNFW"49
M]";@ZRBVE%Q75U+RO;/U6[IUC=V%H.\<; >E9M^%GS;$+ENY:N76H6Y/JNW(
M2M];2FNF,DFYJ3Z>F4I@A(3V !2GG@JP36;,T5>M7BDGL6)Y&0P000L626::
M616QQ111M5SG.5$:B=5+HQE.2A!-S;HDN+;?))>TME*,(N<VE!*K;X))<VWX
M)'5X9B7'S97)2XF"6KBI+]R3&5IU5T]?'OL2.IP3.=-85TL-96M<JR2*JHOV
MG?2NZ"PKJLP5]J5]12DUR<J<6N"X-U\%\AH[O.S*_.6.G&PYOI3YJ-7TI\7Q
M2][^5GXKU^G\9S+VEOB3V?9=X@?Q'[?/#S[E5]3,\I6-CY?R['L5GJLW#)NK
MZO:;W(CGLMZ%A\3(B].B]WPZIT5=8?J%UY:[W3SU;EU8^$K>+'_BHUN+YKT[
MJ-JGIPV^] [2Z<[D>G)SG<RY^_S94M/Y[$+3^?V&U4PF9T
M                                                  !&4]ZGP@9@
M,G_RON,\,V+#YVW4QG-N+Q\*,BQ^?MR,J87D)((F(QD&P3/92R;T[?[N6"94
M=)9GD2=7I?[J/,L?]V^NW:Y-J+E@SD^,K:59X]7XVU6=I?Y/KCP5N"-6/KE[
M#1T[*_[Y]K6$L+(G&&J6X*BA>DU&UF47!*\VK5]\/OOES:<KMR2CPDS#6T
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MG9;^/LK^!_\ E('B=\_Q=9_;O][(@ADDC%X  !N2_5^_]+IXE?Y>?_=EYG/
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M[^']([AS^9*/^7>W&P3TB?S)U/\ E5_@+)J+_M#/Z3=$_D)?ZWD&B<ED0
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M:&=_3)N">VN_6V,^#:5[4X8C\:K-C+#HUQ\;Z?N:4N%*J=::G#?X
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M)MLW+]MNVVV>UNV;6VMM6J6U25Z])+S<B[2DKMV2YM\HQ7PPC2$$DCGL\>9
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MNSN3E]U.<G*3^>3;-T&GX.+I>!8TS"CT8>/9A:MQ^YA;BH17S121]$?(?6
M
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MDOS2_IB^67]9?G?_ #I;43?V_P#Q#@_P.S^#B8%U+^,;_P"W3_7,QH.W/C
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M<QM"1TF<^TN[[L,C\E\^;E9FF[#;^C)*LK?'[623E%>$DTOI*G@-XZ+"5O\
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MA-5FW??;M6637],Q,SGKZUI[71-O9B['#(VC0C>V:U(U558X6331> [A=Q=
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MRX/ZGIL'9L-\GD7HM3:]OE6&U)<&G>@UXDPH@.;"@
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M8VY2?-RN8TK%R3?%RFZM\WL),-DCP    =?K^M$:4FN>X;I.T0QN^7Y!\9M
MS-B?[2-=EL'NW)6J6:Z(^U.JN@Q6%HO5S60QKZR(C7/1[W2>[.9'F[6N67SM
M9DU\SA;E^>W[>1BG>UOHU>,URG9B_G3DOSDB-\98/'@        '9#?JZ?\
MHIN#_P#RRYK_ ,[&V$3NZO\ /7)_:[7X*)F#:/\ $5K]-/\ 7LWBF.CTP
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M;@_S),Q3WUQK>5V5W;:NUZ5MS49_/;Q+MR/^%%5]WL("IMZ/SQ   ')'#?\
MC?XJ_G(T;^4^+.DW-_-O4/X#?_!3/3[)_GGI'\IXOX>V=B":9#])@
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M:^&QR-D7.?VK%3TQL;V)VJOJ.7(9>A$K.J=/LN5W5?HZ=5,F6O3-W-N2:G'
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M?P0?/RX07@9=GA#(
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M%-P?_P"67-?^=C;")W=7^>N3^UVOP43,&T?XBM?II_KV;Q3'1Z8
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MK5N^$M5O1K^*]'R;\'[+ER5K$5/8W;R+OS)DP UNFY\      ZW8W;'YC
M  =B!PU_B@XJ_FVT;^3&+-,FYOYR:A_#K_X69^DS9'\R](_DO%_ 6SDDZ0].
M13O?P_I'<.?S)1_R[VXV">D3^9.I_P JO\!9-1?]H9_2;HG\A+_6\@T3DLB
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M6G='7=R0DIV,C4+D;4N=;%FEC'?[C;M^[V<#&]SCV_N7(QLD6[W?4G[J@O\
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MPN9#5)W>/.-B+I%T_99)IJ5IHEZ$#38(
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M5$7N:Y>US,M]F\OR=S7<9_1O8DJ?IHSA)?X/4>-WO9Z]*A=7.%Y?8:DOSZ$
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M^*OYR-&_E/BSI-S?S;U#^ W_ ,%,]/LG^>>D?RGB_A[9V()ID/TF
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M]H&F;7T3&V]HUORM,Q+2MVX^-%SE)_;3G)N<Y<Y3DY/BSDDZ@[D
M
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M?\4'D!_.1K/\F)"!/J__ )R:/_ ;OX5&V#^SN_F9N/\ E.Q^ 9O\(?FQ,
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MR<8QV7&'S-
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MD<KG*JJJDL+=N%J$;5I*-N*227!)+@DEX)+D8?E*4Y.4FW)NK;YMGYQ>4
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M?SD:-_*?%G2;F_FWJ'\!O_@IGI]D_P \](_E/%_#VSL033(?I,
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M6_;KCV9+CBVIKZ<EX7[D71KG:@^ETG.<8R"2+!+0
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M4*_5H\>7G=4LAM<)0N6:JL#<81J)K$;O]8._YHW^7O\ XEB;?HX_[1_]7_\
MMIK%_M'/^QO_ %M_],(W1-LUC   &_SV!?\ &_Y ?S;:S_*>0B!ZO_YMZ/\
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MHE;Z-=HK<G>G&U.]#JP]'Q+V7*OT>MQ5BRG[U<O*[&G&MJO)-$J URFY
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MAD7E]URE9MOZ/"Y+XNE1D^D,R;P
M                                              (87NY^,K?'[RIS
M.S8'',I<>\YLN<B:RRNQ&5:&Q23Q1\@X*-J(QD:UMAM)?9'&UL4%3*01-_@+
MTV<^G/?3WCV_M8.9-SUG27'&NUYRMI/ZO<?RVUY;;=93M3D^9H_]9/:Q=N>[
M=_5=/M*WMO7U+,L45(PO-I9EI>"Z;TO.44E&-N_;@OHLU9F?2)@
M    ,E?#?D).*O*OQ]WR2RM2C@^5]-9F;".<Q8M=R^8KX/9%ZM^*HN R5E%3
MZ'(O1?@IX?N7HWY0=O\ 6=(C'JNW=/O="]MR$'<M?\I&)E#LGN3\D>[FW-PR
MET6,?6,;S)>RS<N1M7_^1G/Y>1/T-0)^B,    $"G]:8X5_,SS,X>YKI5O0Q
MG-O"D6(OR^ET^<W+B?8+6+R]CUVM:R3LU':-?B[%[GL]+JJ]KV-;);LUJ'UC
M0+^GR=9X^15>Z%R*:_PHS9BW>^-Y>HV\E?1NVZ?/%T?YCB1BC,!XL
M$K_]5!VYM+R&\L-#61J/V3AG3-N;%T3N>W2=W?AG2([UFJC8EY 1%3TW=>]/
MM-Z='X3[UV.K2\+)^XR)Q_OX5_WA[K8ERF7?M?=6T_[V5/\ ?$XPCJ9,
M            ! V_6*_; R/!?+&3\XN'-??)PMS1L'K<PXW$T^L'&?,&9L(M
MC8;<5>)J5-6Y4ORK82P[N9#L#[$4CV?.T8G24[5;QAJ6$MNY\_\ WACQ^]-O
M]DM+[5>V5M<*>,*-?1DS%V[M$>+?>IXZ_>UQ_'3[6;\?DE^NK[41?3,1XH
M              $TO]6V]L#(ZO7@]PSF_7WT<IG,3?Q'C'K>7I^G<J:]F:DN
M/V+F26O8B]:M^<N,L2XS OZL=+C9KEKM?!:I3+'[NSO&%Y_DMITZPC)/(DGP
M<DZQM?J7\4_T2BN<9(R-L[1'!?C;)5)-4MI^Q\Y_.N$?=5\FF3 #!1D    Z
MDOS2_IB^67]9?G?_ #I;43?V_P#Q#@_P.S^#B8%U+^,;_P"W3_7,QH.W/C
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M%3DKF^Q_<\DV*SERBV'7N/8K-=TK9*/'N$D2M)TEFBDRT]^>)R13M:V(>_\
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M7V3L:K>U[ S\O5M1G9C&5A6>F%FRIOI;N78/JE.XW*BI2,>/@MBW_70<$?\
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MNX]NY=\A0MN]!VY3;A>E*L8RDXTB_B2\"/,Y_P#K$T>7+F:ZDJE!SNGQ7]Q
M7)4)*6M^]?X]:]KFOX"/B/E]L>$PF*Q$;86::Z)&8VC!2:D2R[5ZBQHV#[*N
M^TJ?3\2#&=Z6=YYN;>S):EIM;MV<^/GU^*3EQI:I7CX&S32_6SV\T_3<?3XZ
M1K'38L6[:HL:GP14>%;]:<.%>/M/V%]\GQ\3_>DYD_W/2?\ "H^1>E#>3_\
MB.F?9O\ ^:/O_KR=O?\ 9&L_8QO\^>B^^9X]I_O1\R_[GI'^%8_JH;R_VCIG
MV;_^:*_UX^WS_P#A&L_8QO\ /GHOOH>/2?[T?,O^YZ1_A65_JH;R_P!I:9_R
M_P#FBO\ 7C[??[(UG[&-_GST7WT_'E/]Z+F;_<](_P *Q_50WE_M+3/LW_\
M-%5ZX>WS_P#A&L_8QO\ /GHOOK>/"?[T/,_^YZ/_ (6#^J?O/_:.F?9O_P"9
M']>'M_7AI.L_8QO\^>B^^UX[I_O0<T?[GH_^%@_JG[R_VEIGV;_^:+EZW^W[
M_P#A.L?8QO\ /E-??>\=D_WH.:/]ST;_  L*_P!4_>7^TM,_Y?\ S0_KO=O_
M /9.L?8QO\^>B^_#XZHG5>'^:?\ <]&_PM']4_>7^TM,^S?_ ,T7?UW=@?[)
MUC[&-_GS2![@WEOCO,?G>'DK7L/GM>U'":7@=.UG";$^C]YUX*,^1RV5M6H<
M9;NT(Y;F:S-CM5DKW.@CB[E14[6RA[0=O;W;;:;T3-N6KVH7<JY>NSM]72W)
M1A!)R49-*$(\TJ2<J>UPU[[=TK'=S>ZW%@6K^/I5G#M6+-N[T]:47.<VU"4H
MIRN7)<FVXJ->5%@F]WU=?VS*B]K,-%LYWY"I>D;,_#_W5?('Q5JXW3,FZ'E_
MB*DK(:^C[9D+%?+:[316]T&E;>V*[>PE=K6(C*EF&_CXDZ^E7B>]SS!W<7L-
MM'?MR>IV*Z=N&7%W[44X7'[;UFL8S?MG%V[CX=4Y))$C.U/J5WSVUMV](R*:
MKM:'!8]^34[4?9CWZ2E;7LA.-RTE7IA%MLW]\->\3X5<IU:4.Q;GE^&]DL-B
M9-A.2L)<KT&653I/\OMN!9FM8^19)_ EMV*4CV*CEB8O<UL2=R>G/N7H,Y2P
M\:WJ6$JTGC33E3PK:N=%WJ]JA&:3X=3X-SAVGZJNT>Y+4(Y^7=TG/E2MO+MR
M4:^-+UOS+/37DYRMMKBXKBEGAK7D)P)N<->?4>;>)-GBM+$VN[ <C:AEO5?.
MKFQ1-;1S$[O6D<QS49T[NYJITZHJ&*LW:.Z]-DX:AIFH6)1K7S,>]"E.;^*"
MX>_D9HT_?&R]6C&>EZOIF1&5*>7E6)UKR7PS?'W<Z\#Z7*<H<9X-C),UR)HN
M'CD;,^-^4V[ 8]DC*Z,=.]CK>0A:]L#9&J]4^#4<G7IU/AL:'K64VL;#RKC5
M*]-JY+GRY1?/P]IV.1N+;^(E++SL.U%UHYWK<:TY\Y+E55]ACWOGG]X6<;03
M3;3Y,\1JZNG6>EK.UT]\R\7P:Y&R831?SDR[9'-<BHU8.Y6KU1.AZ[2NT_<G
M69*.#HFH4?*5RT[$'^KO^7#Y^H\1K/>GM/H,'/4=P:96/.-J]'(FO^+Q_-G7
MW=-36KSA[]O 6IPV\?P7QWN7+692-[:V;V+LX]TQLCE<R*=GS<.4VW()#T[W
MP/QU'O;T:DS5559F?;'I4W7GRC>W1F8VGXU>,+?[XO4\5P<;4:\E)7)TY]+X
M5P-NWUE;,TZ,K&S\'*U+*IPN7?WM8]SXJ=Z5.;B[5NO!=2JVM"/E+[BWE+Y9
MOM8WD+>G8#1)W=6<8: VWK.C]B*CF-R=1MVWE=G<UR(Y%RMNZD;_ (Q)&GP)
M4[&[0;&V"HW](Q?-U1?^<WZ7+_ZET4;?L^]0A5?2J0Y[A=\.X?<ERL:WF.SH
M[_\ -,>MK'_5QZI3N^W[].Y1_1Z>1@BYWU_4AE Q*E0MGN^E?K4%4JDGC@/W
MO?%G@OA'B?A['\,\W6(>-N/]6U":[!#H38\GD<-B*M3+9CM=MT2I)F<JR:T_
M[#/MS+]EOT)";=7IIWQN?<N?N&]J.F*69EW;JBW?K&,YMQA^Q?:1I%<7P7-D
M_MG>JWM]M+:FG;9LZ7JTHX.%:LN26/24H02G/]F7&<^J;X+C+DN1RROZPMXS
M)]/"G.O^Y:!_AD=!_5,WG_M+2_LW_P#,GIOZYNQ/]EZM]C'_ ,\>B_K#7C(G
M^\ISM_N7'_\ AD/ZIF\_]I:7]F__ )DJO69L5_\ PO5OL8_^>,,O/GWH>,/)
M_P 8MYX+XLXZY/U#.;[=UJIELWMB:K%CH]:Q.>HY_)TX7878,K=^:R4N*A@5
M/31CH))4<Y.O1<A]K?3KK6RMZ8VY];R\+(QL6-QQA:\UR\R4)0BWUPBJ1ZG+
MG7J4>!C7N[ZG-!WYL7*VGH&%GXV7ERM*<[OE**M0N1N2BNBY.59.$8\J=+E5
M^V.>]?[9+<AHEXEJ]WTK^0KX4+DJEL]?J_*5+RW7JYR-:BN<JHUK6HJN<Y5Z
M(C43XJJJOU!\.?(Y(KP\25#[3'L^28.7 ^3OEUJ+/OAGRV8XHX5V.I'*W$JY
MK+%'=^1L38:]GWNWN;)CL-.WK3=TGML2PD<,$).^G?U9*N[,V'?_ 'OQADY=
MMM=7A*S8DOM?"Y=C]/Z-M]%92GAV ].[Q96M[]P<?]\\)XN'<5>CQC>R(/[?
MQMV9+X/I7%UTC"3L0T)O
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M*<DN/M/P7-<URM<BM<U5:YKD5'-<B]%147XHJ*?6FFJKD? TTZ/F> 4
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MM1-_;_\ $.#_  .S^#B8%U+^,;_[=/\ 7,QH.W/C               )GOL
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M
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M[:KMQWDSUA6^C0-7_?\ C47PI7Y2\^VO!>7D*YTQ7T;4K7!)HUQ&:R,H
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M5Q7;4G&[%IIIM--<FFN*:\&BV48SBX32<&J-/BFO8T1/?<2_5F].WVYGN5O
M?.XOC78[+;.1R'CYN%JRG'V5NK_&R,X[VZ1UF]H\MES7=F-R#+>,6:5&QV,?
M78D:9LVKW=R,:,<+<T97K2X*_'Z:7Z./*?Z:-)4YJ3XGA-7V9;NMW]*:A/\
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M+IBU!;23"AG4
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MC;&%G2=;KLJ,W^CM_!)OY91;^<P=KF)]2U:_CI4@IMK]++XE]A.A@(>G.J
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MT?\ 5%^WG_T?/^%?F_\ ]I0_K&=Y?]L_^J8/_1A_4V]-W_VY_P#,-4_Z:/\
MJB_;S_Z/G_"OS?\ ^TH?UC.\O^V?_5,'_HP_J;>F[_[<_P#F&J?]-.?^ ?"[
MQH\7<QL&>X*XV_,;+;3C:V(SMO\ /'?MF^>QU.TMVM7]#<-JV"M5].RO=WPL
MC>OT*Y4^!X_>'<_?._<:SA[LSOK>/CS<[:\G'M=,I+I;K9M6VZKA23:]QD7M
MWV.[6]I\W)U'8&E_4,S+M1MW9?6<N_UPC+JBJ9.1>C&DN-8I-\FZ&49X$RP
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M]D8KX81C!**R$/*'KP
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M(0HW5A_4-R9V(E2,,JY3]*Y-Q_P6C.ND7OK&EX][Q=F-?E22?YJ9F2= =B
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MCTO4]1R\I<$FTIQQ4WPKQ^J\&ZMQHT^GI-L9'DF
M
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M!)+@DN"1<EA>
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M%D6;5S_!\M_9=M_.9>V??\[1(0\;<Y1_-ZOSI&^$QL>H
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M,U*WIN!9L.2Y3G""5RYR7[)<ZIO@N,N2.6SSI[$
M
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M452W%M]$(IT,E3QQ[<
M                                                   CT>_KQ/\
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MPN?3PBI;M_E'V%N27QYVV-PQ?+C'#UBQTTKXPMY> N''IGE/BNM)X>&23"P
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M^S6?V#WVQ,E=.1B/G6,U^ME_O28J8',A
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M-D>M3U!W=:O:5I<\"]>5^Y"W;A@J<Y*,I<%&+<I-1571<DV?O_\ 6D>Z)_\
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MZ^\M2T;N!&RM-QM,\ZWT8OD/S?/M0XR\5T3E\/S^!O$(J$]
M                <!^2'CIQ]Y.<9Y;CC?J3$29DMO6MD@KQRYG3MB;"]E+/
M8B1SHW=\+G=L\"O;';KJZ*3[+NJ>RV+OC6M@:_;UW1IO@TKMIMJ%ZU7XK<UQ
MY\XRHW"5)+BC'G<[MIMSNKM6]MC<-M?$G*Q?23N8UZC4;MM\.*Y3A51N0K"7
M!U40+R-\;^3O%_D"UH7).*6'U%L6=9V6DV237MPPL4ZQ1Y?!W%;T<G16^O6D
M[;-1[T;*QJJU7;,MC;ZT'N!HL=8T*Y6E%=M2IYEF;5>BY'[/3)5C-*L6Z.FE
M_N9VPW5VIW'/;VY[-*UE8OQXV<FTG17+4OL=4'2=MM*<555X!]3\:_OGLZ,Q
MW\QY[_Q_OE.)3A[!W_C_ 'QQ*\/8>/4_&O[Y6C*?,/4_&O[XHROS'CO%&.)X
M[Q1#B>.]2G 49ZJ_\97YBO2>JO\ VU'$KTGJK_VD!6B*:R)^%5_:' J>BO7Z
MD -\_L?\:):V+FWF*W"O_@K$8'CC!6%:CF229NV[9=F8U53[$M6/"8KXI\5;
M85/@GTP_]6.O.&#I6V+;_9+MS)N+W6X^5:^9NY=^>)L#]"6UE<U+7=Z7H_L-
MFUA6G[7=EYU_Y'%6K'S39(@(4&R    A%^;7)[N7O*SG+=F6?FJ$^]Y3 8.=
M'(L4FO:;Z6H8&:!K?LLCM8K!Q3=$^ETBJO5RJJ[6.U6@_DUV\TG26NF\L.%R
MXO%7+U;UQ/WJ=QQ^1)+@:..^&YWO'NSKVNJ77CRSYVK3\'9QJ8]IKV*5NU&7
MRMM\6S%5ST3Z^J_@_9]!D$Q64G/7\/1/P?L^D I*[\'P!<HE)7_@_**>++N!
M15_[O]@K\A6C?,I.=^'X@O2^P47/_"5*_(4G._UA\A<HE!SQ2GREWR%%SOP_
MD*E4OLE!S_\ 6'/D7\OE*+G?A_(.7!<RJ10<_P##^0?GEZ5"@YWUK^XA4JE4
MH.=^7\ Y_(<B5"@YWY2OR<BJ52@YW3Z/I!?R+=SBO+Y2Y+Q90<X>]\R_E\I;
MN<"J1;O<5Y_(7^Y%NYWY1S^0N2^P6[G=?@GT%2[F6[G?D'N1R)4^4MG._*/<
MBJ52@]W3X)]/[/WRI>6SG?D'YY>D6SW?VBO+Y2[F6[G=/VP<B7CX%LYQ7E\I
M5+Q\385XC>V'Y3^8#L?GM5U1-#XLM31^MRMR"RUAM=LU.K'2S:KCO1=F]TD6
M)7)&^C ZAZS?3FM0+U5,2;][T[([?J>+G7_K6N17#&L4G<3\%=E7HL\>:G+K
MHZQA(S5VY[$;^[C]&5I^/]4T"3XY>16%MKQ=J-.N]PK1PCY?4NF5R!*H\./:
MB\8/$3[KV>+"IRWS!12.9>4=]Q]2>7%7V.5WS.CZLK[N'TQ6+_M<['6LFQJN
M:MQS'*T@[W"[Y[UW]UX4KGU#;\N'U:Q)I2C[+UWA.][XOIMO@_+3538!VU]/
MNQ.W*MYT;7XQW'"C^M9$4W"7ML6OBA9]TDY75Q7FM.ALX,,&=
M
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M5NXTX7E^I?3+[$)R?S';;3ROJVM6XOA&[&4'\ZJO\)([),B:9B
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MIF],:SYKM*YYEG(M)J,IV)-1FI0<H]=F2;49*49W$I]&T<P(2P
M         !PGSYX^\8^26@W^/.4,&W)8V?OL8G+5/1K[%JV6]-T<&<UK*2P6
M%Q^2@1W1>K)()X^L4\<L3G,7U>SMZ:_L768:UM^\[=]<)P=7;NPK5V[L$UU1
M?RJ47\4)1DDUX7N'VYVKW/V[<VWNO'5W%E5V[D:*]8N4HKMBXT^B:^1QFJPN
M1E!N+B;>7?A/RMXD[,L6PUG;+QSE;<D6I\DXJI*W$9%J]SXL9FH.Z9VO;''"
MG5]65[F2]KG5Y)F-<YNQOMKW6V[W(P.K"E]7URW%.]BSDNN/ME!\/,M5Y32J
MN"G&+:3U ]Y.Q6[>SVJ=&I1>5MJ]-K'S;<7Y<_%0NKCY-Y+G"3:E1NW*<4VL
M,^_]K]G[IE'YS"=$._\ :_9^Z/G%$._]K]G[H^<41X]1/PH*"B/'J)^$40HC
MQZB?A4%?F/7O_ @'$\*]?Q( >JO_ !_D_M%:,K0]%<G[8X%>D]5?^T@^0KTH
M]%>GXU'$KP)??M7<9?HW\-./;5BJM7+<DW\]R7E6N:J+(W.W4QNNSHYR(Y[+
M.G83&RI\$1.]>G5/M+K4]0FO?CSNAFVX2ZL;!A;Q8?\ %QZKB^:]<NKYOF6X
M[TG[6_)GLKIUVY#HS-3N7<VY[_-ET67\DL:U9E\_"O-[%C"1)$ '"/DGR8SA
MS@'F#DWYAM:WI_'^RY/#R.<C$?L3L=-4UFMWJOV77-ALUH47XKU>G1%7X'JM
MC:$]S;QTS0:=5O)S+49_M?4G=?ZFVI/YCP_<O<RV;V_UC<_5TW</3[T[;Y??
MNAQLK]5>E"/SD$N69\KWR2O<][W.>]SG*YSWN7N<Y[E57.<YR]555ZJIMN44
ME1*D4:'FY2;E*KDWQ;**N_<*U042FK_W11^)=P11<_\ =_L%?D*T;*;G?A7]
MP%R11<_]P?(7?)S*2N_URO!?*5I7F4E<.+YEU*<R@Y_X/R@KS^0HJ[]U07I?
M8*+G_E*T\7R+ODY%%SORCY.15(H.?^ZO]@%Y0<[]U2O(JD47/_+_ &!2O%\B
M_D6[G?VU*_G%R7M*+G?4G[J@NY?*6[G%>7RER7MYE!SQ3Q?,O^3F4'._#^0%
MR1;N?^4KS^0N]R+=SORCG\A<E]@MWN^K\I4N7$H.=^3^R/<N9>E0MG.^M?W$
M*\N"+DJE!SNG[:@O+9SO[8Y%R1;O=^1/WRJX<?$O]Q;N=]?Y 7I&PCQ:]KWR
MX\KOD,SK&BOT+CJXZ%[N3.34N:QKMBE+T>MG7:#ZD^P[:U\*.].2A4EIK(B,
MDL1=>Y,2[W[V;"V+UX^;E?6M7C7][XU+EQ->%R55;M<>:G-3IQ4)<C-/;_L)
MW%[A=&5@8CP]$E3]\Y75:MN+\;<:.Y>X<G;@X5X2G'F28?$SV9_%;QQ^[-EW
MG&_\H+DZGZ-C\X>0<95_,[%7H^CO5UKCGU;V&A].5C7QS927+6H96]\,L/7M
M2&6_/41OC>'7AZ;/\5:+*J\NQ)^;*/LN9%(S?#@U;5J+7"49<R=7;OTR]O\
M9/EYVJP_'&NQH_,R(KR82]MK&K*"XT:=UW9IJL91Y&W1C&1,9'&QL<<;6LCC
M8U&,8QB(UC&,:B-:UK4Z(B?!$,"-N3ZI<6R1B2BE&*I%'L4*@
M
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MJGQ(-Y>-=P\J[AWU2]:N2A)>R46XO\U&?;-V%^U&];XVYQ4E\C54?9'SG(
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M&&3.@
M                                                (E'OI\5MU+RB
MU#DVI52&ARYQQ0=>L)&C5M[5H=IVNY)7/1$218=8GPC?CU<B?#Z.TV)>D_<#
MU'863H5R5;NG9LNE>RUD+S(_)6ZK[_\ !FG?U^;16C]V,+=5F'3CZSID.N5/
MI9&)+R9\?&EAXJ]OS4.3>3KCN1> /,?:D1)9_(CPO\'O)"RYGRKHHMKXHVZ#
MC[D:2JZ6:%D5I,WK-EEIT<22SM>CW='2,;)T6A6EHN\-LZ?RAHNY]<TU<ZNU
MEV7D8R=$ZKHNQ<*ND:47"+<?4[JOO<W;O>VK\[FY=C[7UJ7T:+(T_(6'FN-6
MJ2\VQ-7&H]4DTW1RBI:!ZMF>E9KW*LKH+-2>*S7F9T1\,\$C9896=45.Z.1J
M*GXT)?W(0NPE;N*MN2::]J?!HUWVKMRQ=C>M-QNPDI1:YIIU3^9F4'FS9KY/
MRFYAV2I##7K[SG\=R5'%!_M*)R;KF%Y!<]B*B.:DKME5W1W5Z*O1RN=U<O@^
MUL)V-@:;@W&W/$LRQFWS_>MR>/\ F>53AP]B2X&5N^MVUE=V=:U2S&,;>H9$
M,U)<OW]9M9G#Y?/KQX\>+;JWBP>^,2@     &X_V-OZ:.4_F2WG^_P#I)&GU
M6_T86_Y5L?@[Y-?T$?TXW?Y"ROPV*2^C6^;G        =8_[VWB*OB#[@W,&
MO87$NQG&_+5M.<>,$BA;#CX\!R#<O6\_A,>R)J05JFK;U6RN.KP(O=%2KUU5
M$1[>LONWFN?CW:]B[<E7+L+R;GMZH)*+?OE#IDW[6S"^Y<#\7ZM<A%4LW/CC
M\DN:^:55\E#4H>X.A   -P/MF\>9+R^X@\SO;^Q5]T6\\DZ%K/DIX_4[,[8J
M&2YM\<[V1;8T]'.<UL=CD7CC>\K3]23MAADIPSR/:D';)X3=^5#0L[3]SS7[
MVLW98]]^*LWTOB_47(1?M=6ESX>@T6S+4,?)TJ+^^S@KEOWSMUX?JHR:^9>P
MU%9''9##Y"_B,O0NXO*XN[:QV3QF1JST<ACLA1G?6NT+]*RR*S3NT[,3HY8I
M&M?&]JM<B*BH>YA.%R"N6VI0DDTTZII\FGXI^#.@:<6XR34D^*.Q._5R_*&M
MSU[>FN\:9*^R?>/&'9LIQ3EZTDLDEZ73+\LVU\;YB1CE<V+'_<^3L8:LB+].
M"D^RB=%6*_=;1GIFZ9Y<%3&S(*XO9UKX;B^6J4W^G1EO:&<LK259;^^V).+^
M3G%_8=/U)OQ,9GJ@
M                           #\;8]@P^I:]G=JV*_!BM?UG#938,[D[+N
MVMCL/AJ4^1R=^P[HO;!3I5GR/7ZFM4^G"P\G4<RSI^%!W,R_=C;MQ7.4YR48
MQ7O<FDOE/AU/4<+1]-R-7U*Y&SIV+8N7KMR7T86[47.<W[HQBV_<B$WQAIV?
M]RWSXR;<];R^&Q_+6Y;1N>TY&BZO/D=/X\PM.>>C1JR74N5DEQ6$I4,/35[9
MF-E=%U:YO4VD:]J>'V-[0P>)&W=O:=C6K-J,JJ-[(FTI2:C1TG.5R].C3HI<
M4S17M31-1]4?J&NK4)WK&-K&;?R;\XT<\;#M1;A"+EU1K;M1M8UMM22DX531
MNE_Z@_QQ_P#3'S;_ +IHG^")&#^MWO;_ &9I7V+_ /GB<?\ ^;S[9?[;UW[.
M)_T<UT^Y#[8.I^''&&E\I<8[=O.YX3(;A)J6YMVUN"E=AY<GC)K^M7JBX/$X
MI8*D\V*MP3OF21OK2UVM5CG='YI[)=^-1[EZ]E:!KN-B8N5#&5ZSY/F+K49*
M-V+\R<ZM*<)12HZ*;=4N$:?4YZ4]([*;4P=V;5S,_.P+F:\?)^L>4_+<X.=B
M<?*MVZ1;MW(3<JKJE;2:;I+<%[-'D O,'B5C]#RUY;6V<"Y9V@W&S3-DMRZ?
M<;+EM!NO8CW+%3K8QT^)KHJ-^QB%^GHJK&WU-;/_ ";[B3U?'ATZ=J]OZPJ*
MB5Y4AD1]\G+IO2Y\;Q-#T1]Q?RT[.V]OYESKUC;U[ZI*KK)XTJW,25/",8=>
M/#EPQ_G-MA'8F* "$Q[='^DHX=_G)Y!_DGO!M)[T_P!!^I?P''_#6#13Z:?_
M ,J#1?Y4S/\ 5\HFSFK8WK   $.'Q-_TP]+^LCSU_P#BN2S9=W#_ /R;)?R)
M@?GXQI0[/_\ Y:=O_P#$^K?G9Q,>-:)NO(</LI?TY<#_ #;\A_WOJ&R[U1?T
M4WOX=C_KF:4/0Q_3YC_R9F?K(F[+W1_<'J^*FBOXPXSRE6?R W_$S)0EB?'8
M=QGK-MKZTFYWX.KFIG+7VV8:"1%8LS'696NBA2*Q%OL)V<N=P-66O:[;DMGX
M=Q=2=5]:NKCY,7_DUP=Z2X]+4(M2EU0G5ZL/4=9[1[?>U-K782[BZC9?0U1_
M4;$JQ>3-?Y67%8T'PZD[LTX04+FK+VI/$/CC<-DJ^4_DENFDP8G#9I^2XTT?
M;=NPL&5VK:J5V26;?=KI9+)17/N?$9.+NH0SM<[)7$=/(B5XF);S[Z@^X^MZ
M;@RV!LC%RGD7;73DW[-F;A:M2BDL>U*,6NN<72Y*-/+A2$?CD_+B7Z0^S6V-
M:U2'=KN?G8,<.Q?Z\'%R,BTKF1D1DV\O(C.:EY=N:K:C)-WKE;DOO<(^=)S9
MS%Q'(]D<?*?',DDCFL8QF[ZRY[WN5&M8QK<FKG.<Y>B(GQ52";VUN.*ZI:?F
MI+_@+O\ XIM3CO79LI*,=6TQR;HDLJQ5O]T(^/O[<4YI<MP1S=4I3V-?^Z\[
MQ?GKT;)'08O*177[3K$%AW58V.S-:WE5C5$15^2<BK_!0F-Z0=PXOU?5MJW)
M)9GF6\JW'A6<''RKK7C\#5JOZ=>\UQ_VA^T<YYFW]]V82EIWDW<&[-5I;N*7
MGV%+P7FQED=/[4Z^!EA[>?&W@%Y0>.?'U]G!O!>:Y4T_5,)K/+.&R&FZX_:X
M-IPE*#%7-GR=-];YF?'[A)63(07&(^"1UAT2N2>*:./'G>76^[^P]ZYEEZMJ
MUK;^3D3NXDXWKGE.U.3FK495HI64_+E!TDE%2IT2C)Y?]-VV/3OW6[9Z;D1T
M#0+^[L+#M6-0MSQK/UA7[45;E?G%QZG#)<?.C<58-S<*JY"<8_"><&^>VWX8
M935]5?X@\(<K;[G77;&8T[7\7I^(O:=AZT,#JN1V*9V#S3J4^8GL(VI6DBCD
MECCEDZHUK>_M^U6D=[NYUC(U!;DU73](M=*A>N2O3C>FVZQMKS(=2@E6<DVD
MW&/-NG0=^=P>F'L?EXFD2V9H.K[AR')W,:S;QK<\:W%+IG>?E7>EW&Z6X.*<
ME&4JI)=6Q;QBOZ?G_$#![CHG"N,\?M:WO3-IW'&\98I*2U\;2S#,HN,S#WX_
M&8>K*_:,/!6R+7-@:OI66(JJJ*JX6WW9U+#[D7=,U;5+FL9V)E6K,LJ?564H
M=/5#XI3:\J;E;^D^,7R)*]JLC1=1[+X^M[?T*UMS2]0P;^3#!M]-(1N*YT7*
MPA;BW?MJ%Y-07PSBG5JI'.]C;^FCE/YDMY_O_I)-3U6_T86_Y5L?@[YK0]!'
M].-W^0LK\-BDOHUOFYP   @^^-.S:WION3ZAM&W[!A-5UK"^1&VW<SL6R96A
M@\%B:;<SL;'6\GELG/5H4*S7O1%DED8U%5$Z_$VI[YP<W4^R&3@:;9NY&==T
M6S&%NU"5RY-]%OA&$4Y2?N2;-#7:[5-,T3U/X6JZSDV,32[&Y<B5R]>N0M6K
M<?-O?%.Y-QA"/'G)I$NJSYH^'U2"6Q+Y4^.KHX6][VUN:>.;LZIU1.D56GL<
M]F=WQ_@L8Y?Q&N6';#N3<FH1V_K57[<+)BOG;MI+YV;D[O?'LO9MN[/=VVG&
M*^UU/"D_FC&\Y/Y$FS1[[H?NE\7<G\79SQQ\<LI:VZIM\U&#D/DJ.G?Q6"BP
M6.OU<F[6-42_%2R>5M96]2CCO6W0QTDI-=%"MGYASX)5=A>P6OZ#KUK>V];<
M<:YC*3Q\:L9W'<E%Q\V[TN48*$9-PA5SZZ2ET="4X&>J[U9;3W7M/([9=L[T
M\RSFR@LS-49V[2M0G&?D8_6HSN2N3BE=N.*M>4G"#N^8Y6^>/8U\:,YQ]QAO
M/D-MV.L8V[S"N,P>AU+D,E>TNAZ]/;LVL^D4C&/2GM6<L-^75R?QE?',F9UB
MG8YWDO5;OG%UC7L39NG34[6F]5S(<6FOK%Q)*W5?;6H+XO9*XXOXHM+(/H([
M6Y^W-J9_<C6;4K5_6O+M8D9)J7U2RY2E>HZ?#D76NBO.%F,X_#<3>N?WR?Z:
M.+_F2T;^_P#NQFKTI?T87/Y5O_@[!&?U[_TXVOY"Q?PV42L>&O\ %!Q5_-MH
MW\F,6:^MS?SDU#^'7_PLS;KLC^9>D?R7B_@+9%N]Y3B?+\$^8VI<_P"FK)B(
M>4J6%WG%92LCX_N_D[C:SBL?F)*J-:D;)8ZT&&R#G([N?9MR.5$^ET^?3/N'
M&W;VTR=GZG2Y+3YSL3B^/5BY*G*%?&E7>M\J*,(KW+4YZVMH9G;_ +UX?<31
M*V8:M;M95NY'AT9V%*W"XX^%5%8UYNM7.Y)M>+XUK9Z3W/\ W,-)OV,58K:+
ML>3TY^3P-USI(L1QMQMK%/,;CBG3=CO29L%O&9!D+G(J?-9-B?0J(=W/$CV'
M[&95F%Q2U:Q;O=-R/!SR<F[*%F=/'RU*VW3[2TSR]K4)>JSU28&1<LRCH&3=
MQG.U+BK>%A6(W,FW7C17I0O*+?\ C+Z7B3(VM:UJ-:B-:U$:UK41&M:B=$1$
M3X(B(:T&VW5\S=BDDJ+D0XN*O]-%E/Z[7,G\O]Y-EVX/_P F&W_^%L+_ %>P
M:4=H_P#Y<5W_ /'>I?ZWE$AWS^\X\AX-ZIQ[M\?#TW*N*W?8<OK=R=N\?F3!
MKV0HXV#)XR*2?\S]N^?FS-9MM6,[(.QM-Z]7=>B0R[/]J;/=;4,W39:DM/R,
M6S"[%>1Y[N1E)QDTO.L]*@^BKK*O6N"-DGJ)[]Y'832--UF.BRU?$S\FY9D_
MK7U569Q@IP3?U;(ZW=CYE%2-%;;JZ\.'^!L3X)^YMQ7%RAM/C_Q15Y"N6,K2
MY#U.A>K0\CZM=K9.S3I29?<]1IZ/MN2IYC&Q06ZEUS(F*V=8FKZD<J)Z3=V1
MW9[%;@>@Z?K&H2T:*A+'O2BWC78N*<E"S>=^S&4).4)P3;^'J?PRBSQG;[#[
M >JC:2W7JVW='AN2<KD<S'A**S;$HSE&+N9./'%R)QN04;ENZU%4FXI]49I:
M.?=6\/\ Q[\3=ZT&EP?M]MUK<ZFP7=EXMRF;CV+(Z/7QTN+3#9.'(.[LO5Q.
M>^>GB@AR3I+#GTGOCFE;WI%*ST_=R=Y=P])S+NZL:/EXLK<;65"#MQON2GUQ
M<?H.=OIBY2MI12FDXQ=.J!/JY[+]N.S^X-.L;#S9N]G0O2OX%RZKT\50=ORK
MBG^R1MW>J<8QO.4V[4I1G-=2AONX*VC;]R]IVOL>]WKN3V6]XJ\H0V<CDE<^
M_?QV-UK<L7K]RW-(KI;4]G7:55[IWJKYU7U'*KG*JQ$W9@:;IGJ&EA:3"%O!
MAN#%:C'Z,92NV9W(I<DE<E-=*X1Y+@C87L#5M:UOT@1U/<%RY=U2YM'.4IS^
MG.$+&3;LRDWQDY68VVY.KG7J;;;9J']@_P#I'<Q_S)2?R[U$D=ZN_P"9.F?R
MJOP%XAI_9Y_TFZW_ "$_];QRA[[G$>9U_P A./\ F.*E.[5N1>/:FM39%K)Y
M((=OTK(9%+E*>7[<%5UG7<M0DKLZL6;T9U:U?3>XO])>X\;,V;F;:E-?C#"S
M'=4>%79OQC227-TN0N*3XTK!-\4CC_M =FYNF]Q].WK"W)Z3J>FQL.=&TLG%
MG/JBWRCU6;EEP7#JZ;C2?3)F_?PE\J]#\K>#=.V_7M@HVMUQFOX?%\FZK)>;
M+L&L[?4HP5LLM^I*K;LN+REV)\]&ZK/2M0O3XI*V6..(/=+M_J_;[=>3IN99
MG'2[EZ<\6[TTMW;+DW#I:^%3A%J,X5K"2Y=+BWL0[$]W-O\ =W86%K.FY-N>
MNVL:W;SL=RK>L9,8*-SKB_B=NY).=J[3IN1?/K4XQU->^-Y5:'>T35O%[3M@
MQVP;?-N-+=.1FX>]#>@U3&:_1R-7#Z[F7U97109S,93*-M_+.59JT%%KY6,2
M>%SI#^E3M_J]K5LC?NIV9V=-6-*QC=<7%W97)1<[D*JKMPC'HZEPE*;46^B2
M4/O7KW<V]D;?Q.U&B9-K)UJ6;')S?+FI+'A9C.-NS<<717;ERXKG0_BA&TG.
M*\RVWFI[-_$N:XK\)];NY^I/C[_+&Y;+RO%0LLDCL08C,5,)K.O6)&/<Y$CS
M& U&M?A5O1'5[4:JG<KC%_J7W%B[@[HW[6')3LZ=C6L1R7%.<'.[<7RPN7I6
MY5^V@URH9S]$^SL[:78K%OZC"5O(UC-OZ@H2335NY&U8LR:?A<LX\+L:<X7(
MOG4T'>#7^E7TC^>WE[^\_()+ONM_^3[E?R5A_K\<UY=@_P#\KG _EW4?P>83
M0S6(;PR'#[>'^EKU+^<CR0_S;\O&R[O/_P#D[9/\!TW_ %G#-*'IL_\ RQ,/
M^4]:_P!2U$F/&M$W7@                       &$GE-X#<"^5-6UDMEPS
MM0Y'6!&4>3=2@JU,^Z2*-K*T>QU7,2CME"-L3&*RVGS+(45D%B#KW&5NWW>'
M=_;VY&Q@W?K.AU^+%O-NW1OB[3^E9DZMUA\+EQG"?(P;W6]/O;_NQ:GE:G8^
MI[EZ:1S<=1C=JE2*O1ITY$%1*EQ=:C\-NY;YD;[R<]N3R-\:GY#-6<!)R1QO
M422=O(6C5;5^I1ILZN6;:<"U)LSJRPLZ+++*R7'M<Y&LM2.ZHDX=A][]D;Z4
M,6W>6#KDN'U:^U%RE[+5SA"[7P2:N<*NVD:U.Z'IK[D]LI7,VYCO4]M0J_K>
M+&4XQBO&_:XW+%%]*4E*TFZ*[)F ??U_"9B(_P#2SQW"K'2>.[\0XCI/'<I0
MK1'JKT_^5^3^T*"B/57I^-?V?C*E3U]3\"?L_> /57K^'\G]H4*T9L+]K3C'
M])WF?QDZ>#U\7QW'F.4,K]CO]+\UJS8L!/U^AGI;CD\:O<OT?5\50POW_P!?
M_$/:_/4)4R,UPQ8>_P UUN+Y[,;I(GTL;6_*?O3ICN1ZL73E<S9\*T\B-+3]
MU,B=GC_=)C!K.-R(  !%A][+E%VT^26H<9UITDQ_%/']62U#W=5K[-OEE,WD
MD5J*K6)+KE+#.3X(Y?K^':3_ /2UH/XOV/DZY-4O:AF.C]MK'7EQ^Q=E>_\
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MOS<KLUXTE-I/DD9"GDCV@
M
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M-A]-/M>F[7XDO"496J3]T[7B=KL>]&$KMCA6XJU\:P\'[FIUC\DR9Z8!,B@
M
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MU+D2:VEZ+]2O.%_>VK6K%OF[.'%W)M>QWKJA"$EXTLW57DVN)N1X+]L?PKX
M6E=U;A?!;5LU/T7MW'D__P#Z#L'S5?HL5^I%GF3:_@KS7)U]3&4*/Q^/0CKN
MCO5W(W9U6\[4KMC"E7[SC?>+='SB^BER<?=<G,E#M'L'VJV9T7=.TJSD9\:?
M?\K]\W*KE)*Y6W;E[[5NV9\-:UK4:U$:UJ(UK6HB-:U$Z(B(GP1$0Q4VVZOF
M9C225%R/(
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MD_EVG";S%=M/Z-R/4O=)-*5/=\4'['<B_ [#$BV9:
M
M
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M<NKYII&4YX8R(
M
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M*$B49C
M
M
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M=S_",FFM:UJ-:B-:U$:UK41&M:B=$1$3X(B(>);;=7S,@I)*BY'D
M
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M,E**]R1ZK;NH?C'2K=V3K>A\$OECX_.J/YS:H>+.\
M
M
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M1.4[KYN3<F_G=6>SL8^/BVU9QH0MV5RC&*BE\B22+XXCF
M
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M\4%<@O\ )R<N!YK:.0\?4[N%;3>+>AYD?&B7%5^:73)_=)(FJD?3(X
M
M
M
M
M
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M
M
M
M
M
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MA<BW]+JEXQ:7%HOF8UJ6F7GU.S^QR^[M2^@U^E^BTN5%[4;3#QAW@
M
M
M
M
M
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M?7QJ;5/0[H/XG[!8>:X],M3U#,RGPHW2XL1/V\8XJHWS5&N%#01[P.59DO<
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MJ+W+V?F+[!^B6%0
M
M
M
M
M                                                  #4![U^?LP>
M)>M:%C7M=E>5^;] TZM67U%=+%7K9[9/6<R%LDSX(LIA*;'=C)'=TK>C55?A
M)'TN8<)=Q+^KWU^]]/TK(O-^QMV[=./"KC.;56E1/B0P]=.H78=GL7;V*T\O
M6->Q,:,>/%*-V]6BJZ*Y:MIT3=9*B,%- VZEC(_>XY9J.5E'7M<_0=IV0;%'
MT?0E_2)Q5@YH'-DK,C?%7PF)E[4C:WK(U48B-]-<L:QIUV^^UFW;G&[>O_7K
MT:_;+ZMEW$^=:N=Y<Z\'QX]1@#;NLV,6/??>%ETL8V+^*\:=%Q@_KF!::XQ2
M:5K'E1)+BJ15.DUBQX]^O^V[>RBN]"?DSS,Q-)K4DF;)<PW%?#6<F<KXTC6N
M^I]\<E)T57H_U8/X*HB*F=Y7EF=[88_.&#MF<N2HIY>;;7/G7HQO92DN9%:.
M,].],=S+?PW-5WO;CS=96\#3;KY4HX^9F^VO5#EPJ3#?#31$XT\4/'?2GUV5
M;>(XAT:7+01JY8V9_+X*IF]B[7.Z.<C\[DK#NJHG7KUZ)]":V.YNK?CSN%K6
MJ)N5NYJ5]0;_ ,G"XX6_^3C$W3=D=O\ Y+=H-M:$XJ%ZSHV*[B7)7KEJ-V]]
MF[.;KX^Q<B&O[AFS)MOFYY-Y5)/4^5Y8V/6>[HUO1=*DBTU8^C(H4_BEP/;U
MZ*J].JN<O5R[,>S6#^+NUFA8]*=6G6[O[NG>]KY^97^XN2TE>I'5/QQWWW5E
MIUZ-8O6/^;-8U.2Y>53EX<6^;W+^P[X]X9NK\H^2N=Q=>WF[V<=Q;HUBY79)
M)B\5C<?0S&XY#'K*UW:N<LY>G365G1[64IHNO;(]%C-ZMMY9+S\#8^)<<<6%
MKZU?2?TYRE*%F,J?Y-0G.CX5G&7.*)N?V??;C"6DZMW1U"U&>?<R/J&+*23=
MNW"$+F3.%5_C97+=OJ7%*U<CRE)/4CXVT<)0\X,GMS:-&SI_"^Q<V<VSQ1)#
M)BXL-PO@MTW_  D<2-5T4E:WE=>HU8$9W(Y\[.GP^*2*WO=RKW:NWISG..I:
MI9P<%-U4W/-N6,>;?BFH7)RE7PBR'/;#'P<?OS=UE6[<]%T/)U/5&E1VU:TR
MUDY=I+P<97+-JW"E:N4?#B8)6+$]N>>U9E?/9LS26+$\KE?)-/,]TDLLCU^+
MGR2.555?I53+,(1MP5N"2A%))+DDN"2(_P!RY<O7)7;K<KLI-MOBVVZMOWMD
MB[V!>+G29;R!YJMP*UM/':QQ=@+/:JMF=D;,VV;= KEZ(U:Z8K".1$Z]WJKU
MZ=$[H6^K_7U''T?:]M\93NY5Q>SI2LV7\_7?^QXUX;+?[.[:;EF;CWS>C10M
M6,"U+V]<GD9"_4^7BOQKU<:459*I!TVA@             UG>[OX=?\ +<\$
M>8^*L-C&9'DG6L>SE7AY.G6U^D?08+>0HXBBJN9$VSN>!FR& 1TB^E']Z^HO
M16(YOK]C:]^3VY,?-N.F)-^7=_:YT3;_ $DNF?ZFATVOZ?\ C+2[EB*K>BNJ
M'Z:/A\ZK'YSKB.,M1J\K\%<RZC!#TY%X1A_3WIU=D2I;SV@)+B-1YWUM(F(M
MB_D\%CON#::Z/Z0X[#Z]GI?BZ?X2NS+[PM2Q[[_T3(^\S]BGQE9E[E)]=M^,
MI3M+P,/V+:OXMRVOV:U\:]\>"FOE2Z9>Y1E[3%P[D^(F&<9ZGOGN>>+7B=[@
MW"4V0SGG1X/?-<%^2>NZWE*F/Y#YFXVU/%V[^(S>MY+*=(Z_,-_4LBZ_KV12
M+M=L>3M-8KGX^LD.",R_C;/UG-VOJ"4=N:C]^L2DFX6KDFDU)+_%*2Z9QK^Q
MQ7A)UR#9MW=:P;&K8U7J>+\%Q)_%.*Y-5^WIQB_NF_8B5]XP<T1<\\,:COD[
MJS=D=3AQ&[4ZM.YC(*VV4:=26Y=I8C*=N9Q> VO'VZN=PL=YD5N3!92E-*QK
MI>B84UC3WINH3QE7RJU@VT_A;=$VN#E%IPG3AUQDER/=X61]:QXW7].E'X<?
MD?%)\)*O'I:9D"=6?4
M
M
M
M
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MG0_4.EV*Y*/G29DVZ_JV;&]_B+U(2]TU]!_JE6#]K\M&8QT)V
M
M
M
M
M
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M"OSO6G"]_I-N71/],OME[IIJ:]TDC)$ZD^P
M
M
M
M
M
M         'R6_P"ZX3C?1=RY"V6?Y;7M&U;/[=G)^J=T>*UW%VLO?<Q%_A2_
M+5'(UOTN=T1/BIV.CZ7E:WJV-HV"NK-R\BW9@O;.Y-0C\U6J^XZ?<6N8&V-
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M*$5<7L=II*LW7WUZ/U?+AEQ_8YTMW/L_>Y?-)N/R3J^$3,,Z$[
M
M
M
M
M
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M]
M
M
M
M
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M::;!=5V\Z1O2E2Y"GT;B7Q.+Y],UTS2]_5SDS/\ /,':@
M
M
M
M
M
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MS?[/[MJ]2W)J7=+/M_O33K;P\1M<'DWXIWYQ?-.SCN-M^#64^;3I*'(%FUX
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M:TM7??TOX9/QB^I\$B3X8>/:@
M
M
M
M
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M7C8ZEDSCQ5S*NOS,B:?-Q\R3C;KRMQA'DC)D\*93
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MHRK7JASBW[^FB;\6F_$Y\.L/J
M
M
M
M
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MY+;M.LL>3\8<W"OMCQ^:O)=)OC,:GJ
M
M
M
M
M
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M21VND:C^,<:MQ=&9;?1=AXQFN?#V/FOL5JF9]'F3M0
M
M
M
M
M
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M&(I+X;N<XI]:3YK%MR4T_"]<M2BZVY)2M#7T;=@
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MUS3X,Y(/D.8
M
M
M
M
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MEI.$OI<9J3E6/3Z#'PH8EYO%I'&G5RAX*;=>J/LK5J2Y<(TI1URM.E/N
M
M
M
M
M
M                          ,(O<$\JZ'B/XX;9O=6U7_2#L3)-,XKQLBM
M?)8W/,5+"0YA]=62>KCM3HQRY*QWHD4JUXZZO:^Q'URGV=[?7>XN]L?2;D9?
MB:RU>RY+DK,&JPKPI*]*EJ-.*ZG.C4)&"/49W=Q^SG;+,W!:G'\H\E/&P(/B
MY9-R+I<<:.L,>*E>G5*,NB-MR4KD2#77@SNVY^"K79D]BV;9LQ'!!&BV<GF<
M[G<U=;'&Q%<LUO(9/)Y"RB?%722RO^MRFUJ<\33L-W)NW9P;%MMOA&%NW"-7
M[%&,8KW))>PT(6[>H:QJ,;5M7<G5<J\DE\4[MV[=E1+QE.<YR]\I2?BV2_M/
MQ&F>TE[?-[.9N'%7N5+-"/*9B"1T"NW7G#:Z218G5HK-61LU[7M42)(5=$_K
M]V8ZQ:8U))'HNM[4LG4_45WCAB8KN0V_&?1!\?O&#:E6=UI\(W+M:T:_9;D+
M;=(HW/:+AZ)Z.O3E<S\^-FYNV=M7+B=/WUJF1&ENPI1=9V<>G36+_8+-VZDI
M2:<;.[GM@T?B;;>9MQR5N_S;Y:6]KQV!R-[HN5I\2V<M>K<M;](]SE].?E/:
M62ZU2>C&]<?1S;/X$T2K-ZUB8>J[BQ]LZ;",-K;=C:E<C'Z#RU"+Q,=>[%M4
MR9JK^^7,5\XR-8-_4-1T'9^9O?6KL[F^]XSR(6IS_9(Z?*Y..H9;]CS[_5A6
MG1?>;6?'Z,X,D&^SCX2NX3XS=Y%<AXI8.4>7\+ W5J%R-6VM.XOMO@R%%'1.
M:GR^8W>6&&]/U5SHJ,=2/^*D=9C6'/J6[I+=.N_D7HURN@:;=?FRCRO92K&7
M'QA83E;CR3F[DOB2@S8WZ*.Q+V+M9]RMR6>G=FM6%Y$)+XL;!DU.'#PN934;
ML^;C:5F/P2=V+W9$6R=8                               .!O)KQMXI
M\M^$-]X YHP+<[HF_P"'EQ]M8?0CS& RD?\ '83;-9O3P6F8S9]9R;([=&PL
M<C&S1(V1DD3I(G]GH^K9NAZC:U/3Y=.3:E5>R2\8R7C&2X->SDTZ,^7-P[&?
MC3Q,E5M37SI^#7L:YHQ#]O;DK:M Q^0]O[GM[*GD'XKZG@Z.N9]]W*6,;Y"^
M.T3_ +AXZYWTZ7.W\EDGO].JS$[-C4LVDP.;A2'O;!8JL3O-T8EG*DMSZ9QT
MO-FW*-%6Q?YW+,NE)>/5;E1=<'7FI'7Z3>N6D]*RO]+L15'Q^^6^49JM7[I*
MKZ9>YHV:GD#N@
M
M
M
M
M                                         4;%B"I!/:M3PUJM:&2Q
M9LV)&0P5X(6.DFGGFD<V.*&*-JN<YRHUK4557H70A.Y-6[:<KDFDDE5MO@DD
MN+;?)%ERY;LVY7KTHPM0BW*3:222JVV^"27%M\$B$G[F7F+)Y<^0-ZUKEZ67
MB'C/[PU'C&!KGI6RL"6F_?\ O/I2,C>R?<;M2-\2.:U[,=7JL>U)&O5=I?8O
MMJNW.SH6\V"6X\[IO93\8.GWNQ7CPLQ;3I5.Y*XT^EJFB;U2]ZI=Y.XUR[IE
MQO9FE=>/@KCTW%U??LJC2:>3*,7&J35F%F+2DI5S3]D_PX_/[?;OE3OF(]34
M.,\A)B.,*UZ#K7SG(JUT6]L<,4OV;%31Z-EOH2=CF?>EACXWI-2>C<8>J/N7
M^)](AV_TBY34LZ"GE.+XV\:OPVVUR=^2?4JU\J+4ETW57./H6[*?E%N&YW;W
M!9KHVE7';P8S7"[F4^.\D^<<6,ET.C7GSC*,E.Q)+Y7SPYUC\]O+>'B; ;2F
M$\:?'FOLF3V_=ZTC;&,KX/5W,EY7Y1B:UCH,G-Z=>/#:Y"BRMR-MU9M=W=D>
MT^_M)M.7:+MT]PYF/YN^=9=J-FPU23G=X8F*_&*JW>R9<';AUN:I8J=3Z@M_
MQ]0O>..S].R_([7;;C?GDY47U05JQ1ZAGKA2XZ16-A1^)7KCM*VZY-"AX*^-
M,_N!>4&6YNW35$P'C/P_:U_$8#3'];.(EQ.H4JF/XPX:J2646/*4,/KV/KV-
MAL(U5M]7.F1LN221+^[&^8]GMAV]JZ7D>=OG4HW)W+W*:G>DY96:TOH2G<E*
M./'[3@HUC8H<?8'M=/U&=U[V_-<P_J_:W19V;=G&?Q6W;QXQA@Z;%RX7(6[,
M(3S)TK<XN:4\KJ4L]K6M:C6HC6M1&M:U$1K6HG1$1$^"(B&N]MMU?,W"))*B
MY'D%0                                #%[R3\<H^:&Z)ONEYRMQ[Y"
M\)9F[M/"'*BXUN1;A<AD:2X_9-'W"C%)5N[#Q/R3B43'[%BHYX'S0I%9KR0W
M:E6>+N-)U5Z?YF-D1=W2\B*C>MUI5)UC.+Y1N6W\4)4='5-.,I)_#F8?UGIN
MVWT9=IUA*G+VQ?MA)<)+YUQ29SWIN3V/,ZK@,GM^L?F9M5S&5I-BU=N8H;!!
MA<RC.S(4Z.=QJMJYC&-LL<ZK9].O+-6<Q\L%>57P1];D0M6[TH6)^993^&5'
M&J\&T^3]JXI.M&UQ?UVY3E;4KD>F;7%5K1_*N:]C_,7(^F.$O
M
M
M
M
M
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M?[:;0PMF;9M^7I6':Z4W3KNS?Q7+UUI+JN79MSFZ))OIBHP48KEX\V>S
M
M
M
M
M
M
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M&HJ4(0SC,4F>@
M
M
M
M
M
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MQMVZAB?5H8.']3T7!FOXLP'QG<G%K^,]0E6]GW:>9'J6,Y2Z+D[F>1B0D$
M
M
M
M
M
M
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MBVMNPA9RM=ORMW\[)<4_.R8-3AT=2JK6-))8ZHG%Q\ZBNSFWFR8M,Z@
M
M
M
M
M
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M5N,I)7+M_8F87)*@
M
M
M
M
M
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MLQ5Z,6P_I0QNJ+^LY$4Z0C<C:K*,Y6Y GAYXP_HGJY7SA\MJF,FYLVG#X?\
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M3LZ39N<)7+C3<+VI7X]/UB["MNT_O5J5Q6[=Q9P&*C/(
M
M
M
M
M
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M3H_%)\T2\E;MSE&4XQ<H2K%M)N+HXU7L?3*4:KC1M<FRL6EX
M
M
M
M
M
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MB22X))<$EP2*Q:7@
M
M
M
M
M
M                        '!>X<!:?R/RIIW)W(B?G>SC*M-)QEIN1JQKJ
MNK;/D',^]=[MT7R3LV'<'00104)[")!BX6.=7A2R]UA?6:;N_4M$V_DZ%HO[
MV>=)+*O1;\V[:C]"PI</+LU;E<C'XKLFE.3@E \#K7;O1=S;MPMU;E_?L=*B
MW@XTXKZO8OSIYF7*#;\[)HHPM3G\-B*;MP5V3N'.AY,]\
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
9                              ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>12
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "pfe-3292020x8kcoverpage.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "contextCount": 4,
   "dts": {
    "calculationLink": {
     "local": [
      "pfe-20200428_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "pfe-20200428_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml",
      "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "pfe-3292020x8kcoverpage.htm"
     ]
    },
    "labelLink": {
     "local": [
      "pfe-20200428_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "pfe-20200428_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "pfe-20200428.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd",
      "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd",
      "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 30,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 2,
   "memberStandard": 1,
   "nsprefix": "pfe",
   "nsuri": "http://www.pfizer.com/20200428",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pfe-3292020x8kcoverpage.htm",
      "contextRef": "D2020Q2SD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001000 - Document - Cover Page",
     "role": "http://www.pfizer.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pfe-3292020x8kcoverpage.htm",
      "contextRef": "D2020Q2SD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 3,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.pfizer.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.pfizer.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.pfizer.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.pfizer.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.pfizer.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.pfizer.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.pfizer.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.pfizer.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.pfizer.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.pfizer.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.pfizer.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.pfizer.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.pfizer.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.pfizer.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.pfizer.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.pfizer.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.pfizer.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.pfizer.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.pfizer.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.pfizer.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.pfizer.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.pfizer.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.pfizer.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.pfizer.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "pfe_NotesDue20220.250Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Notes Due 2022, 0.250% [Member]",
        "label": "Notes Due 2022, 0.250% [Member]",
        "terseLabel": "Notes Due 2022, 0.250% [Member]"
       }
      }
     },
     "localname": "NotesDue20220.250Member",
     "nsuri": "http://www.pfizer.com/20200428",
     "presentation": [
      "http://www.pfizer.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "pfe_NotesDue20271.000Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Notes Due 2027, 1.000% [Member]",
        "label": "Notes Due 2027, 1.000% [Member]",
        "terseLabel": "Notes Due 2027, 1.000% [Member]"
       }
      }
     },
     "localname": "NotesDue20271.000Member",
     "nsuri": "http://www.pfizer.com/20200428",
     "presentation": [
      "http://www.pfizer.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.pfizer.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.pfizer.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.pfizer.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>13
<FILENAME>0000078003-20-000034-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000078003-20-000034-xbrl.zip
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MJ1%H&F$,2DG$?A,@<X8>C\3<[_\Y3L=W(/X=1+DW3M[]LM'<_/D#/.*7N1>
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M!HD>6U(Z7@<@CR^;@?R+#:58>+YW@UVH4=;L66]0ZIW%L.V IK.,^(2%*F&
M'W9N:P37([(T6$>C(G)-CC/3AOP:C@?)$/;BI0'A/Y[6@*4AW0:?S?L:.$,-
M3B+T!)VD<@;47@.M<?IA;&;5P 4:\G743^KZ;S;0HY,C&LM&9RMH-+N@H]*'
MB4C5-X/<A!GD]F)GMK/PF<V0N3.=R^\=B'ZKWVPV?;'=VN*\OR?V=IMBIW7@
M];</FE@6-L]TKAFIV6XMQ"'N*&+$.X&QJ^A'J^/J'_$AMJ!RQFRGE?C",[(
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MV?WJ,CM\N<YT>R/M!_>7TW[PA8:LVLK4N]H0/OS(GDPJ[2]%*IG1XGH>:T^
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MCFL;BF ,UV G+,SFLH-2&$)>CO"*0.#KL8=% @C*TC!)([0R:+:+61&.=A$
M+S6VJ6+T7  ".AP8CK@2R40#E^>38] +86;%--@IZ%#P%:69\? *MA[@E@";
MLLZ3>%2"#VB>X% 1:MRHB(;<)#(2@8AC/2RG#R<X.X\FSD] SZV!%R7PT#0
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M!&")QQB@,^,D7@QB[>V%L]@6@UAS?H@U6/<[&G367^"X)%2( R8B]ANE/7B
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MYA+\V+=II$O$W?TG0]W=%T'=]ORXN]]J-E\![F;\5O-G74]H$1HYYR>.&?G
M^9!G9@@./UR(<9(Q^8.L]7N!G5(&8S*<1")!-CZ:!$J").&1+]5HHH"9#B=L
MHW-Y>5X_^K3Y$[ZCPLT*-ZW2M+-;" 19Q4.B+8):OOV^3-LI*$B?L,Y6XZG&
M<YMO:U /LT5AN];,^9V/X?0K"5])>'/'*19WYE6J=^C;5*M,:BH@(5@,S;V9
MHM+[?405UUM;KD</S$H)?O1%GZ>!9H8+6I Y\[0H7,XO<ZO,FV" I.X++%5
MB7X%MF LV,;1\1^;S MXC!V10I%$N55E*"4+Y.16(]Q4]/^8Q/RA'!-'Q[8'
M&':ZAFM'(N%8_8JM&G QF#:/I2L.GXXK;:&B&_>.]@+92=,N%D?3F&7Q3G@S
MQV[3'P"'*(V$<SLU(C"WWJM1K'>IQOY+EFJ\DD*&5[+,TGJ+2E]>&WWYC#Q?
M/&+-=M%46S4_>FG22L[5Q\*7&.;RK+-<AKHKK7&+%U-:L:4]MB\JRZA)Y(CR
M@F-LBJ1C5UA:.,![0G*7Y.U=K2LE?WO1/+5N\6G15%FL%05F%FL83!)>U/:!
M\%H[.^_O3=4RN!Z)&$P/RF:R/5!T6Q\GKZEYH(WA$Z5\TO^/HW3 .CX@NXRM
M7;!Q<MS9-,H]#S1^8T&[#$WO&VQ!;G!:CD9I"#@Z%-[56 'O@'4-94]B,A8;
M!VG,S,XLD>A,*TKD*K@>LP99NH37OT8#PH=-H7J'*(]N2,!YP-6*;BJZL7><
M@^7I13C6;HIRVKOMVRAG)J1J<5.%.!)/JAB8/V9,Q$,5P8+U72*:8'TW(+F(
M95S'9$[L-DQ28B#"; 6:N5<X6N&HO>-_1/"-A__<X0=?1,5J+U G-8>*E2E6
MNL7?4*0CGF"4"$3,$%XB8U?[ 1%3H]8*#+L^@@@"Z%)+M4Q$10(-FRDW?QIX
MM*9K[&D23#_44:E,>Q9T01F=ZDF]3!7MO3K:2P ?Y(QTF#^K;P&W[GTY?,8G
M54RN<5RK^"UF]#E?>=QJ;75L5QAC<SO,J*%6A"5.V-L)THI"2Y?E+XEQCKA-
M.KKE);;=$B4'6@^Q&XF!OX^!ZK-8]$/\; _UHCQ7XOA,MF)^M'"F.FLQ2R<!
M_:+**EY7#M0->Q&E9DRY57QU$\[+AVZ-.K6>U]_BZ,IN*USK1\^E<S<%S=GJ
MQG$QJ9 =1OP?J3OS59'\BGIF/).98]*1X8M0S[M?FEO+D>(.4=Q>([\T5V)6
M54WWE]=55[13T4Y)%LPT)UZ8@)Y7SA0TXQH(ETCH?IAYJ0B6AU!!"39'I]).
MQTRLC,.*0.YVS"Q+LFPO(ECNQWV&[6'CF*9N.+959M^5T\9,&94M+L&!#62H
M]'@>., !+B*BWO2XBHC:JF-+3#NS$).+G=;,+!'85QU;@=-K\$$@]IQ:+^RI
M&R8JDJ:S^$RQ-?;'G;D:6X$"U])"T1X59>8#=</ONKV(KE:VEV*4C4? 1F@B
MI9YC8&N\ITK6S<B#K!L0;"4-?0$WRSPQQ$ =._3J)KG4:S1$2UL/<]2G\Y!!
M82]DP3Y3%;B9HE&5@*],";@YD276?R^G0=EB_'6966.W5=6B+,CZ%+N]@#.F
M0(THXMM&OACF.L)H;#U6H-R+THDQU!.Y)P9<)[&G@:[<R$;2.%U$3%U?UG%I
M>[KEDEMBF*T]7RCR]8]RC&%9LK.KEL/YK?/,AZSRV%9RF8OV#7XNF?-91=<\
M]HIVSTSVAC,6RO6I2YR/0:YGB?.\T8.@-;.\:J:FJQV^T^@;WYT]!>Q&AJ'.
M'REZX=>M;\VOG<X9Z"O8L$CX][& 9UK3HMW]6@_L[O><C>5.0Y!Y@EU@L(B\
M74O0#>\1*[<@G/."@IV;W2VI;((^NRLPNRZ@N#'('^4L>. )H&S19O_>5F.W
MO7W0VK+_OO^IIR*P4>HT#7,<BQ_M'S/;SST)< DL)OSWN[T9MT6V??M%1!N>
M!N]VN6/C'E5@Z7QS!NW>_7+1_=@]NNP>L\LOEYV/.(KUK//Y/^R\>_;E'+\^
M^G)Q><$ZGX]9]W_.NI\ONO..TRAY][*(56>HWF9!EKJ#6N\=;U#QM^;N';\M
M_[:]A_UVOZM*XU71 36M2;1F\; U@[SXC:$2HM3&SOB[GFS#+$<K(B[ZX?N!
MNOEQ*'V@_Y_,F>U8U]UBBNFMI^M29NM=!94**G="I8)$!8G[I,,42$:PGD L
M"23O;O,+3,OV>3>Z\0/E#6C_4KQY#V_8O8<WF!.T-NG,$<X#E%M!L#PW1FG[
MXS=\Z ^5 Y&ZN4<FF'T_Q;D_ B[+PP37 5S!Q85+/G?EL7K#6X/%>W9$4Q?6
MG%&LQV'3>.IU!@ .7[\UT/I2J+Z$?1UAJJ3JLPL>S#5EU[QWR:[#1V#84G4I
M O0RT.4'QEJU]M[^'$;$DW.SDLC%*P?T=KN]YH!^$9ZXT7I_BZ7T1O;7+MW?
M2FDW;NB@N;\<J_],1)XIC"X?YO**^47SH/$HICRUF?Q8%MG-LAC,^[=S+/N-
MG>I87@-3_/RALW[;>^U:_L7IO_AH_%.'=;^/11A7FO[R.)?V#;1J^WOKKH,^
M%ZS;M7;[%B_<VL#Z9?3AYO8;5_B;*ZCQ+V%?Y\3]CRON_T0<J5G;:VVO.4=Z
M1EAOK;ND?1'FV'S39DWI[E;*T[/P)NEC,8MP.6&=]O@[\U6*R:B+Q'7<O)=[
MLEZ6SUY*@/,#8[NU@[U'^25*$T!*X#/?7E^85:W+J>_5MO?F$>?5J:\RCR\Y
MZXV]N>R9]8/(,V=0/RC%<4G!CA5*!JZV_:+;KK;ZYK;ZVATW7VANZ8:N8MO\
M<"QP6"EF*)M!*^8_H4@JE\ZRW RM5G/-W0M/#^.#UIJ#^&5\'-M;;]N'4[Z_
MURX$NGT[:_N2?V?GV/96A5GQ.-/"H>+_2TM%:34>Q9VJ5)3G.9:MQBTE*6_]
M6)Y1+7_K9L?+VAKEU8$E)9[/:(&M4DEU!9@*,!7Y5,"XD\/:II93/;?L&Q[=
M(*SJ[+C XVAYBY:0W?;PY^I']8@EU=@R,FE?T8;I@+&=VQ)2R%[;MJG;K^VI
M/S$]]7'.ISML96[*QAY[U'6SW:SIML;8G3,0U)S33*(Z4F&<CD3$?A,\2(8>
M#D+__2NCV1N<',&Z&_^O%W_,O8Y%H=]<#/HYBI5/!M*]H[')="2\)"<_8?!P
M9K*!IR+L!YT()D(X-XD]#=-0>\WG[S+X;&)CJD]T).(Q+)Q:NA)&?/EZ>EP'
M9*'FBB,:T6 G<=I^\Z8U*TX-M$ J[7M=PWN#U)^ZTDLCT]UZ'*D$@8YMW@0?
M4!]?[!IKVX/C-3<JNL+'3ZU[Q,.T#RBJFU_#7Q('J0D: 97QDE@F(J[I'6!S
M/AYHU$;'5KXB> G\D0+J YJ-@6"\(>[2+$(F$WRFUAD4A4M*]T+$-=$HHB_#
M/MZ1U(@!'P)"(;C2@GB)R++_E+B"0^Q0"_1M0W6]/7^IL:+E\(K6)EN06<@%
MNC?WUT8C*\YJ64A$S0YY*6U;O:P)8_NS!DDUQ>)A%N'+3+' J0Z!BI'=@C8B
M_B:&' M@O)K?5P3[>()%F Y QJTV2!\T/+%B!.O""'A8F$#F46\H.YF@SV7$
MKGD .B..;R?5C<96TS@3WXP2>-H)215&O3*,,NHLS:X$7=WJ];7[,.01FOIT
M\_@G4M3OG-=:J4YKBM_:M<%C1 AT+LF(.M0#YXP&(JY$:X4HCAT6TI!M\F?@
M5$60HD7-F\8&T?"Q2"12^U-(UEJG4)K$-(V<IKGU$E>AS!P()6XBT/$JJ5PA
MXS37ZJ4QSG;2_KQ #'C  .'(&8=OTXQ,Q<FTR[546J_Q^*?F/*;D5FZ$5?.?
M5F>9*S;_Z9G&['3\;VG\=H88M==TB-'#+!_G!06I5PTQFLJ9>?5#C#K'O_]Y
ML>I#C-K5$*-U'D)2C>NIH/((J%20J""Q.H5AU1"C:HC1<\J!=1S64PTQJH88
MW5.(5PTQ6I\9/M40HS<ZQ,CZ(-EJ3#.:]B&^^MIK/<UHYU'UUV^P:<<S 7J[
M.4_+R;<$Z+O-R8=W3GSR44!KLOGRMN\KI2!5<Y >&7@^J ;NK.*Q[#<>U7FV
M.I:7TJ6K.4BOV5!8G8%(;\Y8L .1]K;778U]+EBW:^WFNO>L?!$FN=&<KX'X
M*]K@[NJI_LN4 RLS&>F-B@&<C+2WYJSI^6"]>U!-1GJ)@-J;-G1*=[=2OI^%
M-TD?J\E(CYN,M#]7G_1J1LYK/O6]VO9MN0/5J;^I.4#[U62D!T&DFHQ4;?O-
M;[O:ZIO;ZIOQX+R"$4EOSK>ST=S??3-1RN=RX#['L;3?3DS_3?O5VWMOVF74
MWE\YG]$2=E4^ARD31"\\A^G-"9GFSKH._%GU8UG3\5AO9$[16]]?-8>I&C=4
M >;I^40%C'4%QC+F,"VYV=7ZC&$RB_%ED-+,$P*Q\.L<<($/!(N'/,*6D$Z_
MQS0V,S!XX*4XYR(;'ON"DR"6-#6&/;3_V)-MY:$=PQYVGMVS"^8+#]_J+S1?
MJ-G>LZT@%EN90:BL1;V91#,[&,*="Z&'PTP-A:$GL4B,T\@;\AB?H081']7@
MNWZ MC4@*SY;CUK"NIOI6V)X-(V4P2+V&IMIK P0,^N5<9S":OLJ8F(T#M1$
M"-J#"&/JL&9?OL!0H.?B81W63X. VK2&.$B'VQE1;X2, 5/>"!7W9<CAB'C
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M =?PN3L.&=M[@/V./3Z (2:<?5*A3!3Y X[@>IDD8.3C8Y&<"2KXDC0,Y)6
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MR$"E5_P::;S2C5Y(-SH'JX=F86]$TEI BRGWC[%^NT<YA=J5@+Z/(;T8F$/
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MS8@<\MBT.&>WW&&W2,#^)(2+/;ILJG(Y $;TC\E<OISFIL0_(N%%*=B!V\!
MBA. M.#2_"J-,]9T X;0O7PE3F/CJ589 \SME"[Q++)!,!>1!X#_/KJZ!JD9
M\SU;#JO=2U3@_!T8/5I/BNI*V,H[7BJ][XGU/ETP,%-EK0L4I(D0T?>\!^(T
M4VAD>*T"PDWT<NH"K;KI(8,YBWT52&7,]\SBQCH,-R_+Z6I.[I61\IT>MT1$
M^.#,C2N, \;X6T#T3^($,QU-6ZEKH;"Y?Y9;;Y2J8EJ_I:6Z3=3-M8[>Q&9S
M4;%('-N<HTFBKI"E8-L]'N@<)MR_]GSH1=9'- Z,OG)R^[.E.PXDRE;"4@D^
MHFI[D\.4AH.X9I+53)X4]])$;]^JV3ZF7Z$C))Y@Q\*1>,P.'U(C\&21$C+[
MEX>Y,[ERLSX[XL4TAL%BI&Z6-!+8JF'@QFU+W'MX)B/,8',#TEAW,>!6,L14
M^F.U1GPDB!?O*IBX%DVL D-"VF/?(PD@,=XPQOB*K[O;.RHH3JF:&>BR@MRY
M2@M_WK1P7Y>)Z8\GF#%KF_7EJ0 4(@8&F<7YMK?<X*"M5M4CU7@D#5IAS!#'
M$NDB=S+Z,E05!C>9KD7*8I,S">>%F#RQ9-, ;&@"4EJ3\I5I.@.G&FE/,KEM
M(W(&A\)$=[%*/D1+;)K&D-8#=:-S1,>H &4A.DH40R9HFM;@;'%+N,@WPT&"
MG6.NTP"[D.+.';+3TB3.TG6-PYB\W)Z% 2:1<JP9S@4HV;2:S_MF?38[ M_K
MO,&PA,ALTD\CW55EAAG0.!,01\*5L@16ZQ'LQ+J=K(=U@WD 7L,6G>UYVQS/
M>A-'F9,1+[4]5QYX:K-HAUMWD<CEC(6!,[TL)$K]?D\3?6L6<0S$@*,YGE K
M&VH'Z5Q.,LTG/ZF7F&L!VCAX\]4ZWBO.^8R<TTZA0MRV=<J685I^B+$D";0$
M])8"!=) :Z(JXH<B)!02HW&@)D+D+"GK9F2?@YGV>BH+);?#53*;R]#'K6?<
M);?I;%F$:<K,R37ZJ\ZFS7CL)_.""[-02_2DN,#"<&QG[#0C"$#)M%445A,!
M_700*FPB77/;)]JN1QF/L^T*RVN-\H5_O'OW"*2^$ 'PN60"!*1[06:KT3T8
M#."+S% K0%K%P]ZYQI=XPR?Z- :H-M\#U:,<!#.JHDUKT4L8\TG-:GVQ221D
M/,N  2$0FFH^O%@9]P'EG!4+ <Q>*H94,:3'3/&ML8'$KG.D!(7R;\!13T9>
M.M+R_0Y]*T\2<CM ZXPG7<U#]$9-XFR&D*%QIV<Z-8C.B(5<[^&U1%:$7R1Q
ML9['N+[LF"[23$XIM4Q%[!@I%#G2D/NZS9G;N51#HMTTX[MTV[Z\XSKK&,.(
M.M[6\IS&4)%"I,E&-P0PKY=F:C'E_1?SP"A7RJB">OTAGB\%(?*J>=@B6("H
M19'>88&3YROJD3>8DX<.@$+#MX=5W*^O^W^W<O^_:?=_)<;67(S).$Y)8>V#
M_*KKX2"4N(\UH<B:C9^W)]589Z11!AJE3?DI6' 36W91K!@-C0_#MI0IVL;%
M_-3<IS:C4.,X-4X> UP?ZITC&5M?7Q[<CO5 14S$I7BR347OD3X*XH;"-KIY
MN9RVG;4^FV 6[3 %1(77^4[W,('Y[-H@+PCM,28*1\($BG)8]'25BW$F4&Z;
MEC>FN,[()]2/G[FD=%D=2UY9RMET*<'J$2=]G,HV0Y\,D8X*K$*GLVH6R9']
M"_TPL.$)6+UD$)KAS107(FPG]UM-.\VG'':V[A.1S]1VZL+[FDFDS KR:]3!
MF+J H9^2+M(I+3C/,+!3#+ [D[:P<0"N6VI02J@N4S#,Q30*UAQ">P^IK3\!
M329VR;$SN85\K3H=-59I!%HCL+N$TF],NY=>I#@Z^.)\2JOU0]IVR12HL._4
MT=J08D(1;C]F TJ*=^-P>0""^HCA(LVX8\NK; G['5S*A(@JIO'T3*/U&ID&
MR'= 3"VWIVS*L5#C8/[L.. =OZ%LQ'HN(C&@P:DWC!30,&6U]71))%%7PVV[
ME+O'+O[J7 +5<QH[A+%47#)P$6(:9*^:(2'T-QB*(_,7Y25*X"(U)H!NX/O\
M,ELX0RW\\(LIC<71$B@*2(2) ]+,#22KE8>SKE4@@"3S^$;FUK(J@(F+TQ9,
MD[R)80CDCB(/6LT-Y%#8TBWVYPP?2^8POI/F+YGF&1EKD;&GB%]38*!8L4>Y
M]+DB!+Q4FBR1>_@')N['2E$"_UC%5%I5\92GYRGMU\A3;NMK@0T/"QB9X?8"
M3.83JATTBP$0&3@ %J^ZL7N:+6^[_N03T12V]S99^#GZ4['@=/^>/,3H\31V
M$[. Y6!R#*9C!-R[TCZIK!DHBFVJZ=83EMV-(YEA@XM!3K?:I_S=K9HSD<E;
ME1BK4= 4J:SZ9NHUSO,*K,1Z^RG? ?FP-I1F$B1$[)8?%ZRCB@$\/0/8?HT,
MX$L?9Y3,,@ XIK0/]*5C/ECG3?YJ0*Q%M(PO2&O<4/$$*=M*=>E.23<R#V/P
MIL=8H?K<-_*28GVST7 2AFE"]8*A:?-8D.V=V!TJ$^!P12"J?,<B<@OQ8YNN
MG]7GU6ZC<LURD,N)[R2_9Z'H.69&9A+AQH:RK[T0>KBD\9Q8TB=M1EL7!A(#
MD5B&%&.8LR_JL4G&1Y>K::<>Z]X_%%;@H4W;R!4%FPWU4KK">I;)[;Q&3G%*
M4XQ)II@Z32I&L>F3B["%$QP!'-!@ :N2E[O53&Z/2X#PA3<D5V9*A<%]X=.
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MJ7J6NTC TIRT#4<&YAO(3'6S6=@,9V?&0IV,A2*+]G.*\!*@L@14_9P E2=
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MI+=()4N"X)B.](V$( XRRO!FB:>M*UEBU!V;_]DIC7/R/0F(.0"BML;62[Z
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MMCLWM_??U!VK [ZY9CKGN4KGU,)TSJ2TY?S-\N7U_6.KW6%?VYUKUGZ\_O;
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M/<XI*4F!HW<\#(.P4OV8=04X-,=EIL.T] 4*(7/(77@O#-Y2-(-$1*I&KL.
M+#Z90"QNX,+"^R[2BL)@+$5A?;K >HIGN*YC^ *OB5XR7I#NZT)NFF:! 7\"
M!A/"9N)%MWR\=\Q$(<5)9TFF7*?WF$E*X]:3+8BWHB13SU"V0@8.TB5H:0[X
MX6$,*(02SB#@WS)YI-G4XKMBY+CAHG4B1/ (!J;=P_!+L"JP7%Q*!X0C_A2$
MQ98%F-CJ-F?N)O-Q$%<)T@/246^,5:^:VM3\&-=4ZS&UL!'@*9^1Y/M_XZX^
M" (,U699R9WU1HCPV<SX:J$03SV^4_;@=Z5IF"#&1-SP<'P/OA9JD;^?/H I
M"8(%=%@H3D)!6O3E/_KE1G1=T#&OX7K7=KS><P.JK[O TY(H2T>Q<I".8C7W
MCN+1+ZV)=W<2628FB&\9<7!HF%E@SL",?$QK##3JJ79(WJ.N"K=GTJR?GM>K
M%V<-+?QSO1V4YIL;*(V4NP79[W9L\F5ORX%,]S#")5.P&;TPZ5BFL?(N\L6J
M;'OQYK9_ODC?5<Y#8]$^5N+!AWDJTDQ4.D1DM^ES@W[PR;\#/SC5J9#$)(EL
M)F?50R%K\TCI6_OKU_9MYP&W :YNOWYMW3^LI) /Z>Q5[KAB+DOH]&SE+9/P
MEKB5GCI3:'[HF<A_.DA(8%X1S%J:!HN%!/-.B_MD0-;]5"!7=X5A>NE#&/^0
M_FB)Z[C$I6V,/%"'')0?/.) I4;F^-DMQ_QM#2HW+M[66, UCT[D2WX16Q%;
MY8&M2BM9##-D38"6^]5+\NZ*;D,\NMR67&4!@.4K=V@_= _:?GBWU['1LS*I
M2:-B782F/-AIY$JF(ZMM>Z(?Y. %:B!($L1\L9TI!)T40G%96$L3$B6-0'!:
M8%]0T?#M*8,6O $U ;>8(4:NT(-LQ>DD82ZE\*9S27>F*0S2%,5E[>(9>X2I
MO&-J+VMI;B,K(I[/IEUDE+WM>*!)^*)$P&FU NKFQ.,OQ'4YB7QGQY)KU/^A
M;1<"8F9 K*Y15C5?0"RZG]$.V@R!N!>[VW80Y#OL*MEI"SN3*RF=%4E=:>=R
M)YN3!.#" WBE&G1[!^!B]1G8N?-D"R\HFY?&?SJ$DI7;QU#Q\HW>/0WY-?%3
M;3Z]27<N?0#B:N+J ^'J5!T!B\G5"TM'9GEH7AME<FC^/#S3O-U#\]%1_??/
M>'3"11U4>#^.-G-L?B8,@@?A)1/#D>6\"L$\X0ZC,CPJ&Z?,@NU6+$YFND'M
MDW&"#A,OIA=E[4Q*PSR;WB"QLH\\99?!69$E!8ZTIBJS$5:3"4K7P,Q(,$;A
M]Q%\,!U?JG)#84T@KNNNSRVY9F&DEF6%59ZD""L%3-7[2%\J*_B(ET\J8LT<
MH0GK'.'4ZE$!GP33>[U$V3<+'A&3IV;RR&WNYHS'Y]*LL>136+P(GBQ<3+8(
M?L""-EUN_P&S4&:6Z'.K'*_%-6%[:<(D</A;N$^F+HCQB/%VSWAZ#AAOC637
M!+8L(PNXJN#8F$<-$]2>-UULSXR>BDR*V'7%I+*> !4N?7T "AH>/!(VJ%_?
M#7L;Z%A&SQIS-RI;,S9$8$KY*@.&A)]'KJ.'3XRS2S!\T.&6V7M5/(4CS5(F
M3*9JS*XD'T@^K"8?C +(A_M(!LB %U5%8.0#@*&-, S-9H"H.52X\Z7H^1:S
MS">ABMTJ:QVO>W*LIX W9JIN!G57X_(C7@=Y3;9MV^N5Q)OR!]8;"DQ&^DX!
MZ:O-)8F4<OJ1;$C(/8#D4&9>K,(G1ONQQJ<!'J )D($OGT2@,V3,QMN&B,JH
M_'K11)0H@(AJ;P:0=Z[S!#((*V9C64U,S,""U4'!Z#4J>Z:^-9XB$ID:@52&
MKYCH]40@F?&;6.PCS"*,JN^6&:R7[@>BMOO*#!%$6% 2JW+2()2E8>HA_UF.
M/K:\5*'WZ:<%_#D:6:_!_=R;>L"X'#5> D!17;_A;JQ$G5&%^"7%$0^YL<S%
M>K.[7F.9#4XF=8?)-0T=Z@ZSD^XPAUGTMU8 ZR0J?B_AH68/A@/W4]'?C1?]
MK4_]M_&BO^=9U^%M;K'F[_O>M>4,Z]WN15/17RKZ.W\'%?V-WT!%?_.1>9V#
M.JE4])? O#=@IJ*_NS?I,J Y<=<TP_CP]'&#U.$VW*9E;M1]$)Q"TS/5/@=5
M+]Z-^,N<$8J7()W__.>SE<Z"Y?G@,G$4<50>.&H=JR=?'+734@!3SSR?"9">
M9-0#M(V-NE42WDS>'KZ\4-7*J-#Q<D]K#5JW< @IC1(F/4MP6E#7,DTQFH-4
M,AF0U0$54.ISTY;'48MX/+W4M^$:;)SM1OE ([C?,3#S2?SIF]XKDT*'7SUS
MAPXJ54,N,)MK35(;A*<,R\)H6IH2E_.+L XUN2C\DE-5$V7 J/-[;,@]3[BR
MS&SAD0(AAJ=R^@2GW>J/-.7T]TE[;!")&6J/N:(/I#QRRNVYKH9.%?8)4YD;
M)+4T>R?YC5SE6R%\CLKXX(9'X%. .L#(E!H]ZH8==V^D%BQ%9F:-PE.$IRSQ
MM%_*(=^Q)MS6"+<S<,>"NZHNC6<&-6OP$+,ANA1W(DXFUX$PE0-,:;3IO47M
M<+O3'K[4766/FU. 9MC J1%2'(3'=*37T^QJY!6.N6H+.?6.;%N;1.4<YVI%
M4%_([1A\.\[!/U]'B>0K"9^06&@DUB[V!HE%=UIRT1FR1[[+_MJ*6GT3Y1M(
M\Q >R9=>0?_DHF_C[KT;:MSX!O=O'T3%.V^]!RW>ZHWUI6!1>KP16Q-;'PA;
M:XTTIY6*R=;4NG%SG1GRT+GQG9T9,NGF:#O>7$?'>)N8,GL>F-A4BOHP$2NM
MQDIY:)#X=C4[1)/$YDB.[RI0G4RJQH6]T-3')TR%CI614YRSJ+<2NW/-(7?A
MU9MBFDNL;X=MV[BU1OQ2-:4HI;[];]H9@RLLH#GU,X[5+.^TXU&QIT^UT2E\
M*ZZD[C'Q KBK2_A#X<%JE4 TB7&F[^=&1@$U;YVRK[,6%RI-DI6"3F?''XS(
MS)@/U!(0J4MH ,0]$<IKZ/$R6.#;U./IR=RU(;AS.WHG4]>\6'_J,IRUJ2:*
M*X\$)]>=M :68L2GFXC/1&K09QU9W+;AB^^C'\X !(;+;1GT_@VN^?8*%P2-
MO(?<M"=L)&-=P<O!D=^R:B,9+/&3*1T7Z]*Y3Z8NP*?=&VFTAHE8WI0,>K]Q
MD)[R&73-]YR?A1<N-^ $5%HY@)D9]H\WIROEPG(@$FVP&1RWSVWSKTA:1)$]
M40X[J:*\"'M;=T7?#!X)]^.JE,. RXRX7Q&G9#M1^V*XXR97'FV*^[7)_7F)
MJ6S!%BN(U:$U=F%U!,UT,C0[HNX\&9N.[U=FNPN]-IOY6L$U^W;G2]QE&P5>
MRUXCB14"/@,_*6L7LP!RHEI??]I.V>.><N8:MH0:3V3A@^4_=- 14(#P!L!/
M\%V4"K".M_<W[;RR]@JJL6(==[>8CM]$!H[=/^5V8?3 =1B()\[D %,\8*JG
M.I@HCN]&I<%@B-THS83KNN,'SXG6:3Q#W5>EB[X\_(M=HNLV! I_%=SR!CJ^
MY(=C @%/, IP#$_9@\!&W8YG.YY@)0VD3-=Y$EOUX^J'Z<?U"N#';6@SYLYU
MGDR)0%9;GW@*C*D^@<B&:VPZQX^530(8R T8L0AB("H/'[Z)A5O"L\<H!H&I
M4/9Q2_>#Y!+@)D,$&5YFV#WB!S"G-$P]M#4L1Q\'8E1SB>FG!;;(:&2]!O=S
M;^H!2L(T/DEU":PWLA7>#6)!K&F5HMZ;4E]1J(<]<\EZ_,EQX76O*DU-#^8A
MDE2A#,&!=(4M>J8WD2]P+T<YY5MJ+I$9PIGH^Z;!;5TP4TI_(HF^GSZ<LBN,
MIGI1P:I'5W#INZ_Q'!Z\U!)]4UI1T'4(:DF)S9YPW3#11TX>^0BCN_3#&?[-
MZ4K6"I87:&P448)%LF2[$JR25H#5"R# .HY]\J75NF,MXX<O/27)E(Q0@51/
M:=618X]3-.>O-TS+Q[^O[QY4'B8HRB!4*@>.;QDJ$ZTKV),IGA5SE)GTN](S
M/1]3VU"^*;"JAZ(=L?S]L;<AS\B1"6H9$0],ZKB>XJY SDC!AHJ)@@0Z@!GO
M!P7A0%;W'0S_"L^+K(B1<)5_A/>'MZEK2\!0("-UU^P&4GX--S9)TM^ Q6*#
MF+78O< IFK:KQK,]N>Q;,#A6&B] (-33;A.%LE */9+1=SWXT1W+W=UL901A
M@]CDX.I&Z;Y*/)M6(&NO7P9F%^2O5L-EGAE\R[;]\>VH0F]@D9E6.?G7.*FH
M9TI@0O8JN,N$C0+\2NABV 5U4-/*.R+_N)S :>MS9GA%;SRO$PY!O3O@3W@5
MC!0>R%W#Q+90<(G2[&B:AVP >FO"LW!I&2<2M)"#.RGX)LL<FMZ87TR7^5+T
M?$N9Z;!(IOT$9KSCRM/@;,QGH7.X(F1<N!Q'.C4( U2L'>5\9SLS)=^VS#]$
M6BET#)+E-1)R>!EW QLE4-B1I13REH2)L0!HXWG'S2GE8ZE;;5-$<Y+]\H>^
M%7PC'4N W0!#'*'AYDT61$E*6$8&JP57^, /KEH(-G">XS(4$_A5Q<V8X"23
M8N,FQ5D!3(KK%_ K)(84T?H%-'GACBM^!M^:VWT3<:#.@  [BQ==C!!1@%BI
M^_"M$AP3I_O\&'C+<IX)7QO'UWD!\-6*0RJ,6L?])*4IQ(D%"#2"@P^N0M0,
M\ *5I\/30:GYGHA.6?"N:>%I"O@H 3EEE'I^CX=Y BA#N:L/\&OW#U 4@3J0
MT4/" QGH(Z-\!@$:B&=X/3P,C"PT1^ B$)MX8D-N*N[?>HOOUK/, C=3BH1I
MC?SA(>9$C.#[<8"NY]MZ> (E<0W?8F_UM3ITJ/Z5?+IQ'/]="LL99H_S?R0/
MYI^9 79/UK GUS2F3V:F5_TY<"?BL"].NJ[@?YSP'E#[D5O/_%4>A=.^P<FL
MK3J7X0USQT\W.,;FJF,,;KB[:?_O^IZU.Y< ^<X5>_C^^:%]U6[=_Y==WGZ[
M:W7:UP]YIZ%S^WC]P!YOV?WUY6WGLOVUW7ILWW;8[4U@+=]?W]W>/UY?X26=
MVTYHA%[]]OT!OVQW;F[OOZD[\D[HY?7]8ZO=85_;G6O6?KS^]L!.6.E[I_7]
M"CY=S6K&B(H%(FDA49.H>(+%L81,I3[3R)R8:ER@!-$[F#MF"[Z*W;?$6&IO
M4%E-I3B7V;;/R,&#/SANQH>&E9406 ?B":S7D7*;UAYP68671VA!N&8\!)[]
M&?O*05K C0)8P/.^?@'3'J:VGWJ.!0X>K-['=QB!&>F-^=)7"JKJ"M,V@%TG
M+#"U7K$AS&%N]N[X&&T49M;4D+00IROQ[3*FG!EMP(+-^FE]ZK^?H](A.LP[
M'TGQ,?I'DL8)V71<@*YYM)B)@Q<VSG^.L?ST;UJJGYI9/W#M=VVYI=IN:[VL
M7L-H5\3OJBIC8P=5&=-A(CMO]@8WST_^/9W[E:;KX"8F9]4BB!/J+E:=CN"&
MTK?VUZ_@YSR@:W1U^_5KZ_YA)6.":I7ND"NR*V0:RSO,L))I+FM]$93W',JI
M^A@6$LKO<DBWK(C62$L$A2RD-Y,Q>%B<NY1;#Z-T9OY%3*E67X.N"=)ROWP'
M:@EF3E^!F'"&RAPSX7F:QF%[PH3[J?C#C8;#%#IOV^P;C#MLGEUKS33=ZO/:
M*H/P6'@\IE(?><7CEN/ZR\F<>H=63=R.6IGPCLIO)D6Q F/FE?'2M!4@04]X
M6H"G2IK(-0GJC*J].Z_<\E['/00..797<$8J::D"YZD\:HI<$023('BQWPC,
M3]AFZAVS&60GY]G9[*4^-VUY_,%RU,D[+'.BVN@8IAPYDEN2&+6 C$HF_-8M
MK<74%1Q+I31@VB>9OZO0S";%?BCNL;Y,WS;5:?B@^I4JI@/W.0;J O&GC\<6
MI=#A5\\4I V*R,'G1?+ "4YYAY,ZK%%-LS>?WZC.7MGU846VGNL,F3J#T76"
MG@JRS!S?.[%,7=AX$H]QU^5V4'TC.%(>- 1Q>N.3YA_"P^=,44CROX@,6]*T
M-)N[Q;'A"(*YA^!%FA[TQ4'@@6D8="$"+\'4Q\4Y=%<86$0J*FG,[:A%R73K
M8F+<(C&N5MEOSB4(YAZ"]:UEDI+NV+SNN Q;W*NV5FS(/4^XX)C$SOX3=Q:(
M.XL7#2!,Y1U36I$"EH>W@1!)\&"G&"O9FZX*(1&S%9#92( 3IC(7X$5*0,B/
M_9T!C8LZ$/WV>[29.Q3>P#$FQ;AP*YB8K(!,5M*JC;UVC F">8=@\6R'O1+V
MJJPBA4[V]0QD2:MOXE N*0""\-8@7*U='#2$4Y8KK ')AN-C ==-UBN<>F9F
M1X'S54DX->RVM 9Y*IZSD0DH7G6==T]#CLOO:!?K%U!80GG!"_20)"!)<#"2
MH+:^%[&_DF"J$<!,&Y;HX6\U!9CMLE(?O:<I0&QX6DJ";APWW@LZUMN$N:*/
MC2[#(SU<F6)JDZ[,I C:VV)#>VP0J9IDXU$@6S<MDX?MM+!)?4?URCL[QCXO
M&%7&Y5)U!!X\^"M(&W=Z40OPJ/MIZAX.4XVSU^L$ :-*WQ4K5FTYW=LQE3[E
M$Y+:CJW?]99W0;FH!5H %R?H0AQK (K_=$UU3$!9\Z[J=[LE:S[%.[1)1'+L
M!F0XU'5ZDYRR)8R*7=?##74)JV[V0!;#\TW@+XE]+(/F2.HP!ZW#>NL0]HB9
M-- %;.?$6RVO1Y0K>IAS[<0ZG-:/F>+ZF6Y.QD$W/*RM*=C7:WC(F<V'<)F\
MJEY?76D75V>?&Y=G]<_59J5UH[6:EV>76OU*JU_##1_XU(IM<!T.N _A[=WU
M?>NQW?G"'JZ_?+ON/";U%ESUH?^0_FC)WM*2EF/G(P_M]6/ -SSCE[0#6-)A
M,']+4()?+12):$@:>%K1E5FU17P?)?/F>5+3K7FYM2B.FM^67<W3"ZT>^_]Z
M+;NJ9T>+@]QAG[[,6VQ=Y*YG5S8_9=[<;,E/C3U]U_OF, [6.):WO_V6/F,@
MI:Q]C'=%9$K82&P<_F0:V.W\2=B^4,? \;S>E)/2?0W]#B6@L--X8#U+T5<]
M2%4?U9D8 @ITU0HV_J"P(;H>#R;(J6!"8"PO[-FXJTSK/ 5G]X"^">?5\K3Q
M/6?57)R>K4I]=,M4)SNVH(4787I_Z!MC>A>0GI^+C#HYKL$!GTUG-. @^E?W
M9,9O3>U,*5^J>CSM2A$@#QJ0WT<_G(%-:"0TY@&-*CJ\,S#6"(P$QLDM<_L@
M.P-FG8!)P)S<<A\%%>P^:^.FZ,Z >4; )&!&MZC/SP%8NHYEP#.4^+P/M^?S
MYNLO:4V_#F^JF.&!GA_-G+Y,LN/66,Y<=R)=@RZM4JY4TIR5S657<>*L# .^
MN6>>;?!'M5RIIJGR1QQ '+ ?'%"\@^S$ \0#&5M)J ;2G-8E%B@."Y"+D3<%
M0C[&GK#6QKDG(>146'630$OA],_^Q?,N,>_/Z05M8 Y3+.2C(M<Z9ERYT4AS
MX)=4#6%J$:;JS3314T(4(6H1HAI%4O0$J/P#JEJNG16I;#QAJ@"8(B%%@-JH
MSPM2JU":,)W+JVW(YYU_R52[BYF"AFL(@I_1*0X/R!'K%9#UP"UNG.:N6OHZ
MB"08%A*&U?II[KK9$0P/#H;_5R";@_"4?SQIS=/<M1@GL79P,"2Q1GC:[!YU
M\S2-NYY/.9= 7Y+@R]4V]]9<_@=AX9&S<KQZ#;>"0C?&T+1-Z6$-G"?!Q,M(
MV)+VRPO)X[A?7F]2\CMA*MN-@S1./B&*$+4(4<USRL @1&6[8=Y(U5Z.,$68
M6GR$I$B;F82HO",JP4.MEB\:M0*![#"]YWLA!7?U@?*7#?$D+&>D"L62LUQ@
M=@0!?T$F R$J2T2=$: (4!G'\R[(5R9,97RFJDJ8(DQEB:E2&B\FGQN)Z7KL
M$@AW#<($]QHE7;U DBY7[G4FK-0:.C#^O\8M5$S;XW;?Q+XK7$KAD>M<1%8[
M^J6A%8BM"%#Y!Q35+"-4$:H(545 %2D_ E2F@+K0BN2E$*+RCJ@$5_BB4'M=
MN7*$M[G/[+F^[ODNO([I ^[VA0Q:F +QW+09U__T36FB-WWB"DLU',7VIN1&
M%Y%-R3XE5!&J"%6$*D(5H8I01:C*"E7G30(4 6J3_G2A$':8[G3I"[C,Q\RQ
M 7[#D26B/>A+QY;^4+CL5\$M;Z!S5[#??F>>RVW)=;R*F+2 3$JV!*&*4$6H
M(E01J@A5A"I"56;)W?M4Y).2NXL(P@0/?(]0F4!=$DQSY<9GPHRW'OS"2J8-
M'KHX_F (PU<.N%2*3/L4_F4+C[BV@%P+3%I-598EGVQ*RJ.P,-RG:OD$PF*"
M\)S*Z!&@,I5J6JK*C"37"(:9]M.L4#4!0M1FZZ15BW3DYMU^>M=Q#>%&LUL;
MO3##\?%L]$\5]=]^[<>WE9?_H60Y4AZSGNL, :FV9]H^O)XY(^&J8^*2=47/
M<04;N<Z3*7'3'CXRC[\(B9OY0; @!1QV,MMY9?V-3,96K.ARHYHF]^9-@O.J
MD BV^P!;K:PUT^@P@BW!=J?QV_)9,TT9Y'=3O ]>*&%]'[!^5JY5T_1.(1%-
ML-UI%+!<KZ6)P)"()JP7"NL)@:%:.5UA@]S*;!4[^N!Q&,OX>_5G;#26:8N3
M03 /6K7R\^QJ5&86K!+%=)92$'O!U/*/[PXC0O@Y/@(;&\I94R_4*@$>%!E,
M%Y85_OK/H\J1^@PXU://";/V: Z%9!WQS.Z=(9]CG&?3\ 8?F\W3"ZT>^__/
MT;("(UA\),7'Z!]SY!^- W03ICD[6AR_"]Y8:_[\Z6@.8<%O6JJ?+K)^X)*?
M,A_\DI_.M_BNQIZ^ZWUSN.6DL)##%)>#U)2.91H+A.:6M=]!$S^18K65=/\\
M&6EF:H5YB0EB';2)<+,Q"6],5WHG__:Y"X]DU8J6%"+>:?[D_G%#/@"_"[RO
M)1DVQ &?36<TX&"*1?.U^B/^(?W1@LD$PC[-F9V3)XP\#!6"7P9/./1-]WP
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M4$6H(E05 56D_ A0&4=7M"HYPX2I#3O#VD61!%>NG.%M[AM[KJ][O@NO8_J
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M F CZ38K3>]D0V0N$V=S";$9G4G4JL5)B$VR)7$GHWJ^LK^W[3391#/8 ;F
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MO',=W7>#.F^EWS_?';]OFD#K]%T^1"(N01?RZ& 'FKFF;8:1"!-KE@U5S97
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M@1T7&H&I!H,7_=?R>&AQL[H<DR;!\\=.QQ.W_," T/F(*\,71C(Q6\43FIU
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MX]D 12R]33E*J %05!NF"W84R$:L0"TQ+@#&%BS31)5(T0_D+] R%LR^;7H
MC^"GX[A -IPI)8#25(83O#FAF1 .S4AH1N)KNT*SDE9FU@L@,Q\5(E"052N?
M6L8/7R* @^Q,]:WV27&L8ZN(&"+5$"!% H,B$&!N8.\;@:T3*O/OIP_@#[1:
M=[';R\!VXQ@+R)T!QQ"5KCL8.T3#0[T_XMI%Y0NGI(F$R3![,(U M^F)(<I)
ME!)@.@1LB^$^X"K?G4B40&"$\8WI&B,_'! W[ E& ((M7EH$!N0F55P,)>NX
M ",85'/R2#EM JCQP-W!H80F4=?WQH.<9]FNL#!JJJ;<%3T,06+;WM"(=.R^
MHX:!R;$3>7)\RL:+> F3A9<_< O?-OY^W"*X/=<BN#7=(KCTT%8N7NMX+"]C
MSYEJY16//9="QS#QKMFZ^^U)W?V6JKL?#B2\/#Q7V0[/55XM.%?9$8$4#76$
MTG]J+/^_O6]M;Q-)_GU]SJ?@R>[,X^R1'8&N'L_)<Q1;F7@WL?WW969VWR&I
M99,@T *RX_GTIZN[N4@".T(2T$WMBYW8%H@NJGYUKP(9$HQ!;4]J5M)[BC?O
MF_23(].'"+7?"(/3'J\W3O"\.VUP,_21.>F"2YF]RKYL1DR(>U+*@XWLCSUK
MQ(U9N&B'1L='IKM!?UQ3(YH\K5" B@D3M_AC7_B#:0<K<OTV[U.]>>^3<?CB
M5D)TN6\)_DWNBW_^6\LX21(&T"=T-IZHK$\MFT/5\/N#-:)Z4F_%$8SHX0>.
MLX@N!_[X"+:7WCS\%T]5T!<YM7P(C#Q3EH>@.P&6'Y/9B'(G>&GE'+^11(X%
M8,U@F3DI6\]<**AG8@1FBPLF':4 %36-P@9# ##M[EV(+S$A<$.69@=/?BAT
MR(0D@)"8SO.1]H&,30C;KGP[2_Y08VP&9&4(#;8<@(WX O;<0&'^/NB+(Q'N
M,<N(VW'TF<6KHK8.A.#IS9@2$6"8?$3ZE<1Y@'^R7-F$OC8*PSS%1/^6_&@D
MN'\0H;?6#K!JN$:0L'Y4*A10U0#D@UMY5.^P^/FR\S\SOT(.+0+L92&&"^")
M@<#4IE_RN&.[D\ /WC?"=29]0I\B/'S!:R8=^S4K75RM9DE8%F,"+^DU4V2S
M:A=QSQW8*X?Y):W5W@YF#E?(R_[_P8M-X'MR.*+^U[=#<TI/^XMI/YG/_AM!
M]CT2L[4I+5L91:Q[?,:<U5E7'\__,[S6SB].J7J].--N[C[<G)^=#Z[_K9U>
M?KD:7)P/;ZI^AHO+V^&-=GNI75X-KP>WYQ>_:3?#W[X,+V[IN3Y>7G^AO[N\
MT ZU@[N+P=W9^>WP;-5Q"$^6(;V9!XV#/BD.V:K/EE)\M;&@4!L+#* Y,Q*B
MK)T(#([9#\N(-_<LEV'F&!(&%#^942L0=\V:(S;[K\^C@("6X#TP)<2=#Z@Z
ML&Q+.-<4$L-;,=,H<D[H]SFAO90PY^+D9ZCU<R/&U*):2OOOPJ3?ES= +7 G
M >P;WB -U8VFT=SN>>!E[O2!MC" > 7&JBZ.-'6HXOTPQ,+-?/_!7=@3X65I
M8$LS&Q$\Q)$?6,$B('[$ BF.;'3;E2!*!>/,DH5,.A*$3,YY(-#/"-T>6&]?
M"VZ<T _13V5&.$X8E]+/T ]E!CI"+P<XF_$M_0LX[?32=Y1U%\["7T#(ER=5
M-185&9O@([!PB,=" &'(I%*1D;=Q5)3P=!)WVL&5H';_HS4!9XU[[M3$CUV@
M(_#;-&!$$=-(0KHY<A>!B(!&BH(^+B>!H!J8Z.N:(72'*!D2_@.%"U1"J(2H
M$D*_ZT6_JU.FWV5JCCFC'_.-UH?C#\-A]_2L,^RT]6;_[,/QH'OZ0>^W/W:/
M]2XH27/)UM[C>S V?0U&\2Y;?]-G[*^Y;(?:]?#WX<4=]7^J_M@?SZ]O;@__
MYVYP?4N?'@"**2H AF77;#7*DM<WVZ!/:%U^I>L"TIO-[?I^C,ZK?3^MG!T\
MV7]J5^.&W>P_Y6MU:NWZ7/ENV)/YX5^@?">]W2K=B9E9DXE-=M1A)22,R?7\
M.S7Z;6NR<5M\;U,$[;W:,9M^])TVEVUP]++:A?M977:"!Y8;:-=/D8=0XIZ<
M3BD]N?DX9DWKYN(9]M,3UTPCUYY =];E]>>S/\[/AJ^0LH>D?(V4=Q=@KV@W
MMX/;U2!YE3BS*N2ZO;P=?*9F*S7_+EA$?O!Y<[]%/(R_F+\0LGHAE-:9!Z*-
MDM[B?99?69P^45ME5$,KM-YHGOOTRD")/<KAKJR(O4EF,EJ$-,Q+PSC M>DP
MDSK3[2?M],%T[C-&3.;BOYW2B6=X*V^+[%B$E62U;!&MCEAFVKXHF=5E*Q0]
M9;1CI<1,+5_DX,OYY\_4[;O1+C]J9Y>?/P^N;[8?@%<,(Q3LNM12$&[=P+21
M'A$]+N?$2\M\%QKHKI ]DI<_9'W_=3MO%K_7)L.3&3,-<_SUC./M_)U7Z@W_
M?8M#[_R,JP-N=W5(W6@TC2VF.F_WJ@J;0HX\*1-/MAJZCCPI<U3AH/_31@YD
MH09RU6C5*XQ6>XF<(]3E/V2GT>UL,6]>?:1#EBR:);L-O==!EE19X12GG%'A
M5$ZZ6[T>2C<JG"JQY'&[A2R)WIX:M.BFTN*'0^55+C5;W]P$+?:[IZ'HH_MP
M?GGU:7#]97 ZO+L]/QU\OM%^N[Z\N](.HK]4-TM=W9Z,PME/>I7ZHT211N7J
MS4:SN849F$D)*74R\GP=>/ZXT6QO$== EI?>--/UGZI.*EE"2+I1%5*J'F%2
M#H<[#4/?PMU''$;30S:6;S?:W>VW2B/+*ZQ/>ZA/$5QR@DOO&/4IZM-:L7RG
MWT:6K[$KWZF*NJP\I5(-B_UDH_3=M[3L"47/PV4<7\2<]K+&W8RRQ]U4(XU5
MKTQ53;1YX0K;:+1:QAYXO$XZ&7ES7[RIM_:1"JT3;VZ@T?=FZ!Q7WB2L4,>V
MWJP*M5Z)-R'J[:D"I-%J;]%BAZB'&GF/O*GW]Y$NJ1-O2J&$VJB$:BWHQWN)
MXM9)S)$S]\29G2YRIO0N8:LJ^J4*Q$A-F>2;X+2O0/^N6TO>O!_:%BP:U$S;
MMMCB:X\\$F<A]K).+(^, [9#VJ_G!*<?GO&Y4^6T$]1F/FPS8[[KB^^M1!B6
MG-Y-/8]?5E6U)P62OWEOY(IL*N$TOG#XO4I27G]P1X+6;^9I5$%8RT?M;A-!
MK7)RW\J*#:DL]^UCE/OBY+ZM2V8\*F',Y.K!D^5PJ0$'U7UL6)(06-_?T?_.
MYM9W=*2E0T*C)QD22D[M/.T:J'>V(OJ!7OZ(HO*LZ9__UC=THPSH*MFBIJ>6
M2];D1C;9J(VRK[#L=S9:*5@^,THM^KGZV]66_/W;-*T2;9JR+#;5O>DKC\Q,
MSW(T_CGTIJ6#0KTCF14D-[6[><K84?-LB<W-.KO3+QQ?98-:;TMFY,D-;!T$
M-I3\BD@^Y@<*%'S)B*V"0:-R5CKU;*J[T1^^7.7QPM!W+CF,B#'; HF=9^P%
M*IKMBLYJ7,M=QY).!#0$M%I[S'44^A=3[E5E1JDE7TJ*JV#/Y""\*@=4W86^
M=1\M\R]THJ4#PZYD 40D-BH=J91.Z49U;6LZ=72G"TQ$H3M=.<G7LV8:J2SU
M6'=29%LT=J<57T_74;J2._UTJOO/ ]O6W(#^3<M<-X).M3RPV)?,T9.:VAW9
MFK>4P&F]7>^J;J.>M9W8KE*@3VV@4UT]R3=J6=7=ZDG682"UY+=S;4!36_++
MU.EJ'"\=N*JVW[-2*Y0O'8HC[GV>UNK*;9!5?2%GI1@'=V^?P+K$=BO/E%+<
MO8TL+RG+ZXWC7.-MD.4+-ACVMCO%J,RFLLV]YZJ1,G4/38E F^5](PY7#X<[
MO7UL$4<<1M.CLBRO]_)DPI#EZZ)/6Y59<H?Z5#)PZ7?SE'HAM* VE93A>WTT
M'^OLQNO-JNC*ZI,J->*A>LGF^<B#+;%8GBE==EUO&&VL9BB2WGH+&P4*3_CG
MTV"*E&GI65/Z5"[2ZN,T\0)AK2=;JUDMY#XK9:2RW+>.NW)QHM1RWSJ6#&65
M,&84'KJ;"EFJN\]_!J8SL333MBUPHS6//!)G07STIZ4#1*,I60.>U-3&)38E
M0'2^2B1%;.K,PZML4R.H(:C5W)>NI=Q+.1U6:MF7DN(J&#5ECT8L\8"J>]<W
MBX#2$'UIZ<#0:.9IF$/5DY/:V&=?/"J7VV=?NE5]<%S'^2&8F2XR,XV)Z>J)
MO=&KH]SK'<DJOZ06?#U7[[G:DK]_R59[(&^ZL::Z WWNV,^!B0ZTA!"(>9L"
M+4W)M+L*B/R/^AK1&4=7VH#6L;:SP-I.Q+.JX)G*0HU.<8$RW99L&8,*,MTR
M%*[7;G5K6;!MVM]<ST*76#H U-OH$A=(;4,RY:X")!LEZIO2O>+,B:,JF] M
MQ+0"W>*V7,2N@]2G3]U17.IU73)G3FJQ[V-31O&63*[QX;(<KE='S_F#ZR]L
M:XJ>LW0 J#=1W12H;B0CMA*(7**Z*=V$KJ7C+%NGK=20UD''N7A(2TW/*"[5
MLC4R22W5N)>Y!*E6>0)8^N%4]XNO26".Z1_"HV]Z_:_^8IY!&'KN$]MRR.$#
MGU2N&\V?$M=WYL&;]P?CM[^^H[?82&C0,:\$ O<Q^U-@]@>;BJI2%%D'K[R&
M]:!=K/$NLAQ*+F*CS"LI\[*5B<DM\^BQ%V["M%*3O8H<KIU:<*BZQ_[!,Z>!
M^XA%X/(A8$LR!)2:V#C2LG9N,YK(B%F(60IB%OK&.(0;I;^2%%=!K>,0;F6]
MY2_D&SK+4J(A&IZH>M17/>@LJV0S(V8A9I6.6>@LH[.,TE])BJN@UM%9?OVD
M HW$.72*1[YK6Y,(CB1UI@>VK;D!_9MVZ5#P<.^?T:_>'1]4!%CUXSQM3*^=
M5 8U)^7;,A1[6X6_H1(T3"=7558QAR_=>^CTMVT=W0>A2O8OCO,4IU=8RI7&
MY&Z>]9$5?EEUB%FTCQ%UUE%',496&G4Z>6+/%7Y9%;"%]HXZW:PQ&;4X?"KD
M5BW&(KX&KGE-/+:D"/OIB??*CUQ[0N_PR?7G5F#:977GC]XVM(-)_A;]0EV6
M'WE%!0>*RC(8?H04V6"^*^[]^QZ)LG,:[$0+IQ#!:#3U?81H=O*F55#;R/)5
M8WF]T<\UG0E9O@@5N'-++HT#FM6U:U\+-52-E+EF;I40C$ <KAH.]W--V4 4
M1L-#4H;O[B5UC0ROC"[-2BVB+D5H><VGT8_S#.U&<$%M*B_+M_:1 $26E\6-
MKW!VJF*4VN%.I2*J@5DZ;$LJO'E_L[#GQ#/_<ATL ][Y^]U[X6@?>]4*I'9/
M,FJ7B5<[*S"H\5JEK8MH)2Q7D[(E3&I8DY+B=1#_%U^,RAB 9@V:-6C62'NV
M5+-%=3_Z/U;PX+DS\SNZT?(A8 M7>19([2;N#2D<DUNI8_9K8DBWZKB>&+>B
M% =I!QL1>^4@L:!L<Y)=)%'?O'^K+@+6<*"5WL)U:$7:->A'%R[5F3O*E3A<
M+3WI+V3BN3:ZT?(!H('+A(ND=E,N:JN R+EJCQ7QHNN8C>YA8+ X1.LAH%5.
MZ#.;0%66^HXN%R-*+?4=E/K"S9BL>+BR9U/=9_Y]2IP)NLS2@5]/LE2HU,3N
MYVF$0DVS769,-WXJ+ZE4NOE\H.M9QU?9@$;[N3A4DTR#* %JW7X=I;J')24%
M&BN28:@2<GU<HJVR_].E@Y;JKO&5Z?SU?&^B<RP=!*)S7&@7D%S$5@&1R]L;
M7+IC7,-J3(0SA+,ZPIG*,BUE[[S4@BTEQ560;EP97/I)]]:[_/SH8M^R?%@H
M6\&<U,3N2F:^JP#)^?8F*.(BZUDMVRH;U-BP6&#EI5RTKH/,&W4LMY9-L\HM
M]))UM"AAQN3:I"7+X5+-%-5=YH^>>3^S<&:VA "(3<H%.LV212A4 .2#S)+C
M.EC0M1V:FV=K&L):+6BM JIES?E16:0[DA4Q2"W3Z!C7S%2I:T)Y#][PU93^
MV]-.*>$\<NF0\,B;WN=7?S'/( @]\(EM.>3P@>_LTHWF3XGK._. LA.AW$1O
ML9'$H%M>"?C5.Y(957)3NR=9HDT%?7"@M^KLF;]P?)6->-DD36I<.Y;,8ZJ%
MW!NUG(& <E]D):1D21TES)FVRL[[0?K<&M7SV@/;UMR _DT;.(%U:#E3,@ZL
M1^*C2RT=*+;;6%A5(+6;6$]9J\JJT@WKS.IXE<UJW&E3[)(!S(I53N[KF IO
M-25C1*G%WL"5T"78,B4VN^W_<*VMJL0%^H@SZ!1_?->V)A'\2)(GC[WK3ZX_
MMP(S6G.UZ9VVS91/\F?*RW@7577[]T&+?8-[MY\G+/#:2650M5*^K5QKOBK\
MMBJ'\Y4)2Q1S^-+=E^W#%OL@5,G^3;N5Q[^IL)@K#<JM7I[IS!5^6XA+%)>V
M7G"H("X9[3SAU@ISNM*X9+3SU$%4^&U5 )<*J(O,54>AR.EWT"2Q$27T;144
M7)-?1G)1B?WTQ*,Y(]>>T#O\;H['EI.K+*-0=?XCU"HXN%.6"J\&X_Q]CT39
M.0UVHA93B* WNOH^+/B=O&D5U"BR?!59/D^'%;)\P0;#;@RK% [(/\"Y&@&
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MPSH <"9E5.[SSV4](8SN8ZR?2NZ&^C":U<FG_,G3YS<I/BUPZ(P\8FL'EXO
MMR9$"QZ(=G=T<Z29SD0[-1US8N:IOMX',52*_^P;<_5<+H:JZF_?U#9TR4:?
MEPEDN^MO/,Z5^9#F>)FUK"J;[3TTVXO#K6/<BE*\7.MJPY:>F8]6&;9TV2P
MJ7%+;^<IMD7@VE*R\S772'.\]*I3Q?U_:, FX\ SWUV3F6_-S) $F][H5W\Q
MSR 0)<");3GD\(%7X^A&\Z?$]9UY0,D_IL2GM]A(@##84 DX[N!(W>*(W4/5
M5X)NZ):H^LJ?)*5G#MI2VJ;';2S5'O6$J+85R?MU7M":>7B5$4TR(4- 0T#;
M*(&O\.(#?;O1<G(&)^+%!F(0' 8'I,/!@XV" RL'B5_ -B?91?OIF_=E>$![
M?SD;92WD>SDJ(/\+&;47CU>-T1(%U$ED3HM0V93'D&N!Z4;) D%JH%ZSWB'7
M]%9UQ5'MY[_U#=W8:*)Q^>(F-;9)27$5 "X'X54Y( [$_RMS1,FUZ1'MS/*)
MZ1.<>H]3[W$@UN83X' 2)S)\G1@>USS(8##L;ZI9=>:T;^Y)5XV6K<K0$D?/
MRH;#!N(P&AXU8OC^/G9I(K_+8G>T4TM2*D4J6<R.ZI 2K0[90!BC'6ATU(C?
M>[C?H<Y&1ZXIN[6DE*[7L&+X]V=G8OZ7V._8/V;F=ZP8EJXDH94'X;'^(Q^Q
M<VW,K:I&E*0RHJ-RHTHG:WZHRG5KN5+."%DYRW'S++Q"R-J*YO^HW=&4ABNY
M!$AJM))L#J\*$MTJ<83YW@_73EWFH+A;_X$XY./YG^C,2P=_N6HB4-?D)+9D
MBET%/#XP\I6,%9/G+N#XM6Q4PW&_13K\DC4[*P%K&>-PZP)KV>W'2L.:9)(F
M-ZQAZJ5P6#-*G'FX_[B'4</0P&_$<0//G5L.1@>D@\"69*D<N8DM65V%"I!<
M[M*,"IC1F;V)*IO1LA75R UK&/0L'M9:F5&_6L!:JY8S!W7))$UJ6#,D*RE3
M M:,?*,49#E>QNI)Q2,$UV1JC@-7&WQ\]^>S$SR8&"B0#@U;&)@NL&1-,CVO
M!C:7J7K*MZCUS"H*E2UJ1+4"TVUH4)=@4-<[3E#/9>A&2RY)DQK6#,E2:"K
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M?&--_QK\\,V!0JO8+ER]JZ#/ZLVHP4Q?^?CY)$FB"1E;O/*?&\3PE+8)Y@]
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M$BN(Z_/"%HJ5XJ"E815B.DO(@]QI<:)*U['K3&&_ #/7Q?<'Y#X<Z0"7QN6
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M>;PKZ@'*)%8CN3#5DCK<P!ZF[Q.VB-IU)T^6S=P"[G\>\H$Y2VXHJE+DN30
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MS4ZA<OQW^Q1#TM4G#:&,_KDNI636U24-@?3/]"87T-4;#9'Z>=TKZPS!%VV
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MJ&K9^>BW.F>2'V3X_*RSOW O]K]&3@+0.E YY$%B3*_6/>E] E!+ P04
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MTL(GC8[?'':GM &,'=F^.E2?GEWEV>X"]J58Y#R:3W5(%'<5. MAP()5V:6
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MB B@'U,@U(@,A]W4; '.1TY\&JXAZ;2[_OSAX4'U47WYQN</_P=02P,$%
M  @ 5T.<4!CR<'US&@  I^(  !L   !P9F4M,S(Y,C R,'@X:V-O=F5R<&%G
M92YH=&WM/6ESHTB6GWM^18Y[9\(584G<A\OE"4#0X^@NVVN[MGOGRP2"E,44
M AJ0+>^OWY<)DL#*Q/>E4D64;7AYO9?OSH.#?\RG,;K">1&ER9<=L2_L()P$
M:1@EEU]VOEUX/6/G'X=_.?AKK_>'??8;&J;!;(J3$CDY]DL<HNNHG*#?0UQ\
M1^,\G:+?T_Q[=.7W>E6E;-^0)5$;8SS&ZE@13-_'@3@*!-D0%,$0A='>?%^5
M9"R/#-4W9$&1M= ?B8H9&B(V1K*JJL&BL57O0=W[K(!QUMVC93$GS6[RZ')2
M(DF0A,60*OBD!'P!YZ3XLC,IRVQ_,+B^ONY?R_TTOQR(IFD.YJ3,3E5HOP@F
M.$RCWAB'25KB9:6Q7XQHE3 J!K<*#21!-'N"V)/%13/CHA<E)<YQ4;*;:!1@
M5"_&62\:I>M5BW(ZJ(&<:D57M8)=+0IZ11DNJ\U'>=PO<-"_3*\&-9!4$V]5
M*[.\HUX-7?PG#1CM!H)9G@/SW?1@BOD-W2[%0"#&/IO* & 4#\I1S"Y/((P*
MES,_9U<@$$:%?,8NGL]8Y">4\N.X@XX 7?QGT!&P++CX%QP^">(<=W *!3.J
M1GX:L?LB$%9?("=1PA@?[:D"LN8HG25E?A=KM N19G1F,YW5&=6H=!8<IJJ!
MC$$G?A04[+XHB#7 @*-C , B?W+%H7YRQ1M0-PU;11@#+/)VY=7\Y3QQI"Q+
M6NQFZKI$!V,OBW5KF;I$AZ99*.PH\CF3VBS!0&E6]/P\R-,8,SBY 614#8,@
M2SF]5C".U!0CAJ0MI : [&%>^G[6(GQSF L@J\=@W"M8TTPZI#"6E.(@#OPX
MD'GZ= EG$09'W5S2*,"LGN4X(&Y!R[+3%DC_DB"8@WI>!JO";='@]KT$,T0B
MYXALSI)8(B;E3<;BFR6(94$PE.!U4Z''T T!0Z/7VB%@:?.6;>72XG:IKH;N
M-N-LG='J V;K'B.!4HR&_)Q# P PBN-Y,&'W12","FF0C3G6EH(Z<.O&B:N^
M[U#=?+7-U (U@&ERPV@<@9! :-#+_)SAN:X583,\L]=.$18[9)@CP$"%'D\2
M*QC7&V$-<.F-L :*I__AV%T"8?4# RAF61;PQT?!K+[^G$7E#:<W"F/)_IQ'
M0%$&Z8^C!)-X;C4\WKA8? $Z=,31[P3$PB'D:2("853@15K,X(K8A4ZCP>9O
M\-M&# -7NW0CEE::\-"8,+$@S?#CO1&+L\ H\[T*KDO!B49"5BR">0H1,Q5B
MTZ?F6X1V(9;^J?VI- VNNSTN4H+C6O"="I;%S#B3"P"FOU-U7\RFDS3F5+U5
MJ,,#DKH=((EE2<I)'/D<R:J!'!6&+Z=\%0; +GPG:5[> ^-%,?8(N+VSN#6:
M\-Q?@##EFR=%!-*!V]UH<3!*9E.V_@S+?$!<M &4P'D4+"K,0:-^YV>4"/2V
M3WX[CEGSR_GYC1''C(Q8]H,D;+J#KU4!1E:'N#W=,5>S!$L. \YH < JSI-:
M)N>-L]XLZ$Q<4#!+#<XX>0L L&T,U[ZPO,Z,W;C/<E&)D.8XZO!"")1M7Z8I
MR[VJ+0P!<IP1:)&5A%DY2^PTS!J;-UTS>4# ([_ S9Z")!Q'' .U@C,=1TXE
M5N%E)'!WU,*/=T-NKK0"LJ=@/(DY2KL&LGVHC.]#9:PJB^B7*X>- FS'@A-V
M+B <HC!33 NBL--,%22,<H:>7]4D<)9R*]+QF*/?"(@3M'7KN&8)ENGEZ(*.
M#&8'=DLXHS(95=0A02!VI9\$^+8I2\MBTFW*2 F.BN3S=05D,2A':3-U=I(F
M]["8$"+>LIK ZL6(HRDK&--]*-*,H[HJ&#-],L9$^C&7]'5<N2RX'",W]N5&
MO+4!YUIV3E:(X_<O01W.^9T9<792(,'E7?2 (FM2?8=0L\@?)[RH@X)8$2!G
MBDL6'18N4Z<_Q=:+JWSW';D_?FP#/,,EHT8XJF5CNNC'IAY1[)U:GX,91ZDE
M3*4&EICO2RR@+ ,8C:]X430!L0,=D+$Y1_ 74(Y=8:5X%N1CIWA@[%=_\O&Z
M^I.;KV$$5:ML#2NHHF:FVU%FSQ7/06([1A,<\"(N F+-4AKPW$2 ,(T<PP!4
MUHUE ;)Q6[-FX^C_<-X/4D(E$ -%,EH+"UV.%GM1.DJ"TI]SJ$1AK&%EG#P2
M #K4Z9UY#K8>B.;@?.&@18A%S57.;5#F?E*,TWQ*TZ:D';4G&*UA)!R;6!7G
M!'B=2_8-QU!<&S5;>]TU9*DG:0TWF!M/5#"6M/#,.&;:<+*VQT$0((Q5OLB_
MY*U_ (3%+CXGSPH -N&Y!&<0NHQXKL0"P@HD \SQQ BDPQ1BPJBG:91P\O[L
M<AR/-;P5_"Z-6P5<6AR.CF'FT M6,ISJ '8:G"C/;O^>/?XH9'E5E M"=M!3
M)>,[X^,*SA'&SDP+.\LRC]DR2&."/WYKI(]R?)ER+"<%<4* (.9MN:B 3&W(
M22I66IV=Q>C*8;#CX$O,TW84UA7N<=<%FR58GA&^O&.=N/9]+YL+3)B7,&(9
M7"H8)5-JU$IJRIW#O_QT,,%^"+]_.ICBTD>D=(\LZD#([:1)25"X@.!I!P75
MTY>=$L_+0;5#;4 KEE$9X\/%UKB#0?4,30_JM@]&:7AS>!!&5Z@H;V*8HC$T
MUAO[TRB^V;^(IKA Q_@:G:53/_E,8058[WU1R,K/,,AF3< WB_T;$O'AG<.#
M:+Y/.L%Y]6<4ACBA?P+\N(KUJI'/RS/B) ^),_#?TOEP!R7^E+2'HWT+QAV2
ML7NQ?[F#(I@7SP_*GB0.34.T-%&6'%5Q=-.R-$>691W>>JJE]JZ_]^Y5< =5
MINO+#MBZ_5$*<^LG8S\N  7ZZV#0&O*#,7 3(/J-0U2I'Q\E(9[_BF\:F"BJ
MYPU-33($3U9EV3',H>"XJFPHEFP./6.)R5T%=PX%\D\W0"VL#7K0GH)E)%L<
M'I"\'$TE3'W  M%\]/Z$QBW@N?46+EI_7A!NIU 2LW_9*:)I%I.9'K2;J'IK
M=D$?BW26TR>:YMBO"4<)L2(<Y=JJ *:$(R\6;T GP[MQA'-$.\-,;\HY^K5-
MBMN5:1^#VYW4?61 KS1L]EJ48'V'(.R'9)0]0>E)QJ+Z"M:H !S+*;Z - :P
M[&_QHJ9+)YG^71OH?Y^7T!P1#R?VB^)D?%ZFP7=K'A7+$DXZG:8)??\53T<X
M?S42+^F'+\D(Z:OJ70@]S[,X"J*R&A,*0=$DU3;C>N#[7-1V#A=%UG [&#";
MKT8S6!O.QC,!R.^_C],2%\,9AFJZV(<IVQ@V .SV.=AM&:&3$22A+ZD;RPA-
M[#:/$09M8SIHN%G@<5Y17^[PP*<L4DBJ*NJN97J"J:JF(5N.Y<F.9EM#2]$,
MP2#&VV]5;/AS),+O33 Y++$O2L+?UMV_@R+S$Y;C&"430*!DU!CE ^B/U%MT
MV^B\ MXY#D((B)6BRV0_P.1@Q&>26NG!VQP<I?UB-IWZ^4VS<^G!PR4UZ.-U
MU?$HC4-HXMOQT84[1.<7UH5[WL;C82-^B<&=N\ZWLZ.+(_<<6<=#Y/[A_-,Z
M_L5%SLG7KT?GYT<GQ\\TXL?._N]^,8F2RS)-]M"P[_3__K.H"9^KGY*@*N:C
MQA?C<;,OXZ&#,WB<^?8SZIV<?46+054_V^$'D?)0%@Q),K&VBA4L1]550X5
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M\-Z'J3]0"#SU\\LHJ8;GS\IT\:+B!_JF"D4E0861O&R8K-?\QXR%-:4+:#:
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M4I U/PS<.TL*'&\Y=HO<!T-NRY];Y-XS<L]\*>OC=P62?2;[SWD/U7-> _:
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M+3(P,C P-#(X7V1E9BYX;6Q02P$"% ,4    " !70YQ0<.U.W0P,  !$A@
M%               @ %(10$ <&9E+3(P,C P-#(X7VQA8BYX;6Q02P$"% ,4
M    " !70YQ045OH^JH'  "01   %               @ &&40$ <&9E+3(P
M,C P-#(X7W!R92YX;6Q02P$"% ,4    " !70YQ0&/)P?7,:  "GX@  &P
M            @ %B60$ <&9E+3,R.3(P,C!X.&MC;W9E<G!A9V4N:'1M4$L%
3!@     '  < T@$   YT 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>pfe-3292020x8kcoverpage_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:pfe="http://www.pfizer.com/20200428"
  xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="pfe-20200428.xsd" xlink:type="simple"/>
    <context id="D2020Q2SD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000078003</identifier>
        </entity>
        <period>
            <startDate>2020-04-28</startDate>
            <endDate>2020-04-28</endDate>
        </period>
    </context>
    <context id="D2020Q2SD_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000078003</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-28</startDate>
            <endDate>2020-04-28</endDate>
        </period>
    </context>
    <context id="D2020Q2SD_us-gaap_StatementClassOfStockAxis_pfe_NotesDue20271.000Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000078003</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">pfe:NotesDue20271.000Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-28</startDate>
            <endDate>2020-04-28</endDate>
        </period>
    </context>
    <context id="D2020Q2SD_us-gaap_StatementClassOfStockAxis_pfe_NotesDue20220.250Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000078003</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">pfe:NotesDue20220.250Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-28</startDate>
            <endDate>2020-04-28</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="D2020Q2SD"
      id="Fact-21D981A6132C54C79AA6C3337981F5A5-wk-Fact-21D981A6132C54C79AA6C3337981F5A5">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="D2020Q2SD"
      id="Fact-45FFD96280F3533C89D0CE5384A39DF8-wk-Fact-45FFD96280F3533C89D0CE5384A39DF8">0000078003</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="D2020Q2SD"
      id="d308229e68-wk-Fact-AC57585F35645BF38490C182FFF8697C">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="D2020Q2SD"
      id="d308229e92-wk-Fact-8174B0F36E5853E3AADBE4E9032CC022">2020-04-28</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="D2020Q2SD"
      id="d308229e99-wk-Fact-9AF2602DF9C35C06900BDD6413C89AE9">PFIZER INC</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="D2020Q2SD"
      id="d308229e123-wk-Fact-1E90F69C46465E968F646DF359792354">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="D2020Q2SD"
      id="d308229e128-wk-Fact-185116B200265B9EB4796E7553E01C0B">1-3619</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="D2020Q2SD"
      id="d308229e133-wk-Fact-C75768AD7D045B13B9FE646A9810C89D">13-5315170</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="D2020Q2SD"
      id="d308229e199-wk-Fact-9A7CB7CE5A3E5C7E941DD9AAFED4207F">235 East 42nd Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressPostalZipCode
      contextRef="D2020Q2SD"
      id="d308229e209-wk-Fact-C729B9CB0E40527DA89335CAA2BE433E">10017</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCityOrTown
      contextRef="D2020Q2SD"
      id="d308229e215-wk-Fact-D292D97B85705ABB935A052F1264E1C7">New York, </dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="D2020Q2SD"
      id="d308229e220-wk-Fact-35B7CAE8AB495DDCA6B4B8D31228617A">NY</dei:EntityAddressStateOrProvince>
    <dei:CityAreaCode
      contextRef="D2020Q2SD"
      id="d308229e239-wk-Fact-99A6375BF4E258DE839D82330BD3330D">212</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="D2020Q2SD"
      id="d308229e243-wk-Fact-FCE684C70A3454E583D7CBC6380CB36A">733-2323</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="D2020Q2SD"
      id="d308229e263-wk-Fact-9AC71AA62CE056868A11D93227EE432F">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="D2020Q2SD"
      id="d308229e271-wk-Fact-961A6AB9163C57609A1F7F36CB25FFEF">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="D2020Q2SD"
      id="d308229e280-wk-Fact-C79074B773E55B4C9734B4AD12CA956D">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="D2020Q2SD"
      id="d308229e288-wk-Fact-D075F77AC2155194AB8F856128EE7D04">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="D2020Q2SD_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember"
      id="d308229e389-wk-Fact-05DC1BFE6FFD56CEB245532F7AB59409">Common Stock, $.05 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="D2020Q2SD_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember"
      id="d308229e399-wk-Fact-013146DF83A55317B087E59B54D85427">PFE</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="D2020Q2SD_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember"
      id="d308229e409-wk-Fact-C62FAF5FC78A55EB9E4C63972A731025">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="D2020Q2SD_us-gaap_StatementClassOfStockAxis_pfe_NotesDue20220.250Member"
      id="d308229e415-wk-Fact-E28EAA7A30C755A79E5386FB93145B55">0.250% Notes due 2022</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="D2020Q2SD_us-gaap_StatementClassOfStockAxis_pfe_NotesDue20220.250Member"
      id="d308229e425-wk-Fact-FB4CE69FAAA05A2BBE6BF205B232F02F">PFE22</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="D2020Q2SD_us-gaap_StatementClassOfStockAxis_pfe_NotesDue20220.250Member"
      id="d308229e435-wk-Fact-B905AA51676259CE8645A8E4011794FF">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="D2020Q2SD_us-gaap_StatementClassOfStockAxis_pfe_NotesDue20271.000Member"
      id="d308229e441-wk-Fact-4B105DAF96CD57ABB609BFF52D622C2A">1.000% Notes due 2027</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="D2020Q2SD_us-gaap_StatementClassOfStockAxis_pfe_NotesDue20271.000Member"
      id="d308229e451-wk-Fact-5D6D77303C9A5361A14B3FC036A19B14">PFE27</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="D2020Q2SD_us-gaap_StatementClassOfStockAxis_pfe_NotesDue20271.000Member"
      id="d308229e461-wk-Fact-C0254580AA8357F290FC09B844525130">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="D2020Q2SD"
      id="d308229e473-wk-Fact-E5150C68490D5962815DD28140972F94">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6628973632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Apr. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr. 28,  2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">PFIZER INC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-3619<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-5315170<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">235 East 42nd Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10017<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York, <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">733-2323<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000078003<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $.05 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PFE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=pfe_NotesDue20220.250Member', window );">Notes Due 2022, 0.250% [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.250% Notes due 2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PFE22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=pfe_NotesDue20271.000Member', window );">Notes Due 2027, 1.000% [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.000% Notes due 2027<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PFE27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=pfe_NotesDue20220.250Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=pfe_NotesDue20220.250Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=pfe_NotesDue20271.000Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=pfe_NotesDue20271.000Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>17
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M^L/O)NR\L0?[CXVO@K*%7W<AOP!02P,$%     @ 5T.<4)E<G",0!@  G"<
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M.AQG0GS/]O:1I24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG
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M    A0(  !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<ZV200J#,!
MOR)Y0%=MZ:&HIUZ\MOU T-6(FH3LENKOFWI10:$'+PEAP\Q DCRPD]P83:JQ
M% Q]IRD5BMG> *A0V$LZ&8O:3RKC>LG^Z&JPLFAEC1"'X17<DB&R9,D,\C(5
M+B\C$;RDJY%3 4,''^-:4HA,,&W1R0O\E='B/WI354V!=U.\>]2\43$+!&P'
MQ7,0*>FP?+)K=$U'AZS@>S'G10R/'1Y?,5'W])=9SUZ",*V'O\E$_37 ZM=E
M7U!+ P04    " !70YQ0"X_8 R$!  !7!   $P   %M#;VYT96YT7U1Y<&5S
M72YX;6RU5$U/PS ,_2M3KVC-X, !;;L 5Y@$?R D;ALU7[*]T?U[W&Y#8BIB
M:-LEB?/L]UX2*_/W;0::=,%'6A0-<WY0BDP#05.9,D1!JH1!LX18JZQ-JVM0
M=[/9O3(I,D2><L]1+.=/4.FUY\GC;K^G7A0Z9^^,9I>BVD1[1#K=$Y8(?LBA
MQF6ZD81B\MP)"\G>HA"4"G6"PG%A'TO=ZP80G85_64M5Y0S89-9!2DK*"-I2
M \#!E]1H!/O&Z&*]][O2R"\Z"+'JO/J14%[/!V\]C!L8D$LJL[0%C$D-P&Z\
M/4OPT TF(4PS"HKL1HXGEE:"DNH3+WE$Z%O'@CU)7*BO]["?"=MA/7;AWR"I
M83KOUO]H=)G+H%W\S<A'2NU!7PW_R?(+4$L! A0#%     @ 5T.<4!\CSP/
M    $P(   L              ( !     %]R96QS+RYR96QS4$L! A0#%
M  @ 5T.<4"?HAPZ"    L0   !               ( !Z0   &1O8U!R;W!S
M+V%P<"YX;6Q02P$"% ,4    " !70YQ0']HJ$N\    K @  $0
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M:V)O;VLN>&UL+G)E;'-02P$"% ,4    " !70YQ0"X_8 R$!  !7!   $P
M            @ %7$P  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "@ *
+ ( "  "I%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>4</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>3</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="pfe-3292020x8kcoverpage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001000 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pfizer.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="pfe-3292020x8kcoverpage.htm">pfe-3292020x8kcoverpage.htm</File>
    <File>pfe-03292020xex99.htm</File>
    <File>pfe-20200428.xsd</File>
    <File>pfe-20200428_cal.xml</File>
    <File>pfe-20200428_def.xml</File>
    <File>pfe-20200428_lab.xml</File>
    <File>pfe-20200428_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
